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ABSTRACT 
An intriguing feature of the Actinomycete bacteria which produce most of the 
known antibiotics is their use of secondary metabolites to control aspects of their 
growth and metabolism. The most studied of these 'autoregulators' is the expanding 
group of related butanolides, previously attributed the structures 1.1-1.10, which are 
potent inducers of antibiotic production and/or morphological changes in various 
Streptomyces species. A-factor (1.1) was the first discovered and is one of the most 
active of these metabolites. The work described in this thesis centres on the 
development of an improved synthetic route to these metabolites based on our proposal 
for their biosynthesis. 
H 
0 0 
1.1 A-factor 
H 
3 
2 6 R .... ,,, 
0 OH 
1.2, 1.3 
H 
O OH 
1.4-1.10 
R = various alkyl chains 
In Chapter 2 we propose a biosynthetic origin of A-factor (1.1) in which the key 
step is the creation of the C2-C3 butanolide bond by the cyclisation of a J3-ketoester of a 
1,3-diol. Two plausible methods of cyclisation are proposed: intramolecular alkylation 
via 2.16a or Knoevenagel-style cyclisation via 2.l(;b. 
~OH 
0 
~OH 
0 
O 2.16a LG = leaving group o 2.16b 
Chapter 3 describes attempts to model the former process by base catalysed 
cyclisation of glycidyl esters 3.5, a seemingly very direct route to the required 
3-hydroxymethylbutanolides. In fact none of the required C-alkylation at the secondary 
epoxide site was observed with either simple esters (3.5, R = methyl or phenyl) or with 
a J3-ketoester (R = heptanoyl). The only intramolecular reaction products observed 
resulted from either C-alkylation at the alternative primary epoxide site or 0-alkylation. 
Even with a primary acyclic leaving group (i.e. the 2-iodoethyl ester), exclusive 
0-alkylation was still observed. Analysis of the reaction geometry reveals that severe 
stereoelectronic constraints disfavour the required cyclisation. 
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ABSTRACT (CONTINUED) 
a 
0~ 
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0 0 4.1 O 4.2 
By contrast, the Knoevenagel cyclisation of a J3-ketoester of dihydroxyacetone 
(4.1, R1 = TBDMS, R2 = hexyl) examined in Chapter 4 gave in good yield the 
corresponding butenolide 4.2, which upon further elaboration afforded 11-demethyl 
A-factor in six steps from ethyl acetoacetate with an overall yield of 20%. 
Incorporation of the required alkyl chain for A-factor (R2 = 5-methylhexyl) 
correspondingly gave racemic A-factor (1.1) in 33% yield based on commercially 
available 1-bromo-4-methylpentane, a significant improvement on previous syntheses. 
An alternative method for the preparation of the J3-ketoester 4.1 (R1 = TBDMS, R2 = 
hexyl) using Meldrum's acid was briefly examined, shortening the route to five steps 
and increasing the overall yield of 11-demethyl A-factor to 48% based on Meldrum's 
acid. The efficiency of the synthetic route provides support for the proposal that a 
similar cyclisation occurs in the biosyntheses of the butanolide autoregulators 
(1.1-1.10). 
Preparation of synthetic A-factor brought to our attention the surprising 
inadequacies in the literature data used to support the generally accepted structure of 
A-factor (1.1). In Chapter 5 we have established that A-factor is actually an equilibrium 
mixture of four compounds in solution: the 2,3-trans-6-keto form (2,3-trans-1.1), the 
enol form I.lb and two unreported diastereomers of the 2,3-cis-bicyclic hemiketal 5.12. 
Crystallisation shifts the equilibrium to afford the 6-endo-hydroxy diastereomer of the 
hemiketal 5.12, the configuration of which has been defined by X-ray diffraction. 
A-factor has been shown to readily form ketals with alcohols in the presence of an acid 
catalyst. 
OH 
0 I.lb 
I 
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ABS1RACT (CONTINUED) 
Chapter 6 describes attempts to improve the synthesis of the 
6-hydroxybutanolide autoregulators 1.4-1.10. These had been previously assigned the 
'2,3-cis' relative configuration based on the magnitude of their H2,H3 coupling 
constants, a technique which we expose as unreliable. The direct reduction of 
TBDMS-protected A-factor with sodium borohydride and desilylation gave racemic 
factor-I (1.2, R = 5-methylhexyl, 65% yield) and Grafe's factor (1.S, R = 5-methylhexyl, 
25% yield), respectively. In order to improve the yield of the more active, putatively 
'2 ,3-cis' diastereomer we developed a novel approach to the diastereospecific formation 
of 2,3-cis butanolides via the catalytic hydrogenation of the protected 
6-hydroxybutenolide 6.15. This reaction successfully produced two 2,3-cis-
6-hydroxybutanolide derivatives, but surprisingly neither of them corresponded the 
0-TBDMS derivative of autoregulator l.S. NOESY spectroscopy confirmed that the 
hydrogenation products 6.16 had 2,3-cis relative geometry and that the 0-TBDMS 
derivatives of both of the racemic natural compounds (±)-1.2 and (+)-1.5 had 2,3-trans 
relative stereochemistry, contrary to literature reports. By analogy, all of the former 
'2,3-cis' 6-hydroxybutanolide autoregulators (1.4-1.10) must be reassigned as 2,3-trans 
and thus the two classes of 6-hydroxybutanolide autoregulators 1.2, 1.3 and 1.4-1.10 
differ only in their relative configuration at C6. 
OTBDMS OTBDMS 
0 OH 6.15 0 OH 6.16 
We have further demonstrated that the recently reported absolute stereochemical 
I 
assignment of the C6 hydroxyl group of the natural 6-hydroxybutanolide autoregulators 
is also likely to be erroneous. Detailed analysis of the stereochemical outcome of our 
sodium borohydride reduction of TBDMS-protected A-factor supports our prediction 
that this recent assignment of C6 stereochemistry of the 6-hydroxybutanolide 
autoregulators should be reversed. We have thus been able to fully reassign the relative 
stereochemistry of all of the 6-hydroxybutanolide autoregulators 1.2-1.10. 
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ABSTRACT (CONTINUED) 
In the final chapter, a model biomimetic synthesis of the non-autoregulatory 
butanolide metabolite, butalactin (7.1), has been developed as an extension of our 
synthesis of A-factor. Knoevenagel cyclisation of the dienyl J3-ketoester 7.lla gave the 
butenolide 7.12 which was elaborated to a diastereomeric mixture of epoxides 7.25. 
These are protected stereoisomers of butalactin 7.1, demonstrating that all of the 
functionality required for the first total synthesis of butalactin (7.1) can be installed. 
OTBDMS 
d ~ 0 0 
7.lla 
····M 
0 OHO 
7 .1 butalactin 
OTBDMS OTBDMS 
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ACTINOMYCETE AUTOREGULATORS 
Nature uses as little as possible of anything 
Johannes Kepler 
(1571-1630) 
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Chapter One 
1.1 INTRODUCTION TO ACTINOMYCETE 
AUTOREGULATORS 
3 
Of the more than 6,CXX) antibiotics discovered to date, most have been isolated 
from bacteria of the order Actinomycetales.1 Between 1971 and 1980, 75% of newly 
isolated antibiotics were derived from members of this important group of microbial 
genera, with the remainder originating largely from fungi and other classes of 
unicellular bacteria. 2 
Actinomycetes are multicellular, Gram-positive bacteria, typically isolated from 
soils, and characterised by their relatively complex morphological development, 
generally involving filamentous growth, development of aerial mycelia and spore 
f onnation. This complex morphology appears to be related to their ability to produce a 
wide range of secondary metabolites, including antibiotics. 3 
An intriguing feature of this class of microorganisms is their use of 
self-generated signal compounds or 'autoregulators' to control aspects of cellular 
differentiation and/or the production of secondary metabolites including antibiotics. 
These compounds, of which A-factor (1.1) is the archetypal representative, act at 
extremely low concentrations in a manner analogous to hormones in higher organisms, 
to control aspects of growth and metabolism in disassociated parts of the organism. The 
s~dy of these compounds has contributed greatly to the understanding of the regulatory 
systems of these industrially important microorganisms, in which progress is charted 
through numerous reviews on the subject. 3-7 
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1.2 A-FACTOR 
A-factor 
OH 
- isolated from S. griseus 
- potent regulator of:-
- streptomycin biosynthesis 
- streptomycin resistance 
- aerial mycelium formation 
and sporulation 
- formation of yellow pigment o 1.1 
- leukaemomycin biosynthesis 
The first discovered and most widely studied microbial autoregulator is A-factor 
(1.1).6 It was discovered in 1967 by Khokhlov and coworkers8 during investigation into 
the mechanism of biosynthesis of streptomycin, a clinically important broad spectrum 
aminoglycoside antibiotic produced by Streptomyces griseus. They found that addition 
of a small amount of the culture broth of a normal streptomycin producing strain of S. 
griseus restored the ability to produce the antibiotic to cultures of some non 
antibiotic-producing mutant strains of the same species. This treatment also restored the 
ability of these mutant strains to produce spores, and suggested the presence of a 
multi-functional regulatory factor in wild-type S. griseus strains which was absent in the 
mutant strains. 
NH NH 
11,NJlNH HNJlNH, ~ H6'L( 
0 
0 
H3C 
H 
H~OO CH,P 
Mc:HN 
OH 
streptomycin 
· - from S. griseus 
- aminoglycoside antibiotic 
- clinically used broad 
spectrum antibacterial 
(tuberculostatic) agent 
Isolation and characterisation of the autoregulatory factor 'A-factor' proved 
difficult due to its extremely low concentration in the culture broth (ca 30 µg/L). 6 After 
it was eventually purified and characterised as the surprisingly simple y-lactone 1.1 
Chapter One s 
[2-(6-methylheptanoyl)-3-hydroxymethylbutanolide],9 the full extent and potency of its 
biological actions were revealed. 
A-factor (1.1) was found to be essential not just for the production of 
streptomycin in S. griseus but also for the initiation of its entire biosynthetic pathway. 
Mutant strains of S. griseus lacking the ability to produce A-factor are also unable to 
produce precursors of streptomycin including streptidin or many of the enzymes 
required for streptomycin biosynthesis.6 In addition, A-factor (1.1) has been found to 
control the production of the streptomycin-inactivating enzyme, 
streptomycin-6-phosphotransferase (the enzyme responsible for conferring resistance to 
streptomycin on the producing organism10) as well as more than 10 other unidentified 
proteins.3 A-factor was also found to induce the production of a diffusible yellow 
pigment which contains an amino sugar moiety .11 
Combined with these effects of A-factor on secondary metabolism are its 
regulatory influences on aspects of cellular differentiation and morphological 
development. The normal morphological develop~ent of wild-type S. griseus on an 
agar medium consists of filamentous mycelial growth followed by the formation of 
aerial mycelia from which spore chains develop. However, A-factor deficient mutant 
strains simply form large, diffuse filamentous colonies which fail to develop either 
aerial mycelia or spores. 6 The cells of the mutant strains have also been seen by 
electron microscopic examination to contain very few intracellular membranes and 
other distinctive cellular features which are present in the wild strain.6 Remarkably, the 
profound deficiencies in secondary metabolite formation and cellular differentiation that 
are observed in mutant, A-factor negative strains can be almost completely restored 
when the mutants are grown in the presence of minute quantities ( ca 0.2 ng/mL) of the 
autoregulator A-factor (1.1). Streptomycin and other secondary metabolites are then 
produced as usual, streptomycin-resistance returns 10 and normal sporulation occurs. 6 
Grafe and coworkers have shown that A-factor also regulates the production of the 
anthracyclin-type antibiotic, leuk:aemomycin in other strains of S. griseus.5 
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The addition of 1 ng of A-factor can induce the formation of 1 x 106 ng (1 mg) 
of streptomycin; an induction coefficient of one million. 6 Such is the biological activity 
of this compound that it can be detected by bioassay at the picomolar (l0-12 M) level 
making it one of the most potent natural bioregulators. 4 
Three surveys of other actinomycete species12-14 have shown that substances 
giving an A-factor-like response in mutant indicator-strains of S. griseus are widely 
distributed in other species. In total, 23% of the 510 Streptomyces strains tested 
(> 100 species) and 15% of the 102 other actinomycete strains tested (> 40 species) 
showed a positive response, but the identity of most of these substances and their role in 
the producing organisms are yet to be determined. It is clear that A-factor-like 
microbial hormones are widespread among actinomycetes and considerable effort has 
been directed towards their identification and the understanding of their metabolic role. 3 
There appear to be rather strict structural requirements for autoregulatory 
activity in S. griseus, since Khokhlov reports that almost any alteration to the structure 
of A-factor (1.1) causes a sharp drop or complete loss of activity as shown in Table 1.1.4 
Activity of the 0-acyl derivatives (Entries 10, 12) was attributed to their likely 
enzymatic conversion to A-factor (Entry 1) in vivo during the lengthy biological testing 
procedure.15 
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Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Table 1.1 Structure-Activity Study by Khokhlov et al. for 
Autoregulator Activity in S. griseus 
(CH2)o-R2 
0 
Relative Activity 
Rt= D= R2= (%) 
CH20H (A-factor) 4 CHMei 100 
CH20H 3 CHMei 0-10 
CH20H 2 CHMei < 0.1 
CH20H 5 CHMei 0-15 
CH20H 4 Me <0.1 
CH20H 5 Me 0-20 
CH20H 6 Me 0-10 
CH20H 7 Me < 0.1 
CH20H 8 Me <l 
CH20COCH3 4 CHMei 
-100 
CH20C0Ph 4 CHMei 0-10 
CH20CO(CH2)4CHMei 4 CHMe2 
-100 
CH20COPh 3 CHMe2 <l 
CH20COPh 2 CHMei < 0.1 
CH20C0Ph 1 CHMe2 < 0.1 
CH20C0Ph 5 CHMei < 0.1 
CH20C0Ph 0 C6H5 < 0.1 
H 4 CHMe2 < 0.1 
CH3 4 CHMe2 <0.1 
CH20THP 4 CHMei <0.1 
OCO(CH2)4CHMe2 0 C6H5 < 0.1 
7 
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The determination of the absolute configuration of natural (-)-A-factor (1.1) has 
involved considerable confusion. Khokhlov and coworkers initially proposed a 3R 
configuration based on Klyne's lactone sector rule, 16 a method in which the absolute 
configuration of a lactone is related to the sign of the Cotton effect in its CD spectrum, 
but confusingly their diagram showed 3S configuration.9 In later publications,6 the 
assignment was revised to 3S, and this was apparently confirmed soon after by Mori, 
who synthesised optically active A-factor (1.1) identical to the natural material, from 
(-)-paraconic acid (see Section 1.6.1).17 Mori contributed to the confusion by referring 
to his nature-identical product as '3S-(+)-A-factor17 instead of 3S-(-)-A-factor, an error 
which was corrected in a later paper in which the synthesis of both chiral forms is 
described. 18 Unfortunately, one final revision of the absolute configuration of the 
natural metabolite to its presently accepted designation of 3R-(-)-A-factor was required 
when the assignment of the chiral starting material, (-)-paraconic acid, was reversed, 19 
(see Section 1.6.1). Surprisingly, the 'unnatural' 3S-enantiomer has been reported to 
have approximately 30-40% of the activity of 'natural' 3R-A-factor, 18 although it has 
been proposed that this may be due to partial racemisation occurring via 
translactonisation during the bioassay14 since this process is known to be readily 
catalysed by acid or base.11,20 
0 0 
(3RJ-1.1 
1.1 A-factor 
0 0 
(3S)-1.1 
The C2 of A-factor is likely to be readily epimerisable via the enol form (l.lb) 
and it has been generally assumed that the 2,3-trans configuration 1.la would 
predominate over the 2,3-cis form 1.lc for reasons of thermodynamic stability.9,l8 Prior 
to the present work, no definitive evidence had been reported for the tautomeric 
contributions to the structure of A-factor (1.1). In Chapter 5, the assumptions 
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concerning the relative stereochemistry of A-factor (1.1) are re-examined to reveal a 
surprisingly complex tautomeric mixture. 
OH OH 
I.la 2,3-trans , I.lb enol I.le 2,3-cis 
ReceQt interest in A-factor (1.1) is reflected in the patent granted for its 
over-production by microbial genetic engineering techniques21 and by its very recent 
appearance (in racemic form) as a widely advertised, high value commercial research 
reagent (A$100 per milligram)22 "for studying secondary metabolism and 
morphogenesis in Actinomycetes". 23 
1.2.1 Nomenclature and Numbering of the Butanolide 
Au toregu la tors 
A-factor (1.1) is named in Chemical Abstracts based on dihydro-2(3H)-furanone 
[i.e. ( 4R)-4-(hydroxymethyl)-3-(6-methyl-1-oxoheptyl)dihydro-2(3H)-furanone] where 
the ring substituents are at the 3- and 4-positions. However, all other literature 
references to this and related autoregulators have used the y-lactone moiety as a basis 
for numbering, with the parent ring being called 'y-butyrolactone',4 '4-butanolide'5 or 
simply 'butanolide'.24•25 With the lactone carbonyl carbon as the I-position, the ring is 
substituted at the 2- and 3-positions [i.e. (3RJ-3-(hydroxymethyl)-2-(6-methyl-
1-oxoheptyl)-butanolide ]. 
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0 
1.1 
Generally accepted sequential numbering system 
[(3R)-3-(hydroxymethyl)-2-(6-methyl-
1-oxoheptyl)-butanolide] 
0 
alternative side-chain 
numbering 
10 
OH 
0 1.1 
Chemical Abstracts Service nomenclature 
[( 4R)-dihydro4-(hydroxymethyl)-3-(6-methyl-
1-oxoheptyl)-2(3H)-furanone] 
For NMR assignments and general discussion, the carbon of the hydroxymethyl 
substituent is generally referred to as the 5-position and the acyl chain carbons are 
usually numbered sequentially starting with the carbonyl carbon as C6. 3•26,27 Some 
reports, however, use 'prime' notation for the acyl chain so that the ketone carbon is 
Cl,_ 11,28 
For simplicity and consistency with the majority of the more recent literature, 3•29 
we have adopted the sequential numbering system for A-factor and related butanolides 
as depicted above. In this thesis, the term 'butanolide' is used to refer to the parent 
2(3H)-dihydrofuranone. 
1.3 REDUCED A-FACTOR HOMOLOGUES: 
THE 6-HYDROXYBUTANOLIDES 
Following the discovery of A-factor (1.1), an expanding series of closely related 
regulatory compounds (1.2 -1.10) has been isolated from a variety of Streptomycete 
species, in which the 6-keto group is replaced by a 6-hydroxyl group. These 
compounds have been categorised as possessing either '2,3-cis' or '2,3-trans' relative 
stereochemistry, as shown below, but we have found evidence to undermine the basis of 
these assignments (see Chapter 6). At the commencement of this project the relative 
configuration of the 6-hydroxyl groups of these compounds had not been assigned. In a 
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recent report, Mori and Chiba describe this assignment30 but through mechanistic 
studies and the reinterpretation of their published evidence we have been able to 
demonstrate that their conclusions are likely to be incorrect, (see Chapter 6). 
'2,3-trans' 
1.2R=~ factor-I 
1.3 R=~ IM2 
OH 
0 
'2J-cis 
1.4R=~ 
I.SR=~ 
l.6R=~ 
l.7R=~ 
l.8R=~ 
VB-A 
VB-B 
VB-C 
1.9R=~ VB-D 
1.10R=~ VB-E 
Grafe's 
factors 
from 
S. cyaneofuscatus 
and S. bikiniensis 
vrrgm1ae 
butanolides 
Reported Structures of the 6-Hydroxybutanolide Autoregulators 
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1.3.1 Factor-I 
The first isolated of this group was 'factor-I' (1.2)26 (sometimes called 'factor 1 •27 
or I-factor3) from S. viridochromogenes, which was found by Grafe et al. to show 
interspecific inducing activity by restoring the ability of two mutant strains of S. griseus 
to produce leukaemomycin and to sporulate normally.31 Its autoregulatory effects are 
reported by Grafe and coworkers to be directly analogous to those of A-factor (1.1) but 
with 10 times lower activity.31 Grafe suggests that the observed activity may be due to 
in vivo oxidation to A-factor but this is not supported by an earlier report by Khokhlov's 
group that a racemic compound spectroscopically identical to factor-I (1.2), obtained via 
reduction of (+)-A-factor (1.1), was completely inactive in another asporogenous mutant 
strain of S. griseus.32 Khokhlov contends that the reported activity of the natural 
metabolite may result from contamination with A-factor,4 but Grafe and coworkers 
maintain that these apparently contradictory results reflect differences in the mutant 
indicator strains used. 26 
The indicated 2,3-trans relative geometry was originally assigned on the basis of 
the 12,3 lH NMR coupling constant, a technique whose validity is seriously questioned 
in Chapter 6. The absolute configuration of factor-I (1.2) has not yet been determined. 
0 
OH 
OH 
1.2 
factor-I 
-isolated from 
S. viridochromogenes 
-induces sporulation 
and leukaemomycin 
production in S. griseus 
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1.3.2 Grife's Factors: lnterspecific Regulators from 
S. bikiniensis and S. cyaneofuscatus _ 
Further work by Grafe and coworkers resulted in the isolation of a mixture of 
two butanolide metabolites 1.5 and 1.6 from cultures of S. bikiniensis which could 
restore leukaemomycin production and aerial mycelium formation to blocked mutants 
of S. griseus.28 The biological activity of the mixture was qualitatively and 
quantitatively similar to factor-I (1.2), with an activity approximately an order of 
magnitude lower than A-factor (1.1). The same two inducers were also isolated from 
cultures of S. cyaneofuscatus, together with a third, homologous bioregulator 1.4. 
Although not separated, detailed spectroscopic analysis of the mixtures allowed the 
structures 1.4, 1.5 and 1.6 to be proposed. The structures were assigned by Grafe and 
coworkers to have different ('cis') 2,3-relative stereochemistry to factor-I (1.2) due to 
their lower H2-H3 lH NMR coupling constant (discussed further in Chapter 6). 
OH 
0 3 
6 -R 
T 
0 OH 
l.4R=~ 
l.SR=~ 
1.6 R = -----y 
Grafe's factors 
} - from S. cyaneofuscatus 
} - from S. bildnensis and S. cyaneofuscatus 
- all induce aerial mycelia 
and leukaemomycin 
production in S. griseus 
Structures ~igned by Grafe et al. 
As for factor-I (1.2), the autoregulatory function of these interspecific inducer 
compounds in the producing strains remains to be demonstrated since mutants deficient 
in these compounds are not available for study. 
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1.3.3 The Virginiae Butanolides (VBs) 
In 1979, Yanagimoto and coworkers reported the isolation of a partially purified 
autoregulatory factor for the production of the cyclic depsipeptide antibiotic, 
virginiamycin (staphylomycin), in cultures of S. virginiae. 33 The influence of the 
isolated inducing material on antibiotic biosynthesis by S. virginiae was found to be 
highly dependent on its concentration and the time of addition, with either stimulation 
or inhibition being observed under certain conditions.34 When an adequately diluted 
sample was added to young cells prior to the normal onset of antibiotic production, a 
strong induction of virginiamycin biosynthesis could be measured, demonstrating its 
autoregulatory activity without the need for mutant strains. However, in contrast to 
A-factor (1.1), this autoregulator does not have reported effects on morphogenesis or 
cytodiff erentiation of the producing strain. 
Nearly a decade later the antibiotic inducing material in S. virginiae was 
revealed to be a mixture of several 6-hydroxybutanolide homologues, closely related to· 
those previously identified by Grafe et al. (1.4-1.6) from S. bikiniensis and 
S. cyaneofuscatus. Three of these so-called 'virginiae butanolides', VB-A (1.6), VB-B 
(1.7) and VB-C (1.8) were initially isolated and characterised in 1987,25 followed by 
two further components, VB-D (1.9) and VB-E (1.10),24 in 1989 (Table 1.2). 
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Table 1.2 Accepted Structures and Relative Activities of the Virginiae Butanolides 
1.6 
1.7 
1.8 
1.9 
1.10 
OH 
0 I 6 -R 
l" 
0 OH 
Name 
VB-A 
VB-B 
VB-C 
VB-D 
VB-E 
virginiae butanolides (VBs) 
- isolated from S. virginiae 
- highly active inducers 
of virginiamycin production 
in S. virginiae 
R= Rel. Activity 
~ l()()i 
~ 10 
~ 40 
~ 60 
~ 10 
Note i) VB-A minimum effective concentration is 0.6 nglmL 
VB-A (1.6) was found to be spectroscopically identical to one of Grafe's 
inducing factors (1.6, see Section 1.3.2). The virginiae butanolides (VBs) were all 
assigned '2,3-cis' relative stereochemistry since they shared the same lH NMR 12,3 
coupling value as Grafe's factors 1.4, 1.5 and 1.6 (see Chapter 6 for criticism of this 
assignment). 
The differences in alkyl chain length and methyl branching among the VBs 
result in some differences in biological activity, as shown in Table 1.2,24 but the 
structural requirements for activity do not seem to be as rigid as for A-factor (cf. Table 
1.1). VB-A (1.6) is the most potent VB isolated to date with a minimum effective 
concentration in bioassay of 0.6 ng/mL. 24 A structure-activity survey of numerous 
synthetic straight-chain VB derivatives (cf VB-C, 1.8 and VB-D, 1.9) concluded that 
virginiamycin inducing activity was highest with a C2 hydroxyalkyl chain of 7 or 8 
carbon atoms in length.35 In addition, derivatives attributed '2,3-trans' configuration 
were more than 10 times less active than the corresponding '2,3-cis' derivatives. 35 
Interestingly, substrates incorporating a 6-keto group (cf. A-factor 1.1) generally had 
over 100 times lower activity than the corresponding '2,3-cis'-6-hydroxy compounds, 
Ii 
' 
:1 
I! 
I 
I 
I 
I 
I 
~. 
I 
Chapter One 16 
demonstrating species discrimination between butanolides with 6-keto and 6-hydroxy 
groups. Mori and Chiba have recently defined the absolute stereochemistry of VB-A, 
VB-Band VB-C as 3R by asymmetric synthesis.30 
1.3.4 IM-2 
The latest addition to the class of 6-hydroxybutanolide autoregulators is 'IM-2' 
(1.3),36 a metabolite of Streptomyces sp. FRI-5. IM-2 was initially noted for its ability 
to induce the formation of a blue pigment, 36 but has recently been shown to also induce 
the formation of the nucleoside antibiotics, showdomycin and minimycin. 37 
OH 
IM-2 
0 
3 
2 ..... ,r--
OH 
1.3 
- from Streptomyces sp. FRI-5 
- induces blue pigment formation 
- induces showdomycin and 
minimycin biosynthesis 
0 
It is distinguished from the virginiae butanolides (see Table 1.2) by its 
considerably shorter C2-alkyl chain and by the '2,3-trans' relative stereochemistry 
assigned to it.36 A study of the influence of C2-alkyl chain length in IM-2 analogues on 
inducing activity revealed that while similar activity was observed when the alkyl chain 
was one carbon longer, any further increase or any decrease in the C2 side chain length 
caused a reduction in activity of more than 50-fold,36 indicating that FRI-5 has more 
stringent structural requirements than S. virginiae. 
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1.4 OTHER ACTINOMYCETE AUTOREGULATORS 
In addition to the 2,3-disubstituted butyrolactone autoregulators discussed 
above, several other classes of actinomycete metabolites with autoregulatory functions 
have been reported. These will not be treated in depth here but serve to illustrate the 
variety of autoregulatory molecules which are utilised by actinomyctes to control 
aspects of their metabolism and morphology. 
1.4.1 B-factor 
B-factor, 3'-(1-butylphosphoryl)adenosine (1.11), was isolated and identified in 
1984 as the active factor present in yeast extracts which enabled them to restore 
rifamycin B production to a non-producing mutant strain of Nocardia sp.38 Isolated o~ 
synthetic B-factor (1.11) was active in rifamycin B induction at a concentration of 
2 ng/mL and could stimulate the formation of 1500 times its mass of the antibiotic.38 
The classification of this response as 'autoregulatory' was confirmed with the isolation 
of a substance identical or closely related to B-factor (1.11) from cultures of the parental 
Nocardia sp.39 
o, 
\ ~ 
n 
0 OH 
I 
O=P-o-
B-factor 
- from Nocardia sp. 
- induces rifamycin B 
biosynthesis 
1 
0~ 
1.11 
' 
I 
1 ' 
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1.4.2 Pamamycin 
0 
1.12 
o pamamycin-flJ7 
- from S. alboniger 
- stimulates formation 
of aerial mycelia 
18 
Studies into aerial mycelia formation by S. alboniger revealed the presence of a 
complex system of specific autoregulatory compounds.4° Culture extracts contained 
two unidentified factors which inhibited aerial mycelial growth in addition to a potent 
aerial mycelia stimulating substance, named 'pamamycin'. Pamamycin was also found 
to possess antifungal and antibacterial activity. Marumo's group showed that 
pamamycin was a mixture of more than 8 homologous compounds containing a 
16-membered macrodiolide ring, with molecular weights ranging from 593 to 691.41 
The structure of one homologue, pamamycin-flJ7 (1.12) (MW flJ7), was elucidated41 
and further work established the absolute stereochemistry, as depicted above. 42 
1.4.3 An Au toregulator of Bioluminescence in 
Vibrio fischeri 
Y- 0 0 0 - from Vibrio fischeri :~ - induces biolurninescence 
o 1.13 · 
Another interesting example of autoregulation ( though not in an actinomycete) is 
the induction of the enzymes required for bioluminescence (lucif erase) in the marine 
bacterium Vibrio fischeri by the homoserine lactone derivative 1.13. 43 Luciferase is 
only produced when the concentration of the autoregulator 1.13 in the culture medium 
reaches a critical level. The autoinducer is species specific and its activity is sensitive to 
structural alterations.44 It was thus not surprising that A-factor was found to be 
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completely inactive as an inducer in this organism despite some structural similarities 
between the two autoregulators. 44 
1.4.4 L-factors: The Autoregulators that Weren't 
The risk of spurious results due to contamination of test samples by extremely 
active bioregulators is very real as illustrated during the investigation of the so-called 
'L-factors' (1.14), putative autoregulators isolated from S. griseus cultures by Grafe's 
research group.45 
? 
0 
1.14 
( two diastereomers) 
Despite their considerable structural difference from A-factor (1.1), the purified 
metabolites apparently displayed low but significant A-factor-like autoregulatory 
activity towards leukaemomycin prcxluction in mutant indicator strains of S. griseus 
(ca 5% of A-factor's activity).45 Although Grafe and coworkers "unambiguously 
excluded" the occurrence of traces of A-factor (1.1) by "careful GC analysis", they 
subsequently had to concede that the observed biological activity was in fact due to 
contamination by A-factor, when synthetic samples of the lactones 1.14 failed to show 
any inducing activity.46 Several authors however have failed to note the retraction and 
as late as 1988 'L-factor' has been discussed as an example of a regulatory metabolite.39 
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1.5 MECHANISM OF ACTION OF THE BUTANOLIDE 
AUTOREGULATORS 
20 
Early reviews of the biological activity of A-factor5•6 included speculation as to 
its mode of action but the lack of mechanistic evidence precluded the development of a 
coherent model to explain both the extreme potency and the diversity of its actions. 
However, recent investigations have contributed greatly to the understanding of the 
regulatory cascade initiated by the butanolide autoregulators. 
In 1989, proteins binding specifically to VB-C (1.8)47.48 and A-factor (1.1)49 
were isolated from cultures of S. virginiae and S. griseus, respectively, with the use of 
3H-labelled substrates. These proteins were of similar size (MW ca 30,000) and both 
are present at levels of about 30-40 molecules per genome. 
The supposition that the butanolide autoregulators expressed their regulatory 
activities through binding with these proteins is supported by studies of an anomalous 
mutant strain of S. griseus which does not require A-factor for streptomycin production 
or sporulation. Miyake and coworkers found that this mutant strain (S. griseus 2247) 
has a defect in its A-factor-binding protein50 leading to the conclusion that: "the 
binding protein in the wild-type strain acts as a represser-type regulator for 
streptomycin production and sporulation and that the repression is released by binding 
with Afactor".50 In mutant strains lacking an intact represser protein, A-factor can no 
longer regulate the timing of antibiotic production and sporulation, and consequently 
these processes occur at a much earlier stage of growth than in the wild-type strain.50 
Figure 1.1 depicts a model proposed by Horinouchi and Beppu for the regulatory 
cascade induced by A-factor in S. griseus based on extensive genetic analyses.3 
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Figure 1.1 Model Pro~d by Horinouchi and Beppu for the Regulatory Cascade 
Initiated by A-Factor 
The A-factor-binding protein inhibits the expression of a putative gene 'X', 
probably by attachment to its promoter region until it is removed by binding with 
A-factor (1.1) (Fig 1._l). Subsequent transcription of this gene is believed to produce an 
activating protein (X) that promotes the transcription of further genes ('str R' and 
: 
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'aph D') which code for enzymes necessary for streptomycin production and 
streptomycin resistance, respectively. A similar regulatory relay, possibly involving a 
different activator protein, is believed to promote sporulation and yellow pigment 
production but these have been less studied. 3 
A regulatory cascade of this type results in enormous amplification of the effect 
of A-factor. A-factor's ability to diffuse through cellular membranes allows it to initiate 
this cascade in other widely separated parts of this filamentous organism (or in nearby 
organisms), facilitating the synchronisation of antibiotic biosynthesis and morphological 
differentiation. The environmental cue that ultimately begins this complex regulatory 
cascade by initiating µie biosynthesis of A-factor remains unknown at this stage. 
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1.6 SYNTHESES OF THE BUTANOLIDE 
AUTOREGULATORS 
1.6.1 Synthetic Routes to A-factor (1.1) 
23 
Racemic A-factor (1.1) was first synthesised by Khokhlov's research group in 
197751 to confirm the structure which they had proposed for the autoregulator, based on 
physico-chemical studies.9 In 1982, Mori and Yamane reported the synthesis of both 
optically active forms. 18 Recent years have seen reports of three further syntheses, one 
for racemic A-factor (1.1)29 and two of optically active fonns,20,52 reflecting the 
continuing interest in this potent microbial hormone. All of the syntheses, however, 
follow essentially the same strategy involving the synthesis of a derivative of 
3-hydroxymethylbutanolide (1.17a-e) which was then acylated in the 2-position 
(Scheme 1.1 ). 
a) R=THP 
OR 
OH 
b) R=TMS 
0 
c)R=~ 
0 d) R = """'o,......Ph 
0 1.17 0 
e) R = Jl.'Bu 
Scheme 1.1 Derivatives of 3-Hydroxymethylbutanolide Utilised in Literature 
Syntheses of A-factor 
KHOKHLOV et al. 
In the first synthesis of racemic A-factor (1.1), Khokhlov and coworkers 
investigated three of these derivatives (1.17a, 1.17b and 1.17c) as intennediates.51 
They were prepared in four steps from 2-allyl-1,3-propanediol (1.18) (overall yields 
58%, 38% and 44% respectively) which was itself derived from diethyl malonate (1.19) 
in an undisclosed yield (Scheme 1.2). 
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EtO~Et EtO OEt 
1.19 
OH AcO OAc H+ 
84% 
HO 
0 1.20 0 
1 [protect] Cl~ 
0 
0 
OR 
0 
0 1.17 a R = THP (95%) 
b R = TMS (62%) 1.17c 
1 
i) sodi~ ~s:71 I 
ii)MeO~ 
0 
[deprotect] 
R = THP (7%, 2 steps) 
R = TMS (29%, 2 steps) 
LAH 
HO OH 
1.18 
Ac,P 188% 
i) 03 AcO 
ii) Hz02 
83% 
sodium dimsyl 
(59%) 
0 
1.1 (+)-A-factor 
OAc 
Scheme 1.2 Synthesis of (+)-A-factor by Khokhlov and coworkers 
24 
Acylation of the THP- or TMS-protected butyrolactones 1.17a or 1.17b (sodium 
dimsyl / DMSO; methyl 6-methylheptanoate) followed by deprotection gave racemic 
A-factor (1.1) in only low yields (7% and 29% respectively). The yield was improved 
to 59% with the use of the 6-methylheptanoate ester 1.17c since the required acylation 
could be achieved via a facile intramolecular 0-C acyl transfer and hence no 
deprotection step was required. Unaccountably, this useful improvement has not been 
employed in subsequently reported syntheses of racemic A-factor and its analogues, 
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with the longer and often low yielding protection / acylation / deprotection route being 
universally used. 25,29,35 
MORI AND YAMANE 
In developing a chiral synthesis, Mori and Yamane17•18 chose paraconic acid 
(1.21) as their source of asymmetry since its preparation and optical resolution had been 
previously described53 and the absolute configuration of the two forms had apparently 
been firmly established by Tocanne and Asselineau based on the 2 step conversion of 
(-)-paraconic acid (-)-1.21 into (S)-(-)-2-methylsuccinic acid (1.22),53 (Scheme 1.3). 
r-fC02H Oy H (-)-1.21 
0 
1.21 paraconic acid 
... 
(-)-1.21 was thus 
(erroneously) assigned '(3R)' 
-
-
2 steps 
CHr._ff2H 
HOY 
0 
1.22 
GS)-(-)-2-methylsuccinic acid 
-
0 H yC~H 
0 
-
Scheme 1.3 Supposed ~ignment of (-)-Paraconic acid as 'R' by Tocanne and 
Asselineau, 1965 
Mori and Yamane synthesised both enantiomers of A-factor (1.1) via the route 
outlined in Scheme 1.4, in which the optically pure paraconic acid enantiomers (-)-1.21 
and ( + )-1. 21, obtained by a laborious and inefficient resolution with 
(R)-( + )-a-phenylethylamine, were separately reduced to 3-hydroxymethylbutanolide 
(1.20) and then TMS-protected to form the intermediate 1.17b previously used by 
Khokhlov's group. The overall yield of the final acylation and deprotection steps (30%) 
represented no significant improvement over the Russian synthesis, despite the use of 
LDA, low temperatures (-78°C, 1 h) and the more active acid chloride as the acylating 
agent. Although the overall yield of optically pure products (-)-1.1 and ( + )-1.1 from 
diethylsuccinate was minuscule (ca 0.2%), the synthesis served to demonstrate that 
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(-)-A-factor (-)-1.1, corresponding to the natural metabolite, could be prepared from 
(-)-paraconic acid ( -)-1.21. 
0 
COiEt 
H C0
2
E_t _H_2 __ Oy KOH (aq) 
Raney Ni 71% Et<>iC 
OTMS 
0 1.17b 
i)LDA 
TMSCl 
52% 
30% ii)a~ 
0 
iii) EtOH / H20, ~ 
OH 
0 
(-)-1.1 and (+)-1.1 
1.15 
0 
1.20 
-100% O 
Bl1.3.SMe2 
92% 
resolution with 
(R)-( + )-a-phenyl 
-ethylamine 
(-)-1.21 and ( + )-1.21 
(3% each) 
Scheme 1.4 Synthesis of Optically Active Forms of A-factor by Mori and Chiba 
Relying on the purported assignment of (-)-paraconic acid (-)-1.21 as 'R'53 (see 
Scheme 1.3), Mori assigned '3S' stereochemistry to the natural autoregulator (-)-1.1.17,18 
Unfortunately, Mori and Yamane were unaware at that time of other reputable reports 
supporting the opposite stereochemical assignment (S) for (-)-paraconic acid ( -)-1.21 
based on its formation from aucubin (1.23),54,55 as shown in Scheme 1.5. 
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o (+)-1.21 
(R)-( + )-paraconic acid 
(l<,COifl Oy H 
0 
(+)-1.21 
(l<,Cff:i Oy H 
0 
1.25 
NC02H 
YH 
0 (-)-1.21 
(S)-(-)-paraconic acid 
H)(CHi>1sCH3 
H3C Et 
1.24 
(S)-( + )-3-methylnonadecane 
1.26 
(R)-( + )-paraconic acid (R)-( + )-3-methylbutanolide 
methyl (R)-(-)-3-hydroxy-
2-methylpropionate 
Scheme 1.5 Literature Conversions Supporting the Assignment of 
(R)-(+)-Paraconic Acid (+)-1.21 
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They were also unaware that in 1968 Tocanne and Asselineau had retracted their 
earlier stereochemical assignment of (-)-paraconic acid (-)-1.21 (see Scheme 1.3) when 
they found that the ( + )-enantiomer ( + )-1.21 could be converted in nine steps to 
(S)-(+)-3-methylnonadecane 1.24, supporting its reassignment asR (Scheme 1.5).56 In 
1983, Mori revised his assignment of the absolute configuration of 'natural' (-)-A-factor 
to 3R (depicted below) when he too confirmed that the original stereochemical 
assignment of the optically active paraconic acid enantiomer (-)-1.21 by Tocanne and 
Asselineau53 (see Scheme 1.3) was in error.19 He showed that ( + )-paraconic acid 
(+)-1.21 could be converted in 3 steps to (R)-(+)-3-methylbutanolide (1.25) whose 
stereochemical assignment was in tum verified by its synthesis in 5 steps from 
enzymatically derived methyl (R)-(-)-3-hydroxy-2-methylpropionate (1.26) (Scheme 
1.5). 
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0 0 
(3R)-(-)-1.1 
Currently Accepted Absolute Stereochemical Assignment of 'Natural' A-Factor 
Recently, Mori and Chiba57 have developed an improved route to optically pure 
(S)-(-)-paraconic acid [(S)-(-)-1.21] based on the enzyme catalysed asymmetric 
hydrolysis of the prochiral diacetate 1.27 to the (R)-(+)-monoacetate 1.28 in 86% e.e. 
using pig pancreatic lipase (PPL) (Scheme 1.6). 
07C02H 
0 
i) LiA1H4 AcO 
ii) Ac20 /PY. 
56% 
HCI 
83% 
(S)-(-)-1.21 (e.e. not stated) 
15~ 1 optical enrichment with 0 (R)-( + )-a-phenylethylamine 
07C02H 
0 
(S)-(-)-1.21 
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i) 03 
ii) H20i 
53% 
AcO 
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(86% e.e.) 
l 
Jones' 92% oxidation. 
C02H 
PPL = pig pancreatic lipase 
Scheme 1.6 Preparation of (S)-(-)-Paraconic acid (S)-(-)-1.21 by Mori and Chiba 
Utilising Enzymatic Hydrolysis 
Conversion to paraconic acid 1.21 via the method outlined in Scheme 1.6 gives a 
product enriched (e.e. not stated) in the (S)-(-)-enantiomer (S)-(-)-1.21, which can be 
I 
I 
I 
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further enriched as the (R)-( + )-a-phenylethylamine salt. This is more efficient than 
Mori's previous route (Scheme 1.4, 15% vs 3% ). 
MODIFICATION OF y AMADA et al. 
In 1987 Yamada's group utilised a modification of Mori's original route (see 
Scheme 1.4) for the synthesis of racemic VB-C (1.8).25 Since resolution was not 
required they were able to considerably shorten the synthesis by the direct one-step 
reduction and cyclisation of diethylformylsuccinate (1.15) to 
3-hydroxymethylbutanolide (1.20) using sodium borohydride in ethanol (Scheme 1.7). 
This unusual reduction of an ester group by borohydride was attributed to the 
neighbouring effect of borohydride attached to the hydroxymethyl group of the 
uncyclised intermediate as depicted in Scheme 1. 7. 
NaBH4 
(>2 eq.) 
EtOH 
H H 
' I 
,B 
~ 
Et(hC H 
\ 
OEt 
0 
1.20 
23 % (purified) 
0 
1.16 
(3.2% from 1.15) 
Scheme 1. 7 Yamada 's Synthetic Shortcut 
Although this method shortened the route to racemic butanolides, the yield of 
the purified lactone intermediate 1.20 was quite modest (23%) and thus the overall yield 
of butanolide autoregulators and analogues was still low (e.g. 1.16, 3.2% from 
diethylformylsuccinate, 1.15). 
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POSNER et al. 
Posner and coworkers took a different approach to Mori in their frequently 
overlooked29,52 asymmetric synthesis of the 'unnatural' 3S enantiomer of A-factor 
(3S)-(+)-1.1 (Scheme 1.8).20 Their chiral benzyloxymethyl (BOM) protected 
3-hydroxymethylbutanolide intermediate (S)-(+)-1.17d was prepared in 87% e.e. by 
conjugate addition of a BOM-protected hydroxymethyl carbanion equivalent 
(PhCH20CH20CH2Li) to the enantiomerically pure sulfinylbutenolide 1.29, followed 
by reductive desulfinylation with Raney nickel. Subsequent acylation utilising lithium 
hexamethyldisilazide (LiHMDS) as base was reported to give an improved yield of the 
protected A-factor 1.30 compared to previous analogues acylations (see Scheme 1.2 and 
1.4). Unfortunately, the final hydrogenolysis step involved partial racemisation 
(probably due to traces of acid that are commonly found in Pd/C catalysts) to give the 
product (3S)-(+)-1.1 with only about 50% of the specific rotation reported by Mori.18 
This rather lengthy linear synthesis avoids the need for an enantiomeric resolution but 
the overall yield (0.4% from propargyl alcohol 1.31) is again low. 
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Scheme 1.8 Asymmetric Synthesis of (3S)-( + )-A-Factor by Posner et al. 
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TERAOetal. 
Since the commencement of this project Terao and coworkers52 have developed 
another chiral synthesis based on the high efficiency enzyme-catalysed 
transesterification (using lipase P from Pseudomonas florescens) of the 2-substituted 
1,3-propanediol 1.32 to the (R)-monoacetate 1.33 (95% yield; 98% e.e.) as outlined in 
Scheme 1.9. Protection of the remaining hydroxyl group of 1.33 as the pivalate ester 
followed by hydrolysis of the diethyl acetal and acetate moieties and cyclisation gave 
the lactol 1.34 which was oxidised to the protected 3-hydroxybutanolide intermediate 
1.17e. Acylation using LDA and the requisite acid chloride gave pivalate-protected 
A-factor 1.35 in good yield (74%). The final hydrolytic removal of the ester protecting 
group was conducted with enzyme catalysis (lipase B) in pH 7 buffer solution to 
minimise racemisation, yielding (R)-(-)-A-factor (1.1) with "similar optical purity to 
that reported by Mori" .1s 
HO 1.34 
OEt 
Clr-(OEt 
i)HCI 
ii) Na2C03 EtO 
MeOH EtO 
86% 
i)LDA 
0 
ii)c1~ 
0 0 
74% 1.35 
OEt 
0 
O)l_'Bu 
L~ OH 
EtO 
1.32 
EtO ! i) lipase p 45% ii) AcOCH=CH2 
'BuCOCI OH 
py. 
EtO 
EtO 
1.33 (98 % e.e.) 
lipase B 
pH 7 buffer 
64% 
1.1 
(3R)-A-factor 
Scheme 1.9 Route to (3R)-A-Factor by Terao et al. Utilising Enzymatic Hydrolyses 
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KINOSHITA AND HIRANO 
Very recently Kinoshita and Hirano29 reported another synthesis of racemic 
A-factor (±)-1.1 which utilised as final steps the acylation and deprotection of the 
TMS-protected 3-hydroxybutanolide intermediate 1.17b, as previously described by 
Mori and Yamane18 (cf. Scheme 1.4). Preparation of the intermediate 1.17b however 
was considerably more direct, being achieved in four steps from furoic acid (1.36), as 
outlined in Scheme 1.10. 
1.36 
0 
53% 
OTMS TMSCI 
HMDS/py. 
1.17b 
i)LDA/~A I 
Cl~ 
0 
ii) EtOH / Hp, ~ 
87% 
11.1 (±)-A-factor I 
0 
1.20 
MeOH/ AcCI 
pH 1 
(98% comb.) 
OH 
m-CPBA 
BF3.Et20 (cat.) 
71% 
MeO 1.37 
92% 1 LiAIH4 
MeO 
Scheme 1.10 Route to (+)-A-factor by Kinoshita and Hirano 
OH 
Furoic acid (1.36) was subjected to Birch reduction followed by esterification 
with diazomethane and acid catalysed methanol addition to give the methyl acetal 1.37 
in almost quantitative yield, without isolation of the dihydro intermediate 1.38. 
Transformation to the key butanolide intermediate 1.17b was achieved in good yield 
(57% over 3 steps) but its subsequent acylation and deprotection to (+) A-factor (1.1) 
remained moderate yielding (53%) despite the use of HMPA. 
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1.6.2 Syntheses of the 6-Hydroxybutanolide Autoregulators 
0 
(
C02Et 8 .Jl OEt 
CQiEt 
0 OH 
1.39 
OH 
R 
NaBH4 
MeOH 
0 1.20 
iii) [deprotect] 
NaBH4 
MeOH 
R =various 
alkyl chains 
0 0 
1.40 
R 
OH 
[protect] 
[deprotect] 
OR 
0 1.17 
Aji)LDA 
ii)RCOCI 
OR 
R 
Scheme 1.11 General Literature Routes to 6-Hydroxybutanolides · 
Syntheses of the racemic 6-hydroxybutanolide autoregulators and related 
homologues 1.39 (R = various alkyl chains) have generally been achieved via sodium 
borohydride reduction of the corresponding 6-keto compounds 1.40 (Scheme 1.11, route 
A), prepared using Y amada's modified version of Mori's synthesis, discussed above (see 
Scheme 1.7).25,30,35 A few examples also exist of direct alkylation of protected 
3-hydroxybutanolide 1.17 with aldehydes to form 6-hydroxybutanolides 1.39, after 
deprotection (Scheme 1.11, route B ). 47,58 The efficiencies and stereochemical outcomes 
of these methods are discussed in Chapter 6 (Section 6.3). 
Recently, Mori and Chiba reported the preparation of 'nature identical' optically 
active VB-A (1.6), VB-B (1.7) and VB-C (1.8) via sodium borohydride reduction of 
their chiral 6-keto equivalents, themselves prepared in the same manner as optically 
active A-factor (1.1, see Scheme 1.4).30 This established their absolute configuration at 
C3 as R, in common with A-factor. 
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1. 7 PROJECT AIMS 
At the commencement of this project the existing 'conventional' syntheses of 
A-factor (see Schemes 1.2, 1.4, 1. 7 and 1.8) suffered from excessive length and 
generally low overall yields, especially for optically active A-factor. In view of the 
biological significance of A-factor, there was a need for an improved synthetic route 
and we felt that a promising approach was to using the probable biosynthetic route 
employed by the producing organism as a model. Such a 'biomimetic' approach, if 
successful, would also provide circumstantial evidence that the proposed biosynthetic 
pathway operated in the bacteria which produce A-factor. An improved synthesis of the 
potent autoregulator A-factor (1.1) could also be modified to improve access to the 
expanding array of 6-hydroxy autoregulators 1.2-1.10. In the following chapter our 
proposal for the biosynthesis of A-factor is outlined and our strategy for the 
development of a biomimetic synthesis is defined. 
CHAPTER Two 
BIOMIMETIC STRATEGY 
Lord, I fall upon my knees 
And pray that all my syntheses 
May no longer be inferior 
To those conducted by bacteria. 
D. E. Eveleigh 
Scientific American, 1981, 245, 120 
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2.1 BIOMIMETIC SYNTHESIS: A PERSPECTIVE 
'Biomimetic chemistry' is a term coined by Breslow59 in 1972 to describe "the 
branch of organic chemistry which attempts to imitate natural reactions and enzymic 
processes as a way to improve the power of organic chemistry". 'Biomimetic synthesis', 
formerly known as 'biogenetic-type' synthesis, has been defined by van Tamelen as the 
design and execution of laboratory synthesis based (at least in key aspects) upon 
established or presumed biochemical transformations. 60,61 
The classic synthesis of tropinone (2.1) by Robinson62•63 (Scheme 2.1) in 1917 
is often regarded as the archetypal example of this approach,64,65 but it is clear that 
Robinson's biosynthetic proposals, 66 rather than being used in the design of the 
synthesis, were inspired by the synthetic achievement. 
Robinson, 1917 
-----------Willstlltter, 1903 15 steps 
0.76% 
Scheme 2.1 
Me 
'N 
~o 
2.1 tropinone 
Nevertheless, comparison of this remarkable synthesis with the previous lengthy 
and laborious conventional route used by Willstiitter, 67 provided an early demonstration 
of the potential of this style of organic synthesis. In recent decades, the application of 
biomimetic principles to the planning of syntheses has expanded greatly due to both the 
vast improvement in the understanding of biosynthetic pathways and to the increasing 
sophistication of organic synthetic methods. Considerable advances have been reported 
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in the development of biomimetic syntheses in the areas of marine natural products, 68 
alkaloids, 69, 70 polyketide metabolites 71 and triterpenoids. 72 
The transformations known to be utilised by Nature for the biosynthesis of 
natural products often provide good models on which to base syntheses since their 
success is precedented, albeit with enzyme assistance. Conversely, in cases where the 
biosynthesis is less well established, a facile biomimetic synthesis can provide some 
support for a postulated biosynthetic route and guide further biosynthetic study. 
Biomimetic syntheses are generally characterised by a small number of steps and 
a high total yield.65 They typically utilise a key, biologically inspired transformation 
(e.g. a key bond formation or cyclisation) which constitutes the focal point of the 
synthetic route. The preparation of the required intermediate for this step and 
subsequent elaboration to the natural product (if required), is often accomplished by 
standard synthetic means. Biomimetic syntheses are generally most successful when 
their key step imitates reactions of bio-intennediates which have inherently favourable 
regio- and stereoselectivity rather than when they attempt to mimic transformatio~s 
whose selectivity requires a high degree of enzymatic control. However, it is sometimes 
possible to alter unfavourable intrinsic regioselectivity by strategic modification of the 
substrate. 73 
In the biomimetic synthesis of simple phenolic polyketide metabolites, 74 it has 
been found that the triketo acid and ester precursors cyclised under such mild conditions 
th.at it was suggested that the analogous biological reactions may not be under 
enzymatic control. 75 The selective use of two facile modes of cyclisation achieved the 
efficient biomimetic syntheses of the plant metabolites pinosylvin (2.2) and 
pinocembrin (2.3). 74 
·J 
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OH 
i)CH2N2 
40% ii) KOH{aq), -5°C 
iii) '1 
0 H 
OH 
2.3 pinocembrin 
i) bufferaq pH 5.0 
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ii) - COi, '1 
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Scheme 2.2 
40 
OH 
OH 
2.2 pinosylvin 
However, for more complex polyketide targets, the preparation of the required 
lengthy oligocarbonyl precursors and the control of their cyclisation becomes a 
formidable problem, suggesting that the enzymes involved in this process in vivo 
perform a vital role in the stabilisation and control of the cyclisation regiochemistry of 
the precursors. For symmetrical heptaketides, Harris and coworkers used strategic 
protection of one carbonyl group of the heptaketide equivalent 2.4 to achieve 
spontaneous regiospecific cyclisation, giving exceptionally direct access to emodin (2.5) 
and related metabolites. 76 
0 0 
2~-
2.4 
OH 0 OH i)KOH OH OH 0 
ii) ir-
ill) CI0.3 
HO Me RO 
0 R= (CH2)iOH 
2.5 emodin 
Scheme 2.3 
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The recent extension of this approach to the biogenetically-inspired synthesis of 
the tetracycline antibiotic precursor pretetramid77 (2.6), is an impressive achievement 
but one which required significant departures from the putative biosynthetic route due to 
the inaccessibility of a synthetic equivalent of the required decacarbonyl acyclic 
precursor 2. 7. 
0 0 0 0 0 OH OH OH OH 0 
OH 
0 OH 
2.7 2.6 preletramid 
In other biosynthetic systems, key precursors have been found to be stable in 
vitro and display quite amazing inherent regio- and stereospecificity upon cyclisation, 
despite their considerable size, and have formed the basis of some remarkable 
biomimetic syntheses. 
The recent report of the biomimetic synthesis of the pentacyclic skeleton of the 
Daphniphyllum alkaloids 2.8 in one step from the acyclic squalene derivative 2.9 
provides an extreme example of favourable intrinsic reactivity in a putative biological 
precursor (Scheme 2.4). 78 Five rings and seven a-bonds are created with complete 
diastereospecificity in this awe inspiring biomimetic transformation. 
2.9 
Scheme 2.4 
i) CH3NH2 
ii) AcOH, 80°C 
65% 
2.8 
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The diol 2.10 obtained from squalene 2,3-epoxide (2.12), cylises under mildly 
acidic conditions to give the tetracyclic natural triterpenoid malabaricol (2.11) 
(Scheme 2.5, 7% yield) with concurrent diastereospecific formation of six asymmetric 
centres.79 
2.10 
picric acid 
CHJN02 
20°c, 22 h 
Scheme 2.5 
2.11 (+)-malabaricol 
Of course the exceptionally favourable non-enzymatically controlled reactivity 
demonstrated in the preceding syntheses is unusual and it is sometimes found that key 
biosynthetic steps are not readily amenable to chemical analogy. 
For example, it is ironic that the inherent chemical tendency of squalene 
2,3-epoxide derivatives to cyclise to triterpenoids with a 5-membered C-ring, as 
demonstrated in the remarkable biomimetic formation of malabaricol (2.11) (see 
Scheme 2.5), represents one of the major obstacles to achieving the biomimetic 
equivalent of the inspiring enzyme catalysed cyclisation of squalene 2,3-epoxide (2.12) 
leading to lanosterol (2.13), the biological precursor to the far more common steroid 
skeleton (Scheme 2.6). An enormous amount of effort has been put into the 
understanding of this polycyclisation and to the development of a variety of ingenious 
(though not usually biogenetically-inspired) methods to override the intrinsic reactivity 
of the natural precursors and allow formation of the 6-membered C-ring necessary for 
the steroid skeleton, via related polyene cyclisations. 60,72,80 
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enzyme 
HO 
2.12 squalene 2,3-epoxide 
Me Me 2.13 Ianosterol 
Scheme 2.6 
Another example of adverse intrinsic reactivity is the attempted biomimetic 
construction of the morphine skeleton (salutaridine, 2.15) via the para-ortho oxidative 
coupling of the key biological precursor reticuline (2.14, Scheme 2.7). Although this 
coupling is readily achieved in nature, 81 numerous attempts to mimic it chemically have 
produced mixtures of the onho-para (~3%) and the para-para products (~%) with, at 
most, traces (<0.03%) of the required para-onho product.64 A subsequent report of a 
low yield of the para-ortho coupled product using modified substrates82 does not alter 
the perception that the inherent regioselectivity for this type of coupling reaction is 
unfavourable. 
HO 
'para-para' 
coupling 
S4% 
MeO 
OH 
'ortho-para' 
coupling 
~3% 
-------------
'para-ortho' 
coupling 
~.03% 
2.14 reticuline 
MeO 
HO 
MeO 
OH 
2.15 salutaridine 
Scheme 2. 7 Attempted Biomimetic Syntheses of the Morphine Ring System 
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Today, biosynthetic considerations are often routinely incorporated into the 
retrosynthetic planning of the synthesis of natural products. Unfortunately, it remains 
difficult to predict which putative biological precursors will have favourable intrinsic 
chemical reactivity and a 'trial and error' approach is often required. 
2.2 A BIOMIMETIC APPROACH TO THE SYNTHESIS OF 
A-FACTOR AND RELATED BUTANOLIDE 
AUTOREGULATORS 
Previous syntheses of A-Factor (1.1) (see Section 1.6.6) all follow routes 
determined by chemical expedience rather than by biosynthetic 
considerations. 18,20,29,Sl,52 All are based on the C2-acylation of a protected 
3-hydroxymethyl butyrolactone (1.17) which itself was synthesised by a variety of 
non-biomimetic routes. The acylation of the butyrolactone 1.17 is very unlikely to be 
biomimetic; it has not been proposed as such and there exists no evidence of this 
synthetic intermediate existing in nature. 
OH 
0 
1.17 1.1 
In contrast to the traditional approach of these previous syntheses, we were led 
to consider the viability of developing an improved route to this remarkable bioregulator 
based on our proposal for its biosynthesis which is described in the following section. 
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2.2.1 Proposed Biosynthesis of A-Factor 
At the inception of this project very limited evidence existed as to the biological 
origin of A-factor (1.1). However genetic studies had been performed on the genetic 
determinant of A-factor biosynthesis. 
In 1984, Horinouchi and coworkers identified and cloned a fragment of 
extrachromasomal DNA from S. bikiniensis ('afs A' gene) which appeared wholly 
responsible for the ability to produce A-factor.II It was suggested that the location of 
this gene on an "unstable extrachromasomal element, possibly a plasmid", (where it 
could be easily damaged by a variety of mutagenic agents) explained the ease with 
which A-factor deficient mutants could be produced.I 4 They developed (and 
patented83) a method for the overproduction of A-factor in normally non-producing 
strains of Streptomyces by the insertion of a plasmid incorporating multiple copies of 
the excised·gene.84 The small size of the DNA fragment (1100 base pairs) led to their 
proposal that it coded for only a single enzyme which facilitated the synthesis of 
A-factor from common metabolites of Streptomyces species. 
RETROBIOSYNIHESIS OF A-FACTOR 
The structure of A-factor (1.1) suggested the retrobiosynthetic analysis outlined 
in Scheme 2.8. Disconnection of the C2-C3 bond (path A) reveals the J3-ketoester of a 
three carbon alcohol 2.16 which requires an appropriate group (X) on its central carbon 
to provide activation towards cyclisation. It was envisaged that this activation may be 
achieved with either a biological leaving group (2.16a, e.g. X = phosphate), in which 
case the cyclisation would involve intramolecular alkylation, or by a carbonyl group 
(2.16b) which allows cyclisation via an intramolecular Knoevenagel condensation. The 
esters 2.16a or 2.16b could be further disconnected to the J3-ketoacid 2.18 and the C2 
functionalised 1,3-propanediols 2.19a or 2.19b, respectively. 
Alternatively, the lactone moiety could be cleaved first (path B) to generate the 
cx-alkyl-J3-ketoacid intermediate 2.17 which could be derived from the same precursors 
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as for path A (2.18 and 2.19a or 2.19b) via intermolecular alkylation or Knoevenagel 
condensation. This route is less attractive than path A, since the intermolecular C-C 
bond formation involved would be expected to be a higher energy process than the 
intramolecular equivalent in path A. 
path~ 
rl-1" 
~ 
0 0 
2.16a X = leaving group~ 
(e.g. phosphate) 
b X = carbonyl ( =O) 
1.1 
0 0 
2.17 
X I 2.19 a X = leaving group 
HO~OH (e.g. phosphate) 
b X = carbonyl (=0) 
+ 
0 0 
2.18 
Scheme 2.8 Retrobiosynthetic Analysis of A-Factor 
It was recognised that the carboxylic acid 2.18 would be likely to exist as an 
enzyme-bound thioester 2.20 which would be readily available to the organism via 
normal fatty acid biosynthesis using an isobutyrate starter unit followed by three acetate 
units. It appeared likely that the variety of alkyl chains observed in the other butanolide 
autoregulators (1.2-1.10) result from the incorporation of different numbers of acetate 
units and/or other starter units into such a thioester. 
11 
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Enzyme-S 
0 0 
2.20 
~ 
HOY +HY +HOY +HO~ 
0 0 0 0 
The C2-functionalised diol 2.19a could be readily derived from the biologically 
ubiquitous glycerol (2.21a) or its phosphate 2.21b, while the common metabolite 
dihydroxyacetone phosphate 2.22 provides a ready source of dihydroxyacetone (2.19b) 
or could itself serve directly as the biological precursor. 85,86 
X 
HO~OH 
2.19a 
X = leaving group 
(e.g. phosphate) 
0 
HO~OH 
2.19b 
> 
OH 
HO~OR 
2.21aR=H 
2.21b R = PO/-
0 
HO~OP032-
2.22 
This proposal for the biosynthesis of A-factor from these common biological 
precursors is consistent with the suggested biological origin of A-factor proposed earlier 
by Horinouchi and coworkers, 84 although they only considered glycerol derivatives as 
the source of the three-carbon unit and did not propose any biosynthetic mechanism. 
2.2.2 Synthetic Plan 
The key reaction in any biomimetic route to A-factor (1.1), based on our 
retrobiosynthesis (see Scheme 2.8), is clearly the formation of the ultimate C2-C3 bond. 
By analogy with our putative biosynthetic path A this might be achieved via one or 
other of the two intramolecular processes depicted in Scheme 2.9 (route Ai or Aii ), 
both of which would be expected to be entropically favoured over the analogous 
f, 
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intermolecular processes required for the C2-C3 bond formation using the alternative 
biochemical pathway B (see Scheme 2.8). Thus formation of the required y-lactone 
moiety via the cyclisation of the J3-ketoester intermediates 2.16a or 2.16b, as depicted in 
Scheme 2.9, was chosen for initial investigation. 
;--VOH 
0 
0 
2.16a LG = leaving group 
0 OH 
r-11-/ 
0 
0 
2.16b 
? 
• 
·---------
route Ai 
1.1 
? 
• 
·---------
route Aii 
Scheme 2.9 
Of these two approaches to the synthesis of A-factor, the intramolecular 
alkylation route (route Ai) seemed initially more attractive than the Knoevenagel-type 
process (route Aii) as it was more direct and had clear potential for development as an 
asymmetric route. The following chapter describes our investigations into the viability 
of this methcxl of y-lactone formation, using mcxlel chemical systems. 
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2.3 POSTSCRIPT: CONFIRMATION OF THE 
POSTULATED BIOSYNTHESIS OF BUTANOLIDE 
AUTOREGULATORS 
During the course of this project Yamada's group reported labelling studies 
which confirmed the biosynthetic origin of the carbon skeleton of VB-A (1.6).87 In 
separate feeding experiments (l,3-13C)-glycerol, (I-13C)-acetate and (I-13C)-isovalerate 
were shown to be incorporated, as shown below. However the work did not allow 
elucidation of the stages of the biosynthetic route so it remained to be determined firstly 
whether glycerol was incorporated directly or was first converted to a dihydroxyacetone 
derivative, and secondly, whether the key C2-C3 bond was formed intramolecularly 
(cf Scheme 2.8, path A) or intermolecularly (path B). 
* = 
13c label 
1.6 VB-A 
Whilst it was recognised that our biomimetic studies could not prove which of 
these routes was utilised in nature, a large difference in facility may suggest which was 
more probable, as well as providing an attractive alternative synthesis. 
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CHAPTER THREE 
SYNTHETIC APPROACHES TO BUTANOLIDES 
VIA INTRAMOLECULAR ALKYLA TION 
If at first you don't succeed .............. . 
Try once more .............. and then give up. 
Coffee cup (RSC tea room 1992) 
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3.1 BUTANOLIDES VIA INTRAMOLECULAR 
AL KYLA TION? 
52 
3'-Hydroxypropyl esters 3.1 incorporating a leaving group (LG) at C2' could 
potentially form the 3-hydroxymethyl butanolides 3.2 required for the synthesis of 
A-factor (1.1) upon intramolecular alkylation. However, the use of these esters as 
model substrates is complicated by the need for protection of the primary hydroxyl at 
C3' to prevent unwanted reactivity under basic conditions. 
3.1 
3.3 
...... 
.... 
...... 
...... 
? 
. 
.... 
...... 
....... 
.... 
.............. 
? ,1' .... 
. ------
.. --:---
.... .ir 
-- --
.. .. 
.... 
.... 
.... 
R = alkyl or acyl 
LG = leaving group 
Scheme 3.1 
OH 
0 
3.2 
An attractive alternative approach is to tether the C2' and C3' positions of ester 
3.1 with a group Y to form a ring, as in 3.3, which incorporates protection of the 
hydroxyl whilst maintaining C2' activation. Clearly, the ring must cleave easily and be 
able to form the required hydroxymethyl substituent after opening. The simplest 
suitable ring is an epoxide (3.3, Y =0), although cyclic sulfites, sulfates88 or phosphates 
are other possibilities. The ready commercial availability of 2,3-epoxy-1-propanol 
(glycidol, 3.4)89 made the epoxide system the most convenient for initial investigations. 
11 
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3.1.1 The Epoxide Ring as an Electrophile 
Glycidyl esters are readily prepared by esterification of the relevant acid with 
inexpensive and readily available glycidol (3.4). Optically active forms of glycidol are 
also commercially available, allowing easy entry to a possible asymmetric synthesis. 
With an acyclic leaving group at C2 ', access to optically pure starting materials is 
considerably more difficult.90 By incorporation of the necessary acyl substituent in the 
ester (3.5, R = CO(CHi)4CH(CH3)2) this cyclisation route seemed to offer the potential 
for a remarkably efficient route to A-factor (1.1). 
HO~ 
3.4 glycidol 
+ 
HOlfR 
0 R= acyl or alkyl 
0 
base 
·----------------~ 
? 
• 
0 
3.5 3.2 
1.lR=~ 
0 
Scheme 3.2 
However, in selecting epoxide activation we recognised that we were also 
introducing another possible site for attack, the terminal epoxide carbon C3' on 3.5. 
Since the C3' position is less substituted than C2' it offers a potentially significant 
alternative site for enolate attack. In order to assess the feasibility of achieving 
regioselective C2' attack, a literature search was undertaken for examples of 
5-membered ring formation via the intramolecular opening of epoxides. Table 3.1 
contains selected examples of the intramolecular attack on epoxides at the required 
secondary site by a variety of stabilised anions. 
r 
I· 
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Table 3.1 Literature Examples of 5-Membered Ring Formation via the 
lntramolecular Opening of Epoxides 
Entry No. Reaction Yield Ref. 
Me 
NaNH2/NH3 OH 
91 1 77% 
CN 
~ NaOEt 
2 0 ) C02Et "high" 92 
~COiEt C02Et COiEt 
~Ph LOA OH 
3 72% 93 a } 
~S02Ph 
~ OH 
4 } "BuLi 67% 94 
CONEt2 
04> "Bu3N O~OH 95 5 
rN-Ph 92% 
r~-Ph 
0 0 
~ NaN(TMS):i OH Me-CC 96 6 Me-N } 67% 
\.,.....-:.....CN CN 
~Ph 
Ph 
Base OH 
7 0 
·----!!------ 0% 93 
)r--cN 
0 0 
Entries 2, 4, 5 and 6 (Table 3.1) show that 5-membered rings can be formed in 
good yields via epoxide opening at the required epoxide carbon, even when the 
alternative epoxide site remains unsubstituted and thus might be expected to be more 
reactive. In no case was a 6-membered ring product reported. It appears that the kinetic 
advantage of forming 5 rather than 6 membered rings97 outweighs the advantage of 
II 
/ 
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attack at a less sterically hindered primary carbon. Entry 2 (Table 3.1) provides 
precedent for the use of enolate stabilised anions in this sort of cyclisation. No 
precedent for . y-lactone formation was found, although Entry 5 in which an 
oxazolidinone is formed shows that the nitrogen-containing analogue of our desired 
transformation is feasible. Ominously, the only reference located which mentioned the 
attempted cyclisation of a glycidyl ester to make a y-lactone (Entry 7, Table 3.1) 
reported failure, ''presumably for stereoelectronic reasons".93 
Nevertheless, given the precedent for the desired mode of epoxide opening 
provided by the other entries, an experimental investigation of the cyclisation was 
initiated, starting with the simplest substrate, glycidyl acetate (3.6). 
3.1.2 Cyclisation of Glycidyl Esters 
Formation of the lithium enolate of glycidyl acetate (3.6) at -78°C (1.1 eq., 
LDA, THF), followed by slow warming to room temperature yielded a complex 
mixture of products which did not include any detectable quantities of 3-hydroxymethyl 
butyrolactone (3. 7) by I H NMR spectroscopy. 18 The major product isolated was 
glycidyl acetoacetate (3.8) (50%), resulting from Claisen self-condensation of the 
starting material (Scheme 3.3). Aldol condensation between this product and another 
molecule of the enolate resulted in the formation of 10% of the bis-glycidyl ester 3.9. 
The molecular weight of the bis-glycidyl ester was established by CIMS to be 274 and 
the fragmentations observed by EIMS were consistent with the proposed structure 3.9. 
1H NMR spectroscopy of 3.9 showed a singlet methyl signal at 6 1.39 and a four proton 
pseudo-doublet (6 2.73, J = 5 Hz) which was assigned to the two methylene groups a to 
the ester carbonyls. A system of resonances characteristic of a glycidyl ester moiety 
was shown to represent two such groups by its ten proton integration measurement. 
This structure has interesting diastereomeric possibilities since the central carbon is 
pseudoasymmetric, i.e. it is only chiral when the two epoxides differ in configuration. 
Thus, two meso forms of this molecule are expected in addition to a di-pair. However, 
the three forms are evidently very similar by I H NMR, as would be expected for a 
I. 
11 
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molecule with such widely separated asymmetric centres, since the only indication of 
additional sets of peaks was some slight line broadening. A further 12% of the mass of 
the starting material was isolated as an unidentified mixture of compounds which 
appeared, by I H NMR, to contain intact glycidyl moieties as indicated by complex 
resonances near o 4.5, 4.0, 3.2, 2.9 and 2.7. Similar mixtures of self-condensation 
products were obtained using a more dilute reaction mixture, a lower reaction 
temperature (-60°C) or a Lewis acid (BF3.0Et2). 
LDA/THF 
0 0 
-78 C to 20 C 
3.6 
~ ~o 0\.-------...-- + 
// II c~ 
0 0 
3.8 50% 
07H 
0 
3.7 
not detected 
Scheme 3.3 
OH oA 
3.9 10% 
Self-condensation is a commonly observed side reaction of ester enolates unless 
the ester carbonyl is sterically crowded (e.g. t-butyl esters) or the anion has additional 
resonance stabilisation.98 However, in this case the tendency to self-condense was 
expected to be minimised by the use of the hindered lithium amide base (LOA) and low 
reaction temperatures. 99 It appears that intramolecular attack on the epoxide is not 
facile enough to offer an alternative reaction path. 
This prompted us to re-examine the reported efficient intramolecular epoxide 
opening of glycidyl phenyl carbamate95 (3.10) as listed in Table 3.1 (Entry 5). The 
paper describes exclusive C2' attack by nitrogen under mildly basic conditions to give 
the oxazolidinone 3.11 (Scheme 3.4); this is a nitrogen-containing analogue of our 
desired reaction. Since an earlier report100 described cyclisation through C3' we 
thought it prudent to repeat the reaction. 
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3.10 
Scheme 3.4 
O~OH 
yN-.Ph 
0 
3.11 
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Glycidyl phenyl carbamate (3.10) was prepared from glycidol and phenyl 
isocyanate by the method of Farrissey et al. 95 Cyclisation was indeed found to be facile 
and regioselective, requiring only warming in the presence of pyridine to achieve an 
almost quantitative yield of the oxazolidinone 3.11, thus confirming the more recent 
repon.95 Interestingly, Minami et az.101 report that the glycidyl N-benzylcarbamate 
3.12a cyclised in high yield (81 %) upon treatment with potassium t-butoxide, whereas 
the substrate unsubstituted on the nitrogen (3.12b ), failed to cyclise under identical 
conditions. 
'BuOK . 
3.12 a R = Benzyl 81 % yield 
3.12 b R = H ~ no reaction 
Scheme 3.5 Related Literature Reactions by Minami et al. 
To examine the possibility that the presence of nitrogen substituents in 3.10 and 
3.12a was promoting cyclisation, possibly via steric or electronic effects, we prepared 
glycidyl phenylacetate (3.13), 102 the direct carbon analogue of glycidyl 
phenylcarbamate (3.10). The lithium enolate of glycidyl phenylacetate (3.14) was 
formed using LDA. The first characteristic noted was its surprising stability, since 
virtually no reaction took place even after 22 hours at room temperature. More than 
75% of unreacted starting material was recovered after this period. Complete anion 
formation was confirmed by quenching a sample of reaction mixture with an excess of 
methyl iodide; NMR and GC analysis revealed> 95% methylated starting material. 
I 
I 
I 
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It was subsequently discovered that the addition of an extra equivalent of 
n-butyllithium to the anion solution at -30°C resulted in the formation of two major 
products, in addition to some complex polar material. After chromatography, the more 
polar of the major products was isolated as colourless needles in 40% yield. Its 
I H NMR spectrum lacked both the benzylic methylene singlet (O 3.6) and the three 
epoxide resonances (O 3.2, 2.9 and 2.7) of the starting material, suggesting that 
cyclisation had occurred. In addition, the infra-red carbonyl stretch absorption at 
1771 cm-I suggested that a -y-lactone had been formed. 103 A molecular ion at mlz 192 
in the EIMS was consistent with either the desired 3-hydroxymethyl substituted 
butyrolactone 3.18 or the 4-hydroxymethyl alternative 3.16 (Scheme 3.6). 
~ 0 LOA .. ~3' n-BuLi 0 
-30°C 
~Ph 1.leq., -30°C )r--Ph Ph o, 0 0 Li 3.13 , 3.14 3.15 , , , 
~ Jw ~ , , , 
, , OH 
OH 
Ph + 
Ph 
0 0 
3.18 3.17 21% 3.16 40% 
not detected 2 cliastereomers 
Scheme 3.6 
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Comparison of the 1 H NMR data of the product with those reported for 
reference y-lactones 3.19104 and 3.2025 offered a distinction between these two possible 
structures (see below). The observed downfield methine multiplet at o 4.6-4. 7 is 
expected for the 4-hydroxymethyl compound (cf. 3.19) but not for 3-hydroxymethyl 
butyrolactones (e.g. 3.20). In addition, the characteristic pair of doublets of doublets at 
o 4.4 and o 4.1 due to the C4 methylene protons of the 3-hydroxymethyl butyrolactones 
3.20 was absent. The remaining 1 H NMR data as well as the 13C spectrum supported 
the assignment of the product as a diastereomeric mixture of the 4-hydroxymethyl 
butyrolactones 3.16. These probably are formed by initial enolate carbon attack at C3' 
of 3.14 giving the o-lactone intermediate 3.15, followed by translactonisation, as 
depicted in Scheme 3.6. 
64.64.7, m 
Ph 
0 
3.16 40% 
2 diastereomers 
64.66, m 
' 
' 
'H 
0 
3.19 
64.4, ddl 
6 4.1, ddJ ', 
1j1I 
0 OH 
3.20 
R 
R= various alkyl 
Literature 1 H NMR reference compounds 
The other major product (21 % ) was identified as the carbinol 3.17, resulting 
from the sequential addition of two molecules of n-butyllithium to the carbonyl of the 
ester starting material. None of the desired 3-substituted butyrolactone 3.18 was 
( 
detected by 1 H NMR in any chromatographic fraction. 
The additional n-butyllithium is believed to enhance enolate reactivity by 
deprotonating the diisopropyl amine in the reaction mixture, thus breaking up the 
H-bonded complex between the lithium enolate and the amine in solution and leaving 
the enolate free to react. This complex was postulated by Seebach's group105 to explain 
the incomplete (ca 30%) deuteration of lithium enolate anions. The addition of one 
equivalent of n-butyllithium increases deuteration to ca 95%. Unfortunately, the use of 
this highly nucleophilic base also causes extensive side reactions. 
,. 
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Hexamethylphosphoramide (HMPA) is often used as an alternative means of 
enhancing enolate reactivity.106 For the cyclisation of anion 3.14, the inclusion of 10% 
HMP A in the TIIF solvent resulted in the formation of 25% of the previously isolated 
lactone 3.16 (Path A, Scheme 3. 7). In addition, 30% of an inseparable mixture of the 
glycerol esters 3.23 and 3.24 (5:1 ratio) was isolated. These diols were identified by 
comparison of their lff NMR spectra with other known 1- and 2-monoglycerides107 
Overall recovery was low due to extensive polar by-product formation. Again, no 
4-hydroxymethyl butyrolactone 3.18 was detected. 
)1>3• ~~ Path A 0 x)B ... (via 6-membe.red ring) {o'Li '4 ~Ph LDA 
Ph o, HMPA/THF 
Ph Li 0 
3.14 3.16 25% 
2 diastereomers 
LDA 
HMPA/THF 
OH 
HO~O'r('Ph OH 
,<OH ~ 3.23 25% 0 H20 010 010 + 
HO:)'O'('Ph Ph Ph 
3.22 3.21 HO 
3.24 5% 
Scheme 3.7 
It is unlikely that the diols 3.23 and 3.24 resulted from hydrolysis of the starting 
epoxide 3.13, since the reaction was performed under anhydrous conditions and the 
reaction mixture was buffered to pH 6.5 during aqueous work-up. In addition, a 
subsequent acyl migration would be required to form the observed 2-acyl glycerol 3.24. 
It is much more likely that the diols arose via enolate oxygen attack on the secondary 
epoxide site (C2', Scheme 3.7, Path B) producing the unstable ketene acetal 
intermediate 3.21. Hydrolysis of this acetal could give the two observed 
Chapter Three 61 
monoglycerides 3.23 and 3.24. Oxygen attack on C3' (giving 3.22) is less likely given 
the kinetic advantages of 5 vs. 6 membered ring formation in cyclisations of this type. 97 
Note that 3.22 cannot readily form the observed 2-acyl glycerol 3.24 via hydrolysis. 
Careful re-examination of the 1 H NMR spectra of polar fractions from the 
cyclisation without HMP A (Scheme 3.6), revealed ca 5% of the diol 3.23 and a trace of 
diol 3.24. The observed formation of a greater proportion of these diols in the presence 
of HMP A is consistent with the recognised ability of polar aprotic solvents to promote 
0-alkylation of ambident enolate anions.106 
Thus the presence of the phenyl substituent in the ester enolate 3.14 has reduced 
the reactivity of the anion sufficiently to allow intramolecular alkylation to compete 
with intermolecular Claisen condensation. Unfortunately, the 'wrong' end of the 
epoxide is preferentially attacked by the enolate carbon (Scheme 3.6) and competing 
reactivity of the enolate oxygen has been observed (Scheme 3. 7). The sharp contrast 
between this reactivity and that observed for the corresponding carbamate 3.10 
(Scheme 3.4 ), indicates that it is the nature of the ~ttacking moiety that is the critical 
factor rather than the presence of a phenyl substituent. 
3.1.3 Stereoelectronic Effects in lntramolecular Epoxide 
Opening 
3.14a 3.14b 
For the opening of an epoxide by an enolate carbanion to proceed, the 1t-orbitals 
of the nucleophilic enolate carbon must achieve an attack trajectory which is co-linear 
with the epoxide C-0 bond at the attack site to maximise orbital overlap.108 Studies 
with Dreiding models show that for an intramolecular process, the minimum chain 
length connecting the reacting centres for which this co-linearity is easily achieved is 
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six atoms (e.g. 3.14b). When a 5-atom chain is used (e.g. 3.14a) considerable angle 
strain appears to be involved in achieving the required transition state geometry. 
Baldwin and Lusch109 have made a systematic study of such stereoelectronic 
effects involved in various enolate cyclisations, as an extension of Baldwin's 
well-known previous study of general cyclisation reactions.110 They concluded that it is 
of critical importance whether the enolate C=C bond is ENDO (i.e. inside) or EX.O 
(i.e. outside) to the ring being formed (see Scheme 3.8). 
"Especially when the enolate C=C bond is ENDO to the ring being 
formed in the alkylation, the planarity of the enolate system curtails 
the freedom of movement of the chain of the leaving group and 
approach of the electrophilic halide [ or in our case, epoxide] carbon 
on a trajectory perpendicular to the enolate plane at the a-carbon 
atom, is an important factor in determining the ability of the reactive 
termini to meet in proper orientation." 109 
(ENOLEX.0)-EXO-TE/' 
'favoured' for 3-7 membered rings 
LG = leaving group 
R 
Scheme 3.8 
L_V 
c~ 
-
(ENO LENDO )-EXO-TEI' 
'favoured' for 6 and 7 membered rings 
'disfavoured' for 3-5 membered rings 
R 
They propose that when the chain of atoms connecting and including the 
reacting sites is 6 or more atoms long there is sufficient flexibility to achieve the 
required geometry for cyclisation even when the enolate C=C bond is ENDO, 
i.e. 6-(ENOLEX.O)-EXO-TET and 6-(ENOLENDO)-EX.0-TET alkylations are 'favoured' 
processes (see Scheme 3.8). However, for 3 to 5 membered cyclisations, the required 
reaction geometry can only be easily achieved when the enolate C=C bond is EXO. The 
flexibility restrictions caused when the enolate C=C is ENDO makes the required bond 
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overlap difficult to achieve; i.e. 3 to 5-(ENOLENDO)-EXO-TET cyclisations are 
'disfavoured' (see Scheme 3.8). 
When intramolecular enolate alkylation occurs via attack by the enolate oxygen, 
the necessary reaction geometry is much easier to achieve. The ability of the enolate 
oxygen to react via its sp2 hybridised lone pairs means that it may attack within the 
enolate plane, a process which is much less stereoelectronically demanding than attack 
by x-orbitals perpendicular to the enolate plane (Scheme 3.9).111 
EXO-TET 
'favoured' for 3-7 membered rings LG = leaving group 
Scheme 3.9 
This cyclisation may be classified as a simple EXO-TET process110 (since the 
enolate x-system is not involved) and is 'favoured' for all 3 to 7 membered cyclisations. 
The facile cyclisation of carbamates 3.10 and 3.12a, (Schemes 3.4 and 3.5) is likely to 
occur via this favoured pathway with the nitrogen atom attacking the epoxide via its sp2 
hybridised lone pair, a pathway obviously not available to the analogous carbon 
compound, glycidyl phenylacetate (3.13, Scheme 3.6). 
The reason for the failure of the N-unsubstituted carbamate 3.12b to cyclise 
under conditions which readily cyclised the analogous N-benzyl carbamate 3.12a (see 
Scheme 3.5) is not clear since the relative contribution of differences in acidity, 
nucleophilicity and stereoelectronic effects in the two substrates are difficult to assess. 
The results observed for the cyclisation of the glycidyl phenylacetate anion 3.14 
(Scheme 3.11) are in accordance with Baldwin's analysis of such types of cyclisations. 
Baldwin and Lusch 109 consider the opening of 3-membered rings as being 
stereoelectronically intermediate between a normal tetrahedral and trigonal system. 
Since the rules for EXO-TET and EX.0-TRIG cyclisations are the same, we will denote 
jl 
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epoxide openings as EXO-TEI'' processes for simplicity. Thus, the required enolate 
carbon attack at C2' (Path A, Scheme 3.10) can be considered an example of a 
'disfavoured' 5-(ENOLENDO )-EXO-TEI'' process in competition with two alternative 
'favoured' pathways: 
• enolate carbon attack at C3' (Path B)- a 6-(ENOLENDO)-EXO-TEI''process; 
• enolate oxygen attack at C2' (Path C)- a 5-EXO-TEI'' process. 
The failure of the cyclisation reaction to generate the desired y-lactone may 
therefore be rationalised on stereoelectronic grounds. 
3.14 
PathA 
5-(ENOLENDO)-EXO "JET 
PathB 
~(ENOLENDO)-EXO '1ET 
'favoured' 
0 
3.18 
PathC 
5-EXO "JET 
'favomed' 
0 
3.16 
OH 
HO I 0~ ~ II · Ph 
0 
3.23 
Scheme 3.10 
+ 
Ph 
3.24 
The previously discussed literature examples of successful 5-membered 
cyclisations via intramolecular epoxide openings (see Table 3.1) may be classified into 
two 'favoured' categories of cyclisation using Baldwin's analysis. Entries 1, 2 and 6 
(Table 3.1) are 5-(ENOLEXO)-EXO-TET' processes, whereas Entries 3, 4 and 5 are 
5-EXO-TEI'' cyclisations since the attacking orbitals of the nucleophilic atom are sp2 
hybridised. Only the final, unsuccessful example (Entry 7) is of the same 'disfavoured' 
II 
' , 
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5-(ENOLENDO )-EXO-TEI'' type as the cyclisation that we require. It also probably 
failed due to competition with 'favoured' processes. 
The fact that our required reaction type (Path A) is 'disfavoured' by Baldwin's 
'rules' does not preclude the possibility of it occurring under any circumstances. It 
simply means that 'disfavoured' processes have a kinetic handicap with respect to any 
'favoured' reaction pathways which are available. Indeed reactions which are 
'disfavoured' processes have been shown to proceed (see also Section 4.2.1 ).112-114 In 
the case of 5-(ENOLENDO)-EXO-TEI'' cyclisations, however, we have been unable to 
find any examples of successful reactions. In addition, it must be recognised that the 
biochemical cyclisation which we were attempting to emulate does not involve the 
cyclisation of a simple ester, but rather a J3-ketoester 2.12b, (see Scheme 2.7). Thus the 
feasibility of using a glycidyl J3-ketoester 3.25a as a model cyclisation substrate was 
investigated. 
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3.1.4 Cyclisation of Glycidyl (3-Ketoesters 
It was recognised that the fundamental difference between ester and (3-ketoester 
cyclisation substrates is that, a priori, the latter have the ability to form EX O enols 
3.25b or EX O enolates 3.26a as depicted in Scheme 3.11, thus potentially permitting 
cyclisation via a 'favoured' 5-(ENOLEXO)-EXO-TEI''process. 
r1> 0)--ir-R 
0 0 
3.25a 
R = alkyl 
r1> 0 )r-=r-R 
o _o 
3.26a enolate 
Scheme 3.11 
r1> 0 )r-=r-R 
0 HO 
3.25b enol 
r1> 0 
r-ir-R 
0 0 
3.26b 
The anion of a glycidyl-(3-ketoester may be considered to be a hybrid of the two 
canonical forms 3.26a and 3.26b, (Scheme 3.11) in which the enolate 1t-electron density 
is EXO and EN DO, respectively, to the ring to be formed. The formation of 
5-membered rings via intramolecular alkylation of an ENDO enolate (cf3.26b) has 
been shown in the preceding discussion to be stereoelectronically 'disfavoured'. In 
contrast, EXO enolates readily form 5-membered rings. 1()(),92 However, the enolates of 
J3-ketoesters incorporate both EXO and ENDO 1t-electron density and consequently their 
ability to cyclise is not easy to predict. Conflicting reports regarding this appear in the 
literature. 
Michael and Weiner115 claim that the sodium enolate of the chloroester 3.27a 
cyclises through the enolate carbon (Path A, Scheme 3.12) to give the butyrolactone 
/I 
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3.28 albeit in low yield (35% ). The identity of their product was said to have been 
confirmed by independent synthesis. In addition, they claim that the sodium enolate of 
the chloro y-lactone 3.30 undergoes intramolecular C-alkylation to form the bicyclic 
lactone 3.31 in 70% yield. In contrast, Parker116 reports (without reference to the 
earlier results of Michael and Weiner) that the sodium enolate of the corresponding 
bromoester 3.27b cyclises exclusively via intramolecular 0-alkylation to give the 
ketene acetal 3.29 in 94% yield. 
B 
______ OEt 
3.30 
3.27a X=Cl 
3.27b X=Br 
OEt 
OEt 
3.28 35% 
OEt 
0 
3.29 94% 
3.31 70% 
Scheme 3.12 Literature Reports of f3-Ketoester Cyclisations 
It seems unlikely that this dichotomy of results is due simply to the difference in 
leaving groups between 3.27a and 3.27b since, if anything, a bromide leaving group 
would be expected to enhance C-alkylation.117 Thus, there exist conflicting literature 
precedents for the cyclisation behaviour of glycidyl-f3-ketoester substrates 3.26. 
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3.26 
To address this question of regioselectivity, the 3-oxononanoic ester 3.32a was 
prepared. This straight chain substrate was chosen to provide a close model for the 
methyl-branched system 3.32b which would be required for the preparation of A-factor. 
The branched chain precursors required for the ester 3.32b are far more expensive and 
less available than the straight-chain equivalents, and were thus not suitable for these 
preliminary investigations. 
~ 0 
0 0 
3.32a R=H 
3.32b R=CH3 
R 
Our initial approach to the synthesis of this glycidyl ester was to prepare methyl 
3-oxononanoate (3.33a)118 via the acylation of ethyl acetoacetate (Scheme 3.13) 
followed by cleavage of the acyl acetoacetate intermediate 3.34 with methoxide. The 
yield was 60% (after distillation) over the two steps. In subsequent preparations we 
employed the more direct and faster method of Hue.kin and Weiler119 (see Scheme 3.13) 
in which the dianion of ethyl acetoacetate was alkylated to give the ethyl J3-ketoester 
3.33b, in similar yield (65% ). 
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i)Na 
ii)CI~ 
0 
i)NaH 
ii) "BuLi 
···)~ Ill Br 
Scheme 3.13 
EtO 
0 0 
3.34 
0 
NaOMe 
MeOH 
3.33a R = Me 60% } 
3.33b R = Et 65% J HCI 
AcOH 
3.33c R = H 60% 
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The J3-ketoesters 3.33a and 3.33b were hydrolysed to the J3-ketoacid 3.33c in 
60% yield by a method similar to that of Mitz et al.120 using concentrated aqueous 
hydrochloric acid and glacial acetic acid (1:2) at room temperature for 22 hours. The 
crude prcxluct, which crystallised from the acid mixture, is ca 95% pure (by IH NMR) 
and can be esterified directly. However, if the prcxluct is to be stored, recrystallisation 
from benzene / hexane is recommended to prevent decarboxylation which appears to be 
promoted by impurities. This relatively old acid hydrolysis procedure is far superior to 
the base hydrolysis (K2C03 / MeOH) employed by mcxlern workers 121 which gives low 
(20-30%) yields of unstable prcxluct. 
Esterification of the J3-ketoacid 3.33c with glycidol was first attempted using 
mesyl chloride/ triethylamine122 but this gave only low yields (ca 33%) of the 
glycidyl J3-ketoester 3.32a. The use of N,N-dicyclohexylcarbodiimide (DCC) catalysed 
with 4-dimethylaminopyridine (DMAP)123 improved the yield of ester to 70% after 
distillation (Scheme 3.14). 
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The I H NMR spectrum of the glycidyl-J3-ketoester 3.32a displayed the 
prominent C2 methylene singlet at 6 3.50 and five characteristic resonances for the 
protons of the glycidyl moiety. The lH NMR spectrum also shows that in chloroform 
solution ca 10% of the J3-ketoester exists in the enol form as characterised by the sharp 
enol hydroxyl at 6 11.8 and the enol olefinic proton at o 5.1. 
3.1.S Cyclisations of Glycidyl J3-ketoester (3.32a) 
The lithium enolate of the J3-ketoester 3.32a (1.2 eq., LDA, THF, -30°C) was 
found to be quite unreactive. Gas chromatographic analysis of the reaction mixture 
showed only unchanged starting material even after 20 hours at room temperature. 
Complete enolate formation was confirmed by GC and I H NMR analysis of a sample of 
reaction mixture quenched with an excess of methyl iodide. Less than 5% of the 
sample was unmethylated starting material. 
To eliminate the possibility discussed above that an H-bonded complex105 
between the enolate and the diisopropylamine could be inhibiting anion reactivity, we 
repeated the reaction with the non-amide base, sodium hydride. This base also allows 
the use of elevated reaction temperatures. 
The sodium enolate of the J3-ketoester 3.32a (1.2 eq., NaH, THF, 20°C) was also 
unreactive at room temperature. After heating at reflux for 3 hours three compounds 
were isolated from the reaction mixture using radial chromatography, with the 
remainder being complex polar material. The most polar product isolated, formed in 
15% yield, was identified as the 1-monoglyceride 3.42 (Scheme 3.15). In this case 
none of the isomeric 2-monoglyceride 3.43 was detected. Identification was made by 
1 H NMR comparison with the previously isolated monophenylacetyl glycerides 3.23 
and 3.24 (Scheme 3.7) as well as with reported lH NMR data for other 
monoglycerides. 107 Although a molecular ion was not present in the EIMS, the 
expected M+-CH20H peak at rn/z 215 was observed. These products were probably 
formed in a process directly analogous to that described for the monophenylacetyl 
-
Chapter Three 71 
glycerides 3.23 and 3.24 (see Scheme 3.7) in which the enolate lactone oxygen 
intramolecularly opens the epoxide at C2' (Path C, Scheme 3.15), forming the 
intermediate ketene acetal 3.41, which is subsequently hydrolysed. 
The next most polar compound, formed in 10% yield, was identified as a 
y-lactone by its characteristic infrared carbonyl stretching band at 1780 cm-I, in the 
centre of the normal y-lactone range103 of 1795-1760 cm-I. The observation of a 
second carbonyl band at 1725 cm-I suggested that a ketone group was still present. The 
EIMS displayed a weak peak at mlz 228 which was confirmed as being the molecular 
ion by CIMS. High resolution mass measurement of this peak indicated a molecular 
composition of CI2H2004 which is consistent with either of the two 
hydroxymethyl-substituted y-lactones 3.40 or 3.36, both of which could be formed by 
intramolecular epoxide opening (Scheme 3.15). Although the IH NMR spectrum 
(300 MHz) was very complex due to extensive coupling and the presence of a 
diastereomeric mixture, it allowed us to identify the prcxluct by comparison with the I H 
NMR spectrum of the previously identified diastereomeric 4-hydroxymethyl 
butyrolactones 3.16 (Scheme 3.6). Again we observed the distinctive C4 methine 
multiplets between o 4.58-4. 73 which indicate a 4-hydroxymethyl substituent, rather 
than the C4 methylene protons of a 3-hydroxymethyl compound, which would be 
expected as doublets of doublets at ca o 4.4 and o 4.1.25 The rest of the I H NMR 
spectral data as well as the I3C NMR spectrum were fully consistent with the 
assignment of this product as a diastereomeric mixture of 4-hydroxymethyl 
butyrolactones 3.40. These were presumably formed by enolate carbon attack at the 
primary end (C3') of the epoxide (Path B) followed by translactonisation and 
protonation, as depicted in Scheme 3.15. Attempts to separate the diastereomers by 
reverse-phase MPLC were unsuccessful. 
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The least polar and major product, isolated in 42% yield, was also shown to be a 
y-lactone by its IR carbonyl stretching band at 1782 cm-I. The largest ion detected in 
the EIMS was at mlz 228, suggesting that this lactone was isomeric ,with the other 
y-lactone product 3.40. The possibility that this new lactone was the desired 
3-hydroxymethyl butyrolactone 3.36 was eliminated when the CIMS revealed a 
molecular weight of 382, 154 mass units higher than required. I H NMR spectroscopy 
revealed the distinctive multiplets at o 4.67-4.84 indicating a 4-substituted 
butyrolactone structure as observed previously (cf 3.40 and 3.16). The appearance of 
two methylene singlets at o 3.5 was characteristic of J3-ketoester a-methylene protons, 
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and the observation of an 'extra' heptanoyl moiety in the lH NMR spectrum, led to the 
proposal that the product was the 0-(3-oxononanoyl) butyrolactone 3.39 (Scheme 3.15) 
as a 1: 1 diastereomeric mixture. Further assignments of the I H NMR resonances and 
the presence of 8 carbonyl resonances in the 13C NMR spectrum were in agreement 
with this structural proposal. Again, reverse phase MPLC failed to separate the 
diastereomers. 
These 0-acyl-lactones 3.39 are believed to be formed via the acylation of the 
y-lactone alkoxide intermediate 3.38 by a molecule of non-ionised f3-ketoester starting 
material 3.32a. Surprisingly, the formation of the 0-acyl-lactone 3.39 was not 
appreciably diminished by the use of an excess of sodium hydride (6 equivalents), 
which was expected to have ensured complete ionisation of the f3-ketoester 3.32a and 
hence protect it against nucleophilic attack. Evidently, there exists an equilibrium 
concentration of non-ionised ester 3.32a which is attacked by the alkoxide 3.38. 
Thus, the regiochemistry of cyclisation of the glycidyl f3-ketoester 3.32a is 
essentially quite similar to that observed for glycidyl phenylacetate (3.13, Schemes 3.6_ 
and 3.7). The lactone products observed, in both cases, resulted exclusively from 
enolate carbon attack on the primary epoxide site (C3') rather than at the desired C2' 
position. With both substrates, some intramolecular 0-alkylation was also observed, 
resulting in the formation of the mono glycerides 3.23, 3.24 and 3.42. In neither case 
was there any evidence of the desired mode of cyclisation taking place. Base promoted 
cyclisations of glycidyl esters did not appear to be very promising. Acid catalysed 
cyclisations did not seem any more promising since the stereoelectronic effects 
involved in the attack of an ester enol (e.g. 3.2Sb, see Scheme 3.11) on a protonated (or 
Lewis acid complexed) epoxide are identical to the reactions explored above. 
Our interest in the cyclisation of glycidyl-f3-ketoesters has recently been 
rekindled following the isolation by Pathirana and co-workers 124 of a novel butanolide 
3.44 from a marine Actinomycete which has been shown to have antibiotic properties. 
This metabolite is a 4-hydroxymethyl butyrolactone, very close in structure to the 
lactones 3.40 which we have isolated (see Scheme 3.15). It differs only by its oxidation 
-
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level at C6 and the presence of a Cl I methyl substituent. The cyclisation of the 
glycidyl (3-ketoester 3.45 potentially offers a very direct route to this antibiotic which 
may provide an alternative to the low-yielding route employed by its discoverers for 
their structural confirmation. The route could potentially model the biosynthesis of the 
metabolite 3.44 which may be achieved via the cyclisation and rearrangement of a 
(3-ketoester of the common metabolite glycerol- I-phosphate (i.e. 3.61, see 
Scheme 3.16). For a synthesis of this type to be viable, however, further work would be 
required to increase the yield of 4-hydroxymethyl butyrolactone 3.40 by the 
minimisation of the 0-acylation of the alkoxide intermediate 3.38. Stereocontrol at C4 
could potentially be achieved with the use of optically active glycidol. 
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3.1.6 Cyclisation of lodo-J3-ketoester (3.46) 
Frustrated by attempts to achieve intramolecular enolate carbon attack at the C2' 
position of glycidyl J3-ketoester (e.g. Scheme 3.15, Path A), we prepared the iodoethyl 
J3-ketoester 3.46 as a model cyclisation substrate which offers only a single reaction 
site. This substrate provides direct competition between intramolecular C- and 
0-alkylation by the J3-ketoester enolate. 
3.46 
The use of an iodide leaving group was expected to maximise C-alkylation, an 
effect observed in intermolecular alkylations117 and often rationalised in terms of the 
'Hard-Soft Acid Base' (HSAB) principle.125,126 The enolate carbon atom, being 'softer' 
than the enolate oxygen, preferentially displaces a 'soft' iodide leaving group. 'Harder' 
leaving groups such tosylate and triflate have been found to strongly favour 
0-alkylation. A primary iodide was used in this model substrate to ensure adequate 
reactivity under relatively mild conditions. Thus, the cyclisation of this iodoester 3.46 
should provide a clear test of the viability of forming y-lactones via an intramolecular 
C-alky lation. 
Esterification of 3-oxononanoic acid 3.33c with iodoethanol formed the iodide 
(3.46). Treatment of this product with sodium hydride {THF, 20°C, 5 min) resulted in 
rapid and exclusive oxygen alkylation, forming the ketene acetal 3.48 in 75% yield 
(Scheme 3.17). The acetal was, in this case, sufficiently stable to isolate using silica 
chromatography. No sign of y-lactone products was observed by lH NMR 
spectroscopy in any of the chromatographic fractions. This result conflicts with the 
report of Michael and Weiner 24 who claim y-lactone products 3.28 and 3.31, from 
related substrates 3.27 and 3.30 respectively, (Scheme 3.12). However, it is consistent 
with the report of Parker116 and that of Svendsen et al. 127 who also observed exclusive 
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intramolecular 0-alkylation in closely related 5-membered cyclisations (e.g. 3.27b, 
Scheme 3.12). 
The reaction was repeated using tetra-n-butylammonium fluoride as base, a 
reagent specially recommended for the promotion of C-alkylation in intramolecular 
aldol condensations of ~ketoesters. 128 Again, we observed rapid and exclusive enolate 
oxygen attack to produce the ketene acetal 3.48 in 70% yield. 
I 
~ 
3.46 
Scheme 3.17 
3.47 
0 
3.48 
The fact that we had failed to observe any of the desired intramolecular 
C-alkylation of ~-ketoesters, even with this last promising substrate, led to the 
conclusion that the facile 'favoured' 0-alkylation reaction pathway would dominate the 
reactivity of these systems, regardless of the leaving group employed. Apparently the 
~-ketoester enolates retain sufficient electron density in their ENDO C=C bond to 
ensure planarity across the enolate system and thus preclude reaction via a 'favoured' 
ENOLEXO process. At this stage we decided to discontinue further attempts to form 
y-lactones by this method and instead investigate intermolecular alkylations as a method 
of forming y-lactones which does not have such severe stereoelectronic constraints. 
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The experimental work thus far reflects attempts to model the biosynthetic 
construction of 2,3-disubstituted butanolides in which esterification precedes C2-C3 
bond connection. It is feasible biosynthetically, although perhaps less likely, for this 
order to be reversed, as was depicted in the retrobiosynthetic analysis of the butanolide 
autoregulators in Chapter 2 (see Scheme 2.6, path B). An alternative biomimetic route 
to these butanolides, based on this analysis, is depicted in Scheme 3.18. Thus, a 
suitable ~-ketoester 3.49 could be intermolecularly alkylated at its a-position with a 
protected 1,3-propanediol which is activated at its central carbon by either a leaving 
group as in 3.50 or a carbonyl group as in 3.51. The ~-ketoester diol 3.52 which could 
be derived from the product of either of these reactions would be readily lactonised to 
the desired 2,3-substituted butanolide 3.2. 
X 
PO~OP 
0 
PO~OP 
or 
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While the initial a1ky lation step in a synthesis based on this analysis would lack 
the large entropic advantage of intramolecular reactions, the method would avoid the 
associated severe stereoelectronic constraints which we have encountered, since the ring 
closure step, a lactonisation, would now be of the 'favoured' 5-EXO-TRJG type. 
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To assess the feasibility of this approach, the diprotected iodo-diol 3.53 was 
prepared by treatment of 2-iodopropanediol129,130 with TBDMS-triflate. Iodide was 
again chosen as the leaving group due to its high reactivity and its reported ability to 
maximise C-alkylation of J3-ketoester enolates.117 
When the iodide was heated at reflux in THF for 48 hours with the sodium 
enolate of the ~ketoester (3.33a), no sign of reaction was detected by TLC analysis. 
That the anion was still active after this time was demonstrated by the addition of an 
excess of methyl iodide to the reaction mixture. The a-methyl-13-ketoester 3.54 was 
isolated in 80% yield, (Scheme 3.19). That the enolate was C- rather than 0-methylated 
was determined by the observation in the 1 H NMR spectrum of a methine quartet at 
6 3.52 and a doublet methyl resonance at 6 1.33, features expected only for the 
C-alkylation product 3.54. In addition, the unreacted iodopropanediol 3.53 was 
recovered almost quantitatively (96% ). 
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The lack of reactivity displayed by this sterically crowded secondary iodide, 
even under these rather forcing conditions, prompted us to examine the analogous 
reaction using the ketonic electrophile 3.55. Dihydroxyacetone was diprotected as 3.55 
and was added to a solution of the sodium enolate of the 13-ketoester (3.33a) in diethyl 
ether. After 24 hours at room temperature the silyl ketone had been wholly converted 
into a mixture of complex products whereas the ester 3.33a was largely recovered 
li 
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(90%) by chromatography (Scheme 3.20). The mixture of products, although not 
separated or fully identified, was shown by I H NMR to lack the characteristic 
resonances of hexyl or ethoxyl moieties which would be expected to be present if any of 
the components had been derived via Knoevenagel condensation with the J3-ketoester 
3.33a. The by-products presumably result from base catalysed self-condensation of the 
sil y 1 ketone. 
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The disappointingly low reactivity towards intermolecular alkylation observed 
using either the iodo or keto electrophiles did not encourage further exploration of this 
approach at that time. Instead, the more promising intramolecular Knoevenagel 
cyclisation was investigated. 
3.3 POSTSCRIPT 
Since our decision in September 1988131 to abandon efforts towards y-lactone 
formation via intramolecular enolate alkylation, several reports of closely related 
investigations have been received which fully vindicate the change of strategy. 
In mid-1990, Adams et al. 132 published a report of their many attempts to form 
y-lactones 3.57 via the intramolecular alkylation of a variety of J3-ketoesters and malonic 
esters (3.56, Scheme 3.21), with the intention of synthesising lactone-containing natural 
products including A-factor (1.1). Despite the range of leaving groups, bases and 
solvents utilised they failed to detect any sign of y-lactone products. They concluded: 
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"Regardless of a) the base, b) the solvent, c) the leaving group, and d) 
the substitution degree at the electrophilic reaction site ( 1 ° vs 2 °), 
only 0-alkylation at the proximal CO group has been observed giving 
ketene acetals" (3.58). 
80 
Their report also describes their unsuccessful attempts to repeat the work of Michael and 
Weiner115 who allegedly cyclised the chloroester 3.56 (X = Cl, R = H, Y = OEt) to form 
the corresponding y-lactone 3.57. Under a variety of conditions only the ketene acetal 
3.58 was observed. 
3.56 X= OMs, OTs, I, Cl 
R=H,CH20Bz 
Y=OMe,Me 
Bases: DBU, NaH, K2C03, n-Bu4NF 
Solvents: benz.ene, CH2Cl 2, THF, 
DMF, DMPU, DMSO, acetone 
0 0 
3.57 
y 
0 
3.58 
Scheme 3.21 Exclusive 0-Alkylation Reported by Adams et al. 
In February 1990 Yamada133 informed us of his unsuccessful attempts to 
produce A-factor analogues by methods almost identical to ours, in which he used both 
epoxide 3.59 and acyclic 3.60 electrophiles (Scheme 3.22). 
jl 
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In July 1991, Mori134 reported to us the recent abandonment of a project in his 
research group which was directed towards the development of an asymmetric synthesis 
of A-factor based on the intramolecular cyclisation of glycidyl-f3-ketoesters. He also 
had not observed any signs of the desired regiochemistry in his systems. 
CHAPTER FOUR 
THE BIOMIMETIC SYNTHESIS OF A-FACTOR 
If one way is better than another, 
that you may be sure is Nature's way. 
Aristotle (384-322 BC) 
Nicomanachean Ethics 1099B, 23 
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4.1 y-LACTONES via INTRAMOLECULAR 
KNOEVEN AGEL CONDENSATION? 
84 
Incorporation of a carbonyl group rather than a leaving group at C2' of a 
J3-ketoester, as in 4.1, could allow cyclisation via Knoevenagel condensation 
(alternative intramolecular route Aii, Scheme 2.9). This process also models one of the 
proposed biosynthetic pathways to the butanolide autoregulators (see Chapter 2, 
Scheme 2.8). Base-promoted intramolecular Knoevenagel condensation would give the 
a,f3-unsaturated lactone 4.2, which could then be reduced to form butanolides 4.3 as 
depicted in Scheme 4.1. Our initial investigation of this approach explored the 
feasibility of the key cyclisation step. 
OH OH 
[reduction] ________ .,.. 
R R 
0 0 0 0 
4.2 4.3 
R = alkyl 
Scheme 4.1 
4.1.1 Stereoelectronic Considerations 
The stereoelectronic requirements for intramolecular attack of a J3-ketoester 
enolate carbon at a trigonal electrophilic centre are related to those previously discussed 
in Section 3.1.2 for a tetrahedral electrophile. However, the 1t orbitals of the enolate 
must approach a trigonal centre at a different angle to that in the attack of a tetrahedral 
centre (ca 109° to the C=O axis rather than ca 180° to the C-LG bond).135 
Nevertheless, examination of Dreiding molecular models shows that this difference 
does not appear to affect greatly the strain involved in achieving the geometry required 
for reaction. In both cases, the amount of strain appears to depend mostly on the length 
and rotational flexibility of the chain of atoms linking the reacting sites. Accordingly, it 
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is understandable that Baldwin's 'rules'109 for enolate cyclisations at a trigonal centre, 
summarised in Scheme 4.2, are the same as those previously discussed for tetrahedral 
cases (Scheme 3.8). Thus cyclisations to form 5-membered rings will only be 
stereoelectronically 'favoured' if the enolate 7t-electron density in the substrate is EXO 
to the ring being formed and therefore_ does not restrict the rotational freedom of the 
ring-forming chain of atoms (i.e. a 5-(ENOLEXO)-EXO-TRIG process). 
(ENOI.EXO)-EXO-TRJG 
"favoured for 3-7 membered rings" 
0 
R 
R 
(ENOLENDO)-EXO-TRJG 
"favoured for 6 and 7 membered rings" 
"disfavoured for 3-5 membered rings" 
Scheme 4.2 Baldwin's 'Rules' for Enolate Cyclisations 
J3-Ketoester enolates can be viewed as being the combination of two canonical 
forms, 4.4a and 4.4b, in which the 7t-electron density is EXO or ENDO respectively. 
Thus, cyclisation of J3-ketoesters can in principle proceed through either ENOLEXO or 
ENOLENDO modes. It was recognised, however, that any contribution of the latter 
canonical form 4.4b will promote planarity of the enolate system, so as to hinder the 
freedom of rotation about the Cl-C2 bond which is necessary for the 'favoured' 
ENOLEXO cyclisation process. The mesomeric delocalised anion 4.4 is therefore likely 
to stereoelectronically resemble a substrate for the 'disfavoured' 5-( ENO LENDO)-
EXO-TRIG process, as depicted in Scheme 4.3. Hence, y-lactone formation via 
intramolecular aldol-style condensation of J3-ketoesters appears, stereoelectronically at 
least, to be no more favoured than the previously explored intramolecular alkylation 
approach. 
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4.1.2 Literature Precedent 
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4.4 
'5-(ENOLENDO )-EXO-TRJG' 
"disfavoured" 
After the preceding stereoelectronic analysis, it was initially somewhat 
surprising to find several examples in the literature of the formation of 5-membered 
cyclic carbonyl compounds via the intramolecular attack of enolates on carbonyl groups 
(Table 4.1 ). 
The syntheses of acyl tetronic acids (fable 4.1, Entries la, lb and le) illustrate 
that when an ester carbonyl is the electrophile· (i.e. Dieckmann condensation), 
y-lactones may be formed. However, the elimination of alkoxide following cyclisation 
and the subsequent formation of the highly stabilised anion 4.5 under the basic 
conditions may give assistance to this type of cyclisation which is not available in our 
system. 
Me 
4.5 
In addition, these reactions require much more forceful conditions when the C 1' 
position is unsubstituted (Table 4.1, Entry le), relative to mono- or dimethylated 
examples (Table 4.1, Entry la and lb). The methyl substituents presumably assist 
cyclisation by the so called 'gem-dialkyl' effect, 136 a term used to describe the observed 
rate enhancements of up to 1000 fold which result when gem-dialkyI substituents are 
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present between the reactive sites of a cyclisation substrate. This reaction acceleration 
is believed to arise because the rotamers which lead to cyclisation are not so 
energetically disfavoured. A smaller effect is also observed with mono-substitution. 
Obviously, the substrates we need to cyclise (4.1, Scheme 4.1), being unsubstituted in 
the Cl' position, will not benefit from this effect. 
Entry 
1 
la 
lb 
le 
2 
3 
Table 4.1 Examples of S-Membered Ring Formation via 
Intramolecular Aldol-style Condensations 
R2 0 
Rt~OEt l' Oy--u-Me 
0 0 
R1,R2 =Me 
R1 =H,R2=Me 
R1,R2=H 
0 
Me o 
Me~Me 
HO 
+ 
EtOY"r(OEt 
0 0 
Reaction 
Na/ PhMe, 6 h, 20°C 
Na/ PhMe, 6 h, 20°C 
NaOt-Bu I t-BuOH, 
24 h, 82°C 
NaOH/Hi(), 6 h, 100°C 
NaOEt / EtOH, 9 h, 78°C 
R2 
R1 
0 
Me 
Me 
0 
OH 
Yield 
Me 
67% 
50% 
80% 
75% 
63% OEt 
Ref. 
137 
137 
137 
138 
139 
jl 
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In the second entry of Table 4.1, an enolate attacks a ketone carbonyl, as we 
require, but the conditions necessary for reaction (NaOHaq, 6 h, 100°C) are probably 
too vigorous for more sensitive substrates such as esters. Since this substrate cannot 
form an EX O enol, it demonstrates that the stereoelectronically 'disfavoured' 
5-(ENOLENDO)-EXO-TRIG process can occur, albeit under forcing conditions. 
In the third entry of Table 4.1, the transesterification of diethyl malonate 
precedes an intramolecular Knoevenagel condensation similar to that required for the 
proposed synthesis. However, this cyclisation too is assisted by the 'gem-dialkyl' effect 
and, since two reactions are combined in one rather vigorous step, it is not known what 
conditions are necessary for cyclisation alone. 
Although these literature examples differ significantly from our required 
cyclisation, they do demonstrate that 5-membered aldol-related cyclisations can proceed 
despite their intrinsically unfavourable stereoelectronic characteristics. 
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The silyl protected straight-chain J3-ketoester 4.6 was chosen as a readily 
accessible substrate on which to test the intramolecular Knoevenagel cyclisation. If 
successful, the butenolide product 4.8 could be elaborated to 11-demethyl A-factor 3.36 
by reduction of the tetra-substituted olefinic moiety and desilylation. It was thought 
prudent to incorporate TBDMS-protection in the cyclisation precursor 4.6 to minimise 
undesired reactivity. 
HO~OTBDMS 
0 
HO 
4.7 
0 0 
3.33c 
11-demethyl A-factor 
? 
• 
---------· 
---------· 
Scheme 4.4 
O OTBDMS 
F 
0 0 
4.6 
4.8 
? 
I • 
I 
• 
OTBDMS 
4.2.1 Preparation and Cyclisation of the J3-Ketoester 4.6 
Since the J3-ketoacid 3.33c was already in hand, we had only to prepare the 
monosilyl dihydroxyacetone 4. 7. Dihydroxyacetone ( 4.9) is produced commercially by 
the microbial oxidation of glycerol, 140 but it readily dimerises to the 1,4-dioxane 
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4.10, 141 in which form it is marketed. The monomer can be reformed by distillation of 
the dimer; 142 higher polymers have been reported to form upon extended storage. 143 
Monomeric dihydroxyacetone was protected by reaction with 
t-butyldimethylsilyl chloride (TBDMS chloride) in the presence of triethylamine and 
4-dimethylaminopyridine (DMAP) (Scheme 4.5). The use of an excess (2.5 fold) of the 
inexpensive dihydroxyacetone (4.9) ensured that only a small amount (3%) of the 
disilylated product 3.55 was formed and the monoprotected dihydroxyacetone 4. 7 was 
isolated in 68% yield after distillation (based on TBDMS chloride). 
0 
HO~OH 
4.9 
lTBDMSCI 
0 
TBDMSO~OH 
4.7 
+ 
0 
TBDMSO~OTBDMS 
3.55 
.. 
HO~O~OH 
HO 0 distillation 
4.10 
.. 
0 OH 
_ ( ')<C;OTBDMS 
TBDMSO~) -
HO 0 1so0c, s min 
4.11 
Scheme 4.5 
Following fractional distillation, the monosilyl dihydroxyacetone 4. 7 was also 
observed to slowly dimerise, a process found to be accelerated by the presence of acidic 
impurities. While the methylene resonances of the monomer appeared as sharp 
downfield singlets (O 4.30 and o 4.49), those of the dimer appeared as a complex system 
of peaks (O 3.40-4.25) due to the geminal couplings and the presence of diastereomers 
in this cyclic form. As with the parent compound 4.9, the silylated monomer 4.7 was 
found to be regenerated by distillation or brief heating (5 min., 150°C) of the dimer 
4.11. Silica gel chromatography was also found to promote this reversion. The direct, 
selective protection of the primary hydroxyl groups of the commercial 
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dihydroxyacetone 'dimer' 4.10 was not feasible due to its inhomogeneity and poor 
solubility, probably indicating the presence of higher polymers.143 
Esterification of 3-oxononanoic acid (3.33c) with the monosilyl 
dihydroxyacetone 4.7 was accomplished using N,N-dicyclohexylcarbodiimide (DCC) 
catalysed by 4-dimethylaminopyridine123 in CH2Cl2. Analysis of the crude product 
mixture by lH NMR spectroscopy allowed identification of the 0-silyl J3-ketoester 4.6 
as the major component by its three distinctive down-field methylene singlets, as shown 
in Scheme 4.6. The addition to the NMR tube of a known quantity of diphenylmethanol 
provided an internal integration standard against which the yield of ester was estimated 
to be ca 80%. On storage at 4°C the crude ester 4.6 was observed to slowly decompose 
to a complex mixture of coloured, polar compounds unless all traces of base were 
removed by efficient washing with dilute acid. After this treatment, the product was 
relatively stable, although some decomposition was still noted after extended storage. 
6 5.01, s 
\ O OTBDMS 
';r-VJ' ------· 64.26, s 
0 
0 0 
6 3.54 
4.6 
Scheme 4.6 
6 5.03, s 
OTBDMS 
6 4.95, s 
0 
4.8 
Attempted purification of the crude silylated J3-ketoester 4.6 by radial 
chromatography (Si{)i, CH2Cl2) led to the recovery of only 12% of the product 4.6 and 
50% of a new compound with a slightly higher Rt value. The I H NMR spectrum of the 
new compound lacked the characteristic J3-ketoester C2 methylene resonance near o 3.5. 
However, it displayed two distinctive, closely-spaced downfield methylene singlets 
(6 5.03 and 4.95) in addition to the signals expected for a heptanoyl substituent and a 
TBDMS group. The 13C NMR spectrum contained one ketone carbonyl resonance at 
6 197.1 and three other low-field quaternary peaks (6 181.1, 170.6 and 122.4). 
Since the peak at 6 122.4 was likely to be one of a pair of olefinic carbon resonances, 
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the more proximate of the remaining downfield peaks (O 170.6) was assigned as a very 
strongly deshielded olefinic carbon while the other peak (6 181.1) was assigned as an 
ester or lactone carbonyl carbon. EIMS revealed a parent ion at mlz 340 (HRMS 
indicated CI8H3204Si) with a major fragmentation at 283 (M+-'Bu). It became clear, to 
our surprise and delight, that we had directly obtained the unsaturated y-lactone 4.8, 
(Scheme 4.6). The infrared spectrum provided confirmation with the appearance of 
carbonyl stretching bands at 1775 and 1688 cm-I. As expected, these bands are shifted 
to lower frequencies than were observed for the saturated 2-acyl butyrolactone 3.40 
(1780 and 1725 cm-I) due to their conjugation with the olefin moiety.144 An additional 
band at 1630 cm-I was assigned as the olefin stretching absorption. Ultraviolet 
absorbance maxima at 236 nm (E 8100) and 314 nm (E 2200) were consistent with the 
K (1t-1t*} and R-band (n-1t*} absorbances, respectively, which are expected for a 
f3,f3-dialkyl-a,f3-unsaturated ketone with an a-exo double bond.1o3 
Thus the cyclisation was unexpectedly facile, requiring only treatment with 
silica gel to proceed. Table 2 (see four pages hence) contains a summary. of the results 
of investigations into the cyclisation of the f3-ketoester 4.6. 
Complete cyclisation was achieved using a less polar eluent at the start of 
chromatography (20% hexane in CH2Cl2) before increasing the eluent polarity (to 
100% CH2Cl2; Entry 2). This allowed greater contact time between the substrate and 
silica gel and resulted in an increase in the yield of the butenolide 4.8 to 64% over the 
two steps. In an effort to perform the cyclisation independent of chromatography, the 
f3-ketoester 4.6 was stirred with suspended silica gel (230-400 mesh, ca 20 mg Si02 / 
1 mg substrate) in CHCl3 (Entry 3). Only 30% cyclisation was observed after 3 days at 
room temperature, showing that the cyclisation apparently requires the more intimate 
contact with silica gel that chromatography provides. When the ester 4.6 was adsorbed 
onto silica gel in the absence of solvent (Entry 4), full cyclisation occurred within 
20 minutes. Unfortunately, this treatment also caused extensive formation of polar 
by-products. Two dimensional TLC tests confirmed that the butenolide 4.8 decomposes 
to a mixture of low-R_r compounds while adsorbed onto silica and, to a lesser extent, 
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during chromatography. For this reason, too much contact time between the substrate 
and silica gel is detrimental to yields. Column chromatography of the ~-ketoester 4.6 
(Entry 5) caused full cyclisation but gave a lower yield of butenolide 4.8, presumably 
because the extra time that the silica was in contact with the substrate allowed more 
decomposition to occur. Similarly, it was found that further decreases in the polarity of 
eluent mixtures used in radial chromatography gave the butenolide in lower yield. 
Silica gel is commonly regarded to be a mildly acidic medium and as such has 
been used to promote reactions which only proceed vi a acid catalysis such as the 
hydrolysis of acetals.145 It is conceivable that the cyclisation of ~-ketoester 4.6 also 
proceeds via an acid catalysed process, rather than through the enolate as previously 
discussed. The enol form of the protonated ketone 4.12 could cyclise to form lac tone 
4.13 and dehydrate to the butenolide 4.8 as depicted in Scheme 4. 7. This cyclisation is 
a stereoelectronically 'favoured' 5-(ENOLEXO )-EXO-TEI' process. The proposition that 
the surprising ease of cyclisation was due to acid catalysis was tested in a series of 
cyclisation tests carried out under a variety of acidic conditions (Table 4.2, . 
Entries 6 - 10). 
HO+ OTBDMS ~ °' d __ R !(b 
H..,. 
HO OTBDMS OTBDMS 
R R 
0 0 
4.12 R = n-hexyl 4.13 4.8 
Scheme 4.7 
Stirring the cyclisation precursor 4.6 in a suspension of acid-buffered silica gel 
(pH 4.5) (Entry 6), gave no significant increase in the rate of cyclisation over 
unbuffered silica gel. After treatment of ester 4.6 with c4-acetic acid in CDCl3 for one 
hour at room temperature (Entry 7), only deuterium exchange was observed by 
1H NMR spectroscopy. The presence of p-toluenesulfonic acid (pTSA, Entry 8) with 
the substrate in CDCl3 also failed to catalyse any cyclisation after 1 hour. Attempts to 
promote cyclisation with Lewis acids were also unsuccessful. Treatment with titanium 
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tetrachloride / pyridine146 (Entry 9) gave only starting material after 5 hours at room 
temperature. Anhydrous zinc chloride in ether (Entry 10) also failed to induce any 
cyclisation. Thus, it appears unlikely that the cyclisation proceeds via an acid catalysed 
mechanism. 
In contrast, base catalysis resulted in rapid cyclisation. Formation of the sodium 
enolate of the f3-ketoester 4.6 with 1.1 equivalents of sodium hydride in ether resulted in 
complete cyclisation within 10 minutes at room temperature {Entry 11). The butenolide 
4.8 was isolated as a yellow oil after rapid radial chromatography (CH2Cl2) in a 
combined yield of 58%. Next eluted was a minor component which was isolated as 
colourless prisms (mp 130-1 °C) and identified as the tricyclic dimer 4.14 (4%). The 
rest of the product appeared as a mixture of red-brown polar compounds whose 
complexity did not encourage further examination. Identification of the minor 
crystalline by-product 4.14 was eventually made by I H NMR comparison with the 
closely related 11,11 '-dimethyl compound 4.37a which was formed in a directly 
analogous reaction during the subsequent synthesis of A-factor (1.1). The formation of 
the dimer by a base-catalysed annelation (Scheme 4.8) and structural assignment of 
dimer 4.37a is discussed in Section 4.3.2. It was found that more of the butenolide 
prcxluct 4.8 dimerised when longer reaction times and greater substrate concentrations 
were used (Entries 12 and 14). The use of a dilute reaction mixture at 0°C {Entry 13), 
minimised dimerisation and other side-reactions and the butenolide was isolated in 65% 
yield. 
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Amine bases (diisopropylamine or triethylamine) also promoted cyclisation but 
did not prevent dimer formation despite their lower basicity. Cyclisation experiments 
were conveniently performed on a small scale in NMR tubes, allowing direct 
monitoring of the reaction by lH NMR spectroscopy. It was found that the addition of 
1.1 equivalents of either amine to a CDCl3 solution of the cyclisation precursor 4.6 
resulted in a slower cyclisation than was observed using sodium hydride as base, 
requiring ca 30 minutes for completion. However, during this period approximately 
10% of the product dimerised (Entries 15 and 17). The weaker base pyridine failed to 
promote any cyclisation even when large excesses were used (Entry 18). 
The cyclisation was also found to proceed with non-stoichiometric quantities of 
base. The addition of 0.5 equivalents of diisopropylamine promoted the cyclisation of 
80% of a sample of ester 4.6 after 30 minutes at room temperature in CDCl3, during 
which time approximately 10% of this product dimerised (Entry 16). The presence of 
0.3 equivalents of sodium hydride in ether induced full cyclisation but also extensive 
dimer formation (30%) after 20 minutes at room temperature (Entry 14). A catalytic 
quantity (0.02 eq.) of DMAP was found to catalyse the cyclisation of 50% of a sample 
of ester 4.6 in CDCl3 over an 8 day period at room temperature, with 10% concurrent 
dimerisation and the formation of highly coloured polar by-products (Entry 19). This 
observation confirms the need to remove all traces of DMAP from the J3-ketoester 4.6 
after esterification. Full cyclisation could also be catalysed by suspended potassium 
carbonate (Entry 20), with reaction being promoted by agitation. However, extensive 
dimerisation and the formation of highly coloured by-products were also observed. 
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Table 4.2 Cyclisations of f3-Ketoester ( 4.6) 
0 
OTBDMS 
v<-R + 
O OTBDMS 
,JU 
... 
oH R 
OYnR 
0 0 
4.6 
0 0 
4.8 4.14 R = n-hexyl 
Entry 
No. 
Reagent, Solvent Time, Temp. Ratio % ii Yield v 
4.6: 4.8: 4.14 4.8 
1 Si02 radial chromatography, CH2Cl2 10 min., r.t. 20: 80: 0 iii 50% 
2 Si02 radial chromatography, 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
20% hexane in CH2Cl2 to CH2Cl2 
Si02, CHCl3 (suspension) 
Si02, solvent-free 
Si02 Column chromatography, 
20% hexane in CH2Cl2 
Si02 (pH 4.5), CHCl3 (suspension) 
c4-acetic acid (xs), CDCl3 
p-TSA (1 eq.), CDCl3 
TiC4 (2.0 eq.), pyridine, CC4, THF 
ZnCl2 (anhydrous, 5 eq.), ether 
NaH (1.1 eq.), ether (10 mg/mL) 
NaH (1.1 eq.), THF (40 mg/mL) 
13 NaH (1.1 eq.), THF (5 mg/mL) 
14 NaH (0.3 eq.), ether (20 mg/mL) 
15 i-Pr2NH (1.1 eq.), CDCl3 
16 i-Pr2NH (0.5 eq.), CDCl3 
17 Et3N (1.1 eq.), CDCl3 
18 pyridine (5 eq.), CDCl3 
19 DMAP (0.02 eq.), CDCl3 
20 K2C03 (xs), CDCl3 (suspension) 
12 min., r.t. 
72 h, r.t. 
20 min., r.t. 
20 min., r.t. 
72 h, r.t. 
1 h, r.t. 
1 h, r.t. 
5 h, r.t. 
1.5 h, r.t. 
10 min., r.t. 
20 min., r.t. 
0: 100: 0 
70: 30: 0 
0: 100: 0 iv 
0. : 100: 0 iv 
73: 27: 0 
100: 0: 0 
100: 0: 0 
100: 0: 0 
100: 0: 0 
0: 93: 7 
0: 70: 30 iv 
40 min., 0°C O : 96 : 4 iii 
20 min., r.t. 0 : 70 : 30 
30 min., r.t. 0: 90: 10 
30 min., r.t. 20 : 70 : 10 
30 min., r.t. 0: 90 : 10 
2 h, r.t. 100 : 0 : 0 
8 days, r.t. 50: 40: 10 
2 h, r.t. 0 : 75 : 25 iv 
64% 
22% 
30% 
36% 
20% 
i 
1 
0% 
0% 
58% 
35% 
65% 
I 
I 
I 
I 
I 
I 
i) NMR tube experiment; products not isolated. 
ii) Ratios obtained by 1 H NMR integration of the crude reaction mixture unless otherwise stated 
iii) Ratio of isolated compounds. 
iv) Reaction mixture also contains significant amounts of unidentified polar by-products. 
v) Yield for combined esterification and cyclisation steps based on 3-oxononanoic acid (3.33c). 
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In summary, it was found to be most convenient for small scale preparations 
( < ca 250 mg) to cyclise the ester 4.6 by radial chromatography on silica gel (Entry 2) 
as described in the Experimental section (Method A). Yields of 55-64% based on 
J3-ketoacid 3.33c were obtained. For larger preparations (> ca 250 mg), cyclisation 
utilising sodium hydride in THF was preferred (Entry 13). The use of dilute solutions 
(ca 5 mg/mL) minimised dimerisation of the product, while a low reaction temperature 
(0°C) minimised side reactions and allowed time for monitoring of the reaction by 
reverse phase TLC. Cyclisation does not occur to a significant extent during reverse 
phase chromatography. After cyclisation is complete (ca 40 min.), work-up and rapid 
radial chromatography (Si 0 2, 100% CH2Cl2) gave the butenolide in 55-65% yield over 
the both steps, in addition to ca 3% of the more polar dimer 4.14. 
Attempts were made to perform the analogous cyclisation on the unprotected 
J3-ketoester substrate 4.15 in an effort to avoid silyl protection. The ester 4.15 was 
prepared in 50% yield by esterification of 3-oxononanoic acid (3.33c) with an excess of 
dihydroxyacetone (3 eq.) using DCC/ DMAP. The product was in this case a solid 
which was recrystallised from ether/ hexane as colourless platelets (mp 68-70°C). The 
appearance of two ketone carbonyl peaks (5 202.3, 203.8) in its 13C NMR spectrum 
clearly showed the compound to be monomeric despite the report by Garson and 
co-workers147 that another monoester of dihydroxyacetone ( 1-undecanoyl-
3-hydroxyacetone, 4.17a) readily dimerised to the 1,4-dioxane 4.17b. 
0 
HO~OR 
4.17a R= 
0 
4.15R=~ 
0 0 
RO~O~OR 
HO 0 
4.17b 
Scheme 4.9 Dimerisation of Dihydroxyacetone Derivatives 
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After either radial chromatography of 4.15 on silica gel or adsorption onto dry 
silica gel, no sign of the characteristic low field pair of methylene singlets near o 5.0 
which are expected for butenolide 4.16 was observed by I H NMR spectroscopy. In 
both cases the majority of the ester 4.15 was recovered (ca 60% ), but it was 
accompanied by complex unidentified polar compounds. 
O OH Si02 OH 
;-1-J 
NaH 
0 0 TIIF 0 0 
4.15 4.16 
Scheme 4.10 
When the unprotected ester 4.15 was subjected to sodium hydride promoted 
cyclisation conditions identical to those successfully employed for the silyl ester 4.6 
(Table 4.2, Entry 11 ), a complex mixture of products resulted. The I H NMR spectrum 
of the crude reaction mixture showed a product, representing an estimated 10-15% of 
the material, which was tentatively identified as the hydroxy butenolide 4.16. It · 
displayed two prominent singlet peaks at o 4.94 and 6 5.01, which are very close to the 
C5 and C4 methylene resonances observed for the silylated butenolide 4.8 (o 4.95 and 
o 5.03). In addition, a triplet appearing at o 2.98 (J = 7 Hz) was assigned as the H7 
methylene protons of the butenolide 4.16, since the chemical shift and coupling 
constant were also very close to those displayed by the silyl butenolide 4.8. However, 
after radial chromatography, none of this compound could be detected. Its rate of 
decomposition on silica gel is evidently much faster than for the silyl protected 
butenolide 4.6 and, consequently, it could not be isolated. The complexity of the 
reaction mixture may have been due in part to 'Michael'-style self-condensation 
reactions occurring between the alkoxide anion formed from the unprotected hydroxyl 
group of the butenolide 4.16 and the highly activated olefin moiety. Thus protection of 
the hydroxyl group proved to be necessary to ensure a 'cleaner' cyclisation reaction and 
a much more stable butenolide intermediate. 
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4.2.2 Mechanism of Intramolecular Knoevenagel 
Condensations 
The formation of y-lactones via intramolecular Knoevenagel condensation has 
proven to be unexpectedly facile. This reactivity is in great contrast to the 
intramolecular alkylations of f3-ketoesters which were discussed in Chapter 3, despite 
the stereoelectronic similarities between the processes. The success of the Knoevenagel 
cyclisation may be explained by the lack of any irreversible alternative to the required 
reaction path. The presumed mechanism for the base-catalysed cyclisation of 
f3-ketoester 4.6 based on the mechanism of Hahn and Lapworth148 is outlined in 
Scheme 4.11. 
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Cyclisation through the 13-ketoenolate oxygen (4 .18, path A) is a 
stereoelectronically 'favoured' 5-EXO-TRIG process which may be expected to compete 
with the desired mode of cyclisation (path B) as observed in the previously explored 
intramolecular alkylations (Chapter 3). However, in this case, oxygen attack leads to 
the unstable alkoxy-ketene acetal 4.19, which would readily revert to the stabilised 
enolate 4.18. Attack by the enolate carbon (path B), although stereoelectronically 
disfavoured, leads eventually to the thermodynamically stable butenolide 4.8. The 
initial attack to form the alkoxy-lactone 4.20 is also readily reversible, but this alkoxide 
can undergo a proton transfer to generate the resonance-stabilised 3-hydroxy "'(-lactone 
enolate 4.21. Hydroxide ion may then be eliminated to form the butenolide 4.8, a 
process involving a favourable increase in entropy. The released hydroxide may then 
deprotonate more starting material and thus complete the catalytic cycle, as depicted in 
Scheme 4.11. 
In essence, the readily reversible nature of the two possible cyclisations 
involving nucleophilic addition to the 2'-carbonyl group puts the outcome of the 
reaction under thermodynamic control. The stereoelectronic analyses of various 
cyclisations described by Baldwin1()()-lll only predict the relative rates of these 
processes by assessment of the difficulty involved in achieving the required 
transition-state geometry. Nothing is implied about the relative thermodynamic 
stabilities of the compounds produced. Thus it is possible to observe apparent 
contravention of these 'rules' in the case of thermodynamically controlled reactions if a 
slower, 'disfavoured' process leads to a more stable product than a competing 'favoured' 
process. 
Ager and Mole, however, attempt to rationalise the success of a similar type of 
cyclisation (see Entry le, Table 4.1) using stereoelectronic arguments alone.137 The 
acyl tetronic acid 4.22 is produced via the intramolecular condensation (Dieckmann 
condensation) of the 13-ketoester 4.23. They postulate that the reaction succeeds 
because it is able to utilise the stereoelectronically 'favoured' 5-(ENOLEXO)-EXO-TRIG 
pathway due to a supposed preference for the ENOL-EXO form of the enolate 4.24a. 
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Their argument is based on the result of a trapping experiment in which the lithium 
enolate 4.24 in 1HF was treated with an excess of methyl iodide to give a 75% yield of 
a product assigned as the O -methyl enol-ether 4.25 (Scheme 4.12), although no 
evidence supporting this structure was reported. 
0 
;-Jl--oEt 
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~Me 
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;-Jl--oEt hMe 
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4.23 
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o _o 
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Scheme 4.12 
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0 OMe 
4.25 
Me 
Both this result and their mechanistic supposition are likely to be in error. Other 
studies of the alkylation of J3-ketoesters with alkyl iodides clearly show a strong 
preference for C- rather than 0-alkylation products. 149 For example, in their study of 
C- vs. 0-alkylation, Guibe et al.150 show that alkylation of the lithium enolate of methyl 
acetoacetate with ethyl iodide in dimethoxyethane gives a C : 0 alkylation ratio of 
>100:1. In the previous chapter (see Scheme 3.19), it was described how the trapping 
with methyl iodide of the sodium enolate of methyl 3-oxononanoate (3.33a) in 1HF 
gave a product which was unambiguously identified by I H NMR as the C-methyl 
compound 3.54, in 80% yield. Even if the 0-methyl enol-ether 4.25 has been isolated it 
would not demonstrate any preference for either canonical form. It could simply 
demonstrate greater thermodynamic stability of this product over the alternative 
0-methylation product, which is the unstable ketene acetal 4.26. 
;-fl_oEt 
0 
YlrMe 
MeO 0 
4.26 
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4.2.3 Reduction of the Butenolide 4.8 
Catalytic hydrogenation was the method chosen as most likely to achieve the 
reduction of the tetrasubstituted olefin 4.8 without affecting the silyl, keto or ester 
functionalities, although reactivity was expected to be rather low due to tetrasubstitution 
of the C=C bond. 
0 
OTBDMS 
0 
4.8 
H2 , 10% Pd/C 
MeOH 
88% 
Scheme 4.13 
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4.27 
Hydrogenation over 10% palladium-on-carbon (10% Pd/C) in methanol at room 
temperature and pressure was found to proceed surprisingly rapidly. One equivalent of 
hydrogen was consumed after only 40 minutes, by which time hydrogen uptake had 
virtually ceased. After removal of the catalyst, the saturated lactone 4.27 was isolated 
as an oil in 88% yield (Scheme 4.11). As expected, the IH NMR spectrum of the 
product was considerably more complex than the starting material due to the additional 
coupling with the two new protons. The proton at C2 appeared as a doublet (O 3.64, 
12,3 = 6.8 Hz) and the proton at C3 gave a multiplet (0 3.18) due to coupling with five 
vicinal protons. The C4 methylene protons both appeared as down-field AB quartets 
(O 4.39 and o 4.12) while the two C5 protons were almost co-incident, appearing as a 
pseudo-doublet at higher field (o 3.62). In the I3c NMR spectrum, saturation of the 
olefin moiety was confirmed by the disappearance of the quaternary resonances and the 
appearance of two methine peaks at o 54.7 and o 39.3, assigned to C2 and C3 
respectively. Methylene peaks at o 69.1 and o 61.9 were assigned to C4 and C5 
respectively.103 
Apart from a small amount (ca 5%) of the enol form identified by the enolic OH 
at 11.2, no sign of a second set of resonances was noted by I H or 13 C NMR 
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spectroscopy. This suggested that the product contains a single diastereomer which was 
presumed to be the 2,3-trans diastereomer since the lower steric interaction between the 
substituents in this form was expected to make it thermodynamically more stable. 
Epimerisation at C2 via the enol is presumably facile. The question of C2,3 relative 
stereochemistry is addressed more fully with reference to the corresponding 11-methyl 
compound 4.35, see Section 4.2.3. 
In the EIMS of the 0-silyl lactone 4.27 the appearance of peaks at mlz 327 and 
285, corresponding to the expected cleavages of methyl and t-butyl groups respectively, 
supported the structural assignment. HRMS confirmed the composition of the 
M+-t-butyl peak as C14ff2s()4Si (mlz 285.1523). A major peak at mlz 113 was 
attributed to the heptanoyl fragment ion (Ct,H 13CO+). The infrared spectrum in CC4 
solution displayed two carbonyl stretching bands (1779 and 1720 cm-I) corresponding 
to typical y-lactone and aliphatic ketone carbonyls respectively. 
It was found that prolonged hydrogenation ( 4 h, MeOH, 10% Pd/C) resulted in 
the partial cleavage of the TBDMS protecting group. Hydrogenolysis of the TBDMS 
moiety was unexpected151•152 but not unprecedented, 153 although it is perhaps more 
likely that the TBDMS group was removed by methanolysis catalysed by the traces of 
. hydrochloric acid which are generally present in Pd/C. 154 A waxy solid was isolated in 
15% yield which had a very similar IH NMR spectrum to the silylated lactone 4.27, 
except that there were no signals corresponding to a TBDMS group and a broad OH 
peak at o 1.8 was present which readily exchanged on D20 addition. The identification 
of this product as the desired 11-demethyl A-factor (3.36) was supported by the 
appearance of a molecular ion at mlz 228 in the EI mass spectrum. The low yield and 
the presence of a substantial amount (ca 10%) of an unwanted by-product in the 
reaction mixture made this method unattractive as a preparative, 'one pot' route to the 
desilylated product. 
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4.2.4 Desilylation to 11-Demethyl A-Factor (3.36) 
The t-butyldimethylsilyl (TBDMS) protecting group is generally stable under 
basic or neutral conditions but may be cleaved easily by treatment with acid (e.g. dilute 
acetic acid) or with the use of fluoride. 152 Deprotection of the TBDMS-lactone 4.27 
under acid conditions was found to be rather slow. After treatment with acetic acid / 
THF I water (3 : 3 : 1), as recommended by Corey and coworkers,152 approximately 
15% of unreacted protected lactone 4.27 was isolated in addition to 55% of 
11-demethyl A-factor 3.36 after 48 hours at room temperature. Attempts to improve the 
yield using longer reaction times were complicated by the concurrent increase in th~ 
formation of several by-products, as observed by 1LC. Treatment of the silyl lactone 
4.27 with tetra-n-butylammonium fluoride (THF, 3 eq.) for one hour at room 
temperature gave the product in an improved yield (80% ), but the concurrent formation 
of several polar by-products indicated that a milder desilylation method was required. 
A mixture of aqueous hydrofluoric acid and pyridine in CH3CN has been reported as a 
mild and effective reagent for the removal of TBDMS groups from sensitive 
prostaglandin substrates.155 Using this method the TBDMS group was smoothly 
removed in 7 hours at room temperature to give 11-demethyl A-factor 3.36 in 90% 
yield as a colourless oil which solidified to a waxy solid upon cooling. The identity of 
the product was supported by high resolution mass spectroscopy of its molecular ion, 
which indicated a composition of C12H2004, as required. Fragment ions in the EIMS 
confirmed the substituents on the lactone ring. A peak assigned to the loss of the C3 
hydroxymethyl fragment (mlz 197, M+-CH20H, 16%) was present, as was a heptanoyl 
fragment ion (mlz 113, C7H130+, 68%). 
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Fourier transform infrared spectroscopy (Fl1R) in CC14 solution confirmed the 
presence of a saturated ketone (1720 cm-I) and a y-lactone carbonyl (1785 cm-I; 
typically144 near 1780 cm-I). Nihira ~t al. 35 have previously synthesised this compound 
(see Scheme 1.7) but report the lactone carbonyl appearing at 1760 cm-I when 
measured as a thin film (solvent-free). This lower absorption frequency probably 
results from the increased intermolecular hydrogen bonding expected under these 
conditions. In all other respects, their IR data were consistent with those recorded here 
for lactone 3.36. The reported 1 H NMR data for this compound, 35 although recent, are 
of limited value since they have been acquired at only 60 MHz and include no 
assignments or coupling information. ·While the positions of the reported 'multiplets' 
are in general agreement with our 300 MHz 1 H NMR data, the reported integration over 
two of these regions appears to be in error. The region o 4.0-4.6 which encompasses 
the two doublets of doublets of the H4a and H4b protons, has been mistakenly reported 
as a 3 proton multiplet, and the system of peaks between · o 3.6 and o 3.8 has been 
reported as a two-proton multiplet, when it actually contains the almost coincident 
signals of 3 protons (H2, H5a and H5b ). These errors have been repeated in the data 
reported for eight other analogues prepared by these authors. 35 The spectrum of 
demethyl A-factor 3.36 was generally quite similar to that of the silyl precursor 4.27, 
except that the H5 proton resonances were more widely separated giving two doublets 
of doublets. The vicinal 12,3 coupling constant was virtually unchanged at 7 Hz, 
suggesting that the 2,3-relative stereochemistry has been preserved. 
The I3c spectrum of 3.36 was also very similar to that of the protected 
compound 4.27 except for the absence of signals due to the TBDMS group. The 
removal of the silyl group had surprisingly little effect on any of the resonances 
( < 1 ppm). Although I3c NMR data for this compound have not been reported, the I3c 
data for A-factor itself (1.1),18 although not assigned, provide a close model for the 
3-hydroxymethyl y-lactone nucleus. All the I3c resonances of A-factor, except those 
attributable to its methyl branched alkyl 'tail' (C8 to Cl2), corresponded closely (within 
1 ppm) with a major peak in the spectrum of 11-demethyl A-factor 3.36. 
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A puzzling feature of this compound was that in both the 1 H and 13C NMR 
spectra a co-occurring array of minor peaks (ca 10-20% peak heights) was observed 
which persisted even after further purification. These were eventually attributed to 
other tautomeric forms of the compound. The unexpected identity and significance of 
analogous components occurring with A-factor itself (1.1) are discussed in Chapter 5. 
Thus 11-demethyl A-factor (3.36) has been successfully synthesised by an 
efficient biomimetic route, in an overall unoptimised yield of ca 20% from ethyl 
acetoacetate. Already, this represents a significant improvement over the existing 
synthesis of this compound in 4.5% yield from diethyl formylsuccinate (via a route 
analogous to Scheme 1. 7, Chapter 1 ). 35 This synthesis demonstrates the viability of the 
biomimetic approach and opens the way for the development of an improved synthesis 
of A-factor itself (1.1). The biological activity of 3.36 has been reported to be less than 
20% of that of A-factor itself (see Chapter 1, Table 1.1, Entry 5).4 
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4.3 THE BIOMIMETIC SYNTHESIS OF A-FACTOR 
Adaptation of the preceding synthetic route into a synthesis of A-factor involves 
the incorporation of a terminal branched methyl substituent. The expense and relative 
difficulty in obtaining the required 1-bromo-4-methylpentane ( 4.28) provided incentive 
to improve the efficiency of the synthetic route, particularly in the early stages. 
4.3.1 Synthesis of 8-Methyl-3-0xononanoic acid (4.30) 
R°Yr( 
0 0 
i)NaH 
ii) nBuLi 
iii)Br~ 
4.28 
68%, R=Et 
75%, R='Bu 
Scheme 4.14 
RO 
0 0 
4.29 R=Et ~ 
- 4.30 R=H R = 'Bu------
80% 
4.32 
Alkylation of the dianion of ethyl acetoacetate with commercially available 
1-bromo-4-methylpentane (4.28, 1.1 eq.) gave the ethyl J3-ketoester 4.29 in 62% yield 
after fractional distillation, a yield similar to that obtained for the preparation of the 
unbranched ethyl J3-ketoester 3.33b. A considerable quantity (29%) of the alkylating 
agent 4.28 was recovered unreacted while only a trace of unreacted ethyl acetoacetate 
was isolated. Monitoring of the reaction by gas chromatography confirmed that ethy 1 
acetoacetate was consumed substantially faster than the alkylating agent, indicating that 
the yield of product is limited by side-reactions of the ethyl acetoacetate dianion. 
Isolation of the J3-ketoacid 4.30 after acid hydrolysis (AcOH / cone. HClaq) of 
the ethyl ester 4.29 was more difficult than for the straight chain J3-ketoacid due to the 
lower melting point of the product (mp 44-46°C vs 70-71 °C) and its increased solubility 
in organic solvents. Recrystallisation of the crude product required cold pentane 
(-15°C) and it was necessary to collect and wash the crystals in a cold-room at 0°C to 
prevent melting or redissolution of the product. A yield of 40% of crystalline product 
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was obtained in three crops, and the mother liquor contained a further ca 20% of 
13-ketoacid which resisted crystallisation probably because of the substantial quantity of 
the decarboxylation product, the liquid methyl ketone 4.31, which was also present. 
Non-crystalline, impure 13-ketoacid was found to fully decarboxylate within a few days, 
even at 0°C. This disappointing yield of useable J3-ketoacid prompted attempts to 
improve its synthesis. 
Me 
0 4.31 
t-Butyl esters are known to eliminate methylpropene in the presence of 
trifluoroacetic acid to give the corresponding carboxylic acid in high yield, after simply 
removing this volatile reagent by evaporation.156 Thus the t-butyl ester 4.32 of our 
required 13-ketoacid was prepared by alkylation of the dianion oft-butyl acetoacetate, 
which is readily available and inexpensive (Scheme 4.14). By using a small excess of 
t-butyl acetoacetate (1.1 eq.) with respect to the 1-bromo-4-methylpentane (4.28}, the· 
side reactions which had been observed with the dianion of ethyl acetoacetate were 
avoided and the costly alkylating agent was fully consumed. The t-butyl J3-ketoester 
4.32 was isolated, after distillation, in a 7 5% yield based on the bromide 4.28. 
The t-butyl ester 4.32 was efficiently converted to the J3-ketoacid 4.30 by 
treatment with an excess of trifluoroacetic acid in CH2CI2 for 2 hours at room 
temperature. Removal of the solvent under vacuum at room temperature gave the 
13-ketoacid 4.30 in an almost pure state. Recrystallisation from pentane at -15°C gave 
an 80% yield of fine colourless needles in two crops, with very little methyl ketone 4.31 
being detected in the mother liquors. Samples of this product have proved stable 
towards decarboxylation for up to a year at 4°C. 
I: 
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4.3.2 Esterification and Cyclisation 
Esterification of the f>-ketoacid 4.30 with mono-protected dihydroxyacetone 4. 7 
and subsequent cyclisation were performed by the methods developed for the model 
synthesis (see Scheme 4.15). Esterification with DCC followed by cyclisation using 
silica gel chromatography as described above gave the unsaturated lactone 4.34 in 65% 
yield over the two steps. Larger batches (> 250 mg) were more conveniently cyclised 
by treatment with 1 equivalent of sodium hydride in TIIF (0°C), furnishing the product 
in slightly lower yield (60%) after chromatography. 
HO~OTBDMS 
0 
4.7 
HO'l("i(R 
0 0 R=~ 
4.30 
;--iJTBDMS 
SiOi orNaH Ou---n-R ~~---.. 
0 0 
4.33 
Scheme 4.15 
0 
OTBDMS 
0 
4.34 
As observed in the cyclisation of the straight chain ester 4.6 with sodium 
hydride, a significant by-product was noted in the reaction mixture by TLC, especially 
when longer reaction times and/or more concentrated reaction mixtures were used. . In 
some cases this compound represented 15-20% of the product mixture, separable by 
chromatography; it could be recrystallised as colourless needles from hexane, (mp 
130-132°C). CIMS revealed a molecular weight of 708 for the compound, 
corresponding to twice the molecular weight of the silyl butenolide product 4.34, 
indicating a dimeric structure. A distinctive feature of its I H NMR spectrum was a 
closely spaced pair of deshielded methine singlets at o 5.38 and o 5.34, which are 
similar in spacing to the H4 and H5 methylene singlets of the unsaturated lactone 4.34, 
but are shifted downfield by ca 0.3 ppm. A broad peak at o 2.0 which disappeared with 
the addition of D20 was assigned as an hydroxyl proton. Integration of the region 
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(o 1.5 to 6-0.2) indicated the presence of two alkyl chains and two TBDMS groups 
giving further credence to a dimeric structure. 
The 13C NMR spectrum of the dimer displayed five downfield quaternary 
resonances (6 126.6, 169.2, 174.9, 176.3 and 197.7). The presence of only one ketone 
group was indicated by the single peak (O 197. 7) in this region. The resonance at 
o 126.6 is close to the chemical shift of the C2 olefinic carbon of the butenolide product 
4.34, which suggested that the dimeric compound may contain a similar 
cx-acyl-cx,J3-unsaturated lactone moiety. The remaining three quaternary peaks were 
therefore assigned as two lactone carbonyls and a strongly deshielded olefin. The 
twenty five remaining peaks in the 13C NMR spectrum were consistent with the product 
being a single diastereomer of a dimeric compound. 
Consideration of possible dimeric forms of the butenolide 4.34 or the ester 4.33 
led to the proposal of two structures 4.37a and 4.37b which were consistent with all of 
the existing· spectral data. It is envisaged that these dimers could result from initial 
Michael-style addition at the doubly activated C3 position of the butenolide product 
4.34 of another butenolide molecule which had been deprotonated at either C4 or C5. 
Annulation would be completed by base-promoted reaction between the remaining 
acidic site and the ketone carbonyl, resulting in a tricyclic dimer containing two 
y-lactone moieties fused to create a central 6-membered ring with the molecule 
possessing either an angular (4.37a) or linear fused geometry (4.37b). 
0 
TBDMSO 
4.37a R=Me R 
4.14 R=H 
TBDMSO 
R 
TBDMSO 
4.37b R 
The appearance of a single set of peaks in the 13C NMR spectrum of the dimer 
shows the proposed annulation to be remarkably regio- and diastereoselective. 
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Evidently, only one of the regioisomers 4.37a or 4.37b is formed and a single relative 
configuration of its five asymmetric centres is preferred. Two dimensional lH-lH 
(COSY) and 1H_l3C (HETCOR) correlated spectra were obtained (see Appendices Ai 
and Aii) which supported our general structural proposal and facilitated assignment of 
the lH and 13C spectra. However, the similarity of the expected NMR spectra for the 
two proposed regioisomeric structures 4.37a and 4.37b and the lack of any vicinal 
1 H-1 H couplings between the two halves of these dimers made it difficult to distinguish 
between these two possibilities. 
Close inspection of the 2D lH-lH correlated spectrum (COSY, Appendix Ai) 
revealed several low-intensity cross-peaks representing small long-range couplings 
(< 0.5 Hz) which were not apparent in the ID lH NMR spectrum, notably 12,sa, 12,5', 
J4•,sa, and J4',4a· While the first two are reconcilable with either dimeric structure 4.37a 
or 4.37b as four-bond (4]) couplings, the latter two (J4•,5a, J4•,4a) are only feasible for 
the angular fused-tricyclic dimer 4.37a, since the protons involved are separated by too 
many bonds in the alternative, linear structure 4.37b~ Thus the angular structure 4.37a 
is favoured and since the lH NMR spectrum of the analogous demethyl dimer isolated 
in the previous reaction series (Section 4.1.3) was nearly identical, except for the 
resonances attributable to the alkyl chains, it too was assigned an angular fused-tricyclic 
structure 4.14. 
4.3.3 TBDMS Protected A-Factor (4.35) 
OTBDMS 
0 0 
4.35 
The butenolide 4.34 was reduced, as in the demethyl reaction series, by catalytic 
hydrogenation over 10% palladium-on-carbon. However, we found that ethyl acetate 
was a superior reaction solvent to methanol, since it does not promote the desilylation 
and other unwanted reactivity previously observed during extended hydrogenations 
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(Section 4.1.5). Using ethyl acetate and ca 3% by mass of catalyst, approximately 
3 hours under ambient conditions were required for complete reduction of the 
butenolide 4.34 to TBDMS-protected A-factor 4.35. No extraneous products were 
observed to appear by 1LC even after 12 hours. The saturated lactone 4.35 was isolated 
as a colourless oil after chromatography, in 80-90% yield. So clean was the conversion 
that the variation in yield is more likely to reflect the purity of the butenolide than the 
efficiency of the reaction itself. It was found to be counterproductive to attempt to 
purify further the silyl buteno)4~es 4.8 or 4.34 prior to hydrogenation in view of their 
instability, especially under basic conditions or in contact with silica gel. Additional 
purification of a sample of the butenolide 4.34 by further radial chromatography on 
silica gel (15% EtOAc in hexane) gave the compound of sufficient purity· for 
satisfactory microanalysis but ca 40% of the sample was lost by decomposition. 
Attempted purification on alumina (PTLC) was found not only to be ineffective, but 
also to c~use substantial decomposition to polar compounds. Sephadex 
chromatography (LH-20) at least did not cause degradation but was also ineffective for 
purification. Even when stored at 4 °C under dry argon after efficient acid washing, the 
butenolide 4.34 underwent significant degradation to coloured polar material within a 
few weeks. 
An obvious approach to the problem of instability of the butenolide 4.34 is to 
not purify it at all, but to catalytically hydrogenate the crude product. Unfortunately, 
the crude butenolide from sodium hydride promoted cyclisation was usually less than 
50% pure and contains the many minor by-products from both the esterification and the 
cyclisation steps, including substantial amounts of N ,N-dicyclohexylurea, probably 
some N-acyl urea, the dimer 4.37a, some methyl ketone 4.31 and a veritable menagerie 
of complex polar compounds. Attempts to hydrogenate the crude butenolide 4.34 
showed it to proceed very slowly (> 30 h), and required the addition of several extra 
portions of catalyst (total ca 6% by mass) to enable the reaction to go to completion. 
The crude butenolide 4.34 evidently contains an unidentified compound (or 
compounds) with the ability to interfere with catalytic hydrogenation, presumably by 
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poisoning the catalyst. Extrication of the required silyl lactone 4.35 from the resulting 
complex reaction mixture was more difficult than usual due to the presence of close-
running impurities and some of the product was inevitably found in mixed fractions 
which required further chromatography. The yield of 0-silyl A-factor 4.35 from 
3-oxononanoic acid is 40-55% which is less than that obtainable when the butenolide 
intermediate is purified (ca 58% ). Thus the purification of the butenolide intermediate 
4.34 by rapid radial chromatography appeared to be a prudent step which, although 
involving some loss, facilitates its efficient conversion to the A-factor precursor 4.35. 
TBDMS-protected A-factor 4.35, in complete contrast with the preceding two 
intermediates, is a robust compound which is stable to silica gel chromatography, basic 
conditions and can even be purified by Kugelrohr distillation ( oven temp. 130°C, 
0.1 mm Hg). As such, it is a very suitable precursor since it can be readily purified or 
stored for long periods before deprotection to A-factor (1.1). Its purity and stability 
make it an excellent substrate for full NMR spectral characterisation, providing a well 
established benchmark for the eventual assignment of the spectra of A-factor 
(Chapter 5). 
The 13C NMR spectrum is completely consistent with that of the previously 
synthesised 11-demethyl 0-silyl A-factor 4.27, apart from the expected differences 
involving the alkyl chain. AI113C and lH NMR peaks were unambiguously assigned 
using two dimensional lH-lH (COSY) and 1H_l3C (HETCOR) correlated spectra (see 
Appendices Bi and Bii). In CDCl3 solution ca 5% of the product exists in its enol form 
4.36, as is clearly demonstrated by integration of the sharp, H-bonded enol hydroxy 
peak appearing at o 11.2. 
Chapter Four 
OTBDMS 
····,,rR 
0 0 
4.35a (2,3-trans) 
R=~ 
.. 
114 
OTBDMS OTBDMS 
.. 
R 
0 0 
4.36 (enol) 4.35b (2,3-cis) 
Scheme 4.16 
As had previously been seen for the TBDMS-protected demethyl butanolide 
4.27, only one diastereomer of the keto form 4.35a or 4.35b was apparent in the 13c 
and 1 H NMR spectra. Although it had been assumed that the 2,3-trans diastereomer 
would dominate the tautomeric equilibrium depicted in Scheme 4.16 due to its expected 
greater thermodynamic stability, the magnitude of the H2-H3 vicinal coupling constant 
(12,3 = 6.8 Hz) caused us to review this assumption. The magnitude of this coupling 
constant has been used by several groups26,28,35 to assign the 2,3-relative 
stereochemistry of the 6-hydroxy butanolide autoregulators (see Section 1.3, 1.2-1.10). 
This empirical correlation between the 2,3-relative configuration and the vicinal 
coupling constant is based on a 1 H NMR study by Savostianoff and Pf au 157 in which 
this relationship was tabulated for 60 variously substituted y-lactones. They concluded 
that for 2,3-cis configurations the vicinal coupling constants are smaller, ranging from 
5-9 Hz, whereas the 2,3-coupling of 2,3-trans substituted y-lactones range from 
9-12 Hz. Grafe and coworkers assumed this relationship to be general and used it to 
assign the relative 2,3-stereochemistry of isolated 6-hydroxy butanolides 
(Scheme 4.17). Thus, factor-I (1.2) from S. viridochromogenes, with a 2,3-coupling 
constant of 9.4 Hz, was assigned 2,3-trans,26 whereas Grafe's factors 1.4, 1.5 and 1.6 
from S. bikiniensis and S. cyaneofuscatus were declared to be 2,3-cis due to their 
smaller 2,3-coupling value (7.3 Hz). 28 Yamada's group has also-used this method to 
assign the 2,3-geometry of the expanding group of butanolide autoregulators isolated 
from S. virginiae (VB's A-E, 1.6-1.10, see Chapter 1, Section 1.3.3) as well as a range 
of synthetic analogues. 35 
I 
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Although the general applicability and reliability of this method of 
configurational assignment was questionable, the fact that the 2,3-coupling constant of 
TBDMS-protected A-factor 4.35 is well within the range reported by Savostianoff and 
Pfau 157 for 2,3-cis configuration made it prudent to re-examine our assumption of 
2,3-trans geometry. During the catalytic hydrogenation of the butenolide 4.34, 
hydrogen is delivered cis to the double bond so the 2,3-cis lactone 4.35b is likely to be 
the initial product. It was conceivable, though improbable, that the cis-keto form 4.35b 
had actually been isolated rather than being converted into the supposedly lower energy 
2,3-trans configuration via the enol 4.36 (Scheme 4.16). This was considered possible 
only if: 
• the rate of tautomerisation under the reaction and isolation conditions was 
slow and/or 
• the conformational energy of the 2,3-cis tautomer 4.35b is, contrary to 
expectations, lower than that of the 2,3-trans form 4.35a. 
To test these propositions, the silyl lactone 4.35 was fully converted into its 
enolate anion 4.39 by reaction with an excess of sodium hydride in ether. It was 
expected that protonation of this would occur substantially at the enolate oxygen to 
form, initially, the enol 4.36.158 Subsequent tautomerisation should give both keto 
tautomers, provided their conformational energies are similar. 
r 
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4.39 ( enolate) 
The product isolated after quenching the enolate with acid was identical by 
I H NMR to the starting material. It was considered faintly possible that this product 
was simply the kinetically favoured protonation product and was not necessarily the 
more thermodynamically stable form, so DBU (ca 0.5 eq.) was added to the NMR 
sample to catalyse the thermodynamic equilibration of the tautomeric components. 
However, no change was observed by IH NMR spectroscopy after 2 hours at room 
temperature. 
Thus, the isolated keto diastereomer could be the 2,3-cis tautomer 4.35b only if 
this structure has substantially greater thermodynamic stability than the 2,3-trans 
diastereomer 4.35a. Although this was considered to be very unlikely given the 
increased steric interaction expected between the 2,3-cis substituents, energy 
minimisations were conducted for both structures using MM2 force-field calculations as 
implemented in PC Model (version 88.0). The results from numerous energy 
minimisations of both structures using a wide variety of initial conformations 
consistently indicated that the 2,3-cis tautomer 4.35b was between 5 and 10 kcal/mo! 
higher in energy than the 2,3-trans form 4.35a. This result, although not definitive 
s4tce all possible configurations of all bonds had not been searched, suggests that the 
observed keto diastereomer of TBDMS-protected A-factor is likely to have 2,3-trans 
relative stereochemistry despite its low 2,3-coupling constant. Thus, the reported 
correlation between the 2,3-vicinal coupling constant and the relative stereochemistry of 
2,3-disubstituted "(-lactones seems highly questionable and the faith shown by other 
workers in this technique for the assignment of the geometry of the 6-hydroxy 
butanolide autoregulators and related compounds may have been misplaced. In further 
studies we have confirmed that this correlation is not reliable, as discussed in Chapter 6. 
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4.3.4 Desilylation to A-Factor (1.1) 
OH 
Desilylation of TBDMS-protected A-factor 4.35 using glacial acetic acid, 1HF 
and water (3 : 3 : 1 ), as described above in the demethyl reaction series, was again found 
to proceed slowly. After 48 hours, the appearance of by-products in the reaction 
mixture (TLC) made it expedient to stop the reaction before completion. On 
chromatography, 15% of the silyl starting material was recovered followed by A-factor 
(1.1; 71 % based on unrecovered starting material) as a colourless oil which formed a 
waxy solid upon cooling. The yield was later increased dramatically to 95% with the 
use of the mild and effective reagent system HFaq / pyridine in acetonitrile, as described 
above for the synthesis of 11-demethyl A-factor 3.36. The overall yield is 33% over 
6 steps from commercially available 1-bromo-4-methylpentane, which compares very 
favourably with the existing synthetic routes both in yield and simplicity (see Chapter 1, 
Section 1.6). 
Note that racemic synthetic material has ca 10% of the activity of pure 
(3R)-A-factor, probably due to partial in vivo racemisation occurring via 
translactonisation as mentioned in Section 1.2.18 Thus in contrast to many natural 
products, an efficient synthesis of racemic A-factor provides material with activity 
comparable to that of the enantiomerically pure autoregulator. 
Detailed spectroscopic analysis of the product confirmed its identity and also 
revealed surprising shortcomings in the published data. The interpretation of hitherto 
unreported features of the spectral data of A-factor has led to the revision of its 
structure, both in solution and in its pure state, as discussed in the following chapter. 
That these unreported features are not peculiar to our product was revealed by a spectral 
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comparison (lH NMR and Fl'IR) with an authentic sample of A-factor purchased from 
Funakoshi Co. Ltd. 
4.3.5 Biosynthetic Implications of the Synthesis 
FOR THE BUTANOUDE AUTOREGULATORS 
Despite the assurance of Aristotle (see Chapter 4 title page), our discovery of an 
efficient biomimetic route to A-factor (1.1) by no means proves that the biosynthesis of 
the natural product follows the same path. However, the facility with which we formed 
the key C2-C3 butanolide bond by Knoevenagel-style cyclisation is in stark contrast 
with the fundamental stereoelectronic barrier to the desired type of cyclisation which we 
identified during investigation of the other potentially biomimetic route involving 
intramolecular alkylation (Chapter 3). Hence, assuming that the C2-C3 bond of 
A-factor is biosynthesised via an intramolecular process, it appears far more likely that 
it would be achieved through the cyclisation of the 13-ketoester of a dihydroxyacetone 
derivative 4.40 rather than via the corresponding glycerol-type substrate 4.41 
(Scheme 4.18). It is possible that the free primary hydroxyl group of the cyclisation 
precursor 4.40 would have some form of biological protection (P) in view of the 
instability we observed for the unprotected butenolide intermediate. The chirality of 
A-factor is thus likely to derive from the asymmetric reduction of the intermediate 
butenolide 4.42 (probably with NADPH) rather than from the pre-established chirality 
of a glycerol-type precursor 4.41. Confirmation of the intermediacy of the butenolide 
4.42 might be gained by feeding studies using labelled versions of the intermediate 4.42 
with A-factor producing organisms. An intriguing possibility for future study would be 
the use of non-producing organisms such as bakers yeast159 to effect the in vivo 
asymmetric reduction of synthetically produced butenolide 4.42 to optically active 
A-factor (1.1). 
I 
Chapter Four 
4.40 P = biological 
protecting group 
.. 
OR OH 
r-V 
0 H 
0 
4.41 
·---/!---
OR = biological 
leaving group 
(e.g. phosphate) 
Scheme 4.18 
119 
4.42 
0 
1.1 A-factor 
Very recently, Yamada and coworkers published further evidence for the 
biosynthesis of VB-A (1.6), 160 extending their earlier feeding studies87 which 
established the biological origins of its carbon skeleton, (see Chapter 2, Se~tion 2.3). 
The new work confirmed the biological intermediacy of a P-ketoacid derivative by the 
intact incorporation into VB-A (1.6) of the doubly 13C-labelled P-ketothioester 4.43, 
(Scheme 4.19) a mimic of the expected enzyme bound biosynthetic intermediate 4.44 
(Scheme 4.20). In a further experiment, they found that incorporation of [2H5]-glycerol 
(4.45) resulted in the formation of VB-A (1.6) which lacked deuterium at C3, 
suggesting that the glycerol moiety had been oxidised to a dihydroxyacetone derivative 
e.g. 4.46 prior to the formation of the butanolide C2-C3 bond (Scheme 4.19). The loss 
of another deuterium label at C4 (pro-S) was rationalised by an enzyme catalysed 
exchange process of the putative butenolide intermediate 4.47 (Scheme 4.20). 
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Scheme 4.19 Incorporation Studies for VB-A Biosynthesis by Yamada 's Group 
The report of Yamada's group160 concluded with a proposal for the biosynthesis 
of VB-A (1.6) (Scheme 4.20) which is directly analogous to our biomimetic route. A 
preliminary report of our biomimetic synthesis of 11-demethyl A-factor (3.36)131 was 
cited as evidence for the feasibility of the key cyclisation step. 
,, 
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Very recently, Midland and coworkers reported the isolation of two novel 
bacterial signal molecules, 'syringolides 1 and 2' (4.48a and 4.48b), from Pseudomonas 
syringae pv. tomato. These have been demonstrated to elicit a defence response in 
infected soybean plants.161 The report includes a proposed biosynthetic route to these 
compounds (Scheme 4.21), starting with the acylation of D-xylulose (4.49) with a 
J3-ketoacid derivative 4.50 (Step A, Scheme 4.21). The Knoevenagel-style cyclisation 
(Step B) is analogous to the key cyclisation of our biomimetic route to A-factor and was 
in fact modelled on the above biosynthetic proposal for VB-A (1.6), reported by 
Yamada's group 160 (Scheme 4.20). We feel that the subsequent Michael addition to 
the butenolide moiety (Step C) is likely to be facile in view of the strong Michael 
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acceptor properties, as demonstrated by the ease of dimerisation of our analogous 
butenolide intermediates 4.8 and 4.34. We also expect the hemiacetal formation (Step 
D) to be a favoured process by analogy with similar reactivity we have observed with 
related substrates, as described in Chapter 5. On the whole, our research has 
unintentionally provided a good biomimetic model supporting this proposed 
biosynthesis and work is now in progress in our research group to develop a potentially 
very direct biomimetic synthesis of syringolides ( 4.48a and 4.48b ). 
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4.4 Postscript: A Synthetic Short Cut 
Although a simple and efficient synthetic route to A-factor (1.1) and its 
homologue 3.36 had been discovered, it was felt that it could be further improved to 
make the synthesis more convenient, especially on a large scale. Thus an alternative 
route to the key 13-ketoester intermediates 4.6 or 4.33 was sought and the elegant 
method developed by Oikawa and coworkers, 162 which uses Meldrum's acid ( 4.51) for 
the synthesis of a variety of 13-ketoesters, looked very promising (Scheme 4.22). Such 
is the acidity of Meldrum's acid (pKa 4.97)163 that only pyridine was required as a base 
for its acylation by acid chlorides. Of particular interest was the fact that no catalysis 
would be required for the alcoholysis of the intermediate acyl Meldrum's acid 4.52 to 
form the required 13-ketoester 4.6. Hence, base-sensitive 13-ketoesters would be less 
likely to decompose during reaction and could be isolated by merely evaporating the 
solvent. 
OY...O 
0 
Cl)lR1 
o~o 
pyridine 
CHzC12 
Meldrum's acid 
4.51 
OTBDMS 
Ri EtOAc 
0 
HO R1 
4.52 
OTBDMS 
NaH 
THF,0°C 
Scheme 4.22 
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I -CO2 f -Me~O 
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R1=~ 
R2=~0fBDMS 
0 
During the preparation of this report, it was decided to quickly assess the 
viability of this attractive, modified approach by its application to the synthesis of 
11-demethyl A-factor 4.27 as outlined in Scheme 4.22. 
r 
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The acylation of Meldrum's acid with heptanoyl chloride was complete within 
1 hour at room temperature, giving the crude heptanoyl Meldrum's acid 4.52 as an 
orange oil. I H NMR showed this product to be of high purity and confirmed that it 
exists entirely in the enol form. The enol hydroxyl appeared as a sharp, strongly 
deshielded singlet at o 15.2. The crude intermediate 4.52 was subjected to alcoholysis 
with 2.5 equivalents of TBDMS-protected dihydroxyacetone 4.7 in benzene solution. 
After 2 hours at reflux, no intermediate 4.52 was detected by TLC so the solvent was 
evaporated. The unreacted silyl dihydroxyacetone 4. 7 was removed from the product 
mixture by Kugelrohr distillation (oven 100°C, 0.1 mm Hg). The residual 
yellow-orange oil contained the J3-ketoester 4.6 in an overall yield of ca 65% from 
Meldrum's acid, as estimated by IH NMR integration using an internal integration 
standard (diphenylmethanol). This is a substantial improvement over the best 
J3-ketoester yield attained via our previous 3-step methods (cf J3-ketoester 4.33, ca 48% 
overall from t-butyl acetoacetate) and the crude product is of considerably higher purity 
than had previously been obtained. In addition, the difficulties discussed above 
involving the isolation and storage of inherently unstable J3-ketoacids· had been 
circumvented. 
The crude J3-ketoester 4.6 was cyclised using sodium hydride under the usual 
conditions ( 1.1 eq ., THF, 0°C, 40 min.) to form the crude butenolide 4.8 as an orange 
oil. After work-up, 1LC and IH NMR analysis showed the product to be of such high 
purity that the wasteful purification by silica gel chromatography was deemed to be 
unnecessary. Thus, the catalytic hydrogenation (H2, 10% Pd/C, EtOAc) was attempted 
without further purification and in contrast to previous attempts to hydrogenate 
unpurified butenolides, the reduction proceeded smoothly to completion over 12 hours. 
TBDMS-protected 11-demethyl A-factor 4.27 was isolated after radial chromatography 
in an overall yield from Meldrum's acid 4.51 of 48%. Since the subsequent desilylation 
to demethyl A-factor 3.36 has been previously performed in 90% yield (HFaq / pyridine 
I CH3CN), the expected overall yield of demethyl A-factor 3.36, after a single trial of 
this route, is ca 43%. Although time did not permit the optimisation of this 
I: 
I 
,, 
r, 
I 
II 
I: 
i 
,, 
II 
11 
1, 
Ii 
(! 
11~ 
Chapter Four 125 
dramatically improved variation of our synthetic route or its application to the synthesis 
of A-factor itself (1.1), there is no reason to suspect that the route is not of general 
applicability and that similar or improved yields of A-factor itself (1.1) and its other 
homologues could be attained. This route represents a substantial improvement on all 
existing syntheses of this group of compounds (cf. Chapter 1, Section 1.6), due to: 
• the higher overall yield; 
• its simplicity, only five steps being required with only one intermediate 
needing chromatographic purification. All reagents are readily available and 
easily handled; 
• its convenience; all reactions are performed at room temperature or 0°C and 
the full reaction series requires less than 2 days, even on a large scale. 
With (±) A-factor recently becoming a commercial product commanding a price 
of ca A$100 per milligram, 22 these factors make our process an excellent candidate for 
development as a commercial process. 
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CHAPTER FIVE 
A-FACTOR REVISITED 
Nature is not embarrassed by difficulties in analysis 
Augustine Jean Fresnel (1785-1827) 
Chapter Five 127 
CONTENTS 
I 
5.1 INTRODUCTION ............................................................................. .. 128 
5.2 SPECTROSCOPIC ANALYSIS OF A-FACTOR .................................. 129 
5.2.1 Infrared Analysis ................................................................ 129 
5.2.2 Ultraviolet Analysis ............................................................ 131 
5.2.3 Mass Spectral Analysis ...................................................... 133 
5.2.4 I H NMR Analysis .............................................................. 136 
5.2.5 13C NMR Analysis ............................................................. 137 
5.3 THE STRUCTURE OF A-FACTOR IN SOLUTION ........................... 141 
5.3.1 Acidic Decomposition' of A-Factor ................................... 141 
5.3.2 Bicyclic Methyl Ketal of A-Factor ..................................... 144 
5.3.3 Identification of Novel Forms of A-Factor ........................ 146 
5.3.4 The A-Factor Equilibrium: 'Ring-Chain 
Tautomerism' ...................... ............................................ 150 
5.4 BI CYCLIC HEMIKET ALS OF A-FACTOR ...................................... 152 
5.4.1 Isolation of One Hemiketal of A-Factor ............................. 152 
5.4.2 X-Ray Structural Analysis .................................................. 153 
5.4.3 Correlation Between 12,3 and C6 Configuration ................ 155 
5.4.4 Isomerisation Rate .............................................................. 157 
5.5 PRELIMINARY INVEsTIGATION OF A BIOASSAY FOR 
A-FACTOR HEMIKETAL ........................................................ 160 
5.5.1 Techniques for Bioassay .................................................... 160 
5.5.2 Synthesis of [2H]-A-Factor Hemiketal ............................... 163 
5.5.3 2H NMR Monitored Study of Isomerisation Rate .............. 165 
5.6 CONCLUDING COMMENTS ..................................................... ........ 168 
Chapter Five 128 
5.1 INTRODUCTION 
Khokhlov and coworkers established that A-factor was a 2,3-disubstituted 
y-lactone which they expected to be readily epimerisable at the C2 position via the enol 
form 1.lb.9 They assumed that the autoregulator existed exclusively in the 2,3-trans 
form 1. la, since this was presumed to be thermodynamically more stable than the 
2,3-cis isomer I.le. Their assignment of the absolute configuration at C2 followed 
from this assumption of trans stereochemistry and their (erroneous) determination of 
the absolute configuration of C3 (see Section 1.2). A minor but unquantified proportion 
of the compound was shown to exist in the enol form I.lb in solution by UV 
spectroscopy. No other structural forms of A-factor were discussed. Mori and 
coworkers agreed with Khokhlov that the 2,3-trans isomer 1.la "seems to be more 
thermodynamically stable" than the 2,3-cis form 1.le, but no supporting evidence was 
presented.18 Mori and coworkers were, however, more cautious than Khokhlov et al., 
declaring that "the configuration at that position (C2) is uncertain". Possible 
contributions of other isomeric forms were not discussed. Interestingly Grafe et al. 
reported that a sample of synthetic (+)-A-factor 1.1, obtained from Khokhlov for 
bioassay, was "according to its 200 MHz lH NMR spectrum a mixture of 2,3~is and 
trans isomers".26 Although neither the lH NMR data nor the isomeric ratio was 
reported, this comment implies a significant contribution (> ca 5%) by the 2,3-cis form 
I.le which was not noted by Khokhlov or Mori. Subsequent reports of the synthesis of 
A-factor and homologues have failed to contribute any new evidence relating to the 
identity or the relative contributions of isomeric structures, despite the use of high 
resolution lH and 13C NMR spectroscopy.20,29,35 
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In this chapter, a re-examination of the spectroscopic properties of A-factor 
reveals its isomeric composition to be considerably more complex than has hitherto 
been assumed. 
5.2 SPECTROSCOPIC ANALYSIS OF A-FACTOR 
The spectral data supporting the previously reported syntheses of 
A-factor18•20•29,51 1.1 vary considerably, both in the quality of data and in the accuracy 
of interpretation. Where reported the IH NMR data, in particular, are of limited value 
due to the low resolution and/or the inaccuracy of assignments. 18,20 We found these 
shortcomings surprising for such an extensively studied molecule, so a comprehensive 
review of the IR, UV, MS and NMR spectral data of A-factor 1.1 was undertaken. 
S.2.1 Infrared Analysis 
All reported infrared data for A-factor 1.1 have been for thin films, a technique 
which tends to compromise resolution and give spectra which are influenced by 
intermolecular hydrogen bonding.18,29,51 Under these conditions, hydrogen bonding 
reduces the y-lactone carbonyl stretching frequency from 1782 cm-I, the diagnostic 
position which we observe in CC4 solution, to 176518,29 or 177015 cm-I. It may have 
been this shift to a less definitive frequency which delayed the identification of natural 
A-factor 1.1 as a y-lactone during the initial investigation of its primary 
characteristics, 15 until degradation studies were performed. 9 
As a thin film, intermolecular hydrogen bonding gives rise to a broad OH 
stretching absorption centred at 3460 cm-I, whereas in CC4 solution we observed two 
sharp absorbances at 3639 and 3606 cm-I in addition to this broad absorption. The 
former band lies within the narrow range (3630-3643 cm-I)144 expected for the 'free' 
OH stretching vibration of the primary hydroxyl group of A-factor 1.1. However, the 
latter, slightly weaker band (3606 cm-I) is difficult to reconcile with the accepted 
structure 1.1, since it appears in the region characteristic144 of a tertiary hydroxyl group 
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(3(j()()-3620 cm-I). The significance of this band was revealed by further chemical and 
spectroscopic studies described below (Section 5.3.3), which resulted in the 
reassessment of the structure of A-factor in solution. 
Major infrared absorbances of A-factor in the 850-17 50 cm-I region, recorded as 
a thin film, 18,29 are in good agreement with those we observed for our product in CC4 
solution (+5 cm-1). The ketone carbonyl band appears at 1720 cm-I and a pair of 
absorptions at 1367 and 1383 cm-I are presumably the characteristic CH3 bending 
absorptions of the gem-dimethyl group. 144 In the otherwise very similar spectrum of 
11-demethyl A-factor 3.36, this doublet was replaced by a single absorbance at 1380 
cm-I. It is likely that the weak band at 1647 cm-I, also reported by Kinoshita and 
Hirano, 29 is due to the chelated lactone carbonyl stretching absorption of the enol form 
of A-factor I.lb. Similar bands, attributed to this vibration, have been reported for 
a-acetyl-y-butyrolactone S.1 (see below) and for several J3-ketoesters.164 Other peaks in 
the 'fingerprint' region were not unambiguously assigned but their similarity with the 
reported data served to further confirm the identity of our product 
"," 0 
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Literature Model for Lactone Carbonyl Stretching Frequency 
A sample of racemic A-factor which was subsequently obtained from Funakoshi 
Co. Ltd. exhibited an IR spectrum in CCl4 solution identical to that obtained for our 
product. 
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S.2.2 Ultraviolet Analysis 
In neutral or mildly acidic MeOH solution, A-factor exhibits a single maximum 
at 257 nm (E 1200) which we attribute to the tr-tr* transition of the enolic form l.lb. 
This band completely obscures the very weak n-p* absorptions (£ < 30) which may 
have been expected for the carbonyl groups of the keto form 1.la. The absorption 
bands at 206 nm15 and 226 nm9 reported by Khokhlov's group for the naturally derived 
material in MeOH, are evidently due to the presence of impurities. We found that the 
presence of adventitious traces of base in the UV solution caused a second band of 
variable intensity to appear at 283 nm. This band disappeared with the addition of a 
trace of acid and was presumed to be due to the partial formation of the enolate anion 
S.4, since f3-dicarbonyl compounds in general are known to form enolate ions which 
absorb in this region.103,165·166 This is likely to be the origin of a second, unassigned 
maximum at 283.5 nm (E 250) which was reported by Mori (solvent not specified), in 
addition to the dominant band [255 nm (£ 855)].17 
Khokhlov and coworkers report that with the addition of aqueous potassium 
hydroxide solution to a sample of A-factor in MeOH, the absorption maximum shifted 
in wavelength from '250 nm' to '282 nm' and intensified from£ 2330 to£ 13000. They 
attributed this to the formation of the ring-opened carboxylate anion S.2.9 Upon 
acidification, a hypsochromic shift back to '252 nm' was observed, initially forming an 
intense band (£ 5500), which then steadily diminished to the intensity of the original 
enol absorbance (£ 1800) after 30 minutes. They suggested that the initially large peak 
at '250 nm' was due to the formation of the carboxylic acid S.3 which then slowly 
lactonises to reform the original keto-enol mixture 1.la-1.lb, with an attendant drop in 
intensity (Scheme 5.1). No direct evidence for the ring-opening was provided but, in a 
separate experiment, A-factor was treated for an unspecified period with ethanolic 
KOH, (EtOH: 0.01 M KOHaq, 1:1, 20°C), to form a product which was assigned, by IR 
spectroscopy alone, as the potassium salt of the ring-opened carboxylate S.2. No UV 
data was reported for the product and its r~lactonisation to A-factor was not described. 
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We also observed that the acidification of a basic solution of A-factor 
(0.005 M NaOH / MeOH), caused a hypsochromic shift from 283 nm (E 20100) to 
257 nm (E 7700) and that the resulting peak gradually attenuated, over 15 minutes, to an 
intensity compatible with that of the enol content of A-factor in MeOH (E 1200). We 
also noted analogous behaviour for the TBDMS protected precursor to A-factor 4.27 
and contend that this behaviour can be explained without invoking the opening and 
reclosure of the lactone ring. While it is likely that y-lactone opening will eventually 
occur in the presence of hydroxide, it is considered improbable that this would happen 
almost instantaneously at room temperature, as would be required to explain the 
observations during UV spectroscopy. It appears more likely that the large peak at 
283 nm, observed in alkaline solution, is simply due to formation of the enolate anion 
5.4 and that upon acidification, protonation of the enolate occurs preferentially on the 
C6 oxygen (rather than at C3) to initially form substantially more of the enol form 1.lb 
than normally exists in an equilibrated solution of A-factor in methanol. Subsequently, 
the absorbance at 257 nm due to the enhanced levels of enol form 1.lb, diminishes as 
the normal keto-enol equilibrium is re-established (Scheme 5.2). In support of this 
alternative explanation is the observation by Eigen, in his report on proton transfer 
processes, that during protonation of the enolate anions of J3-dicarbonyl compounds, the 
I 
I 
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thermodynamically less stable enol tautomer is generally formed faster than the keto 
form.158 
slow 
R 
-
5.4 Amax 283 run I.lb Amax 257 run 
Scheme 5.2 
5.2.3 Mass Spectral Analysis 
0 
1.1 
0 
R 
R=~ 
The EI mass spectrum of natural (-)-A-factor was reported by Khokhlov's 
group15 and is, apart from some minor peaks presumably arising from impurities in the 
natural material, very similar to the spectrum obtained for our synthetic product. Their 
spectrum was originally used to establish the molecular weight of A-factor (mlz 242, 
M+) and to confirm the existence of a hydroxymethyl substituent (mlz 211, M+-
CH20H), but no other peak assignments were made at the time. Mori and Yamane18 
have subsequently determined the elemental composition of twenty one of the most 
significant peaks in the mass spectrum of their synthetic (-)-A-factor by high resolution 
mass measurements, but did not attempt to rationalise the formation of these fragments. 
One major fragment at mlz 141 (28%) appears to be an artefact since it was reported to 
have the unlikely composition of C 11H9, and is not observed in our EIMS spectra or in 
that of Khokhlov and coworkers. Since some of the other reported peak compositions 
were also difficult to explain and other peak intensities differed significantly from those 
exhibited by our product, we sought to rationalise the mass spectral fragmentations of 
A-factor, as depicted in Scheme 5.3. 
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The depicted homolytic cleavages are supported by the appearance of 
appropriate homologous peaks in the mass spectra of the closely related compounds 
11-demethyl A-factor 4.34 and [3-2H]-A-factor 5.15. Using these comparisons, it was 
deduced that the implausible composition C1oH10 reported by Mori and Yamane18 for a 
fragment ion at mlz 143 was probably in error. Repetition of the high resolution mass 
measurement gave a composition as C6H104, which corresponds to the expected 
cleavage of the C-C bond adjacent to the ketone carbonyl group (Scheme 5.3). 
OH 
0 0 
5.15 
With this example of the unreliability of the reported high resolution mass 
measurements, the compositions of other significant fragment ions at mlz 211, 127 and 
109 were also checked by HRMS, but all were in agreement with the data of Mori and 
Yamane. The large peak at ml z 109 was confirmed as having the rather surprising 
composition of CgH13. Its origins were puzzling, especially when it was noted that the 
EIMS of 11-demethyl A-factor 4.34 lacked a significant analogous peak at 14 mass 
units lower (ml e 95). A linked B2/E scan of unimolecular metastable fragmentations 
giving rise to the ion at mlz 109, indicated that this fragment resulted largely from the 
loss of H20 from the 6-methylheptanoyl fragment (mlz 127). We rationalise the 
dominance of this fragmentation path for A-factor, by the formation of the highly 
stabilised tertiary allylic carbonium ion, as depicted in Scheme 5.3. 
McLafferty rearrangements (a and b, Scheme 5.3) generate the 
hydroxymethylbutyrolactone fragments at mlz 116 and mlz 158, both of which may then 
lose a CH20H fragment to give major peaks at mlz 85 and atm/z 127, respectively. 
The fragment at mlz 102 (C4H603) also appears in the spectrum of [3-2H]-
A-factor, 5.15 suggesting that carbon 3 is probably not present in the fragment. Since 
three oxygen atoms are present, it appears likely that the fragment represents carbons 
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1,2,6 and 7. A fragment with the required composition could be formed from the 
radical cation mlz 158 via a process involving the cleavage of two bonds (C2-C3 and 
C4-0) with the associated transfer of two hydrogen atoms, as depicted in Scheme 5.3, 
(cleavage c). 
Note that the existence of tautomeric forms of A-factor (described in detail later 
in this chapter) means that some fragments may have different (or mixed) origins from 
those depicted in Scheme 5.3. 
5.2.4 lff NMR Analysis 
The published lH NMR data for A-factor are of remarkably poor quality. The 
60 MHz data reported by Mori and Yamane18 in 1982 without an accompanying 
spectrum, was not assigned and was of such poor resolution as to make it of very 
limited use for comparison purposes. The data were presented largely as integrated 
'multiplet' ranges with no coupling information, and even this limited information 
contains three significant errors (Figure 5.1). The multiplet regions extend only too 4.2 
and thus exclude the H4a proton of the keto form of A-factor 1.la which we have found 
to appear at o 4.43. In addition, the region o 3.5-3.8 is reported to contain two protons 
when it in fact contains three (l.la, H2, H5a and H5b), and the region o 1.0-2.0 which 
is said to represent 9 protons, actually contains 7 ( or possibly 8 if the hydroxyl proton 
was present in this region). Reports of subsequent syntheses of A-factor, up to as late 
as 1992, have uncritically accepted this data and declared their product to exhibit 
identical NMR spectra.20•29,30 Posner and coworkers, 20 in their report of the 
asymmetric synthesis of (+)-A-factor, included their own 400 MHz lH NMR data 
(Figure 5.1 ), again with no spectrum but with still more errors, apparently resulting 
from an attempt to reconcile their spectrum with the flawed data of Mori. Despite the 
high field strength used, their spectral information is also presented as unassigned 
'multiplet' regions with no coupling data, and again no peaks downfield of o 4.2 are 
reported. In common with Mori's data, the region 'o 3.800-3.661' is incorrectly reported 
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to represent only two protons where three actually appear. In addition, the region 
'o 3.103-2.61' is stated to encompass three protons when in fact only two appear (I.la, 
H7 a and H7b ). Given these significant departures from our spectral data, it was 
surprising to find that when a copy of the actual spectrum was later obtained from 
Posner, it was virtually identical to ours (Figure 5.1) apart from the presence of some 
solvent peaks. A sample of (+)-A-factor subsequently obtained from Funakoshi Co. 
Ltd., presumably prepared by a method related to that of Mori and Yamane, 18 also 
displayed a lH NMR spectrum essentially identical to ours. 
Clearly, the literature provided little assistance in the assignment of high field 
I H NMR spectra of A-factor or even for the confirmation of the structure of our 
product. Fortunately, we had previously comprehensively studied TBDMS protected 
A-factor 4.35 by NMR, as described in the preceding chapter, and this provided an 
excellent NMR comparison. A-factor in CDCl3 displayed, inter alia, a set of peaks 
which corresponded closely to the spectrum of TBDMS protected 2,3-trans-A-factor 
4.35, and accordingly these resonances have been assigned to the 2,3-trans keto form of 
A-factor I.la, as shown in yellow in Figure 5.1. Disturbingly, the spectrum also 
displayed a complex array of unidentified secondary peaks displayed in blue in 
Figure 5.1, representing approximately 40% of the sample. The expected enol form 
I.lb accounted for only about 4% of the sample, as indicated by the integration of the 
distinctive enol OH resonance at o 11.2 (not shown in Figure 5.1). The complexity of 
these secondary peaks suggested the presence of at least two other chemical species. 
These 'extra' peaks persisted even in samples of A-factor which had undergone further, 
careful purification by silica gel chromatography and reverse phase MPLC (RP8, 82.5% 
5.2.5 13C NMR Analysis 
13C NMR analysis revealed the presence of a mixture of compounds even more 
clearly. The major set of peaks corresponded very closely (within 0.5 ppm) to the I3c 
NMR data for A-factor reported by Mori and Y amane18 and Kinoshita and Hirano. 29 
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Figure 5.1 Comparison of 1H NMR Spectrum of A-Factor (300 MHz, CDCI3) with Literature Data 
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We assigned these peaks to 2,3-trans-A-factor 1.la, as shown in Figure 5.2, by 
comparison with the unambiguously assigned I3c spectrum of TBDMS protected 
2,3-trans-A-factor 4.35 (see Appendix Bi and Bii). This assignment revealed that 
Kinoshita and Hirano had incorrectly assigned C8 and ClO, as shown in Figure 5.2. 
Neither research group, however, mentions the presence of any other resonances, 
whereas in our spectrum, three additional sets of peaks are apparent, with peak heights 
approximately 40%, 40% and 8% of the major component. The smallest set of peaks, 
although partially obscured in the upfield region, is assigned as the enol tautomer 1.lb, 
by its close correspondence to the resonances observed for the enol form of 
TBDMS-protected 2,3-trans-A-factor 4.35, as shown in Table 5.1. The two larger sets 
of 'extra' peaks were very similar in chemical shift values, suggesting that they 
represented closely related molecules, while their significant difference from the peaks 
of 2,3-trans A-factor 1.la militated against either of them representing the 2,3-cis 
. isomer. 
Table 5.1 Comparison of 13C NMR Data of Enol Tautomers 4.36 and 1.lb 
OR 
0,,, 8 -0 
Chemical Shift o (ppm) 
Enol form Cl C2 C3 C4 cs C6 Cl 
4.36 R = TBDMS 173.2* 96.0 39.3 70.0 64.8 176.8* 32.7 
l.lbR=H 173.7* 95.5 t 70.0 64.4 176.6* 32.9 
t not resolved * denotes interchangeable assignments. 
Thus the structure of A-factor in solution was found to be significantly more 
complex than had been assumed by previous workers in this field, and we sought to 
clarify the situation. 
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5.3 THE STRUCTURE OF A-FACTOR IN SOLUTION 
5.3.1 Acidic 'Decomposition' of A-Factor 
Clarification of the complex spectroscopic behaviour of A-factor was, initially, 
impeded by the observation that solutions of carefully purified A-factor in CDC13 
appeared to form several new products during long data acquisition periods. These 
samples, which initially displayed a single spot in several TLC systems, showed at least 
four additional less polar compounds after removal of the solvent. It was soon 
discovered that this unwanted reactivity during NMR spectroscopy could be avoided 
with the use of acid-free CDC13, prepared by passage of the solvent through a short 
column of basic alumina immediately before use. However, the nature of this 
'decomposition' was of interest since A-factor had ~ot previously been reported to be 
acid sensitive. 
The supposition that the 'decomposition' was caused by the adventitious traces 
of acid, which are commonly found in CDC13, was supported by the formation of the 
same products when a trace of anhydrous HCl was added to a stable solution of 
A-factor in acid-free CDCl3. Careful radial chromatography (Si02) using a mildly basic 
eluent gradient (0 to 1 % MeOH in CH2Ch containing 0.1 % pyridine) allowed partial 
separation of the four products (ca 15% each), followed by unchanged A-factor 
(ca 28% ). The two more polar products were completely separated while the less polar 
pair of products remained a mixture. 
The lH NMR spectra of the two fully separated, more polar products were 
broadly similar. Both were very complex but both contained very similar sets of 
resonances which corresponded remarkably well with those assigned to 2,3-trans 
A-factor I.la. Most diagnostic were resonances near o 2.6 (dt), 3.0 (dt) and 3.6 (d, 
J = 7 Hz) (cf. H7b, H7a and H2 of I.la, Figure 5.1). Other peaks matching those of 
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2,3-trans A-factor I.la were also observed, although the peaks matching the H5a and 
H5b resonances appear more widely separated in the new products, suggesting some 
structural difference at C5. Both new products also displayed many additional 
resonances, suggesting that they were considerably more complex than A-factor, 
although each apparently incorporated a reasonably intact 2,3-trans A-factor moiety. 
The lH NMR spectrum of the other two less-polar products (combined) showed broadly 
the same characteristics, suggesting that all four may be closely related. 
That the relationship of all four compounds was indeed very close (probably 
diastereomeric) was shown by EIMS and CIMS which displayed identical 
fragmentation patterns for all product fractions. All products displayed a large 
M+NI4+ ion at ml z 484 in their CI mass spectra, indicating a common molecular 
weight of 466, while the base peak for all compounds, in both the EI and CI mass 
spectra, was mlz 225. A molecular weight of 466 corresponds to a dimer of A-factor 
(MW 242) minus a molecule of water. Consideration of plausible dimeric structures of 
A-factor incorporating a largely intact 2,3-trans A-factor moiety and an overall loss of 
H20 led to the proposal that the new products were stereoisomers of either 5.7 or 5.8. 
OH 
0 
.• 6 
·1 
0 
5.7 5.8 
Dimer structures of the type 5. 7 were thought less likely on the grounds that the 
indicated cleavage, required to give the base peak (mlz 225) in the EI and CI mass 
spectra, is not a favoured process since an unstable vinyl cation would be formed. In 
contrast, the corresponding cleavage of the ketal dimer structures 5.8 would form a 
heteroatom-stabilised tertiary cation. An APT spectrum of one of the products ( the 
most polar) gave further support to the ketal dimer structure 5.8 (see Appendix C). In 
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the downfield region(> 80 ppm) there were 4 quaternary peaks (6 202.7, 173.1, 171.8, 
109.7), and the one at 6 109.7 is in the range expected for the ketal carbon (C6').167 The 
alternative structure 5. 7 requires five downfield quaternary peaks including a distinctive 
olefinic resonance for C2' expected at 6 ca 96 (cf Table 5.2, 4.36, C2 at 6 96.0) which 
was clearly absent. The remainder of the APT spectrum was fully consistent with the 
proposed ketal dimer 5.8. The observation of four distinct products is consistent with 
the two possible pairs of diastereomers 5.8a and 5.8b, each of which contains a 
2,3-trans A-factor moiety and a cis-fused [5,5]-bicyclic moiety connected at an 
asymmetric ketal carbon (C6'). A method of predicting the C2'-C6' relative 
stereochemistry of the dimers 5.8 is proposed below (see Section 5.4.3). These dimers 
incorporate A-factor in a previously unknown bicyclic ketal form and their facile 
formation implied that simpler bicyclic ketals should be formed readily using other 
alcohols. 
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5.3.2 Bicyclic Methyl Ketal of A-Factor 
Treatment of a CDCl3 solution of A-factor with an excess of methanolic HCl 
(0.25 M) in an NMR tube, allowed ketal formation to be monitored by I H NMR 
spectroscopy. After 5 minutes the spectrum showed the presence of approximately 70% 
of two methoxy compounds in a 12:1 ratio (as judged by their methoxyl peaks at 6 3.16 
and 3.22 respectively), and about 30% unreacted A-factor (1.1). Strangely, over the 
following hour the amount of starting material did not appear to decrease significantly 
(although the ratio of products changed to ca 5:1) and after subsequent work-up and 
chromatography, ca 30% of the starting material was recovered. It was interesting to 
note that the lH NMR spectrum of this recovered A-factor run immediately following 
chromatography showed a lower than usual proportion of the 'extra' components 
(representing ca 20% of the sample rather than the usual ca 40% as in Figure 5.1), 
although when the spectrum was re-run 2 days later, the proportions had returned to 
normal. It was later found to be a consistent feature of A-factor (1.1) that material 
analysed by lH NMR spectroscopy immediately after chromatography had lower levels 
of the 'extra components' with levels gradually increasing to the usually observed 
relative proportions, shown in Figure 5.1, over a few days. 
The two products arising from acidic methanolysis could be isolated, without 
separation, in a 50% overall yield (15:85 ratio) and were identified by NMR and mass 
spectroscopy as C6 epimers (5.9a and 5.9b, respectively) of the 2,3-cis bicyclic methyl 
ketal 5.9. Their molecular weight was determined as 256 by CI mass spectroscopy of 
the mixture and their EIMS showed the expected major losses at M+-OMe (mlz 225) 
and M+-C1H15 (m!z 157). By lH NMR, their H2 doublets were almost coincident at 
6 3.16 and they displayed 12,3 couplings of 10.9 and 9.2 Hz, for the minor (5.9a) and 
major (5.9b) epimers respectively. The vastly reduced ring-strain which would 
accompany the formation of cis-fused rather than trans-fused 5-membered rings dictates 
that these are 2,3-cis fused systems even though the coupling constants are within the 
range expected for 2,3-trans substituted y-lactones. 157 This provided further evidence 
-
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for the lack of general applicability of such empirical correlations, as discussed above 
(see Section 4.2.3). As expected, the H7 protons were shifted upfield significantly (ca 1 
ppm) with respect to their position in 2,3-trans A-factor 1.la, due to the loss of the 
ketone functionality. Although the relative stereochemistry at C6 could not be 
determined at this stage, a method for making the indicated assignment was later 
achieved (this is described in Section 5.4.3). The 13C NMR (APT) spectrum (see 
Appendix D) showed the absence of ketone signals and the appearance of the ketal 
carbons (C6) near o 110. The C4 and C5 peaks of the new compounds were shifted 
downfield and were all nearly coincident around o 72. All of the resonances (apart from 
those due to the methoxyl groups) correlated very well with those assigned to the 
cis-bicyclic portion of the previously isolated A-factor dimers 5.8 (cf Appendix D and 
Appendix C). 
IJ 
m~.~ 
O H OMe 
5.9a 
diastereomeric mixture 
(15:85) 
5.9b 
An attempt to fully convert A-factor to its methyl ketals 5.9 by increasing the 
reaction time to 48 hours, resulted in the isolation of only 40% of the mixed ketals 5.9a 
and 5.9b, (45:55) and a new product (40%) which coincidently had the same Rt as the 
starting material. The new product was shown by EIMS and CIMS to be isomeric with 
the methyl ketals 5.9 but did not show the same facile loss of C1H1s (m/z 157). 
Important differences in I H NMR spectra (acid-free CDCh) were observed, most 
notably, the absence of both the H2 doublet at o ca 3.2, and the methoxyl resonance, 
also expected near o 3.2. A new three-proton singlet which appeared at o 3.74, 
suggested the presence of a methyl ester. These features, in addition to the observation 
of generally more complex coupling patterns, led to initial consideration of the novel 
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[2,2,1]-bicyclic ester structure 5.10, whose formation via methanolysis of the lactone 
followed by intramolecular ketal formation was considered feasible. 
0 
5.10 
HO 
MeO 
5.11 
However, re-measuring the lH NMR spectrum in untreated CDCl3, allowed the 
re-assignment of one doublet of doublets (6 2.73, lH) as a hydroxyl proton due to its 
collapse to a singlet and change in chemical shift (to 6 3.8). This clearly eliminated 
structure 5.10 and the dihydrofuran structure 5.11 was proposed instead. The prominent 
M+-OCH3 peak (mlz 225) observed in its EIMS and the absence of a significant 
M+-C1H1s fragment were well explained by this structure. Although only a small 
sample was available, a 13C spectrum was obtained which was consistent with this 
modified structural proposal (see selected resonances above). It was envisaged that the 
dihydrofuran 5.11 could be formed from the methyl ketals 5.9 via methanolysis of the 
y-lactone followed by elimination of methanol to form the double bond. 
Re-lactonisation would then be disfavoured by the excessive ring strain involved with a 
bridgehead olefin. 
5.3.3 Identification of Novel Forms of A-Factor 
During NMR identification of the bicyclic ketals of A-factor 5.8 and 5.9ab, 
striking similarities were noted with the unassigned 'extra' sets of peaks in the lH and 
13C NMR spectra of A-factor, highlighted in Figures 5.1 and 5.2. In particular, it was 
observed that the H2 resonances of the cis-bicyclic ketal moieties appear as doublets 
between 6 3.16 and 3.22 (12,3 ca 9 or ca 11 Hz), and two such doublets also appeared as 
minor peaks in the spectrum of A-factor, displaying just such coupling constants 
(Figure 5.3a). In addition, the 13C peaks of C4 and C5, which appear grouped around 
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o 72 in the spectrum of the bicyclic ketals S.9ab and the dimers S.8 (see Appendices C 
and D), have remarkably similar counterparts as 'extra' peaks in the 13C spectrum of 
A-factor (see Figure 5.3b). Closer comparison revealed that, in fact, every peak (except 
the methoxyl resonance) in the 13C spectrum of the bicyclic methyl ketals S.9ab and in 
the bicyclic portion of the dimers 5.8 corresponded with one of the 'extra' resonances in 
the 13C spectrum of A-factor to within 2 ppm. Close correspondence was also noted 
between the 1 H NMR spectra leading to the assignment of the unknown components, 
which together represent ca 35% of A-factor in chloroform solution, as the two 
diastereomers of the bicyclic hemiketal form S.12a and 5.12b. Thus it became possible 
to assign all of the 'extra' resonances present in the NMR spectra of A-factor, as shown 
in Figures 5.3a and 5.3b. 
Further support for this assignment comes from the previously noted 
observation of an otherwise inexplicable band in the IR spectrum of A-factor at 3606 
cm-1, a frequency which is highly characteristic of a tertiary hydroxyl group. 144 
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5.3.4 The A-Factor Equilibrium: 'Ring-Chain Tautomerism' 
Thus a much clearer picture of the behaviour of A-factor in solution began to 
emerge (Scheme 5.4a). In an equilibrated solution of A-factor in chloroform, the major 
component is 2,3-trans keto A-factor I.la (62%) which may be epimerised at C2 via 
the enol form I.lb (4% ). In the 2,3-cis configuration the molecule is evidently 
significantly more stable in the bicyclic hemiketal forms 5.12a and 5.12b (17% each) 
than in the 2,3-cis keto form I.le, since no evidence of any contribution of the latter 
isomer has been found. 
I.la 2,3-trans keto 
(62%) 
I.lb enol 
(4%) 
lj 
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0 8 oH 
6-endo-OH 
5.12a hemiketal 
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Scheme 5.4a The A-factor Equilibrium in CHCl3 
This equilibrium between a hydroxy ketone and its cyclic hemiketal (or lactol) is 
an example of so-called 'ring-chain tautomerism'168 although the process is probably 
more correctly classed as an isomerisation since the term 'tautomerism' is generally 
applied to equilibrations which only involve the migration of a hydrogen atom. 169 A 
well studied example of this type of isomerisation is the mutarotation of keto sugars in 
which anomeric ex- and J3-cyclic forms 5.18a and 5.18b equilibrate in aqueous solution 
via the acyclic keto form 5.19, which constitutes 20% of the mixture at 26°C (Scheme 
5.4b).170 Another example is the equilibrium between 5-hydroxy-2-pentanone 5.20 and 
its lactol isomer 5.21.171 In CDC13 solution the open chain form 5.20 (55%) is favoured 
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over the ring form 5.21 ( 45% ), proportions which are analogous to those we observe for 
A-factor (1.1) between its keto 1.la and the bicyclic hemik:etal forms 5.12 (ratio 65:35). 
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H»CHPH HO;QOH CH20H .. HO OH .. 0 CH20H 
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HO 0 
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Scheme 5.4b Literature Examples of 'Ring-Chain Tautomerism' 
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5.4 BICYCLIC HEMIKETALS OF A-FACTOR 
5.4.1 Isolation of One Hemiketal of A-Factor 
Since the proposed hemiketal forms 5.12a and 5.12b had only been observed in 
solution as a 1: 1 diastereomeric mixture and always in association with the 2,3-trans 
and enol forms of A-factor, the task of providing definitive proof of their existence, full 
assignment of their NMR spectra, assignment of relative stereochemistry and the 
acquisition of other spectral data would have been extremely problematic without a 
serendipitous discovery. It was found that a sample of neat A-factor which had been 
refrigerated for several weeks (ca 5°C) showed significant enrichment in one of the 
hemiketals, by lH NMR spectroscopy. The diastereomeric ratio had changed to ca 6:1, 
and the combined hemiketal forms represented ca 78% of the total isomeric mixture. 
Since the proportion of one diastereomer (characterised by its 12,3 value_ of 11 Hz) had 
increased it was then possible to easily distinguish the individual spectra of the two 
hemiketals which in turn facilitated their assignment as shown above in Figure 5.3. 
It was surmised that this enrichment had been caused by the partial 
crystallisation of one hemiketal, since it had been noted that the sample after storage 
appeared more solid than the oily wax that characterises 'fresh' samples of A-factor. 
Crystallisation of one component of the equilibrium mixture could distort the 
equilibrium in its favour. Many attempts were made to enhance this crystallisation 
process but only oils were obtained. Eventually, a solution of A-factor in 
dichloromethane / pentane (ca 40:60, ca 50 µL/mg) was cooled at -5°C overnight, and 
we were rewarded with beautiful colourless plates, melting at 69-72°C. The crystals 
were immediately submitted for X-ray crystallographic analysis (see below). It was 
later found that this crystallisation could also be accomplished in neat carbon 
tetrachloride (ca 20 µL/mg). An infrared spectrum of the crystalline product in the 
solid phase (KBr disc) confirmed the lack of a ketone carbonyl absorption and showed 
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that the lactone carbonyl stretching band had shifted to 1743 cm-I, presumably as a 
result of intermolecular hydrogen bonding in the solid phase. The tertiary hydroxyl 
stretching absorption appeared at 3395 cm-I, a frequency expected with the influence of 
strong intermolecular hydrogen bonding.103 In the previously discussed spectrum of 
A-factor (1.1) in CC4 (see Section 5.2.1) the 'free' OH stretching absorption of this 
tertiary hydroxyl group and the one of the alternative bicyclic diastereomer 5.12b are 
presumably responsible for the otherwise inexplicable band at 3606 cm-I. 
Slow evaporation of a solution of A-factor in dichloromethane : pentane ( 1 : 1) at 
-5°C, resulted in the deposition of a fine amorphous powder which contained both 
hemiketals 5.12a and 5.12b in a 55:45 ratio with no associated trans-keto A-factor I.la, 
as judged by IH NMR spectroscopy. 
The corresponding 11-demethylhemiketal 5.22a crystallised from solutions of 
11-demethyl A-factor (3.36) in cold carbon tetrachloride/ hexane. On standing, NMR 
solutions of 5.22a formed a mixture containing trans-11-demethyl A-factor (3.3.6) and 
the exo-hydroxy diastereomer (5.22b) as well as 5.22a. (These structures were assigned 
by comparison with the NMR spectra of 5.12.) 
5.4.2 X-Ray Structural Analysis 
Concerns that the crystals were too thin for X-ray crystal structure analysis 
proved unfounded and within two days the structure had been solved by Jonathon White 
(see Experimental, title page) as the endo-hydroxy bicyclic hemiketal isomer of 
A-factor 5.12a (Figure 5.4). When the X-ray reflection data were recorded at room 
temperature a satisfactory structure solution could only be obtained for the rigid, 
bicyclic ring moiety since the flexible alkyl chain exhibited some packing disorder 
which could not be resolved. When the reflections were remeasured at -143°C the 
nature of the disorder became apparent. The alkyl chain was shown to exist in three 
distinct conformers which have 25%, 25% and 50% relative abundances. 172 Figure 5.4 
depicts the structure of the most abundant conformer, while Appendix Ei shows all 
atom sites detected. 
I 
0 
H 
3 
:2 0 l l 8 9 
H ---6H 
5.12a 
6-endo-OH hemiketal 
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(50% thermal ellipsoids of the most 
abundant confonner are shown) 
Figure 5.4 X-Ray Crystal Structure of 6-endo-Hydroxy A-Factor Hemiketal (5.12a) 
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Bond lengths and angles observed in the structure are unexceptional (see 
Appendix Eii). Strong intramolecular hydrogen-bonding between the hydroxyl and 
lactone carbonyl groups of 5.12a, such as is expected in the enol form of A-factor l.lb, 
is precluded by the 3.27 A separation between the oxygen atoms. For the 
diastereomeric hemiketal 5.12b, hydrogen-bonding is also not possible since it was 
calculated that the corresponding distance would be ca 3.8 A. 
5.4.3 Correlation Between J 2 , 3 and C6 Configuration 
Low temperature IH NMR spectroscopy of the crystalline product (acid-free 
CDC13, -20°C) confirmed that this endo-hydroxy epimer 5.12a has a 12,3 value of 
10.8 Hz, and thus the other diastereomer, the exo-hydroxy hemiketal 5.12b, must give 
rise to the second 2,3-coupling constant of 9 .1 Hz which was observed in spectra of the 
isomer mixtures. These two coupling constants are remarkably consistent for all 
C6-epimeric pairs of bicyclic lactones which have been isolated [5.8a, 5.8b (2 
diastereomers each), S.9a, S.9b, 5.12a and 5.12b], despite significant variation in the 
size of the oxy-substituent at C6. The striking consistency of the two 12,3 values 
suggested that the correlation with C6 configuration observed for the hemiketals 5.12a 
and 5.12b may be extrapolated to include the A-factor ketal pairs 5.8a and S.8b, S.9a 
and 5.9b, as shown in Table 5.2, although the general applicability of this correlation 
remains to be investigated. 
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Table 5.2 Proposed Assignment of C6 Relative Configuration 
of Bicyclic Ketals Based on J~ Values 
Compound 
5.12a 
5.9a 
5.8a (2 diast.) 
5.12b 
5.9b 
5.8b (2 diast.) 
l2,3 value (Hz) 
10.8 
10.9 
11.1, 11.1 
9.1 
9.2 
9.0, 9.1 
H 
ffio 2 i 6.,,,R2 
0 H R1 
R 1 (endo-substituent) 
OHt 
OMe 
0-(2,3-trans A-factor) 
(CH2)4CH(CH3)2t 
(CH2)4CH(CH3)2 
(CH2)4CH(CH3)2 
t Assignment supported by X-ray structure. 
R2 (exo-substituent) 
(CH2)4CH(CH3)2 t 
(CH2)4CH(CH3)2 
(CH2)4CH(CH3)2 
OMe 
0-(2,3-trans A-factor) 
In the case of the methyl ketals 5.9a and 5.9b, this assignment is supported by · 
lH NMR observations made during their formation (see Section 5.3.2). The A-factor 
sample used as starting material was noted to be significantly enriched in the hemiketal 
isomers 5.12a and 5.12b, (I.la : 5.12a : 5.12b, 28:44:28%) presumably by partial 
crystallisation during storage. Within 5 minutes of the addition of the methanolic HCl, 
the hemiketals had been almost entirely converted into a mixture of bicyclic methyl 
ketals 5.9 in which the epimer exhibiting a 9.2 Hz 2,3-coupling constant dominated by a 
ratio of 12: 1, while the 2,3-trans keto A-factor remained largely unchanged. 
Assignment of the kinetically favoured epimer as the exo-methoxy ketal 5.9b is 
consistent with its formation via preferential attack by methanol from the less hindered 
exo-face of the intermediate oxonium ion 5.13 (Scheme 5.5). Over the following hour, 
some equilibration between the epimers was observed, reducing the ketal epimer ratio 
to ca 6: 1. The quantity of the 2,3-trans keto A-factor I.la remained almost 
undiminished over this pericxi. 
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The observation that the keto form of A-factor 1.la was not appreciably 
consumed after 1 hour in the presence of methanolic HCl (see above) shows firstly that 
methyl ketal formation occurs largely (or exclusively) through the bicyclic .hemiketal 
isomers 5.12a and 5.12b and secondly, that the keto-hemiketal conversion (1.la to 
5.12) is SUl])risingly slow under these conditions. 
Investigation of the rate of isomerisation was made possible by the isolation of 
the crystalline hemiketal 5.12a. A sample of this isomer in acid-free CDC!], showed by 
NMR that equilibration (to a ratio of ca 1:1) with its C6 epimer 5.12b was relatively 
rapid (ca 12 h), but isomerisation to the 2,3-trans keto isomer 1.la proceeded much 
more slowly; reforming the previously observed equilibrium mixture (I.la : 1.lb : 
5.12a: 5.12b, 62:4:17:17%, see Scheme 5.4a) only after ca 3 days at room temperature. 
Further investigation showed that these equilibration processes are both 
apparently accelerated by the presence of water. The isomerisation of a solution of the 
crystalline A-factor isomer 5.12a in acid-free CDC13 was monitored by lH NMR 
spectroscopy for 9.5 hours before the addition of D20. Figure 5.5a illustrates that the 
rate of hemiketal-keto isomerisation established during this initial equilibration period 
was significantly increased after the D20 addition. Under these conditions, 
Chapter Five 158 
re-establishment of the previously observed isomeric equilibrium required ca 20 hours 
in the presence of D20. 
The addition of D20 also allowed simultaneous measurement of deuterium 
substitution of H2 in the isomers using 1 H integration (Figure 5.5b ). As expected, the 
2,3-trans keto form 1.la rapidly appeared fully deuterated at C2, due to both H2 
exchange of the extant quantity of the keto form and to the formation of additional 
[2-2H]-keto isomer from the hemiketals 5.12, via addition of a deuteron to the enol 1.lb 
(same mechanism for both processes). In contrast, the hemiketals 5.12 exchanged 
deuterium at C2 much more slowly, requiring more than 50 hours for complete 
deuteration, presumably because they need to be first converted to the 2,3-cis keto form 
1.lc before exchange at C2 can occur. (The hemiketal itself is presumably not acidic as 
the conjugate base is a bridgehead enolate.) Since this deuteration and the equilibration 
with 1.la both presumably require the enol form I.lb as an intermediate (see Scheme 
5.4a), it is not surprising that they occur over a similar time frame. It appeared likely 
that in these processes the rate determining step was the ring-opening of the bicyclic 
ring system to form the 2,3-cis keto isomer I.le. 
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5.5 PRELIMINARY INVESTIGATION OF A BIOASSAY 
FOR A-FACTOR HEMIKETAL 
5.5.1 Techniques for Bioassay 
160 
The discovery of novel hemiketal forms of A-factor which constitute a 
significant proportion of A-factor, at least in chloroform solution, raises the question of 
the identity of the actual biologically active species. Presumably only one form of 
A-factor binds to a protein receptor, and the relatively slow isomerisation rate for the 
hemiketals might allow the possibility of using a biological assay to differentiate the 
activities of the keto and hemiketal forms. Viewed simplistically, the 3-dimensional 
structure of the 2,3-cis hemiketal forms 5.12 appeared more similar to the series of 
closely related 2,3-'cis' 6-hydroxybutanolide autoregulators 1.6-1.10 (VBs A-E) than 
did the 2,3-trans keto form I.la. Since 6-hydroxybutanolides are supposedly much 
more active when they possess 2,3-cis relative stereochemistry, 35 it was an intriguing 
possibility that the binding protein of A-factor may possess similar structural features to 
the VB binding protein which could result in preferential binding to one ( or both) of the 
A-factor hemiketals 5.12 by virtue of their 2,3-cis geometry and their 6-hydroxy 
functionality, one possible version of which is depicted below. Regardless of the merit 
or otherwise of this speculation, it was of interest to ascertain whether the hemiketal 
forms are biologically active or inert. 
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If a biological assay for A-factor existed which could be completed substantially 
faster than the period required for hemiketal / keto equilibration, then it would be very 
interesting to compare the relative activities of the pure hemiketal 5.12a with that of a 
sample of A-factor which had been allowed to reach equilibrium. 
A-factor and analogues have been previously been bioassayed by plate assay, 14 
in which a plate culture of an A-factor deficient mutant of Streptomyces griseus is 
treated with a spot sample of the compound to be tested. After further incubation for 2 
days, the induction of streptomycin production in this location is tested by subsequent 
introduction of a culture of Bacillis subtilis, and measurement of the diameter of the 
inhibition zone around the sample site. It was considered likely that during the time 
required for this test, a sample of A-factor hemiketal 5.12a would largely (or 
completely) revert to the usual mixture of A-factor isomers, making detection of any 
activity difference unlikely. 
Fortunately, around this time an A-factor protein-binding assay was reported by 
Miyake et al.49 which only required the A-factor to be dissolved for less than 2 hours. 
The binding assay involved the preparation of a crude, cell-free protein extract from a 
culture of a streptomycin-producing strain of S. griseus followed by the addition of a 
sample of radioactively labelled [3H]-A-factor. Incubation for 90 minutes, followed by 
Sephadex G-25 chromatography, allowed separation of the receptor-bound 
[3H]-A-factor from the unbound compound. Peaks of radioactivity due to these two 
forms were detected by liquid scintillation counting of the chromatographic fractions. 
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For this promising technique to be of use in differentiating the protein-binding 
efficacies of equilibrated A-factor and its pure hemiketal isomer 5.12a, it had first to be 
established that the isomeric equilibration rate in the solvent system of the 
binding-assay was sufficiently slow for the composition of the two samples to remain 
significantly different for the duration of the test (ca 2 hours). Secondly, an efficient 
method for the preparation of tritium-labelled A-factor hemiketal had to be developed. 
The required equilibration rate could have been easily measured by lH NMR if 
the binding-assay solvent system could have been replicated in fully deuterated form. 
Unfortunately, the assay requires a rather complex buffer system to stabilise the 
proteins, and its components are not readily available as fully deuterated compounds. 
[Buffer system: triethanolamine (50 mM), KCl (0.5 M), NaCl (0.15 M), 
phenylmethylsulfonyl fluoride (0.1 mM), EDTA (5 mM), 2-mercaptoethanol (5 mM), 
glycerol (10% v/v), pH 7.0]. Rather than try to approximate this system with available 
(but expensive) deuterated materials it was considered that an inverse approach may be 
better, in which the isomerisation of deuterium-labelled A-factor hemiketal 5.12a was 
observed, by deuterium NMR, using the normal, non-deuterated buffer mixture as a 
solvent. An extra benefit of this approach is that the technique used to prepare 
[2H]-A-factor could later be applied to the synthesis of the tritium-labelled material 
required for the protein-binding study. 
It was recognised that, in view of the acceleration of equilibration observed 
when D20 was added to a CDCl3 solution of A-factor hemiketal (Figure 5.5a) the 
largely aqueous buffer mixture may increase further the rate of isomerisation, although 
the magnitude of any effect could not be predicted due to the complexity of the system. 
It was felt that the neutrality of the buff er would at least minimise any increase in the 
isomerisation rate. 
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5.5.2 Synthesis of [2H]-A-Factor Hemiketal 
The only previous report of the preparation of isotopically-labelled A-factor was 
by Miyake et al.49 who introduced a tritium label at CS using a route whose complexity 
and inefficiency left considerable scope for improvement (Scheme 5.6). It was based 
on Mori's asymmetric synthesis from (-)-paraconic acid, with the label being inserted 
via a low yielding reduction of the acid function using [3H]-diborane; a reagent which 
had to be prepared from [3H]-NaBI4. Since the label was introduced early in the 
synthesis, the remaining moderate yielding steps cause extensive losses of costly and 
hazardous tritiated materials. An overall yield of 7% was obtained, with 78% of the 
originally introduced tritium label being lost due to low chemical yields. 
09'C~H 
0 
(-)-paraconic acid 
0 
32% 
[ 5-38]-A-factor 
0 
T H T 
OH TMSCI 
... 
40% 
0 
55% (2 steps) 
OTMS 
T = tritium [3m 
Scheme 5.6 Synthesis of [5-3H]-A-Factor by Miyake et al. 
Fortunately, an additional feature of our synthetic route is that it allows the easy 
introduction of a C3 label at a late stage of the synthesis, during the reduction of the 
butenolide intermediate 4.34. Substitution of deuterium for hydrogen in the usual 
catalytic hydrogenation procedure provided a simple method of generating the required 
[3-2H]-A-factor 5.15 (Scheme 5. 7). 
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5.16a 6-endo-OH 
Scheme 5.7 
We were initially somewhat surprised to find that the product from the catalytic 
deuteration of the butenolide 4.34 in methanol solution over 10% palladium-on-
charcoal contained ca 28% of the non-deuterated lactone 4.35, in addition to the 
' . 
expected 3-deutero compound 5.14 (lH NMR analysis). This was confirmed by EIMS 
which, after correction for M+ 1 and M+2 peaks, indicated the presence of 24% of 
non-deuterated product 4.35. Since contamination with hydrogen gas was highly 
unlikely, the C3 hydrogen presumably originated from the solvent via 'transfer 
hydrogenation'.173 This process, in which hydrogen is transferred catalytically from a 
donor molecule (such as an alcohol or hydroaromatic) to an acceptor, has been utilised 
synthetically as an alternative method of hydrogenation and is promoted particularly by 
palladium.173 This result illustrates that the transfer hydrogenation mechanism may 
account for a surprisingly large amount of the reactivity of catalytic hydrogenations 
carried out in alcoholic solvents using palladium catalysis. The formation of the 
unlabelled product 4.35 could presumably be avoided if a non-alcoholic solvent was 
used (e.g. ethyl acetate) but this was not pursued since the level of specific deuterium 
incorporation achieved was adequate for the purposes of the isomerisation rate study. 
Desilylation of the lactone S.14 gave [3..2H]-A-factor S.15 in an overall yield of 62%. 
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Crystallisation from CC4 allowed isolation of the [3-2H]-endo-hydroxy hemiketal 
isomer 5.16a. 
Although this method could also be utilised for the incorporation of a tritium 
label to A-factor, it would be further improved if an alternative method of reduction 
could be found to circumvent the inevitable hydrolytic loss of label from C2 and the 
operational difficulties associated with small scale catalytic tritiation. Since the double 
bond is highly polarised, it was thought that it may be possible to use a hydride 
reducing agent to effect conjugate reduction, as long as conditions could be found 
which avoided concurrent reduction of the ketone functionality. 106 A tritiated hydride 
reducing agent could thus potentially insert the label specifically and efficiently at C3, 
with hydrogen addition at C2 occurring through subsequent protonation. This approach 
was not explored at this stage but a closely related regioselective reduction using 
sodium borohydride was subsequently accomplished, as described in Chapter 7. 
5.5.3 2ff NMR Monitored Study of lsomerisation Rate 
High resolution 2H NMR spectroscopy is a powerful analytical technique for the 
study of reaction mechanisms and kinetics, which until recently has not been widely 
employed due to misconceptions about its sensitivity, resolution and practicality.174 
The low magnetogyric ratio of the deuterium nucleus does lead to low detection 
sensitivity, (0.96% relative to lH and 66% relative to 13C) but when fully deuterated 
samples are used, sensitivity is in practice more than 50 times greater than for the 
widely used natural abundance 13C spectroscopy. In addition, the low sensitivity of 2H 
nucleus is somewhat offset by its rapid relaxation via quadrupolar interactions which 
allows transients to be accumulated more rapidly than with lH or 13C spectroscopy. 
Short relaxation times and the lack of nuclear Overhauser enhancement allow accurate 
integration of deuterium signals. Although the significant electric quadrupole moment 
of the 2H nucleus might be expected to lead to serious line broadening as a result of 
quadrupolar relaxation, the effects are much less than for other heavier quadrupolar 
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nuclei such as 14N, llB and 35Q and line widths attained are often comparable to those 
of I H spectroscopy when measured in Hz. For example, the 2H resonance of 
deuterochloroform has a width at half height of ca 0.5 Hz. Peaks may sometimes 
appear broadened by inhomogeneities of the external magnetic field or from the 
incomplete coalescence of multiplets arising from the 1H-2H couplings but these effects 
can be minimised by careful magnetic field shimming and by I H decoupling. A very 
useful feature of 2H NMR spectroscopy is that the deuterium chemical shifts are 
essentially the same as those of the analogous I H isotope, which facilitates the 
assignments of peaks. 
Prior to the commencement of the isomerisation rate study it was necessary to 
confirm that the 2H NMR resonances of the keto and hemiketal isomers S.1S and S.16 
could be distinguished and quantified. A sample of labelled A-factor was allowed to 
come to isomeric equilibrium in acid-free CHC13 before running a IH decoupled 
2H NMR spectrum. The spectrometer was run unlocked since the deuterium lock 
channel was in use as the observation channel. As in the analogous I H spectrum, two 
broad resonances were observed at 6 3.4 and 3.2 representing the C3 deuterium of the 
combined hemiketals 5.16 and keto isomer 5.15, respectively, with an integration ratio 
(34:66) which corresponded well to previous measurements. A crystalline sample of 
the endo-hydroxy hemiketal S.16a, dissolved in CHCl3, initially displayed a single peak 
at o 3.4. As a test of the feasibility of monitoring the isomerisation, some of the 
aqueous buffer mixture required for the protein-binding assay was then added followed 
by an equal volume of acetonitrile to assist miscibility of the mixture, 
(CHCl3 : buffer: CH3CN, 4:1:1). The altered solvent composition shifted the peak 
slightly upfield to 6 3.3 and caused the appearance of two low intensity peaks at o 4.5 
and 2.0 attributed to the natural-abundance 2H resonances of water and acetonitrile, 
respectively. Spectra run periodically over the following 8 hours showed the gradual 
diminution of the peak representing the hemiketals 5.16 and the appearance of a peak at 
o 3.0 representing the keto isomer 5.15. After 8 hours, the integration ratio of these 
peaks was ca 60:40 and still falling but further monitoring could not be performed due 
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to restricted spectrometer time. It was estimated that more than 12 hours would have 
been required for full equilibration. This trial successfully demonstrated that kinetic 
monitoring of the isomerisation by 2H NMR was viable but the results lacked relevance 
to the proposed binding-assay since chloroform was the dominant component of the 
solvent mixture. 
Unfortunately, solubility did not allow a test of isomerisation to be performed 
using only the binding-assay buffer mixture as the solvent. It was not possible to 
dissolve sufficient labelled A-factor hemiketal 5.16a in the buffer mixture for it to be 
discernible by 2H spectroscopy within a reasonable acquisition period. As a 
compromise, acetonitrile (30%) was added to the buff er mixture to allow dissolution of 
the required amount of the hemiketal S.16a. A trace of CDC13 was added as a 2H NMR 
reference. Surprisingly, a series of 2H NMR spectra run immediately following 
dissolution indicated that under these conditions, equilibration of the hemiketal S.16a 
was essentially complete in less than 10 minutes. The spectrum run after ca 10 minutes 
showed resonances representing the hemiketal and keto isomers at o 3.0 and 2.7 
respectively, with an integration ratio of 36:64. After 12 hours the isomeric ratio had 
not altered significantly (33:67), indicating that an equilibrium composition remarkably 
similar to that observed in chloroform solution, had been rapidly reached. To 
investigate the possibility that the high salt content of the buffer solution may have 
induced heating of the sample during radio frequency irradiation, the kinetic test was 
repeated using a buffer mixture containing no sodium or potassium chloride, but the 
same result was observed. Since the presence of 16% acetonitrile in the preliminary 
isomerisation trial did not cause a dramatic increase in isomerisation rate, it appeared 
that the buffer mixture itself had caused the observed rate increase. 
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It was thus reluctantly concluded that it was likely that hemik:etal A-factor S.16a 
would equilibrate too rapidly during the proposed protein-binding assay for any 
significant difference in binding capability to be measured. Future approaches to the 
determination of the biologically active isomer of A-factor may be directed towards: 
• development of new methods for bioassay which do not promote 
isomerisation, 
• isolation of the purified binding protein and its crystallisation in its 
• 
ligand-bound form, (to this end the purification and cloning of the closely 
related 6-hydroxybutanolide autoregulator binding protein of S. virginiae 
was recently reported175), 
preparation of non-isomerisable analogues such as 5.17 (X = CH2) and the 
testing of these for possible biological activity. 
H 
5.17 
5.6 CONCLUDING COMMENTS 
Reassessment of the spectral data of A-factor has led to the discovery of novel 
bicyclic hemik:etal forms of A-factor 5.12 which are in solution equilibrium with the 
conventionally drawn form of A-factor 1.la and which represent over one third of the 
compound in solution or up to 100% in the absence of solvent. The previous 
uncertainty over the isomeric structure of this potent autoregulator has now been 
resolved, allowing definitive assignment of NMR data. The unique crystalline form of 
A-factor, the 6-endo-hydroxy hemiketal 5.12a, in addition to facilitating X-ray 
crystallographic determination of relative stereochemistry also provides a convenient 
and stable form in which to store the autoregulator. The hemiketal isomers of A-factor 
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have been shown to react readily with alcohols to f onn ketals, a fact which will be of 
considerable interest to the commercial supplier of A-factor, Funakoshi Co. Ltd., who 
currently follow the potentially risky practice of supplying A-factor as an ethanol 
solution. Supply of the product in the stable crystalline 6-endo-hydroxy hemiketal form 
S.12a may circumvent the current requirement for expensive and inconvenient dry-ice 
cooling during transportation (probably only required to minimise reaction with 
ethanol). It has also been demonstrated that our synthetic route to A-factor provides an 
improved method for the introduction of a non-exchanging label. 
.... 
CHAPTER SIX 
THE 6-HYDROXYBUTANOLIDE 
A UTOREG ULA TORS: 
SYNTHESIS AND STRUCTURAL REVISION 
If error is corrected whenever it is recognised as such, 
then the path of error is the path of truth. 
Hans Reichenbach (1892-1953) 
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6.1 INTRODUCTION 
Following the isolation of A-factor (1.1) from cultures of S. griseus, 15 an 
expanding series of related butanolide autoregulators incorporating a 6-hydroxy rather 
than a 6-keto group has been isolated from various Streptomyces species (Table 6.1, 
1.2-1.10). The occurrence and biological activities of these compounds were discussed 
in Chapter 1. 
6.2 REPORTED STEREOCHEMICAL ASSIGNMENTS 
6.2.1 2,3-Relative Stereochemistry 
The first 6-hydroxybutanolide isolated, by Grafe and co-worker~ in 1982, was 
factor-I (1.2) from S. viridochromogenes.26 As mentioned earlier in this 'thesis, its 
stereochemistry was assigned as 2,3-trans on the basis that its 12,3 coupling constant 
(9.4 Hz) lies within the range earlier reported by Savostianoff and Pfau157 for a variety 
of 2,3-trans substituted y-lactones (9-12 Hz) despite the fact that the 2,3-substituents in 
factor-I were quite different. This assignment appeared to be supported soon after by 
the isolation28 from S. bikiniensis and S. cyaneofuscatus of three further 
6-hydroxybutanolide autoregulators 1.4, 1.S and 1.6, of which 1.S was diastereomeric 
with factor-I (1.2). All of these later isolated compounds displayed a common vicinal 
12,3 value of 7 .26 Hz which was in the centre of the range observed by Savostianoff and 
Pfau157 for 2,3-.cis substituted y-lactones (5-9 Hz). 
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Table 6.1 Reported Structures of 6-Hydroxybutanolide Autoregulators 
Isolated from Streptomyces 
OH 
0 
2, 3-Relative 
Stereochemical Auto- Alkyl substituent Streptomyces 12,3 12,6 Assignment regulator 'R' Species (Hz) (Hz) Reference (Literature) CDCI3 CDCl3 
2,3-trans factor-I viridochromo genes 9.4 4.6 26 ~ 1.2 
" IM-2 FRI-5 9.3 36 (CDCI3) 
1.3 6.1 3.46 
(DiO) (DiO) 
2,3-cis 1.4 bikiniensis and 7.26 3.81 28 ~ cyaneofuscatus 
" 1.5 bikiniensis and 7.26 3.81 28 
cyaneofuscatus 
" VB-A cyaneofuscatus 7.26 3.81 28 
1.6 and virginiae 7.40 3.77 25 
" VB-B virginiae 7.26 3.63 25 
1.7 
" VB-C virginiae 7.26 3.63 25 
1.8 
" VB-D virginiae 7.3 3.7 24 
1.9 
" VB-E virginiae 7.5 3.6 24 
1.10 
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When Yamada's group subsequently isolated the 'virginiae butanolides' (VB-A 
1.6, VB-B 1.7, VB-C 1.8, VB-D 1.9 and VB-E 1.10),24,25 they were also found to 
display 12,3 coupling constants of about 7 .3 Hz, thus all were assigned 2,3-cis 
configuration by analogy with Grafe's assignments. Similarly IM-2 (1.3)36 was 
assigned 2,3-trans configuration due to its 12,3 value of 9.3 Hz. The relative 
stereochemistry of C2 and C3 was shown to be important for the antibiotic inducing 
activity of the virginiae butanolides (1.6-1.10). A structure-activity relationship study 
by Yamada's group on forty one synthetic analogues incorporating a variety of 
structural modifications showed that, for a given alkyl chain length, those assigned as 
'2,3-cis' were ten times more active in inducing antibiotic production in S. virginiae than 
the '2,3-trans' type.35 
Interestingly, one '2,3-trans' compound used in this study lacking oxygen 
functionality at C6 used in this study displayed a 12,3 value of only 7 .0 Hz which is 
significantly below the range of 9-12 Hz observed by Savostianoff and Pfau, whilst its 
'2,3-cis' diastereomer also showed the relatively low 12,3 value of 5.8 Hz.157 
OH 
.. ~ ./'.... ./'.... 
•,,,.,,,,,,,, ~ ~ ' 
0 0 
2,3-trans J 2.3 = 7 .0 Hz 2,3-cis 12,3 = 5.8 Hz 
In combination with our own observation of low 12,3 values for 2,3-trans P-keto-
y-lactones (Table 6.2), this shows that significant overlap exists between the possible cis 
and trans 12,3 ranges. Thus the empirical correlation between l value and relative 
configuration is risky, especially when all diastereomers of a given compound are not 
available for comparison. 
Table 6.2 J2;J Couplings in A-Factor and Derivatives 
OR1 R1 R2 12,3 (Hz} 
1.1 H Me 7.0 3 
4.35 6.8 2 TBDMS Me 
~····1 4.36 H H 7.0 
0 0 4.27 TBDMS H 6.8 
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6.2.2 Absolute Configuration at CJ 
At the start of the present study no definite proposals had been made regarding 
the absolute configuration of the 6-hydroxybutanolide autoregulators. Since it appeared 
likely that these compounds are produced biosynthetically via reduction of a 6-keto 
A-factor-type intermediate, we thought it plausible that they would share the 3R 
configuration of A-factor (1.1). 
This was recently confirmed by Mori and Chiba30 who synthesised the virginiae 
butanolides A-C (1.6-1.8) via sodium borohydride reduction of optically pure 
(3R)-A-factor analogues (6.3a-c, Scheme 6.1), which were themselves prepared from 
(S)-(-)-paraconic acid (6.2) using the same strategy as in their asymmetric synthesis of 
A-factor17 (1.1) (see Section 1.6.1 Scheme 1.4). The minor products from these 
reductions of A-factor analogues (6.Ja-c), assigned as '2,3-cis', were identified as the 
natural virginiae butanolides A, B and C (1.6, 1. 7 and 1.8) by the correlation of high 
field NMR data and CD spectra. 24,25 Chiroptical data for the other naturally occurring 
6-hydroxybutanolides have not been reported but it is considered likely that they too 
share the 3R configuration. 30 
OYCOiH __ _ 
0 
6.2 (S)-(-)-paraconic acid 
0 0 
6.3a R=~ 
6.Jb R=~ 
6.3c R=~ 
NaBH4 
MeOH 
0 
OH 
OH 
'2,3-cis' 
l.6VB-A R=~ 
1.7VB-B R=~ 
1.8VB-CR=~ 
Scheme 6.1 Asymmetric Synthesis of Virginiae Butanolides A-C by 
Mori and Chiba 
r 
I 
jl 
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6.2.3 Configuration of the 6-Hydroxy Substituent 
All of the '2,3-cis' 6-hydroxybutanolide autoregulators so far discovered (Table 
6.1, 1.4-1.10) display very similar 12,6 values (3.6-3.81 Hz), which has led to the not 
unreasonable proposal that their configurations at C6 are probably the same. 25 
Following the success of their assignment of the absolute configuration at C3 of the 
virginiae butanolides, Mori and Chiba then attempted to assign the absolute 
configuration of the 6-hydroxy substituents.30 Two independent methods were used but 
unfortunately both appear to be seriously flawed. 
Their first method involved an attempt to establish the C2-C6 relative 
configuration of the '2,3-cis' autoregulator (±)-6.S by stereochemical analysis of its rigid 
2,3-cis-bicyclic derivative 6.6 (Scheme 6.2). The autoregulator (+)-6.S was obtained as 
the minor diastereomer from the sodium borohydride reduction of (+)-A-factor (1.1) 
and was identical by NMR to Grafe's factor 1.S. The 2,6-configuration of (+)-6.5 was 
assumed to be common to all '2,3-cis' 6-hydroxybutanolide autoregulators because of 
the close correspondence of vicinal coupling values (1.4-1.10, Table 6.1). Treatment of 
(±)-6.S with p-toluenesulfonyl chloride in pyridine caused tosylation of the primary 
hydroxyl group. When heated in pyridine the tosyl group was displaced by attack of the 
secondary hydroxyl group to form a bicyclic derivative assigned the structure 6.6. 
OH 
0 
(+)-6.S 
Assigned 
'(2S * ,3R * ,6R *)' 
i) p-TsCI, PY. 
ii) py., lO(tC, 5 h 
45% 0 
6.6 
H 
'J2 3 = 7.5 Hz' 
' 
'J26 = 9.2 Hz' 
' 
Scheme 6.2 Attempt by Mori and Chiba to Define the C6 Relative Configuration 
of a '2,3-cis' Butanolide 
The 1 H NMR spectrum of 6.6 displayed the H2 proton as a doublet of doublets 
(O 3.10) with_ coupling constants of 7.5 and 9.2 Hz. These coupling constants were 
assigned as 12,3 and 12,6 respectively, in the absence of confirmatory vicinal coupling 
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values from the H3 or H6 multiplets. Although not stated, the lower coupling constant 
was probably assigned to accord with the 7.3-7.5 Hz range for the 12,3 values of 'cis' 
compounds as shown in Table 6.1. Mori and Chiba then asserted that the value of 
9.2 Hz was "in accord with ... 2,6-anti configuration" (i.e. exo-alkyl chain, 6.6) and that 
since the cyclisation was achieved with retention of configuration at C6, then the 
starting butanolide (and hence 1.5) must have had the indicated 3R*, 6R* configuration 
(6.5, Scheme 6.2). 
However, the A-factor bicyclic hemiketals (5.12a and 5.12b) which we have 
isolated (see Chapter 5) represent very close NMR models for the bicyclic y-lactone 6.6 
and display 12,3 values of 10.8 and 9.1 Hz respectively. 
H 
099.~ 
0 HOH 
5.12a 12.3 = 10.8 Hz 5.12b 12,3 = 9.1 Hz 
Thus it is highly likely that Mori and Chiba incorrectly assigned the 12,3 and 12,6 
couplings, casting doubt upon their stereochemical conclusions. Furthermore, in 
Chapter 5 (Section 5.4.3, Table 5.2) we showed that for the diastereomeric pairs of cis-
bicyclic y-lactones (5.12, 5.9 and 5.8), 12,3 coupling constants of either ca 9 Hz or 
ca 11 Hz were observed, where the lower value was correlated with a C6 endo alkyl 
chain (cf. 5.12b) and the higher value to a C6 exo alkyl chain (cf 5.12a), regardless of 
variations in the size of the other C6 substituent, (see Table 5.1). Although not 
definitive, the reassigned 12,3 coupling constant of 9.2 Hz for 6.6 is indicative of a C6 
endo alkyl substituent (cf. 5.12b) which is contrary to the assignment of Mori and 
Chiba. 
In an attempt to confirm their C6 assignment, Mori and Chiba utilised a 
high-field lH NMR version of Mosher's method176 to predict the absolute 
configurations at the secondary alcohol position of the optically active butanolide 
autoregulators (3R)-1.S and (3R)-l.2 obtained by reduction of (3R)-A-factor (1.1).30 
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This version of Mosher's method, first described by Tanako et al.111 involves the 
preparation of both (R)- and (S)-a-methoxy-a-(trifluoromethyl)phenylacetates (MTP A) 
of a secondary alcohol and comparison of the I H chemical shift changes induced in the 
other proton resonances of the molecules by the phenyl groups of the chiral acyl 
moieties. The direction of the 1 H chemical shift differences (i\6) observed between 
protons of the two diastereomeric MTP A esters can then be empirically correlated with 
a particular absolute configuration of the alcohol. 176-178 
Accordingly, Mori and Chiba converted the (3R)-6-hydroxybutanolides 1.5 and 
1.2 into two pairs of silyl protected (R)- and (S)-MTPA esters (6.8a, 6.8b and 6.9a, 6.9b 
respectively). They used the 500 MHz lH NMR data of these derivatives to assign a 
'6R' configuration to the 2,3-cis butanolide 1.5 and a '6S' configuration to the 2,3 trans 
butanolide 1.2, a result which is in accord with their synthetic attempt to assign C6 in 
(+)-6.5 (see Scheme 6.2). 
0 '2,3-cis' 
1.5 R 1, R2 = H Grilfe's factor 
6.8a R1 = ·1i-f Ph 
R2 = (R)-M'IPA 
6.8b R 1 = ·1i-f Ph 
R2 = (S)-M'IPA [ 
CF3 ] 
M'IPA= rf-Ph 
0 OMe 
0 OR2 '2,3-trans' 
6.9a R1 = ·+-f Ph 
R2 = (R)-M'IP A 
6.9b R1 = -~i-f Ph 
R2 = (S)-M'IPA 
Scheme 6.3 Substrates Prepared by Mori and Chiba for Determination of C6 
Absolute Configuration by Mosher's Method 
However, we have re-examined these data using both the original description of 
the method 176 and the recent lucid explication of the required analysis given by Ohtani 
et al .178• This revealed firstly that the reported data are deficient in key areas, and 
secondly that when analysed properly, they yield the opposite stereochemical 
,, 
l 
I' 
Chapter Six 179 
assignments to those reported, i.e. (6S')-l.5 (structure 6.30) and (6R)-l.2 (structure 6.31) 
[see Appendix F for the revised data analysis]. The reassignment of 1.5 would support 
our tentative reassignment of the 2,6-relative configuration of the bicyclic derivative of 
(+)-6.5 (Scheme 6.2). Structures 6.30 and 6.31 below represent our tentative C6 
stereochemical reassignment of autoregulators 1.5 and 1.2. 
Tentative Stereochemical 
Reassignment of 1.5 
Tentative Stereochemical 
Reassignment of 1.2 
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6.3 SYNTHESIS OF THE 6-HYDROXYBUTANOLIDE 
AUTOREGULATORS 
6.3.1 Existing Routes 
180 
The most commonly employed route to 6-hydroxybutanolides is reduction of the 
corresponding 6-keto (A-factor type) butanolide with sodium borohydride in methanol 
(Scheme 6.4, Route A). 25•3o.35 
iii) deprotection 
o 1.17 
R1 = various alkyl 
R2 = protecting group 
.... ,,,R1 
O OH 
'2,3-trans' J2,3 == 9 Hz 
+ 
0 
'2,3-cis' J2,3 == 7 Hz 
Route A: 6-37% and 2-18% 
Route B: 66-83% crude 
(no purity or diastereomeric ratios given) 
Scheme 6.4 Existing Routes to 6-Hydroxybu.tanolide Autoregulators 
A wide range of 6-hydroxybutanolides has been prepared by this method, 
including a racemic series containing n-alkyl substituents (R1 = CH3 - yH19)25·35 and 
the pair of diastereomeric autoregulators factor-I (1.2) and Grafe's factor (1.5) as well as 
the optically active natural virginiae butanolides A-D (1.6-1.9).30 The reduction gives 
two diastereomeric products in a 2:1 to 3:1 ratio (isolated) which have been assigned 
'2,3-trans' and '2,3-cis' relative stereochemistry respectively, on the basis of their 12,3 
coupling constants (as discussed above). In the only case where the diastereomeric ratio 
present in the crude reaction mixture was measured (R = n-C5H11), a ratio of 2.5:1 was 
J 
! 
I 
I! 
l 
I 
L 
I • 
I 
I 
l 
) 
!l 
Ii 
J 
j' 
J: 
ll: 
1. 
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reported. 25 Isolated yields of the products are moderate to low due to both the chemical 
yield and to the difficulty in chromatographically separating the diastereomers. Even 
using reverse-phase preparative HPLC, separation is only partial and yields of purified 
diastereomers are low. 25.35 
A related mixture of diastereomers, also favouring the '2,3-trans' form, is 
isolated from the alternative synthetic route (Route B, Scheme 6.4) in which the anion 
of the protected 3-hydroxymethylbutanolide 1.17 is alkylated with an aldehyde. 
However, for the only two examples reported [R1 = (CH2)4CH{CH3)2, R2 = SiMe347 
and R1 = (CH2)4CH(CH3)2, R2 = CH2Ph58] no quantification of diastereomeric ratios or 
isolated yields are reported. 
Thus the existing routes to the 6-hydroxybutanolides have several significant 
deficiencies : 
• 
• 
• 
moderate chemical yield; 
difficult separation of diastereomers; 
unfavourable diastereoselection 
• low isolated yields (2-18%) of the more active '2,3-cis' diastereomer. 35 
Our investigations into the synthesis of the 6-hydroxybutanolides began with the 
desire to address these synthetic shortcomings. 
6.3.2 Improved _Syntbesis of 6-Hydroxybutanolides via the 
Reduction of 6-Ketobutanolides 
To obtain comparative data on the reported reduction of (+)-A-factor (1.1) 
(Method A, Scheme 6.4) the reaction was repeated essentially as described by Mori and 
Chiba, 30 except that a lower reaction temperature was employed (Scheme 6.5). 
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OH 
·····1 
0 0 
NaBH4 
MeOH 
-10 to -2o·c 
lh 
182 
OH 
... ,,,R + 
0 OH 0 
1.1 (±)-A-factor 1.2 {±)-factor-I 1.5 {±)-Grtife's factor 
72% combined (2.1 : 1) 
[cf Mori and Chiba 0-2o·c, 1 h giving 37%: 18% isolated; 2.1: I] 
Scheme 6.5 Reduction of A-Factor with Sodium Borohydride 
1 H NMR analysis of the crude reaction mixture showed, as reported by Mori 
and Chiba, two products in a 2:1:1 ratio which corresponded well with the 200 MHz 
lH NMR data reported for factor-I (1.2)26 and Grafe's factor from S. bikiniensis and 
S. cyaneofuscatus (1.5).28 Radial chromatography in several solvent systems failed to 
separate the diastereomers, which appeared as a single spot by TLC, and they were 
collected as a mixture in 72% yield. The chromatographic separation reported by Mori 
and Chiba30 failed to give adequate separation in our hands. 13C NMR analysis of the 
mixture confirmed the identity of the diastereomers by comparison with published 
data. 26•28 The mixture clearly consisted of only two diastereomers and no evidence of 
other 6-hydroxy diastereomers was observed in any other fraction. Small amounts of 
several unidentified polar byproducts were collected in late fractions but by 1 H NMR 
spectroscopy these were very different in structure from the major products. Thus it 
appears that using this reduction, the desirable '2,3-cis' diastereomer would be available 
in a maximum of ca 23% yield (cf 18% by Mori and Chiba30) even if it were possible 
to efficiently separate the diastereomers. 
In an attempt to improve the yield and possibly alter the product ratio, the 
reduction was repeated using TBDMS-protected (+)-A-factor (4.35), a stable and easily 
purified intermediate from our synthesis of A-factor. 
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OTBDMS 
0 
·····1 
0 
4.35 
NaBH4 
MeOH 
-10 to-2o·c 
45min 
OTBDMS 
+ .... ,,,R 
O OH 
6.11 '2,3-trans' 
65% 
l n-BlJ4NF 79% 
1.2 factor-I 
0 
183 
OTBDMS 
6.12 '2,3-cis' 
25% 
l n-B14NF 93% 
1.5 Grttfes factor 
Scheme 6.6 Reduction of TBDMS Protected A-Factor 
The resulting reaction mixture again showed two diastereomers (6.11 and 6.12) 
with I H NMR resonances directly analogous to the unprotected products 1.2 and 1.5. 
Unfortunately, the proportion of the desired '2,3-cis' diastereomer 6.12 was marginally 
lower (6.11 : 6.12, 2.7 : 1) but, in compensation, the two products could be much more 
easily resolved by chromatography (Rf 0. 73 vs 0.52, 4% MeOH in CH2Cli) and the 
combined yield of diastereomers was significantly increased (90% ). Radial 
chromatography afforded the pure diastereomers in 65% and 25% yields respectively. · 
The separated diastereomers were then deprotected using tetra-n-butylammonium 
fluoride to give (+)-factor-I (1.2) and (+)-Grafe's factor (1.5) in 79% and 93% yields 
respectively, establishing a more convenient and higher yielding route to these 
compounds. 
In an attempt to rationalise the unfavourable diastereomeric ratio formed on 
reduction of the 6-keto compounds 4.35 and 1.1 we considered the stereochemical 
course of the reaction more closely. Firstly, it was not at all clear why the reductions 
should give only two diastereomeric products when four are theoretically possible, two 
2,3-cis and two 2,3-trans products. Assuming that our tentative reassignment of the C6 
stereochemistry of the reduction products 1.2 and 1.5 obtained by Mori and Chiba30 
was correct (see Section 6.2.3, structures 6.30 and 6.31) then it appeared likely that the 
products we observed from the reduction of TBDMS protected A-factor (4.35) (i.e. 6.11 
and 6.12) should have the relative stereochemistry 2R*, 3S*, 6R*, and 2S*, 3S*, 6S* 
respectively, as shown in Scheme 6.7. [Note that the stereochemical designations of C3 
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configuration in 3-hydroxymethyl butanolides are reversed with silicon protection of 
the hydroxyl group.] 
Observed diastereomers? 
H OTBDMS 
H OTBDMS 
0 
0 0 
6.11 '2,3-trans' 6.12 '2,3-cis' 
'Missing' diastereomers? 
H OTBDMS H OTBDMS 
0 0 
6.13 '2,3-trans' 6.14 '2,3-cis' 
Scheme 6.7 
Thus the ge~eration of the two alternative diastereomers 6.13 and 6.14, which 
are C6 epimers of the observed products, appeared to be inhibited in some way. Other 
groups who have performed directly analogous reactions seem unsurprised by this 
exceptional diastereoselectivity, since none have commented on it.25•30,35 Although not 
stated, Yamada implies in his schemes that the '2,3-trans' : '2 ,3-cis' product ratio 
follows from the diastereomeric ratio of the 6-keto starting material, in which the major 
form was also presumed to have '2,3-trans' geometry. However, we have shown in 
Chapter 5 that 6-ketobutanolides [e.g. A-factor (1.1), see Scheme 5.4a] do not exist to 
any significant extent in the 2,3-cis 6-keto form I.le but rather as the 2,3-cis bicyclic 
hemiketals 5.12a and 5.12b. Furthermore, the TBDMS-derivative 4.35 has been shown 
to exist in solution only in the 2,3-trans keto 4.35a and enol 4.36 forms (95:5 mixture, 
CDCl3) (Scheme 6.8). No evidence exists for any contribution of the 2,3-cis keto form 
4.35b, and therefore it is unlikely that the '2,3-cis' reduction product derives from this 
tautomer simply via a face selective reduction of its ketone carbonyl. 
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OTBDMS 
·····1rR 
0 0 
4.35a 2,3-trans 
95% 
R=~ 
OTBDMS 
O H-0 
4.36 enol 
5% 
Scheme 6.8 
OTBDMS 
0 
4.35b 2,3-cis 
not observed 
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The possibility that the composition of the mixture of reduction products is 
thermodynamically controlled via C2 epimerisation would require that a substantial 
difference exists between the conformational energies of the observed diastereomers 
6.11 and 6.12 and their 'missing' C6 epimers, 6.13 and 6.14 (Scheme 6. 7). However no 
rational basis for such a dichotomy of conformational energies could be found when 
Dreiding models of the diastereomers were compared. 
Energy minimisations were also conducted on the four structures using MM2 
force-field calculations as implemented in PC Model (version 88.0). Special attention 
was given to the possibility of forming intramolecular H-bonds between the 6-hydroxyl 
and the lactone carbonyl since it was felt that this feature could potentially confer 
significant stabilisation to any diastereomers in which it was present. Results obtained 
after many minimisations of each diastereomer (starting from a variety of 
conformations) were that the minimum energy conformations were all within 
approximately 3 kcaVmol of each other, with the '2,3-trans' diastereomers 6.11 and 6.13 
being generally slightly lower in energy (ca 1-2 kcaVmol) than the '2,3-cis' forms 6.12 
and 6.14, as expected on the basis of steric hindrance. Interestingly, none of the lowest 
energy conformations displayed the postulated H-bond, even when the structures to be 
minimised were started with the H-bond in place. It was recognised that considerable 
caution must be used in the interpretation of results from iterative MM2 energy 
minimisation studies of this sort, since all conformations of all bonds have not been 
searched, and consequently the low energy conformations revealed may only represent 
local minima. In addition, H-bonding effects depend significantly on the emphasis 
'I 
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given to them in the MM2 calculations implemented by each particular molecular 
modelling program. It could only be concluded that this computer modelling study did 
not reveal a significant difference between the conformational energies of the observed 
diastereomers 6.11 and 6.12 and the 'missing' ones 6.13 and 6.14. Thus a rational 
explanation for the remarkable diastereoselectivity of this reduction remained elusive at 
this stage. 
6.3.3 Synthesis of 2,3-cis 6-Hydroxybutanolides via 
Catalytic Hydrogenation of 6-Hydroxybutenolides 
Since reduction of 6-ketobutanolides formed a discouragingly low proportion of 
the more active '2,3-cis' 6-hydroxy diastereomer, a more direct synthetic approach to 
their synthesis was sought 
0 
0 
OTBDMS 
4.34 
I 
I 
R 
R=~ 
? : [1,2-reduction] 
• I 
t 
OTBDMS 
CH2 I cat] 
--------R ? 
. 
6.15 
OTBDMS OTBDMS 
0 ~ 0 Q,,,,H.,..... 
4.35b 2,3-cis-o-keto 4.36 enol 
l t 
OTBDMS OTBDMS 
0 
···,,rR 
O 0 
6.16 2,3-cis--o-hydroxy 4.35a 2,3-trans--6-keto 
Scheme 6.9 
In Chapter 4 (Section 4.2.3) it was shown that catalytic hydrogenation of the 
butenolide intermediate 4.34 gave the 2,3-trans product 4.35a even though the 
hydrogen atoms were presumably delivered cis from the catalyst surface, initially 
forming the 2,3-cis diastereomer 4.35b. Conversion to the more thermodynamically 
1, 
I 
I 
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stable 2,3-trans diastereomer could readily occur even under essentially neutral 
conditions via the enol tautomer 4.36 due to the considerable acidity of the H2 proton 
and to the stability gained in the enol form by intramolecular H-bonding. It was 
reasoned that if the acidity of the hydrogenation product could be diminished by prior 
reduction of the activating ketone (i.e. 6.15) then it may be possible to retain the 
initially-formed 2,3-cis configuration (6.16, Scheme 6.9). 
Thus the 2-acyl butenolide 4.34 was reduced using sodium borohydride in 
methanol in the presence of anhydrous cerium trichloride, conditions which promote 
selective 1,2-reduction 179 (Scheme 6.10). 
OTBDMS 
0 0 
4.34 
NaBH4 / CeCI3 
MeOH, 0°C, 5 min 
Scheme 6.10 
OTBDMS 
0 OH 
6.15 70% 
+ 
OTBDMS 
0 0 
4.35 10% 
Using 1.05 molar equivalents of each reagent (thus 4 equivalents of hydride), 
the allylic alcohol 6.15 was isolated in 70% yield in addition to 10% of the familiar 
1,4 reduction product 4.35. None of the fully reduced 6-hydroxybutanolides 6.11 or 
6.12 were seen by lH NMR in any chromatographic fractions. The lH NMR spectrum 
of the desired 6-hydroxybutenolide 6.15 showed the new C6 proton as a pseudo triplet 
at 8 4.51 and the hydroxyl proton as a broad resonance at 8 2. 70. In addition, the 
creation of the new C6 chiral centre caused a chemical shift difference in the H5a and 
H5b protons such that they appeared as two narrowly separated doublets at 8 4.73 and 
4.66, rather than as the 2 proton singlet observed with the starting butenolide 4.34. 
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Catalytic hydrogenation of the allylic alcohol 6.15 proved to be more complex 
than initially envisaged. The substrate was hydrogenated over 5% palladium-on-carbon 
in methanol until 1 equivalent of hydrogen had been absorbed (3 h) forming a mixture 
of four products in addition to a small amount of unreacted starting material. After 
chromatographic separation of these products, we were surprised to find that by I H 
NMR spectroscopy none of them corresponded to any previously isolated products. 
The lH NMR spectrum of the major product (47% yield) was very simple and 
appeared to resemble that of the 6-ketobutenolide 4.34. It possessed two 2-proton 
singlets at 6 4.58 and 4.77 [cf butenolide 4.34: o 4.98 (s, 2H, H5), 5.05 (s, 2H, H4)] 
which were thought to represent the H5 and H4 protons of a 3-silyloxymethylbutenolide 
moiety. Also, in common with the butenolide 4.34, the product displayed only one 
other signal downfield of 2 ppm; that being a 2-proton triplet at o 2.24 [cf 4.34: o 2.96 
(t, 2H, H7)]. The reason for all three of these product resonances appearing at 
significantly higher field than observed for the related peaks of 4.34 was not discovered 
until CIMS revealed the product to have a molecular weight of 340 which is 16 mass 
units lower than that of the 6-ketobutenolide 4.34. The 6-deoxy structure 6.17 was 
subsequently proposed since the lack of the 6-keto group explained the lower chemical 
shift observed for the H4 and H5 protons and was also consistent with all other 
spectroscopic data for the compound including 13C NMR, EIMS and HRMS. 
6 4.77 (s, 2H) 
' ' ' 
' .. 
0 
6.17 
OTBDMS 
--.-5 
\ 
\ 
\ 
\ 
_ - 6 4.58 (s, 2H) 
6 2.24 (t, 2H) 
cf 
6 5.06 (s, 2H) 
'- OTBDMS 
0 0 
4.34 
--
_ - 6 4.98 (s, 2H) 
\ 
\ 
\ 
\ 
6 2.96 (t, 2H) 
The 6-deoxy product 6.17 is apparently formed by catalytic hydrogenolysis of 
the allylic hydroxyl group of 6.15, a process which reportedly often competes with 
catalytic hydrogenation when substrates contain an allylic carbon-oxygen linkage, 
particularly when the double bond is tetrasubstituted.154 
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In contrast with the major product 6.17, the second most abundant 
hydrogenation prcxluct (17%) displayed a highly coupled I H NMR spectrum. Peak 
integration suggested the presence of two closely related compounds in a 70:30 ratio. 
Their CIMS indicated that they shared a molecular weight of 342, which is two mass 
units higher than the 6-deoxy butenolide 6.17. Assignment of their structures as the 
saturated 6-deoxy diastereomers 6.18 (presumably derived via hydrogenation of the 
butenolide 6.17) was supported by I3C NMR spectroscopy, EIMS and HRMS. The 
C2-C3 relative geometries of the diastereomers 6.18 could not be readily assigned as 
their 12,3 values were not discernible from the complex multiplet (O 2.38-2.62) which 
represented their combined H2 and H3 resonances, but it was considered likely that the 
major prcxluct would have 2,3-cis configuration resulting from cis delivery of hydrogen. 
OTBDMS 
0 
6.18 2 diastereomers (70:30) 
The third and fourth prcxlucts (4% each) appeared to be diastereomeric by the 
marked similarity of their lH NMR spectra. Both displayed the now familiar, highly 
coupled 6-proton spin system that is characteristic of a saturated butanolide moiety but 
both also had a single proton multiplet near o 4.0 which was near the position expected 
for the methine H6 in 6-hydroxybutanolides (cf. 1.2 and 1.5). CIMS indicated a 
molecular weight of 358 for both compounds, supporting their tentative assignment as 
the desired 6-hydroxybutyrolactones 6.16. 
6.16 2 diastereomers 
However, we found this assignment difficult to accept since neither compound 
corresponded to the 6-hydroxy diastereomers 6.11 and 6.12 previously isolated from the 
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sodium borohydride reduction of TBDMS A-factor 4.35 (see Scheme 6.6). Was it 
possible that we had unexpectedly isolated the 'missing' diastereomers 6.13 and 6.14, 
(Scheme 6.7)? It seemed inconceivable that a single '2,3-trans' and a single '2,3-cis' 
diastereomer could be produced by this method. Greater quantities of these intriguing 
compounds were required for full spectroscopic analysis, so attempts were made to 
modify hydrogenation conditions to favour hydrogenation over hydrogenolysis. 
Rylander154 suggests that choice of catalyst has an influence over the proportion 
of hydrogenolysis which occurs during hydrogenation of compounds containing allylic 
oxygen functions. He observes that platinum generally promotes less hydrogenolysis 
than palladium and rhodium was particularly recommended to prevent the cleavage of 
allylic hydroxyl groups. The hydrogenation of the 6-hydroxy butenolide 6.15 was 
repeated (Table 6.3) using platinum black (Entry 2) and 5% rhodium-on-alumina (Entry 
3) in an attempt to favourably alter the ratio of products. 
I' 
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TABLE 6.3 Catalytic Hydrogenation of the 6-Hydroxybutenolide 6.15 
OfBDMS 
0 
R=~ 
6.15 
I H2/caL 
191 
arBDMS OfBDMS <YfBDMS arBDMS 
0 OH 
6.16a and 6.16b 
+ 
0 
6.17 
+ + 
0 
6.18 
Entry 
% Prcxluct ratioi (% Isolated)ii 
Hydrogenation 
No. Conditions iv 6.16a 6.16b 6.17 6.lSiii 
1 10% Pd/C 4 (4) 4 (4) 52 (47) 38 (17) 
MeOH,3h 
2 Pt black 23 (20) 23 (20) 5 (4) 18 (10) 
Benzene, 20 h 
3 5% Rh/Alumina 19 (16) 19 (15) 0 (0) 19 (14) 
MeOH,4.5 h 
i) ratio detennined by 1 H NMR integration of reaction mixture 
ii) isolated percentage yield given in parentheses 
iii) 70:30 diastereomeric mixture 
iv) all at room temperature and pressure 
R 
0 0 
4.35 
Recovered 
4.35 6.15 
0 (0) 3 (4) 
25 (15) 4 (4) 
44 (32) 0 (Q)V 
v) ca 2% each of the other 6-hydroxybutanolides 6.11 and 6.12 were also isolated 
Hydrogenation over platinum black (Entry 2, Table 6.3) was carried out in 
benzene since lower solvent polarity has been reported to favour hydrogenation over 
hydrogenolysis. 154 When using platinum black considerably less of the hydrogenolysis 
products 6.17 and 6.18 were observed than with the previous palladium-catalysed 
reaction (Entry 2, 23% vs Entry 1, 90%). However a new, competing process was 
revealed with the identification of 25% of the 6-ketobutanolide 4.35 in the reaction 
mixture. This product presumably results from migration of the double bond 
(Scheme 6.11) to form 4.36, the enol form of the observed ketone 4.35. 
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Pt 
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Scheme 6.11 
OTBDMS 
0 
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4.36 
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·····1 
0 0 
4.35 
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The isomerisation of allylic alcohols to ketones is well documented but in 
apparent contrast with our results, palladium catalysis is generally reported to promote 
this side reaction to a greater extent than platinum.154 For example, reduction of 
cyclohexen-2-ol over palladium affords a mixture of 67% cyclohexanol and 33% 
cyclohexanone, whereas over platinum only cyclohexanol is formed. 180 · 
In spite of the formation of the additional by-product 4.35 using platinum 
catalysis, the proportion of the desired 6-hydroxy diastereomers 6.16a and 6.16b was 
substantially higher ( 46%) allowing the isolation of each of the purified diastereomers 
in 20% yield. 
Using 5% rhodium-on-alumina in methanol (Table 6.3, Entry 3), isomerisation 
to the 6-keto byproduct 4.35 dominated the reaction ( 44% ), while the proportion of 
hydrogenolysis products was further reduced to 19%. These results are consistent with 
the reported lower capacity of rhodium (cf platinum) to cause hydrogenolysis but its 
greater ability to promote bond migration. 154 Interestingly in this reaction traces 
(ca 2% each) of the other, previously observed diastereomers 6.11 and 6.12 were also 
isolated. Overall the combined yield of the 6-hydroxybutanolide hydrogenation 
products 6.16a and 6.16b was sightly lower (31 % ) than for the platinum catalysed 
reduction (Entry 3, 31 % vs Entry 2, 40% ). 
II 
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Thus, using platinum black or 5% rhodium-on alumina, moderate yields of the 
6-hydroxybutanolides 6.16a and 6.16b were obtained. Further investigation into the 
three competing modes of reaction (i.e. hydrogenation / hydrogenolysis / isomerisation) 
was deferred, pending the full stereochemical elucidation of the 6-hydroxybutanolide 
diastereomers 6.16a and 6.16b. 
6.4 RELATIVE STEREOCHEMICAL ASSIGNMENT OF 
FOUR DIASTEREOMERIC 
6-HYDROXYBUTANOLIDES 
We had thus prepared and purified four different compounds (6.11, 6.12, 6.16a 
and 6.16b) which were shown to be isomeric (CIMS and HRMS) and displayed similar 
features by lH NMR spectroscopy. Further support for their assignment as 
diastereomers of the TBDMS-protected 6-hydroxybutanolide was obtained by the very 
close similarity of their 13C NMR (APT) spectra. All compounds displayed a 
C6 methine carbon in the range 6 70.6-71.1 and all other peaks showed similarly close 
correspondence ( within 3 ppm). 
6.4.1 Assignment of 2,3-Relative Stereochemistry 
The relative stereochemistry of the C2 and C3 lactone substituents had 
previously been assigned by other research groups on the basis of the magnitude of the 
12,3 coupling constant, as described above. Our misgivings regarding the general 
applicability of this empirical relationship (see Section 4.2.5) seemed well founded 
when the two 'new' diastereomers 6.16a and 6.16b displayed the 12,3 values of 8.0 and 
7.2 Hz respectively (see table below). Not only were these values very close but they 
are also between the values we measured for the previously isolated diastereomers 6.11 
and 6.12 (i.e. 8.6 and 7.0 Hz respectively) which had been assigned '2,3-trans' and 
'2,3-cis' configurations respectively. Since we were not convinced of the validity of 
" 
Chapter Six 194 
assigning stereochemistry on the basis of a coupling constant difference of less than 
1 Hz, a different and more reliable method was sought 
OTBDMS 
6.11 6.12 6.16a 6.16b 
12,3 (Hz) 8.6 7.2 8.0 7.2 
0 
Four diastereomers 
The nuclear Overhauser effect (NOE) is a very useful NMR technique for the 
elucidation of molecular conformations, since it can provide information on interatomic 
distances. It is generally performed by the saturation of a particular proton resonance, 
followed by observation of the effect on the NMR peak intensity of other proton 
resonances in the molecule caused by through-space dipole-dipole interactions. For 
small molecules (MW < ca 2000) the effect is usually positive and its magnitude i.s 
generally inversely proportional to the internuclear distance raised to the sixth power. 
Although conclusions based on internuclear distances obtained by quantitative analysis 
of NOE effects may be risky, the qualitative comparison of these effects within a 
molecule and between similar molecules (especially stereoisomers) can provide a solid 
basis for stereochemical assignment.181,182 
In principle, a comparative study of the relative NOEs between the H2 and H3 
proton resonances of the four diastereomers (6.11, 6.12, 6.16a and 6.16b) could be used 
to determine their relative configuration. Unfortunately the very close proximity of 
these peaks in the spectra of three of the compounds precluded this type of experiment, 
since the required selective irradiation could not be achieved. 
A NOESY (nuclear Overhauser effect spectroscopy)183 experiment is a two 
dimensional method for simultaneously obtaining all interproton NOE interactions 
within a molecule. 182·184 The requirement for selective irradiation is avoided since all 
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0 
resonances are simultaneously saturated with a non-selective 90 radio frequency pulse, 
making the method particularly useful for molecules with complex spectra. 
NOESY spectra (500 MHz, CDCl3) were obtained for the four 
6-hydroxybutanolide diastereomers (Figures 6.1-6.4) using a phase sensitive version of 
the experiment in which the cross-peaks due to NOE interactions appear with opposite 
phase (coloured red) to both the diagonal peaks and to spurious 'artefact' cross-peaks 
arising from the data processing (coloured blue/green). The same sample preparation 
techniques, 181 experimental parameters and data processing were used for all 
compounds, allowing valid comparisons to be drawn between the spectra. 
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The NOESY spectra (Figures 6.1 and 6.2) of the two diastereomers 6.16a and 
6.16b, prepared via catalytic hydrogenation, both displayed NOE interactions which 
were consistent with 2,3-cis stereochemistry. Although for diastereomer 6.16a (Figure 
6.1) the H2 and H3 peaks were coincident (thus obscuring any cross-peaks) the 
significant H5-H6 and H5-H7 NOE interactions supported the 2,3-cis assignment. A 
similar H5a-H6 interaction was also seen for the diastereomer 6.16b (Figure 6.2) in 
addition to the diagnostic, very strong H2-H3 cross-peak. No sign of expected 
2,3-trans NOE interactions such as H2-H5 or H6-H3 were observed for either 
compound. Confirmation of this important result came from examination of the 
remaining two diastereomers 6.11 and 6.12 (Figures 6.3 and 6.4). 
While for butanolide 6.11 (Figure 6.3), the observed NOE interactions (notably 
H5-H2 and H6-H3) were consistent with its expected 2,3-trans geometry, the 
interactions displayed by the supposedly '2,3-cis' diastereomer 6.12 (Figure 6.4)~ did not 
support this assignment. Only its re-assignment to 2,3-trans stereochemistry 6.12b 
would explain the strong H5-H2 cross peak and the H3-H4a / H2-H4b interactions, as 
shown in Figure 6.4. The cross peak observed between H2 and H3 (Figure 6.4) is much 
smaller than the 2,3-cis NOE interaction observed in Figure 6.2 (volume ratio ca 5.1:1) 
reflecting the greater distance between trans disposed protons (ca 2.3 A versus ca 3.1 A 
from measurement of minimised structures). 
These results, although contradicting long-held beliefs regarding the relative 
stereochemistry of the natural 6-hydroxybutanolides, make good chemical sense. The 
hydrogenation of the butenolide 6.15 thus generated (among other products) two C6 
epimers of the 2,3-cis 6-hydroxybutanolide 6.16a and 6.16b, exactly as expected from 
cis delivery of hydrogen (Scheme 6.12). 
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Similarly, the mystery surrounding the apparently unusual diastereoselectivity of 
the sodium borohydride reduction of TBDMS protected A-factor 4.35 evaporated when 
the 6-hydroxy products 6.11 and 6.12b were identified simply as C6-hydroxy epimers 
which incorporate the 2,3-trans geometry of their ketone precursor 4.35. However it 
was initially difficult to rationalise the reassignment of 2,3-trans geometry to both 
borohydride reduction products with the reported conversion of one of them (allegedly 
'2,3-cis' 6.5) into a cis fused bicyclic compound 6.6 (or its C6 epimer), by Mori and 
Chiba (see Scheme 6.2). 30 It now appears likely that during the prolonged treatment 
with hot pyridine (100°, 5 h) some C2 epimerisation of the (presumably 2,3-trans) 
butanolide occurred, allowing cyclisation to occur, to form the observed moderate yield 
(45%) of 2,3-cis bicyclic product 6.6. Alternatively, preliminary translactonisation of 
the 2,3-trans 6.S (acid or base catalysed in p-TsCl / pyridine) would also produce a 
2,3-cis butanolide capable off orming some of a cis bicyclic product. 
With this 2,3-stereochemical reassignment the supposed empirical relationship 
between the J 2,3 coupling constant and C2, C3 relative stereochemistry in y-lactones 
(which previously had been universally applied to the stereochemical assignment for 
6-hydroxybutanolide autoregulators)24-26•28•30•35 was · exposed as being dangerously 
unreliable. Even the simple 'rule' that 2,3-trans diastereomers have higher 2,3-vicinal 
coupling values than the equivalent 2,3-cis compounds157 was shown to have 
I 
11 
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exceptions, since the values for the 2,3-cis products 6.16a and 6.16b (12,3 = 8.0 and 
7 .2 Hz respectively) are both higher than the coupling constant of the 2,3-trans 
diastereomer 6.12b (12,3 = 7.0 Hz). 
Since the reassigned 2,3-trans diastereomer 6.12b had previously been 
desilylated to give (+)-1.5 (a typical representative of the natural 6-hydroxybutanolide 
autoregulators) it is highly likely that all other members of this class previously 
assigned as '2,3-cis' should also be reassigned, as shown in Scheme 6.13, since they all 
display directly analogous lH and 13C NMR spectra. 
1.4R=~ 
Grlife's 
1.SR=~ 
factors 
from 
S. cyaneofuscatus 
OH l.6R=~ and S. bikiniensis VB-A 
R 1.7R=~ VB-B 
OH 
l.8R=~ VB-C 
virginiae 
butanolides 
l.9R=~ VB-D 
1.lOR=~ VB-E 
Scheme 6.13 Reassigned 2,3-Stereochemistry of the Former '2,3-cis' 
6-Hydroxybutanolides 
The increased activity exhibited by this class of compounds which was 
previously attributed to their 2,3-cis geometry35 is now shown to result from their C6 
hydroxyl stereochemistry. Since the two methods used by Mori and Chiba30 to attempt 
to define this configuration are likely to be erroneous (see Section 6.2.3) we have used 
an alternative approach to this problem (Section 6.4.2). 
It was ironic that although we had successfully achieved our goal of developing 
a diastereospecific synthesis of the 2,3-cis 6-hydroxybutanolides, our work exposed 
errors in the previous stereochemical assignment of the target class of autoregulators, 
Chapter Six 203 
which removed the original need for the synthesis. However, our synthesis does 
provide access to a novel class of butanolides with as yet unknown biological activity. 
6.4.2 Prediction of C6 Configuration of the 
6-Hydroxybu tan olid e Au toregu la tors 
With our clarification of the 2,3-stereochemical outcome of the sodium 
borohydride reduction of 2,3-trans-6-ketobutanolides, it was proposed that 
rationalisation of the factors influencing the diastereoselectivity of the reaction could 
lead to a prediction of the relative stereochemistries of the secondary alcohols produced. 
In the reduction of 2,3-trans TBDMS A-factor (4.35) we observed a 2.7:1 ratio 
of diastereomers 6.11 and 6.12b, (Scheme 6.14). A similar ratio (1.2: 1.5, 2.1 : 1) was 
obtained by reduction of the (±)-A-factor (1.1) itself. 
OR 
2 diastereomers 
4.35 R = TBDMS 6.11 : 6.12b 2.7 : 1 R = TBDMS 
NaBH4,MeOH 
1.1 R=H 1.2 : 1.5 2.1 : 1 R = H 
Scheme 6.14 
The unequal formation of the C6 epimers during reduction clearly reflects a 
preference for attack by borohydride on one face of the ketone moiety due to the 
asymmetry of the rest of the molecule. 
This type of 1,2-asymmetric induction involving the attack of nucleophilic 
reagents on chiral aldehydes or ketones has been well studied 185-187 and the 
stereochemical outcome has been found to be strongly influenced by steric effects on 
the attacking nucleophile. These reactions are generally accepted as being under 'steric 
approach control' which implies an early 'reactant-like' transition state. 186,187 It was 
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thus important to our consideration of competing transition states to have information 
regarding the preferred conformation of the 6-keto group of the substrate. 
We performed MM2 energy minimisations (PC Model, version 88.0) using the 
simplified model structure 6.19 to represent the general class of 2,3-trans 
disubstituted-2-acyl butanolides. The minimum energy conformation was found to 
have the ketone C=O bond almost syn-periplanar to the C2-C3 bond (torsion angle 
• 0 = O-C6-C2-C3 = -15 ), as depicted in Fig 6.5. In this conformation the steric 
interaction of C7 is minimised, a factor which is of major importance in the highly 
regarded188 Fellin model of the required transition state geometry for nucleophilic 
attack on chiral ketones ( see Scheme 6.15).186 
- H 
H 
H 
' 
' 
' 
' \ 
0 (0-C6-C2-C3) = -15° 
Figure 6.S Minimum Energy Conformation of 6.19 
The relative conformational energies of other orientations of the 6-keto group 
were determined by repeatedly calculating the energy of the structure 6.19 as the C2-C6 
bond was rotated stepwise. 
0 = O-C6-C2-C3 
2·(1Y--&i 
0 0 6.19 Ri, R2 = H 
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The resultant plot (Figure 6. 6) showed that the minimum energy conformation 
depicted in Figure 6.5 (0 = -150) is the most stable of the minima by ca 5 kcaVmole. It 
is therefore _likely that this conformation of 6-ketobutanolides is the most populated by a 
considerable margin. 
Assuming that reaction occurs primarily through the most stable ground-state 
conformation, the approach by borohydride to the faces of the carbonyl function could 
form transition states 6.20a or 6.20b, as shown in Scheme 6.15. 
Felkin's Model 
of the Transition State 
RL = largest or 
most electronegative group 
RM= next largest group 
Rs = smallest group 
0~ 
0 
vs 
6.20a 6.20b 
j 
6.21b 
Scheme 6.15 
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The transition state 6.20a in which the borohydride approaches on a relatively 
unhindered trajectory, towards the ketone face remote from the lactone carbonyl (Cl}, 
would be clearly favoured since it avoids the considerable steric strain associated with 
the alternative approach geometry (6.20b). The polarity of the lactone carbonyl group 
is also likely to favour transition state 6.20a since Fellin observes that transition states 
which maximise the separation of the incoming nucleophile and an electronegative 
group are stabilised.186 Overall, the proposed transition state bears a close resemblance 
to Felkin's model of the transition state (Scheme 6.15) leading to the postulate that 
epimer 6.21a is likely to be the dominant reduction product. The minor product 6.21b 
could result either from the disfavoured transition state 6.20b or via reaction through an 
alternative, higher energy conformation of the substrate 6.19. 
The sodium counter ion has not been mentioned in the above discussion since it 
is not expected to have a significant influence on the transition state. Wigfield and 
Gowland189 observe that "Although in some related reductions the cation does play an 
important role, there is no evidence for a role for Na+ in NaBH4 reductions in 
alcohol". For example, the addition of crown ethers to NaBI4 reductions in methanol 
has been found to have no effect on the reactions.190 
For substrates 6.19 in which R1 = OH (cf A-factor 1.1) there is the possibility 
that the y-hydroxyl group could influence the course of the ketone reduction by 
'chelation controI'191 in which borohydride bound to the hydroxyl could fix the reaction 
geometry by chelation to the ketone oxygen. We concluded that this effect was unlikely 
to be significant not only because it would involve an unfavoured 7-membered cyclic 
transition state, but also since we observed that the stereochemical outcome of the 
reduction was barely altered when the hydroxyl group was protected (see 4.35, Scheme 
6.14). This is consistent with the findings of Baker et ai. 191 who found that his example 
of this unusual form of asymmetric induction188 could only be observed using lithium 
triethylborohydride (LiBEt3H); sodium borohydride was completely 
non-diastereoselective, while zinc borohydride and lithium showed minimal selectivity. 
I, 
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Therefore, with the assumption that the 6-ketobutanolide 4.35 reacts primarily 
via its most stable C2-C6 conformation (cf. 6.19, Figure 6.5), we propose that the major 
product 6.11 from its reduction with sodium borohydride is likely to have 
2R*, 3S*, 6R* configuration (cf. 6.21a) while for the minor diastereomer 6.12b 
2R*, 3S*, 6S* geometry is predicted (cf. 6.21b), as shown in Scheme 6.16. Analogous 
assignments can also be made for the (±)-A-factor reduction products (+)-1.2 and 
(+)-1.5 (Scheme 6.16). [Note again that the stereochemical designation for C3 reverses 
with removal of the silyl protecting group.] 
TBDMS-A-factor 
(+)-4.35 
A-factor 
(+)-1.1 
NaBH4 
MeOH 
OR 
6.11 R = TBDMS 
(2R•,3s• ,6/l) 
(+)-1.2 R = H 
(2R* ;JR •,6R*) 
+ 
+ 
OR 
0 H OH 
6.12b R = TBDMS 
(2R • ,'3S* ,6S) 
(+)-1.5 R = H 
('lR* ,'3R* ,6S) 
Scheme 6.16 FuUy Reassigned Stereocbemistry of the NaBH4 Reduction .Products 
These predictions of C6 configurations conflict with the recent assignment by 
Mori and Chiba30 but are consistent with our previously discussed reassessment of his 
evidence (Section 6.2.3). 
We were not able to use the NOESY spectra of 6.11 and 6.12b (Figures 6.3 and 
6.4) to provide confirmation of our predicted C6 configurations due to uncertainties 
regarding their precise molecular geometry in solution. Similarly, we could not assign 
the C6 geometry of the 2,3-cis 6-hydroxybutanolides 6.16a and 6.16b on the basis of 
their NOESY spectra (Figures 6.1 and 6.2). In addition, since no diastereoselectivity 
was observed in their formation by catalytic hydrogenation, arguments based on 
asymmetric induction could not be employed. 
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Since the compounds 1.2 and 1.5 are representative of the two diastereomeric 
classes of naturally occurring 2,3-trans 6-hydroxybutanolide autoregulators, it is 
possible for us to predict the complete relative stereochemistry of all of the natural 
metabolites (Scheme 6.17), based upon the close similarity of their crucial lH NMR 
resonances to those of either 1.2 or 1.S (see Table 6.1). Note that the indicated 
assignment of autoregulator IM2 is not as definitive as the others since its 12,3 value was 
not recorded in CDCl3 solution (see Table 6.1). 
OH 
0 
'2R*, 3R*, 6R* 
1.2R=~ factor-I 
l.3R=~ IM-2 
OH 
O H OH 
'2R*, 3R*, 6S* 
1.4R=~ 
I.SR=~ 
l.6R=~ 
1.7R=~ 
l.8R=~ 
VB-A 
VB-B 
VB-C 
l.9R=~ VB-D 
1.10 R=~ VB-E 
Grtife's 
factors 
from 
S. cyaneofuscatus 
and S. bildniensis 
vrrg1mae 
butanolides 
Scheme 6.17 Predicted Relative Configuration for All 6-Hydroxybutanolide 
Autoregulators 
From biosynthetic considerations it is thought likely that all of these closely 
related autoregulators share the 3R configuration eventually established by Mori for 
A-factor (1.1) 18 and for three of the 6-hydroxybutanolides (1.6, 1. 7 and 1.8.)30 Thus 
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the predicted structures as drawn in Scheme 6.17 are likely also to represent the 
absolute configurations of the natural butanolide autoregulators. 
CONFIRMATION OF THE STEREOCHEMICAL REASSIGNMENTS 
Shortly after these predictions were made, our efforts towards their confirmation 
were arrested by the appearance of a report by Sakuda and Yamada in which identical 
stereochemical conclusions were drawn using an entirely different approach. 27 
Apparently alerted by anomalous NOE results that their previous assignment25 of 
'2,3-cis' geometry to the virginiae butanolides (VB-A to E, 1.6-1.10) may be in error24, 
they prepared conformationally defined bicyclic benzylidene derivatives 6.23 and 6.24 
from (+)-VB-A (1.6) and its diastereomer 6.22, the products of sodium borohydride 
reduction of the lower homologue of A-factor (6.25), (Scheme 6.18). The primary 
hydroxyl groups were first converted to chlorides to remove the possibility of 
epimerisation at C3 via translactonisation. Subsequent DIBAL reduction to the lactol, 
followed by linkage of the 1,3-diol moieties as the benzylidine derivative, gave a single 
diastereomer for each reaction sequence. 
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OH 
6.25 
NaBl4 
MeOH 
+ 
OH 
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-
H OH 
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SCHEME 6.18 Synthesis of Benzylidene Derivatives by Sakoda and Yamada 
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The six-membered benzylidene rings of the bicyclic derivatives 6.23 and 6.24 
were defined as both existing in the expected 'chair' form by the observation of 
significant NOE enhancements between their H6 and benzylidene methine protons, 
(Scheme 6.18). Vicinal coupling constants (11,2 and 12,6, Scheme 6.18) were then used 
to define the relative stereochemistries between Cl, C2 and C6 for both molecules. 
Evidence for the 2,3-trans stereochemistry of 6.24 (and hence 1.6 'VB-A') came from 
observation of a small NOE enhancement at H5 upon irradiation of the H2 resonance, in 
addition to its 12,3 value. The 2,3-trans assignment of 6.23 is less convincing since it 
rests entirely on the magnitude of its 12,3 coupling ("< 3 Hz") as no H2-H5 NOE is 
observed. No explanation for the failure to detect a H2-H5 NOE interaction for 6.23 is 
given, nor is it readily apparent why the markedly differing 12,3 values (6.23, 
12,3="< 3 Hz"; 6.24, J 9 Hz) should both "support 2,3-trans orientation". In addition, 
they have not rigorously excluded the possibility of translactonisation occurring during 
the chlorination step of their derivatisation. 
Note however that their evidence supportjng our proposed C2-C6 relative 
configuration remains valid regardless of the merits or otherwise of their method of 
assignment of the C2-C3 geometry. Our technique for the assignment of C2-C3 
geometry is considerably more definitive since it is based on the direct stereochemical 
analysis of all four diastereomeric forms (6.11, 6.12b, 6.16a and 6.16b) of protected 
derivatives of the two natural 6-hydroxybutanolides factor-I (+)-1.2 and Griife's factor 
(+)-1.S. 
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6.5 CONCLUDING COMMENTS 
Although starting in this area with intentions to improve the synthesis of the 
supposed '2,3-cis '6-hydroxybutanolide autoregulators, our work in this area concludes 
with the reassignment of two of the three chiral centres of the target class of 
compounds, which are the most biologically active and numerous group of these 
autoregulators (1.4-1.10). Our work has redefined the synthetic task as the formation of 
the required C6 epimer of a 2,3-trans 6-hydroxybutanolide. 
Yamada's group has recently had some success in this pursuit. Sakoda and 
Yamada27 have shown that derivatives of VB-A(l.6) are available from the less active 
but more readily available C6 epimer (6.22, Scheme 6.18) via epimerisation using the 
Mitsunobu reaction.192 The enzymatic reduction of 6-ketobutanolide (6.25) to VB-A 
(1.6) has also apparently been very recently achieved, 160 using cell-free extracts of 
S. antibioticus in the presence of NADPH, but no further details of th~ efficiency or 
specificity of this process are yet available. 
Rather than entering this area of synthesis we instead turned our attention to a 
more challenging target with which to test the scope and limitations of our biomimetic 
route to 2,3-disubstituted butanolides. 
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CHAPTER SEVEN 
A MODEL BIOMIMETIC SYNTHESIS OF 
BUTALACTIN: 
A BUTANOLIDE ANTIBIOTIC 
Round about the cauldron go; 
In the poison 'd entrails throw. 
William Shakespeare (1564-1616) 
Macbeth, Act IV, Scene 1 
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7.1 INTRODUCTION 
In 1991 Franco and coworkers reported the isolation of a novel y-lactone 
metabolite named 'butalactin' (7.1) from Streptomyces sp. Y-86,36923.193 Its 
structure194 was found to have much in common with A-factor (1.1), such as the trans 
disposed 3-hydroxymethyl and 2-acyl substituents, but incorporated several novel 
features: the 2-hydroxyl group, the conjugated trans olefin and the 9-cis-epoxide. 
However, despite the structural similarities with A-factor, their occurrence and 
biological activities differ markedly. 
OH 
5 butalactin 
- from Streptomyces sp. Y-86,36923 
- antibiotic activity against 
Gram positive bacteria 
- no known inducing properties 
- weak inhibitor of glycopeptide 
3 
2 Mo I •• ,,,f ~ 9 10 
O OHO 11 
7.1 antibiotic production 
The metabolite is present in the culture broth at a level of ca 40 mg/L which is 
3-4 orders of magnitude higher than levels of A-factor (1.1) and related autoregulators 
in their cultures. Unlike A-factor butalactin does not induce antibiotic production or 
morphological changes in S. griseus, even at 100 times the usual concentration194 
(though given the species specificity of the autoregulators this is not entirely 
surprising). It has no effect on the production of antibiotics of a wide range of 
producing strains, except for a weak inhibitory effect on the production of glycopeptide 
antibiotics of the vancomycin class. Remarkably, it also exhibits its own moderate 
antibiotic activity against Gram positive bacteria and has been patented for use as 
such.21 
To date this interesting metabolite has not been synthesised and no information 
exists regarding its absolute configuration, its biosynthesis or the stereochemistry of the 
cis-epoxide moiety relative to that of the lactone substituents. 
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7.2 SYNTHETIC PLAN 
As a synthetic target the molecule presents several additional challenges to those 
encountered during the synthesis of A-factor due to its increased functionality, and 
therefore represents a good test of the versatility of our biomimetic route to 
2,3-substituted butyrolactones. We thus embarked on a brief investigation into the 
applicability of our biomimetic route to the synthesis of butalactin (7.1). 
The retrosynthetic plan depicted in Scheme 7 .1 is based on our synthetic route to 
A-factor and highlights the chemical transformations required in addition to the pivotal 
Knoevenagel cyclisation of the dienoic f3-ketoester 7.3 to dienoic butenolide 7.4. It also 
reflects, of course, a retrobiosynthetic analysis of butalactin (7 .1), at least as far as the 
carbon skeleton of the metabolite is concerned. It is likely that the diene functionality 
originates early in the process, and represents incomplete reduction during fatty acid 
biosynthesis. We would anticipate that the oxidation steps introducing epoxide and 
tertiary alcohol functions occur late in the process, but their relative timing is arbitrary 
and maybe the reverse of that depicted. 
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Scheme 7 .1 Retrosynthesis of Butalactin 
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If the butenolide 7.4 could be prepared using-chemistry analogous to that used 
for the synthesis of A-factor, we then would require:-
• Regiospecific reduction of the 2,3-bond in butenolide 7.4, in the presence of a 
diene moiety. 
• Diastereoselective C2-hydroxylation of the J3-ketolactone 7.5. 
• Regiospecific epoxidation of the 9-cis-olefin 7.6. 
· However, despite advances in synthesis of 2E,4Z-dienoic esters195,196 they 
remain far less accessible than their E,E-analogues. In exploring the feasibility of the 
preceding synthetic plan it was thus prudent to use the inexpensive and readily available 
E,E-hexa-2,4-dienoic acid (7.7, sorbic acid) as the starting material (cf 7.2) for a model 
synthesis. The terminal E-olefinic bond could in principle be subsequently converted to 
a trans- or a cis-epoxide by direct epoxidation or by a two-step epoxidation involving 
inversion, respectively. Thus the synthesis of the E,E-analogue (7.12) of the E,Z-diene 
7 .4 was our initial synthetic objective. 
I 
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7.3 PREPARATION OF THE DIENYL BUTENOLIDE 7.12 
OTBDMS 
0 
7.12 
Sorbic acid (7. 7) was converted to sorbyl chloride and condensed with the 
remarkably stable lithium enolate oft-butyl acetate, 197 as shown in Scheme 7 .2. The 
resulting (3-ketoester 7.8 was isolated after fractional distillation as a yellow oil (53%) 
which could be recrystallised from hexane to give low-melting pale yellow needles. 
Solutions of these pale crystals formed bright yellow solutions, presumably due to the 
presence of more of the highly conjugated enol form 7 .Sb in solution. lH NMR 
spectroscopy showed that in chloroform solution ca. 23% of the compound was 
enolised compared with 6% enol for t-butyl 3-oxononanoate (3.33d), thus . 
demonstrating that the presence of the conjugated diene moiety gave extra stability to 
the enol form. 
HO~ 
o 7.7 
l SOCl2, benzene 
Cl~ 1Bu0 
0 
53% 1Bu0 
Scheme 7.2 
0 0 
Jt 
I 
0, ... 0 
''H' 
~ 
7.8a 
~ 
7.8b 
The t-butyl ~-ketoester 7 .8 was converted to the ~-ketoacid 7 .9 using 
trifluoroacetic acid as described for the synthesis of A-factor, to give a 50% yield of 
pale yellow needles. Additional product was detected in the mother liquors but it 
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resisted crystallisation due to the presence of impurities, most notably the methyl ketone 
7.10 formed by decarboxylation. As we had observed for other ~-ketoesters, the 
impure, non-crystalline material decarboxylates spontaneously on standing for several 
hours. In CDC13 solution, lH NMR spectroscopy showed that approximately 38% of 
the ~ketoacid existed in the enol form 7.9b. 
OTBDMS 
/Y 
HO 
0 
0, ,..o HO~O'fBDMS 7.9b 4.7 'H 
J t DCC/DMAP Jf OTBDMS 
CH2CJi ~ HO 
ca. 55% 0 0 
0 0 7.9a ~ ~ 
0 7.lla 
-COi SiOi 
OTBDMS 
~ 
0 7.10 
0 
7.12 34%, 2 steps 
Scheme 7.3 
Esterification with t-butyldimethylsilyl (TBDMS) protected dihydroxyacetone 
4.7 using DCC/ DMAP as described previously, gave the diketo dienyl ester 7.11 as the 
major product in the reaction mixture (Scheme 7 .3 ). Assignment of the I H NMR 
spectrum of the crude product was complicated by the presence of 50% of the enol form 
7 .llb but all of the expected resonances were observed. The addition of an internal 
integration standard (triphenylmethane) allowed the yield of the cyclisation precursor 
7.11 to be estimated as 55%. In retrospect, the ester 7.11 could probably be synthesised 
1' 
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more simply and in higher yield via Meld.rum's acid, using the attractive route which we 
later briefly evaluated for the synthesis of 11-demethyl A-factor (4.27, see Section 4.4). 
Cyclisation of the crude dienyl f3-ketoester 7 .11 was easily accomplished using 
radial chromatography on silica gel (10-30% EtOAc in hexane), a transformation 
directly analogous to that utilised in the synthesis of A-factor. The dienyl butenolide 
7 .12 was collected as an orange oil which could be crystallised from pentane solution as 
short orange needles. Successful cyclisation was confirmed by the appearance of two 
distinctive singlet resonances near o 5.0 in the I H NMR spectrum which closely 
resemble the H4 and H5 resonances of the butenolide intermediate 4.34 from the 
synthesis of A-factor (see below). The diene moiety was visible as four downfield 
proton resonances. HRMS established the molecular weight as 322 and the formula as 
6 5.00*, s * = interchangable assignment 
6 5.12*, s 
6 1.90, d 
, 
0 0 : ' ,, 
, ' ... 
6 7.26, d ~ 6 6.32, m 
7.12 6 7.38, dd 
6 5.05, s 
OTBDMS 
s------
0 0 
4.34 
6 4.98, s 
The combined yield for the esterification and cyclisation steps (34%) was lower 
than that attained in the synthesis of A-factor (65%) which may in part be due to an 
increased tendency of the butenolide to degrade in contact with silica gel. 
Cyclisation was also catalysed by sodium hydride and diisopropylamine (as 
observed in the synthesis of A-factor), but the high levels of complex by-products 
observed precluded the synthetic use of these methods. The increased sensitivity of this 
butenolide intermediate 7.12 relative to the previously encountered butenolide 4.34 
reflects the increased functionality present, and hence a method for its rapid conversion 
to the more stable saturated lactone 7.14 was required . . 
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From this point the synthetic route diverges from that used for A-factor since 
catalytic hydrogenation, utilised for reduction of the butenolides 4.8 and 4.34, is clearly 
unsuitable for the reduction of 7 .12 due to the presence of the cliene moiety. 
OTBDMS 
0 
7 9 7.12 R=~ 
4.8 
4.34 
R=~ 
R=~ 
OTBDMS 
? 
. ___________ .._ 
7.14 
Our search for a method for regioselective conjugate reduction focussed upon 
reagents which could exploit the highly polarised nature of the C2-C3 double bond. 
This bond is 'doubly activated' towards Michael-style attack by two a-carbonyl groups. 
Thus we required a nucleophilic hydride reducing agent which would preferentially 
reduce a doubly activated olefin while leaving the mono-activated cliene, the lactone 
and the ketone functionality unaffected. 
A survey of the available reagents for conjugate reduction l9S,l99 revealed most 
to be either insufficiently selective, synthetically impractical or not readily available. 
One recently reported commercially available copper hydride reagent,200 [(Ph3P)CuH]6, 
held great promise due to its remarkable selectivity towards conjugate reduction. No 
1,2-reduction is observed with a,J3-unsaturated esters, ketones or even aldehydes.201 
However, when illogical transport regulations covering the air-freighting of even small 
quantities of hydride reagents prevented its procurement, and time prevented its 
preparation, we re-examined some of the more readily available reagents. 
I 
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Sodium borohydride in alcohol usually converts simple a,J3-unsaturated ketones 
to mixtures consisting predominantly of the allylic alcohol (1,2-reduction) with varying 
smaller amounts of the saturated alcohol (from both 1,4- and ketone reduction).202 As a 
model, the available butenolide 4.34 was treated with sodium borohydride (ca 1.5 fold 
excess over the amount required for full reduction) in methanol to give a ratio of 1,2- to 
1,4- plus 1.2-reduction products (6.15 : 6.ll-+{;.12b) of ca 1 :20 ( 4% : 73% isolated) 
(Scheme 7.4). The detection of a small amount of 6.15, despite the excess of reducing 
agent, is expected since a,J3-unsaturated esters (and presumably lactones) are generally 
inert to sodium borohydride in alcohoI.203,204 Hence the fully reduced products 6.11 
and 6.12b are likely to have been formed via initial 1,4-reduction of the butenolide 4.34 
to ketone 4.35 followed by 1,2-reduction. It was not surprising that the intermediate 
saturated ketone 4.35, was not detected since it had previously been shown to undergo 
rapid 1,2-reduction to the 6-hydroxybutanolides 6.11 and 6.12b under similar reaction 
conditions (see Chapter 6, Section 6.3.2). This showed that sodium borohydride 
appeared to have a distinct preference for initial 1,4- rather than 1,2-r~uction of the 
butenolide 4.34 and that it might be possible to isolate the desired saturated ketone 4.35 
if reactivity towards its ketone moiety could be minimised. 
OTBDMS 
R 
NaBI4 
MeOH 
-10 to 20°c 
45min 0 0 
4.34 
R=~ 
OTBDMS 
R 
OH 
6.15 
( 1,2-reduction) 
OTBDMS 
R 
0 
4.35 (1,4-reduction) 
(not detected) 
Scheme 7.4 
OTBDMS 
+ 
... (R ,,, 
H 
0 OH 
6.11, 6.12b (2 diastereomers) 
{l,4- and 1,2-reduction) 
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An example of the required selectivity was reported by Kadin205 who 
demonstrated that the ketone and lactone activated olefin moiety of 3-benzoylcoumarin 
(7.13a) could be 1,4-reduced without any appreciable concomitant reduction of the 
ketone, using sodium borohydride in pyridine (Scheme 7 .5). The subsequent extension 
of these conditions to the 3-acetylcoumarin 7.13b206 showed that the phenyl group was 
not essential for this selective reduction. 
R 
0 0 
7.13a R=Ph 
7.13b R=CH3 
NaBH4 
pyridine 
200 to 50°C 
30 min. 
80% 
R 
0 OH 
Not observed 
Scheme 7.5 Literature Examples of Selective 1,4-Reduction 
Unfortunately, in our case these conditions were unsuitable since the dienyl 
butenolide 7.12 was found to be unstable in pyridine solution. lH NMR spectroscopy · 
revealed 50% decomposition to a highly coloured unidentified mixture after less than 
5 minutes in d5-pyridine. The reported high 1,4-selectivity of sodium borohydride in 
pyridine reflects the reported very low reactivity of this reagent system towards the 
reduction of ketones. 207 Ritchie reported no measurable reduction of cyclohexanone 
until aqueous work-up.207 Similar lack of activity towards ketones has also been 
observed for sodium borohydride in a range of other aprotic solvents including 
acetonitrile, DMF and diethyleneglycol dimethylether (diglyme)208 despite 
unsubstantiated reports to the contrary.203 This contrasting reactivity of sodium 
borohydride in hydroxylic versus non-hydroxylic solvents is presumably due to the vital 
participation in the former case of the hydroxylic solvent in the transfer of hydride to 
the ketone carbonyl, (see Scheme 7 .6). 209 We surmised that aprotic solvents other than 
pyridine may also retard carbonyl reduction sufficiently while still allowing the 
conjugate hydride addition to the doubly activated C3 position of our butenolide 
intermediate 7.12. 
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Scheme 7 .6 Participation of Hydroxylic Solvent in Reductions with Borohydride 
Reduction of the dienyl butenolide 7.12 with an excess of sodium borohydride 
suspended in anhydrous THF (30 min, r.t.) gave, after rapid quenching with dilute 
aqueous hydrochloric acid, exclusive 1,4-reduction to form the butanolide 7.14 in 65% 
yield after chromatography. The deep orange colour of the isolated oily product 
immediately suggested that the conjugated dienone moiety was intact. The high 
proportion of the highly conjugated enol form 7.14b (55%, by lH NMR spectroscopy) 
was probably responsible for the intense colour. In the 1 H NMR spectrum of the 
product, the similarity of the H2, H3, H4 and H5 resonances of the keto-form 7.14a 
with those observed for TBDMS-protected 2,3-trans-A-factor (4.35), including a 
similar 12 3 coupling constant (7.14a: 7.3 Hz cf. 4.35: 6.8 Hz), led to a tentative 
' 
assignment of 2,3-trans geometry as depicted in Scheme 7. 7. The four diene protons of 
the keto form 7.14a appeared between 6 6.2 and 7.4 as observed for the butenolide 
precursor 7.12, while those of the enol form 7.14b were at slightly higher field 
(o 5.9-7.1). In its EIMS, the product displayed a small parent ion at mlz 324 whose 
composition was shown by HRMS to be C11H2s04Si, as required for 7.14. The base 
peak at ml z 95 presumably resulted from the stabilised dienyl acyl cation confirming 
that the diene moiety remained unreduced. 
Neither 6-hydroxy products 7 .15 or 7 .16 nor products resulting from the 
reduction of the diene moiety 7 .17 were seen in either the crude reaction mixture or any 
chromatographic fractions, confirming that the required regioselective reaction had been 
achieved. 
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The solubility of sodium borohydride in THF is low (ca 0.9 mg/mL)210 but 
clearly sufficient to allow reduction. Any additional reducing agent remains suspended 
and presumably dissolves during the reaction to replace what has been used. 
Investigations were not carried out at this stage to test the scope and limitations of this 
convenient regioselective reaction, although it seems likely that similar reactivity may 
be achievable with other aprotic solvents, or with other selective borohydride reagents, 
such as sodium cyanoborohydride or quaternary ammonium borohydrides.210 
The borohydride reduction also provides an alternative to catalytic 
hydrogenation for the reduction of the butenolide intermediates in the synthesis of 
A-factor (1.1) and its homologues. The use of THF makes the reduction step 
compatible with the base-catalysed cyclisation step, allowing the attractive possibility 
of achieving both in a 'one-pot' reaction (Scheme 7.8). Preliminary trials using the 
saturated diketoester 4.6 showed that cyclisation with one equivalent of 
diisopropylamine in THF (5 min, r.t.) followed by the addition of an excess of scxlium 
borohydride (25 min, r.t.) gave a mixture of products from which a 20% yield of the 
acyl lactone 4.27 could be isolated (cf. 57% for the 2 step method, see Chapter 4). In 
the absence of the amine, scxlium borohydride alone was sufficiently basic to promote a 
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significant amount of cyclisation and reduction, although the resulting reaction mixture 
was even more complex and the yield of product 4.27 was lower (ca 10-15%). 
OTBDMS 
~ 
0 0 
0 
4.6 
Diisopropyl 
amine (1 eq.) 
THF, 5 min., r.t. 
Scheme 7.8 
OTBDMS 
4.8 
1 
NaBI4 (2 eq.) 
THF, 25 min., r.t 
OTBDMS 
0 
4.27 (20%, 2 steps) 
This potentially useful synthetic short-cut was not pursued further but it raises 
the attractive possibility of extending the method with the use of chiral hydrides211 to 
produce optically active autoregulators. A chiral reduction of this sort is likely to be 
directly analogous to the biosynthesis of optically active butanolides, where the chiral 
hydride donor would probably be nicotinamide-adenine dinucleotide phosphate, 
reduced form (NADPH). 
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7.5 a-HYDROXYLATION OF THE '3-KETOLACTONE 7.14 
The task of selecting a reagent which was likely to achieve the introduction of a 
hydroxyl group a to the two carbonyl groups of the dienyl f3-ketolactone 7.14 was 
assisted by the recent report of work by Chen and co-workers212 in which the 
f3-ketoester 7.18 was cleanly a-hydroxylated to give (+)-kjellmanianone (7.19) through 
oxidation of the potassium enolate with m<hloroperbenzoic acid (m-CPBA), (Scheme 
7.9). This method was found to be simpler and more reliable than the earlier technique 
of Irie et a/.213 which required potassium fluoride, 18-crown-6 and triethylphosphite in 
DMSO under an oxygen atmosphere to achieve the same oxidation. For our purposes 
the use of m-CPBA was particularly attractive since it might simultaneously epoxidise 
the C9-C10 olefin, thus potentially completing the model synthesis in a single step. 
0 0 
7.18 
i) KH Chen et al. 
ii) m-CPBA (1.2 eq.) 
63% \ 
CH3 
\ KF, Oi, DMSO I 
18-crown-6, P(OEth 
7.19 
3h, r.t. 
60% 
Irie et al. 
Scheme 7.9 Synthesis of (+)-Kjellmanianone (7.19) 
Thus the sodium enolate 7.20 of the f3-keto lactone 7.14 was formed in THF 
using sodium hydride (1.1 eq.), before m-CPBA (1.2 eq.) was added with 
ultrasonication to assist dissolution. The initially yellow solution decolourised 
immediately suggesting that neither the highly conjugated enolate 7 .20 nor any enol 
forms were present. Workup after 10 minutes gave a crude mixture which contained_ 
two products. After chromatographic separation, lH NMR analysis of the two 
colourless oils (29% and 52% yields) revealed them to be closely related. Both had 
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intact diene moieties, as shown by four olefinic resonances and both showed the 
familiar H3, H4 and H5 resonances of a saturated y-lactone. Their identity as the two 
diastereomers of the required 2-hydroxy butanolides (Scheme 7.10) was supported by 
the lack of H2 doublets and the appearance of sharp hydroxyl singlets near o 4.2. When 
EIMS and 13C NMR spectroscopy supported this identification it only remained to 
determine the relative stereochemistry of the new 2-hydroxyl substituents. 
TBDMS 
7.20 
m-CPBA 
(1.2 eq.) 
Scheme 7.10 
OTBDMS 
0 
7.21a + 7.21b 
29% 52% 
2 diastereomers 
The relative configuration of the carbon substituents of the butalactin ring (7.1) 
had been determined by Chatterjee and co-workers194 as trans by the observation of an 
NOE interaction of undisclosed magnitude, between H7 and H3. An NOE study of the 
two 2-hydroxy butanolide diastereomers 7.21a and 7.21b showed that only the minor 
diastereomer 7.21a exhibited such an NOE interaction (7%) (Scheme 7.11), suggesting 
a 2,3-trans disposition of carbon substituents, as required for the synthesis of butalactin 
(7.1). The major diastereomer 7.21b showed small NOE enhancements at H5 (2%) and 
at H4b ( 4%) upon irradiation of H7, indicating 2,3-cis relative geometry of the carbon 
substituents. 
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This unfavourable diastereoselectivity was not entirely surprising since the 
presence of the bulky substituent at C3 would be expected to favour attack by the 
peracid from the opposite face of the enolate 7.20 or enol 7.14b (attack b) as depicted 
below, leading to a predominance of the '2,3-cis 'product 7.21b. 
0 
~JOTBDMS 
I 
: attaC__u--o_____...: ~ 
• 
•, 
•, H 
7.21a 
~kb ~ ~7.21b 
RO 
b 7.20 R=Na 
7.14b R=H 
~ 
It appeared likely to us that the species being attacked by the m-CPBA was the 
en~l 7.14b rather than the enolate 7.20 as implied by Chen et al.,212 since the latter 
would be expected to be protonated by the peroxyacid or the 10-20% m-chlorobenzoic 
acid which is present in commercial m-CPBA. As discussed in Chapter 4, the 
protonation of J3-dicarbonyl enolates occurs on oxygen 158, initially forming the enol 
7.14b which could then undergo epoxidation and rearrangement to the 
2-hydroxybutanolides 7.21 as shown in Scheme 7.12. 
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The possibility of circumventing the involvement of the enolate was tested by 
the addition of excess m-CPBA to an NMR sample of the butanolide (7.14) in CDCl3. 
Within 10 minutes the enol 7 .14b, which represents 55% of the sample, was fully 
converted into a similar mixture of the previously identified 2-hydroxy butanolides 
7.21a and 7.21b, whereas the keto form 7.14a remained largely unchanged even after 
1 hour. This test confirmed that the enol form 7.14b is rapidly oxidised but the 
sluggishness of the keto-enol conversion prevents the oxidation going to completion in 
a reasonable period. It appears that formation of the enolate before m-CPBA oxidation 
probably serves only to allow full conversion of the starting material to the enol f onn 
7.14b prior to oxidation, although some direct oxidation of the enolate 7 .20 
(Scheme 7 .12) cannot be ruled out No evidence for epoxides was noted in this reaction 
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despite the use of an excess of m-CPBA, demonstrating that the double bonds had been 
considerably deactivated towards the reagent by conjugation with the ketone group. 
An interesting possibility for future investigation, especially for the synthesis of 
butalactin itself, would be to attempt recycling of the undesired diastereomer 7 .21b by 
desilylation to the 3-hydroxymethyl butanolide 7.29b and equilibration, using either 
acid or base catalysis, via translactonisation as shown in Scheme 7 .13. It is possible 
that the desired diastereomer 7 .29a may be thermodynamically favoured due to its 
2,3-trans disposed carbon substituents. 
I 
I 
OTBDMS 
7.21b 
: [desilylate] 
t 
7.29b 
. ? 
• 
----------
----
Scheme 7.13 
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7.6 EPOXIDATION OF THE DIENONE MOIETY 
The electron deficient double bond of a,J3-unsaturated ketones can often be 
epoxidised using a nucleophilic reagent such as the sodium salt of t-butyl 
hydroperoxide or related reagents,214 but for dienones such as 7.21, the more electron 
deficient 7 ,8-double bond may be preferentially oxidised. 
OTBDMS 
Peracids such as m-CPBA are electrophilic epoxidising reagents whose 
reactivity is considerably abated by the presence of electron withdrawing substituents in 
the substrate. 106 Since the 9,10-double bond of 7.21 is less deactivated due to its 
remoteness from the carbonyl, it was considered that it might be possible to achieve the 
required regioselective oxidation with these reagents. 
Epoxidation of the y,6-bond of the dienyl ester 7.22 was achieved by Ceroni and 
Sequin (Scheme 7.14) using m-CPBA in CHC13.215 For dienyl ketones, however, the 
reaction is more challenging due to both the stronger deactivating influence of the 
ketone and to the sensitivity of ketones to Baeyer-Villiger oxidation.216 The 
regioselective oxidation of 7.24217 (Scheme 7 .14) provides a rare but encouraging 
example of the required selective epoxidation, although a very long reaction time 
(5 days) was required. Both these examples show that the distal y,o-double bond of the 
dienone system can be preferentially epoxidised even when the a,J3-double bond is 
more substituted, a feature which promotes epoxidation by peracids. 
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When the more abundant 2,3-cis dienone diastereomer 7 .2lb was treated with 
1.1 equivalents of m-CPBA in CDC13, reaction was found to be very slow. Monitoring 
by I H NMR spectroscopy revealed that approximately 30% of the starting material had 
reacted after 16 hours at room temperature, forming one major and several minor 
products, as judged by comparative integration of the emerging new methyl doublets 
between o 1.2 and 1.8 and the diminishing methyl doublet of the starting dienone at 
o 1.9. After the addition of a further quantity of m-CPBA (2.0 eq.) followed by 26 more 
hours standing at room temperature only approximately 10% of the starting material 
remained and the now rather complex reaction mixture was worked up. The major 
products 7 .25 were isolated as an inseparable 1: 1 diastereomeric mixture after 
preparative TLC in 25% yield (Scheme 7.15), in addition to some starting material (ca. 
8%) and a complex mixture of unidentified polar by-products. 
TBDMS 
0 
7.21b 
m-CPBA, (3.1 eq.) 
CDCI3, 42 h, r.t. 
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The monoepoxides' structure 7.25 was supported by their EIMS which showed, 
by the appearance of the largest ion at mlz 299 (M+-tBu), that a single oxygen atom had 
been added. A major fragment ion at mlz 111 was assigned to the acylium ion from the 
cleaved epoxy enone side chain (C~.,02+), replacing the large mlz 95 peak assigned to 
the cleaved dienone substituent (C~.p+) which was observed for the starting dienone 
7.21b. 
The products 7 .2S displayed 1 H NMR characteristics expected for a 1 : 1 
diastereomeric mixture of the 9, 10-mono epoxides 7 .2S, as demonstrated by comparison 
with lH NMR data for butalactin (7.1)194 and cis-epoxide 7.23215 (Table 7.1). Most of 
the resonances of the two diastereomers were superimposed or so close in chemical 
shift that, with the exception of the H4 resonances, it was not possible to extract 
individual coupling data. The doublet signal representing both of the terminal methyl 
groups was shifted upfield too 1.40 from the observed position of o 1.90 in the starting 
dienone, as expected for a methyl substituent of a cis-epoxide (cf 7.23, Table 7.1). The 
two epoxide protons (H9 and HlO) of the diastereomers appeared superimposed as 
multiplets at o 3.22 and 3.0, respectively, positions also consistent with the cis-epoxide 
structure 7.25 (cf 7.23). The protons of the unreacted olefin moieties (H7 and H8) were 
not resolved, appearing as a single four proton multiplet at o 6.8, while the chemical 
shifts of the protons of the hydroxymethyl butyrolactone moieties (H3, H4 and HS) 
were similar to those of butalactin (7.1). 
,. 
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Table 7.1 lff NMR Comparison ofEpoxides 7.25 with Literature Models 
OTBDMS OH 
4 3 
5 
0 M 11 1 •• 6 ~ 
' 10 
'11' 10 OH s 
0 0 11 '8' '10' 0 7 .1 butalactin 7.23 
Proton No.1 o lHNMR olHNMR o lHNMR 
H3 (CH) 3.0, m 2.95, m 11 
H4 (CH2) 4.33, 2xdd 4.39, dd 11 
4.52, 2x't' 4.57, dd 
HS (CH2) 3.75, 'd' 3.84, dd 11 
3.89, dd 
H7 (CH) 6.8, m 6.82, dd 11 
HS (CH) 6.8, m 7.06, dd 6.29, dq 
H9 (CH) 3.22, m 3.60, ddd 3.32, dd 
HlO (CH) 3.0, m 3.38, dq 3.03, dq 
Hll (CH3) 1.4, d 1.28, d 1.40, d 
Notes i) protons numbered as shown above. 
ii) equivalent proton not present. 
The 13C NMR spectrum of the product 7.25 clearly showed its diastereomeric 
composition by the appearance of many of the resonances ( especially those near the 
epoxide moiety) as 1:1 'doublets'. It was readily apparent that resonances due to the C9 
olefin of the starting diene 7.21b (O 130.2 and 144.6) had been replaced by new peaks 
corresponding to a 9,10-epoxide moiety at o 57 - 58 (see Table 7.2). Comparison of the 
I3c NMR data with those of literature models butalactin (7.1) 194 and cis-epoxide 
7 .23215 , reveals good correlation when structural differences are considered, as shown 
in Table 7.2. The monoepoxides 7.25 are protected diastereomers of butalactin (1.1) 
and their formation demonstrates that all of the functionality required for butalactin 
synthesis can be assembled by this route. 
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Table 7.2 l3C NMR Comparison ofEpoxides 7.25 with Literature Models 
OTBDMS 
11 
.. 
10 OH 0 0 
7 .25 (2 diastereomers) 
CarbonNo.1 o 13CNMR 
Cl (C=O) 174.2iii 
C2 (quat C) 82.2iii 
C3 (CH) 50.&ii 
C4 (CH2) 67.4iii 
CS (CH2) 58. 7, 58.8iV 
C6 (C=O) 194.liii 
C7 (CH) 124.8, 125.0 
CS (CH) 146.6, 146.7 
C9 (CH) 57.3, 57_4iv 
ClO (CH) 57.9, 58.liV 
Cll (CH3) 17.5iii 
OH 
4 5 
0 M 1 •• 6 
' ~ 10 
'11' OH I 
0 0 11 '8' '10' 
0 7.1 butalactin 7.23 
o 13CNMR o 13CNMR 
174.1 ii) 
81.9 ii) 
43.9 ii) 
69.0 ii) 
59.8 ii) 
193.9 ii) 
125.4 132.1 
145.0 138.5 
55.6 55.3 
56.0 56.1 
13.1 17.5 
Notes i) carbons nwnbered as shown above. 
ii) equivalent carbon not present. 
iii) represents unresolved peaks. 
iv) assignments may be interchanged. 
It was recognised that since the hydroxylation and epoxidation steps both utilise 
m-CPBA, they could potentially be combined, thereby eliminating the need to isolate 
the intermediate hydroxy dienones 7.21a and 7.21b. 
Thus the sodium enolate of the dienone 7.14 in THF was treated with 3.2 
equivalents of m-CPBA with ultrasonication to assist dissolution. Monitoring by TLC 
showed that formation of the expected 2-hydroxy dienone intermediates 7.21a and 
7.21b was completed in less than 10 minutes but that further reaction was slower. A 
small amount of a component corresponding to the mono-epoxides 7.25 was noted 
during the first hour but this was subsequently overshadowed by two other products at 
higher Rt- After 16 hours, additional m-CPBA was added (1.0 eq.) since the hydroxy 
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dienone intermediates 7.21a and 7.21b had not been fully consumed. After 29 hours 
the reaction was worked up and subjected to radial chromatography to afford the two 
higher Rt products in 9% and 13% yields, in addition to some of the 'major' 2,3-cis 
hydroxy dienone intermediate 7.21b (27%), and a complex array of unidentified minor 
products. None of the 'minor' 2,3-trans hydroxy dienone 7.21a was detected and only a 
trace (ca 1 % ) of the mono-epoxides 7.25 was seen by NMR spectroscopy in the crude 
reaction mixture. 
The two new products showed very similar EI mass spectra, both displaying 
ions at mlz 356 (M+) and 299 (M+-C4H9) which suggested that they were isomeric with 
the previously isolated 2-hydroxy mono-epoxides 7.25. In contrast with the epoxides 
7.25, however, they did not exhibit a fragment ion at mlz 111 corresponding to cleavage 
of an epoxidised dienone side chain. I H NMR spectroscopy was more informative, 
showing that the new, closely related oxidation products both possessed four olefinic 
protons but no resonances attributable to epoxide protons (o 3.0 - 3.3). Since both also 
displayed a singlet due to an hydroxyl proton near o 3.7 and a set 9f resonances 
characteristic of an intact 0-silylated hydroxymethyl butyrolactone moiety, the 
compounds were assigned as the diastereomers of the Baeyer Villiger oxidation product 
7 .26 (Scheme 7 .16). 
OTBDMS 
0 
7.14 
i)NaH/THF 
>»)) • 0 
ii) m-CPBA 
(3.2 eq.) 
OTBDMS 
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OTBDMS 
0~ 
9% · 13% 
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(E,E)-1,3-pentadienyl acetate (7.27)118 provided a good lH NMR model for the 
dienyl ester moiety, and the close correspondence of signals (see below) gave strong 
support for the proposed structures. It is somewhat surprising that these products were 
isolated unepoxidised since their double bonds were no longer deactivated by 
conjugation with the carbonyl group. It is probable that the complex array of minor 
by-products contains compounds resulting from their epoxidation. 
The relative configuration of the diastereomeric Baeyer Villiger oxidation 
products 7 .26a and 7.26b was not determined but it appears likely that the more 
abundant diastereomer 7.26b shares the 2,3-cis configuration of the more abundant 
2-hydroxy dienone intermediate 7.21b, as depicted below. 
OTBDMS 
.. 0 
OHO ··r 
H 
6.13, dd S.75, m 
H H 
H 
CH3 
1.78, d 
7.26,d S.96,m 
7.26a 'minor' 
TBDMS 
0 
6.11, dd 5.15, m 
H H 
H H 
7.25, d 5.9S, m 
CH3 
1.78, d 
7.26b 'major' 
S.96, m S.68, m 
H H 
H3CYO 
0 H H 
7.28, d S.96, m 
1 H NMR comparison 
7.27 
1.76, d 
CH3 
Thus attempted concurrent hydroxylation and epoxidation of dienone 7 .14 with 
m-CPBA in THF was found to promote instead Baeyer Villiger oxidation of the 
intermediate dienones 7.21. This contrasts with the previously observed reactivity in 
CDCl3 for the m-CPBA oxidation of 2,3-cis dienone diastereomer 7.21b (see Scheme 
7.15). Re-examination of the lH NMR spectra obtained for that reaction revealed no 
sign of either of the Baeyer Villiger products (7.26a or 7.26b), despite the long reaction 
time (42 h), and the excess of reagent employed (3.1 equiv.). The reaction solvent 
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appears to crucially affect the mode of oxidation by m-CPBA, and future work on 
optimisation of this epoxidation step will utilise CHCl3 or CH2Cl2 rather than ethereal 
solvents. 
Another promising approach to achieve regioselective epoxidation may be 
through the use of dimethyl dioxirane (7 .28),219 a powerful, recently developed 
epoxidising agent which is reported to cause no Baeyer Villiger oxidation during 
epoxidation of enones. 220.221 While its reactivity towards conjugated dienones has not 
been reported, it has been shown to preferentially epoxidise the distal 4,5-olefin of 
sorbic acid (7.7, Scheme 7.17)220, demonstrating its electrophilic nature. Although the 
reagent is inconvenient to prepare, especially on a large scale, 222 its ease of use and 
promising reactivity make it a good candidate for future investigation. 
HO~ 
0 
7.7 
o-o 7.28 X (insitu) 
Acetone 
2h, r.t 
HO 
0 
86% 
Scheme 7 .17: Regioselective epoxidation by Curci et al. using Dimethyl Dioxirane 
7. 7 CONCLUDING COMMENTS 
Synthesis of the diastereomeric monoepoxides 7.25, which are silyl protected 
stereoisomers of butalactin (7.1), has demonstrated that our biomimetic approach can be 
used to install all the functionality required for the target molecule. Although the final 
hydroxylation and epoxidation steps require improvements in their diastereoselectivity 
and regioselectivity, the stage is set for application of this synthetic route to the first 
synthesis of butalactin. 
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GENERAL PROCEDURES 
Solvents and reagents were purified, where necessary, according to the 
procedures described by Perrin and co-workers223 • All organic extracts were dried over 
anhydrous magnesium sulphate. The bulk of the solvents were removed under reduced 
pressure using a rotary evaporator. Solvent traces were removed by evaporation under 
high vacuum ( < 0.5 mm Hg). All air and moisture sensitive reactions were carried out 
under a positive pressure of anhydrous argon using flame-dried glassware which was 
cooled under anhydrous argon. Commercial n-butyllithium solutions (ca 1.6 M in 
hexane) were assayed by titration with 2,5-dimethoxybenzyl alcohol224 as described by 
Winkle and co-workers.225 Phosphate buffers (pH 3.5, 5.0, 7.0) were prepared by the 
addition of phosphoric acid (100%) to a 1 M aqueous solution of discxlium hydrogen 
phosphate until the required pH was achieved. 
Column chromatography was performed on Merck silica gel 60 (230-400 mesh) 
unless otherwise stated. Radial chromatography was performed on a Harrison Research 
7924T Chromatotron using rotors coated with 1, 2 or 4 mm layers of Merck silica gel 
60 PF254. All coated rotors were dried at 60°C for at least 4 hours before use, and 
eluted with MeOH after use. Normal phase thin layer chromatography (TLC) was 
performed on precoated glass plates (Merck silica gel F254). Reverse phase TLC was 
performed on Merck HP1LC RP-8 F254 plates. Chromatograms were visualised under 
short wavelength UV light, or by spraying with 13% (w/v) vanillin in sulphuric acid; 
followed by heating at ca 200°C. Eluent mixtures are reported as the % v/v of the 
minor constituent. 
Melting points were determined on a Reichert hot-stage microscope and both 
melting and boiling points are uncorrected. 
1 H NMR and nc spectra were recorded on the following instruments: Varian 
CXP20 (lH NMR 80 MHz), Jeol JNM FX-200 (lH NMR 200 MHz, 13C NMR 
50.1 MHz), Varian XL-200 (lH NMR 200 MHz, nc NMR 50.3 MHz), Gemini-300 
(1H NMR 300 MHz, 13C NMR 75.5 MHz), Varian VXR-300 (lH NMR 300 MHz, 13C 
NMR 75.4 MHz) and Varian VXR-500 (lH NMR 500 MHz). lH NMR spectra have 
been recorded in CDCh using the residual CHCl3 peak 6 7.26 ppm as a reference 
because of the extensive use of silyl ethers. For nc NMR spectra recorded in CDCh, 
the centre peak of the solvent triplet was set at 77.0 ppm. Chemical shifts (6) are 
quoted in ppm on the 1 H NMR and nc scales. The following abbreviations are used to 
denote multiplicities and assignments: s (singlet), d (doublet), 'd' (pseudo doublet), 
dd (doublet of doublets), ddd (doublet of doublet of doublets), t (triplet), dt (doublet of 
triplets) q (quartet or quaternary carbon), m (multiplet), br (broad) and 
• (interchangeable assignments). Acid-free CDCh, where required, was prepared by 
passing CDCl3 through a 2 x 0.5 cm column of basic alumina (Merck 90, 70-230 mesh) 
immediately before use. Distortionless enhancement by polarisation transfer (DEPT) 
and the attached proton test (AP1) were used in the assignment of 13C spectra 
Two dimensional NMR experiments were performed on either a Varian 
VXR300 or a VXR500 spectrometer. The pulse sequences used were: homonuclear 
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1 H/1 H correlation spectroscopy (COSY), heteronuclear 1 HJ13C correlation spectroscopy 
(HETCOR) and phase sensitive nuclear Overhauser and exchange spectroscopy 
(NOESY).181 
Infra-red spectra were recorded on a Perkin Elmer 683 or a Perkin Elmer 1800 
(FT) spectrophotometer using solutions in spectroscopic-grade solvents. Peak 
intensities and shapes are abbreviated as follows: s (strong), m (medium), w (weak), 
br (broad), sh (shoulder). 
Ultraviolet spectra were recorded on a Varian OMS 90 or a Hewlett-Packard 
8450A spectrophotometer using solutions in spectroscopic-grade MeOH unless 
otherwise stated. 
Mass spectra were recorded on AEI 902 and V.G.-Micromass 7070 double 
focussing mass spectrometers. High resolution mass measurements were obtained from 
the AEI 902 instrument. The molecular ion (M+) and fragment ions are reported as 
their mass-to-charge ratios (mlz) followed by their relative intensities, as compared with 
the base ( 100%) peak. 
Microanalyses were carried out by the Australian National University 
Microanalytical Service. 
NOMENCLATURE AND NUMBERING 
A-factor and related butanolides are named in Chemical Abstracts as 
3,4-disubstituted dihydro-2(3H)-furanones where the ring oxygen is the '1_' position (see 
below). However, for consistency with the preceding text and with the nomenclature 
used in the general chemical literature relating to the butanolide autoregulators, NMR 
assignments are quoted using the continuous numbering shown for A-factor (1.1) 
below, and on various structures in this section. All butanolides and related compounds 
in this section are named using a system based on the parent butanolide ring in which 
the ring carbonyl carbon is the '1' position. All other compounds are named and 
numbered in accordance with IUP AC nomenclature. 
OH 
0 1.1 
Chemical Abstracts Service nomenclature 
(4R}-dihydro-4-(hydroxymethyl)-
3-(6-methyl-1-oxoheptyl)-2(3H)-furanone 
OH 
1.1 
Nomenclature used throughout this thesis 
(3R)-3-(hydroxymethyl)-2-(6-methyl-
1-oxoheptyl)-butanolide 
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Cyclisation of Oxiranylmethyl acetate (3.6) 
LDA/THF 
-78°C to 20°C -
~ 
0 + )---irCllJ 
OH 0 Q,rrYO t .. /'i Z 2 4 ~
y 3 r 
0 CH3 0 
0 0 
3.6 3.8 50% 3.9 10% 
To a cooled (0°C) ether solution (5 mL) of diisopropylamine (108 mg, 
1.06 mmol) under an argon atmosphere, was added a solution of n-butyllithium in 
hexane (0.64 mL, 1.6 M). After stirring for 20 min, the mixture was cooled further to 
-78°C and glycidyl acetate226 (100 mg, 0.86 mmol) in anhydrous ether (1 mL) was 
slowly introduced. The mixture was allowed to slowly warm to 20°C over 4 hours, 
before it was quenched by the addition of aqueous phosphate buffer solution (pH 3.5). 
Extraction with CH2Ch (4 x 2 mL), drying and evaporation of the solvent gave a pale 
yellow oil. Radial chromatography (1 mm, Si02; 0-5% MeOH in CH2Ch) separated 
two major products followed by a complex mixture of polar compounds. 
The first eluted compound was oxiranylmethyl 3-oxobutanoate (3.8) (34 mg, 
50%), isolated as a colourless oil. 1H and nc NMR data for this compound identical to 
that reported by Witzeman and Nottingham. 227 
The second eluted product was a diastereomeric mixture of the 
di(oxiranylmethyl) 3-hydroxy-3-methylpentanedioate (3.9) (7.8 mg, 10%) as a . 
colourless oil: 
1H NMR (200 MHz, CDCl3) 6 1.39 (s, 3H, CH3), 2.67 (dd, J3'a.3'b and J3"a.3"b = 4.8 Hz, 
J3'b,2' and J3·'h.2" = 2.6 Hz, 2H, H3'b, H3"b), 2.72 (d, l2a.2b and f 4a,4b = 5.0 Hz, 4H, 
H2, H4), 2.86 (dd, J3'a,3'b and J3"a,3"b = 4.8 Hz, J3·a.2· and J3"a.2" = 4.2 Hz, 2H, H3'a, 
H3"a), 3.24 (m, 2H, H2', H2"), 3.93 (s, lH, OH), 3.97 (dd, l1·a,l'b and 
l1"a.l"b = 12.2 Hz, l1'b,2' and lr'b,2" = 6.1 Hz, 2H, Hl'b, Hl"b), 4.47 (dd, li·a.t'b and 
lr·a.1"b = 12.2 Hz, l1·a.2· and lt"a,2" = 3.0 Hz, 2H, Hl 'a, Hl "a). 
EIMS mlz 259 (M+-CH3, 9%), 185 (5), 183 (6), 159 (38), 143 (12), 127 (12), 116 (20), 
85 (45), 57 (42), 43 (100). 
CIMS mlz 292 (M+NH4+, 72%), 275 (M+H+, 61), 257 (20), 176 (100), 159 (84), 117 
(88) . 
HRMS: Found 259.0817; C15H2904Si (M+-CH3) requires 259.0818. 
The last band eluted contained a mixture of several unidentified compounds 
which appeared by 1 H NMR spectroscopy to contain intact epoxide moieties, as 
indicated by complex resonances at near 6 4.5, 4.0, 3.2, 2.9 and 2. 7. 
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Oxiranylmethyl benzeneacetate (3.13) 
0 
~3' 
0 )r-Ph 
0 
3.13 
The glycidyl ester (3.13) was prepared according to the method of Fuganti and 
co-workers.102 The crude product was purified by flash chromatography (20% hexane 
in CH2Ch in 69% yield as pale yellow oil, bp 92-95°C / 0.2 mm Hg. 
1H NMR (80 MHz, CDCl3) 6 2.56 (dd, l3'a,3b = 4.9 Hz, J3b,2' = 2.5 Hz, lH, H3'b), 2.77 
(dd, l3'a,3b = 4.9 Hz, l3•a,2' = 4.2 Hz, lH, H3'a), 3.1-3.3 (m, lH, H2'), 3.65 (s, 2H, 
H2), 3.92 (dd, J t 'a,l 'b = 12.3 Hz, ltb,2' = 6.0 Hz, lH, Hl 'b), 4.41 (dd, 
lra,tb = 12.3 Hz, l1·a.2· = 3.1 Hz, lH, Hl'a), 7.28 (s, 5H, ArH). 
EIMS mlz 192 (M, 5%), 136 (4.5), 118 (48), 91 (100), 86 (47), 84 (70), 65 (12). 
Experimental 
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Cyclisation of Oxiranylmethyl benuneacetate (3.13) 
OH 
Ph + 
3.13 3.17 
0 
3.16 
2 diastereomers 
METHOD A: USING WA WITH n-BU1YILrrHIUM 
To a cooled (-30°C) THF solution (20 mL) of diisopropylamine (87 mg, 
121 µL, 0.86 mmol) under an argon atmosphere, was added a solution of n-butyllithium 
in hexane (0.56 mL, 1.55 M). After stirring for 5 min, the glycidyl ester (3.13) 
(150 mg, 0.78 mmol) in THF (3 mL) was introduced. The mixture was allowed to 
warm to 20°C and was stirred for 1 hour. A sample analysed by TLC (2% MeOH in 
CH2Cli) indicated only starting material. After re-cooling to -30°C an additional 
equivalent of n-butyllithium in hexane (0.56 mL, 1.55 M) was added. This mixture was 
stirred at 10°C for 2 hours before being quenched by the addition of pH 3.5 phosphate 
buffer (3 ml.) and water (5 mL). Extraction with CH2Cl2 (4 x 5 mL), drying and 
evaporation of the solvent gave a pale yellow oil. Radial chromatography (2 mm, Si02; 
0-5% MeOH in CH2Cl2) separated two major products followed by a complex mixture 
of polar compounds. 
The first eluted compound was a,a-dibutylbenzeneethanol (3.17) (38 mg, 21 %) 
isolated as a colourless oil: 
1
H NMR (80 MHz, CDC13) 6 0.91 (m, 6H, 2 x CH3), 1.37 (m, 12H, 6 x CH2), 2.74 (s, 
2H, CH2Ar), 7 .25 (m, 5H, ArH). 
EIMS mlz 177 (M+-~H9, 24%), 143 {M+-CH2Ar, 100), 92 (37), 91 (ArCH2+, 60), 85 
(26), 83 (26), 69 (85), 57 (63), 55 (46). 
The second eluted product was a diastereomeric mixture of the 
4-hydroxymethyl-2-phenylbutanolides (3.16) (60 mg, 40%) as colourless needles from 
hexane/ CH2Cl2, mp 82-91 °C: 
1
H NMR (300 MHz, CDCl3) 6 2.33-2.50 (m, 2H, 2 x H3b), 2.60-2.73 (m, 2H, 2 x H3a), 
3.69 (t, J = 5 Hz, lH, H2), 3.73 (t, J = 5 Hz, lH, H2), 3.90-4.07 (m, 4H, 2 x H5), 
4.60-4.67, (m, lH, H4), 4.70-4.76 (m, lH, H4), 7.25-7.43 (m, lOH, ArH). 
13
C NMR (50 MHz, CDCl3) 6 32.4 (C3), 32.7 (C3), 46.1 (C2), 46.9 (C2) 63.2 (CS), 
64.1 (C5), 78.8 (2 x C4), 127.0, 127.2, 127.3, 127.8, 128.3, 128.5, 136.9, 137.8 
(12 x Are), 177.1, 178.1 (2 x C=O). 
IR (CCl4) Umax 3600 m (OH), 1771 s (lactone C=O), 1500 m, 1453 m, 1358 m, 1170 br 
s cm-1• 
EIMS m/z 192 (M+, 34%), 161 {M+-CH20H, 9), 148 (M+-002, 12), 133 (29), 118 (23), 
117 (100), 115 (20), 105 (74), 104 (47), 91 (21), 77 (22). 
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Analysis: Found C 68.2, H 6.4; C11H1203 requires C 68.5, H 6.3 . 
METHOD.B: USINGLDAINHMPA-THF(l:10) 
To a cooled (-60°C) solution of diisopropylamine (190 mg, 264 µ~, 1.87 mmol) 
in anhydrous THF (10 mL), under an argon atmosphere, was added a solution of 
n-butyllithium in hexane (1.15 mL, 1.61 M). After stirring for 5 minutes a solution of 
glycidyl phenylacetate (3.13) (300 mg, 1.56 mmol) in THF (3 mL) was slowly 
introduced. After stirring for a further 30 minutes at this temperature, anhydrous 
hexamethylphosphoramide (HMP A) (1 mL) was added. The mixture was allowed to 
warm to 0°C and stirred for 4 hours, after which time no starting material was detected 
by TLC (5% MeOH in CH2C!i). The reaction was quenched by the addition of 
phosphate buffer (pH 3.5, 3 mL) and water (3 mL). Approximately half of the THF 
was removed by rotary evaporation before extraction with EtOAc (3 x 7 mL). The 
extracts were washed with saturated aqueous copper sulphate solution (3 x 3 mL) to 
remove HMPA, followed by water (2 x 5 mL). Drying and evaporation of the solvent 
yielded an oil from which two products were isolated using radial chromatography 
(2 mm Si02; 0-8% MeOH in CH2Cl2), as well as a complex mixture of highly polar 
compounds. 
The first eluted product was the previously identified diastereomeric mixture of 
4-hydroxymethyl-2-phenylbutanolides (3.16) (75 mg, 25%) (see Method A above for 
spectral data). 
The second eluted product was an inseparable mixture (5:1) of 
2,3-dihydroxypropyl phenylacetate (3.23) and 1,3-dihydroxypropyl phenylacetate 
(3.24), (98 mg, 30% combined) as a colourless oil. 
HO 3 <j>Ht 0~ ~ II Ph 
3.23 o 
1H NMR (200 MHz, CDCh) for diol 3.23: 8 3.48 (dd, 13a,3b = 11.7 Hz, J3b,2 = 6.0 Hz, 
lH, H3b), 3.60 (dd, 13a.,3b = 11.7 Hz, l3a,2 = 3.7 Hz, lH, H3a), 3.65 (s, 2H, CH2Ar), 
3.80-3.92 (m, lH, H2), 4.13 ('d', J = 5.5 Hz, 2H, Hl), 7.40-7.20 (m, 5H, ArH); for 
diol 3.24: o 3.74 (d, J = 4.8 Hz, 4H, Hl,3), 4.85 (m, lH, H2) (other peaks obscured 
by 3.23). 
13C NMR (50 MHz, CDCh) (for diol 3.23) o 41.0 (CH2Ar), 63.1 (C3), 65.5 (C2), 70.0 
(Cl), 127.1, 128.4, 129.1, 133.4 (6 x Are), 172.5 (C=O); fordiol 3.24: o 61.4 (Cl, 
C3), 75.5 (C2), other peaks coincident with those of 3.23. 
EIMS mlz 210 (M+, 1 %), 179 (M+-CH20H, 5), 135 (8), 118 (9), 91 (67), 86 (60), 84 
(100), 49 (28). 
Experimental 
Methyl 3-oxononanoate (3.33a) 
0 0 
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3.33a R=Me 
3.33b R=Et 
3.33c R=H 
3.33d R='Bu 
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The methyl J3-ketoester (3.33a) was prepared from ethyl acetoacetate and 
1-bromopentane by the method of Stallberg-Stenhagen.119 Fraction distillation yielded 
the product in 60% yield, bp 77-82°C / 1 mm Hg. [Lit 228 bp 137°C / 28 mm Hg]. 
lH NMR (80 MHz, CDCl3) 6 0.88 (m, 3H, H9) 1.1-1.9 (m, 8H, H5,6,7,8), 2.25 (t, 
J = 5 Hz, enol H4), 2.53 (t, J = 1 Hz, 2H, H4), 3.44 (s, 2H, H2), 3.73 (s, 3H, OMe), 
5.00 (s, enol CH), 11.3 (s, enol OH), [10% enol content]. 
EIMS mlz 186 (M+, 3.4%), 168 (M+-H20, 2), 155 (M+-OMe, 3), 144 (4), 143 (4), 129 
(26), 116 (100), 113 (62), 101 (45), 97 (22), 85 (37), 84 (95), 74 (58), 69 (52), 59 
(45), 57 (43), 56 (27), 55 (46). 
Ethyl 3-oxononanoate (3.33b) 
The ethyl J3-ketoester (3.33b) was prepared by alkylation of the dianion of 
ethyl acetoacetate with 1-bromopentane using the procedure of Huckin and Weiler.118 
Fractional distillation of the crude product afforded the title compound in 65% yield, 
(bp 68-69°C / 0.25 mm Hg [Lit.229 bp 87°C / 0.8 mm Hg]). 
lH NMR (300 MHz, CDCl3) 6 0.88 (m, 3H, H9) 1.28 (m, 9H, H6,7,8 + ethyl CH3), 
1.60 (m, 2H, H5), 2.19 (t, J = 1 Hz, enol H4), 2.54 {t, J = 1 Hz, 2H, H4), 3.43 (s, 
2H, H2), 4.20 (q, J = 1 Hz, 2H ethyl CH2), 4.97 (s, enol CH), 12.11 (s, enol OH), 
[10% enol content]. 
EIMS mlz 200 (M+, 0.8%), 168 (M+-H20, 1), 155 (M+-OEt, 3), 143 (11), 130 (51), 115 
(11), 113 (44), 88 (22), 85 (16), 84 (40), 59 (16), 55 (18). 
t-Butyl 3-oxononanoate (3.33d) 
The title ester (3.33d) was prepared by alkylation of the dianion of 
t-butylacetoacetate with 1-bromopentane using the method of Huckin and Weiler. 118 
Fractional distillation of the crude product afforded t-butyl 3-oxononanoate in 70% 
yield; bp 80-82°C / 0.1 mm Hg [Lit.162 bp 88°C / 0.15 mm Hg]. 
1 H NMR (300 MHz, CDCh) 6 0.85 (m, 3H, H9), 1.20-1.35 (m, 6H, H6, 7 ,8), 1.44 (s, 
9H, t-butyl), 1.56 (m, 2H, H5), 2.49 (t, J = 1 Hz, 2H, H4), 3.31 (s, 2H, H2), 4.85 (s, 
enol CH), 12.1 (s, enol OH), [6% enol content]. 
13C NMR (75 MHz, CDCIJ) 6 13.9 (C9), 22.4 (C8), 23.4 (C5), 27.9 ('Bu), 28.7 (C6), 
31.5 (C7), 42.9 (C4), 50.6 (C2), 81.8 (q, 1Bu ), 166.5 (C3), 203.4 (Cl). 
EIMS mlz 172 (M+-'4H8, 2%), 155 (3), 113 (17), 102 (18), 85 (8), 84 (16), 59 (12), 58 
(12), 57 (100), 55 (10). 
Analysis: Found C 68.3, H 10.9; C13H2403 requires C 68.4, H 10.6. 
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3-0xononanoic acid (3.33c) 
METHODA 
The title acid was prepared via acid hydrolysis of the methyl (3.33a) or ethyl 
~-ketoesters (3.33b) by a procedure based on that of Mitz and coworkers. 120 To the 
3-oxononanoate ester (3.33a or 3.33b, 5.0 g) in glacial acetic acid (80 mL) was added 
concentrated hydrochloric acid ( 40 mL, 36% ). The solution was stirred at 20°C for 
20 hours before it was concentrated on a rotary evaporator (temp< 30°C). After about 
80 mL of solvent had been removed the product crystallised. Further crystallisation 
was promoted by cooling in ice before the ~-ketoacid was collected by filtration and 
washed well with water (3 x 30 mL). Concentration of the filtrate yielded additional 
crops of product which were combined and dried in vacuo over P205, to give 
3-oxononanoic acid (3.33c) as colourless plates (2.8 g, 61 % from 3.33a; 2.58 g, 60% 
from 3.33b ), mp 70-71 °C (Lit. 230 mp 70.5°C). 
If the product is to be stored for an extended period it is recommended that it be 
recrystallised from benzene-hexane (mp 70.5-71.0°C) and stored at low temperature to 
minimise the risk of decarboxylation. 
lH NMR (300 MHz, CDCl3) 6 0.87 (m, 3H, H9), 1.20-1.37 (m, 6H, H6,7,8), 1.52-1.67 
(m, 2H, H5), 2.21 (t, J = 1 Hz, enol H4), 2.56 (t, J = 1 Hz, 2H, H4), 3.50 (s, 2H, 
H2), 5.02 (s, enol CH), 10.2 (br s, lH, OH), 11.5 (s, enol OH), [18% enol content]. 
13C NMR (75 MHz, CDCl3) 6 14.0 (C9), 22.4 (C5)*, 23.3 (C8)*, 28.6 (C6), 31.5 (C7.), 
35.3 (C4 enol), 43.2 (C4), 48.1 (C2), 88.2 (C2), 172.2 (Cl), 176.9 (Cl enol), 182.2 
(C3 enol), 203.9 (C3). 
EIMS mlz 172 (M+, 0.4%), 128 (M+-C02, 7), 113 (5), 102 (11), 85 (8), 84 (14), 71 (29), 
58 (100). 
METHODB 
To t-butyl 3-oxononanoate (3.33d) (14.8 g, 65 mmol) in CH2Cl2 (60 mL) was 
added trifluoroacetic acid (40 mL). The mixture was stirred for 2 hours at room 
temperature before the solvents were removed using a rotary evaporator. Solvent traces 
were then removed under high vacuum (0.1 mm Hg) to leave a crystalline mass. 
Recrystallisation from pentane gave 3-oxononanoic acid (8.85 g, 80%) in two crops, 
mp 69 .5-70°C (spectroscopic data above). 
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Oxiranylmethyl 3-oxononanoate (3.32a) 
9 
0 0 0 0 
3.33c 3.32a 
To a cooled (0°C) solution of 3-oxononanoic acid (3.33c) (1.49 g, 8.7 mmol) in 
dry CH2Cl2 (45 mL) was added glycidol (3.4) (0.71 g, 9.6 mmol) and 
N ,N-dicyclohexylcarbodiimide (DCC) (1.98 g, 9.6 mmol) followed 5 minutes later by 
DMAP (50 mg) and DMAP hydrochloride salt (50 mg). After stirring overnight at 
room temperature the resulting white suspension was concentrated by the evaporation 
of ca 30 mL of solvent with a stream of dry argon. After cooling to 0°C the 
precipitated N,N-dicyclohexylurea was removed by filtration and the filtrate was 
washed with pH 5.0 phosphate buffer (2 x 15 mL) and water (3 x 15 mL). Drying and 
evaporation of the solvent gave a pale yellow oil which was purified by Kugelrohr 
distillation (oven temp. 80-90°C / 0.1 mm Hg) yielding the f3-ketoester (3.32a) as a 
colourless oil (1.40 g, 70%). 
lH NMR (300 MHz, CDCI)) 6 0.87 (t, J = 6.8 Hz, 3H, H9), 1.20-1.38 (m, 6H, H6,7,8), 
1.59 (m, 2H, H5), 2.20 (t, J = 1, Hz, enol H4), 2.53 (t, J = 1.4 Hz, H4), 2.66 (dd, 
l3•a;3"o = 4.9 Hz, J3"o,2' = 2.6 Hz, lH, H3'b), 2.85 (dd, J 3'a,3"o = 4.9 Hz, 
13"o,2' = 4.0 Hz, lH, H3'a), 3.22 (m, lH, H2'), 3.50 (s, 2H, H2), 3.99 (dd, 
Ira.lb= 12.3 Hz, 11 'b,2 = 6.2 Hz, lH, Hl 'b), 4.47 (dd, l1·a,1"o = 12.3 Hz, 
J 1 ·a.2· = 3.0 Hz, lH, Hl 'a), 5.03 (s, enol H2), 11.87 (s, enol OH), (enol content 
ca 10%) 
13C NMR (75 MHz, CDCI)) o 13.9 (C9), 22.4 (C8), 23.3 (C5), 28.6 (C6), 31.4 (C7), 
43.1 (C4), 44.6 (C3'), 48.8 (C2), 49.0 (C2'), 65.5 (Cl'), 166.8 (ester C=O), 202.4 
(ketone C=O). 
IR (CC4), umax 2930 s, 1755 s (ester C=O), 1723 s (ketone C=O), 1660 s, 1630 s, 
1222 s, 1150 m cm-1. 
EIMS mlz 171 (M+-C4H9, 2%), 158 (4), 116 (McLafferty rearrangement, 41), 113 (28), 
84 (51), 69 (19), 57 (29), 43 (100). 
CIMS mlz 246 (M+NI4+, 25%), 229 (M+H+, 100). 
Analysis: Found C 63.2, H 8.7; C12H2004 requires C 63.1, H 8.8. 
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Cyclisation of Oxiranylmethyl 3-oxononanoate (3.32a) 
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Mineral oil was removed from sodium hydride (50% oil dispersion, 126 mg, 
2.6 mmol) by washing and decanting twice with dry pentane (2 x 3 mL) under an 
atmosphere of anhydrous argon. The hydride was suspended in dry THF (6 mL) and 
cooled to 0°C before a solution of the J3-ketoester (3.32a) (500 mg, 2.19 mmol) in THF 
(10 mL) was introduced dropwise. Stirring for 30 min at room temperature resulted in 
no reaction as determined by reverse phase TLC (RP8; 20% H20 in MeOH). After 
heating at reflux for 3 hours the reaction mixture was quenched by the addition of a 
phosphate buffer solution (pH 5.0, 5 mL) and then extracted with ether (3 x 10 mL). 
The organic extracts were washed with water (2 x 5 mL), dried and evaporated to give a 
yellow oil. Radial chromatography (4 mm Si02; 1-5% MeOH in CH2Cl2) separated 
three products with the remainder being complex polar material. 
The first eluted band was identified as a 1: 1 diastereomeric mixture of the 
0-(3'-oxononanoyl) butyrolactones (3.39) (175 mg, 42%). 
lH NMR (300 MHz, CDCl3) o 0.88 (m, 12H, 2 x H12,9'), 1.19-1.41 (m, 24H, 
2 x H9,10,11,6',7',8'), 1.5-1.7 (m, 4H, 2 x H8), 2.07-2.43 (m, 2H, 2 x H3b), 2.52 (t, 
J = 8 Hz, 4H, 2 x H4'), 2.57-3.08 (m, 6H, 2 x H3a,7), 3.49 (s, 2H, H2'), 3.51 (s, 2H, 
H2'), 3.78 (dd, J = 8.8 Hz, J = 10.0 Hz, lH, H2), 3.84 (dd, J = 5.5 Hz, J = 9.6 Hz, 
lH, H2), 4.20-4.43 (m, 4H, 2 x H5), 4.67-4.84 (m, 2H, 2 x H4). 
l3C NMR (75 MHz, CDCl3) o 13.9 (2 x C12, 2 x C9'), 22.3 (2 x Cl 1, 2 x C8'), 23.1, 
23.2, 23.3 (2 x C8, 2 x C5'), 24.8 (C3), 25.4 (C3), 28.5 (2 x C9, 2 x C6'), 31.4 
(2 x ClO, 2 x C7'), 42.1, 42.3 (2 x C7)*, 43.0, 43.2 (2 x C4')*, 48.6, 48.8 (2 x C2'), 
52.3, 52.7 (2 x C2), 65.4 (2 x C5), 75.7, 76.4 (2 x C4), 166.7, 166.9 (2 x ester 
C=O), 171.7, 171.8 (2 x lactone C=O), 202.0, 202.3_, 202.6 (4 x ketone C=O). 
IR (CC4) Umax 2935 s, 1782 s (ylactone C=O), 1758 s (ester C=O), 1725 s (ketone 
C=O), 1410 m, 1150 m cm-1. 
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EIMS mlz 228 (M+-~H1s02, 0.3%), 210 (1), 197 (1), 171(2), 158 (4), 116 (40), 113 
(23), 84 (41), 69 (12), 57 (31), 55 (21), 42 (100). 
CIMS mlz 400 (M+Nl4+, 100%). 
The second band to be eluted was identified as a 1: 1 diastereomeric mixture of 
4-hydroxymethyl-2-heptanoylbutanolide (3.40) (50 mg, 10% ). 
lH NMR (300 MHz, CDCh) 6 0.88 (m, 6H,2 x Hl2) 1.20-1.42 (m, 12H, 2 x H9,10,l 1), 
1.52-1.72 (m, 4H, 2 x H8), 2.16-2.39 (m, 2H, 2 x H3b), 2.54-3.08 (m, 6H, 
2 x H3a,7), 3.ro-4.03 (m, 6H, 2 x H2,5), 4.58-4.73 (m, 2H, 2 x H4). 
13C NMR (50 MHz, CDCIJ) o 14.0 (2 x C12), 22.4 (2 x Cl 1), 23.3, 23.4 (2 x C8), 24.6, 
25.1 (2 x C3), 28.6 (2 x C9), 31.5 (2 x ClO), 42.3, 43.2 (2 x C7), 52.8, 53.5 
(2 x C2), 64.0, 64.3 (2 x C5), 79.1, 79.6 (2 x C4), 172.1, 172.5 (2 x lactone C=O), 
202.6, 203.4 (2 x ketone C=O). 
IR (CC4) Umax 2930 s, 1780 s (')'-lactone C=O), 1725 s (ketone C=O), 1650 m (enol 
lactone C=O), 1225 m, 1150 m cm-1. 
EIMS mlz 228 (M+, 0.3%), 210 (M+-H20, 1.5) 197 (M+-CH20H, 3), 171 (2), 158 (9), 
116 (33), 113 (98), 85 (30), 70 (11), 57 (20, 55 (42), 43 (100), 
CIMS mlz 246 (M+Nl4+, 100%), 229 (M+H+, ro). 
HRMS: Found 228.1362; C12H2o()4 (M+) requires 228.1362. 
The third and final band eluted was 2',3'-dihydroxypropyl 3-oxononanoate 
(3.42), (81 mg, 15%): 
1H NMR (300 MHz, CDCl3) o 0.88 (m, 3H, H9) 1.18-1.38 (m, 6H, H6,7,8), 1.50-1.66 
(m, 2H, H5), 2.52 (t, J = 7.2 Hz, 2H, H4), 3.51 (s, 2H, H2), 3.61 (dd, 
J3'a,3'b = 11.5 Hz, J3'b,2' = 5.7 Hz, lH, H3'b), 3.60 (dd, J 3'a.3'b = 11.5 Hz, 
l3·a.2· = 4.1 Hz, lH, H3'a), 3.95 (m, lH, H2'), 4.25 (d, J = 5.4 Hz, 2H, Hl '). 
EIMS mlz 215 (M+-CH20H, 3%), 186 (2), 173 (4), 158 (16), 155 (6), 116 (22), 113 
(55), 85 (17), 84 (42), 69 (14), 61 (14), 57 (21), 55 (14), 43 (100). 
HRMS: Found (M+-CH20H) 215.1284; C11H 1904 requires 215.1284. 
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2-Iodoethyl 3-oxononanoate (3.46) 
To a stirred solution of DCC (264 mg, 1.28 mmol) in anhydrous CH2Ch (6 mL) 
at 0°C was added 3-oxononanoic acid (3.33c) (200 mg, 1.16 mmol) and DMAP 
hydrochloride (20 mg). After 30 min at 0°C, 2-iodoethanol (220 mg, 1.28 mmol) was 
introduced and the mixture was stirred at 20°C for 20 hours. The suspension was 
cooled (0°C) and concentrated to ca 4 mL in a stream of argon before removal of the 
precipitated N,N-dicyclohexylurea by filtration. The filtrate was washed sequentially 
with water (10 mL), 5% acetic acid (10 mL) and water (2 x 10 mL) before being dried 
and evaporated. Radial chromatography of the residue (2 mm Si02; 0-1 % MeOH in 
CH2Cli) allowed the isolation of the iodo 13-ketoester (3.46) as a lemon-yellow waxy 
solid (227 mg, 60% ). 
lH NMR (80 MHz, CDCl3) o 0.88 (m, 3H, H9) 1.10-1.90 (m, 8H, H5,6,7,8), 2.55 (t, 
J = 1.0 Hz, H4), 3.30 (t, J = 6.8 Hz, 2H, H2'), 3.46 (s, 2H, H2), 4.39 (t, J = 6.8 Hz, 
2H, Hl'). 
EIMS mlz 326 (M+, 0.5%), 298 (0.3), 256 (15), 227 (4), 199 (6), 155 (63), 113 (29), 101 
(9), 85 (17), 84 (27), 69 (23), 57 (14), 55 (22), 45 (21), 43 (100). 
Analysis: Found C 40.4, H 5.9; C11H1903I requires C 40.5, H 5.9. 
Experimental 253 
Cyclisations of 2-Iodoethyl 3-oxononanoate (3.46) 
9 
0 0 
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METHOD A: USING SODIUM HYDRIDE 
A solution of the iodo ester (3.46) (94 mg, 0.29 mmol) in anhydrous THF 
(2 mL) was transferred via a cannula to a stirred suspension of sodium hydride (50% oil 
dispersion, 16.3 mg, 0.34 mmol) in TIIF (2 mL) at 20°C, under an atmosphere of argon, 
After 5 min, 1LC (Si(h; 5% MeOH in CH2Ch) indicated the disappearance of starting 
material so the reaction mixture was quenched by the addition of phosphate buff er 
(pH 5.0, 1 mL) and water (3 mL). Extraction with CH2Ch (3 x 3 mL) and subsequent 
drying and evaporation of solvent gave a pale yellow oil. Radial chromatography 
(1 mm Si02; 0-2% MeOH in CH2Cl2) facilitated the isolation of the ketene acetal 
(3.48) (43 mg, 75%) as a colourless oil. 
lH NMR (200 MHz, CDCh) 6 0.88 (m, 3H, H9) 1.10-1.45 (m, 6H, H6,7,8), 1.45-1.70 
(m, 2H, H5), 2.40 (t, J = 1 Hz, 2H, H4), 4.40 (t, J = 1 Hz, 2H, Hl ')*, 4.62 (t, 
J = 1 Hz, 2H, H2')*, 4.95 (s, lH, H2). . 
EIMS mlz 198 (M+, 2% }, 155 (1), 141 (4), 128 (39), 113 (100), 86 (15), 69 (56), 55 (9), 
45 (12), 43 (27). 
HRMS: Found (M+) 198.1256; C11H1s03 requires 198.1256. 
METHOD B: USING TETRA-n-BUTYLAMMONIUM FLUORIDE 
The iodoethyl ester (3.46) (79 mg, 0.23 mmol) in anhydrous THF (10 mL) was 
stirred over crushed molecular sieves (4 A, 0.8 g) for 1.5 hours at room temperature 
before a solution of tetra-n-butyl ammonium fluoride (1.0 M in THF, 0.5 mmol) was 
added. Analysis by 1LC (1 % MeOH in CH2Ch) after 5 minutes showed no starting 
material. The molecular sieves were removed by filtration and phosphate buffer 
(pH 5.0, 2 mL) was added to the filtrate. Extraction with CH2Ch (3 x 5 mL), drying 
and removal of the solvent left a residue of yellow oil. Radial chromatography (2 mm 
Si02; 2-4% MeOH in CH2Cl2) isolated the ketene acetal (3.48) (33 mg, 70%) as a 
colourless oil. (spectroscopic data above). 
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1,3-Bis(t-butyldimethylsilyloxy )-2-iodopropane (3.53) 
I 
TBDMS~OTBDMS 
3.53 
254 
A chilled (0°C) solution of 2-iodopropane-1,3-diol 129,130 ( 404 mg, 2.0 mmol) in 
CH2Ch (10 mL) and pyridine (0.5 mL) was treated with TBDMS-
trifluoromethanesulf onate ( 1.16 g, 4.4 mmol) and stirred for 10 minutes. The reaction 
was quenched with saturated aqueous sodium bicarbonate solution (2 mL) and water 
(5 mL). The aqueous layer was extracted with CH2Ch (3 x 5 mL) and the extracts 
combined with the organic layer. Drying and evaporation of the solvent gave a light 
yellow oil which was purified by Kugelrohr distillation ( oven temp. 90-110°C / 
0.3 mm Hg). Yield of the diprotected 2-iodopropanediol (3.53) as a colourless liquid is 
830 mg (96% ). 
lH NMR (200 MHz, CDCl3) 6 0.07 (s, 12H, SiCH3), 0.90 (s, 18H,'Bu), 3.87 (d, 
J = 5.5 Hz, 4H, 2 x Hl,3), 4.10 (pentet, J = 5.5 Hz, lH, H2). 
nc NMR (50 MHz, CDC}J) 6 -5.4, -5.3 (SiCH3), 18.3 (q, t-Bu), 25.8 (1Bu), 36.5 (C2), 
64.5 (Cl,3). 
EIMS mlz 373 (M+-~H9, 14%), 259 (5), 215 (4), 189 (18), 147 (66), 133 (17), 131 
(56), 115 (14), 101 (10), 89 (34), 75 (19), 73 (100), 59 (21), 57 (11). 
HRMS: Found (M+-C4H9) 373.0517; C11H2602Si2I requires 373.0516. 
Experimental 
Attempted Intermolecular Alkylation of Methyl 3-oxononanoate (3.33a) with 
Iodide 3.53 
255 
The J3-ketoester (3.33a, 93 mg, 0.50 mmol) in THF (2 mL) was slowly 
introduced to a suspension of sodium hydride (50% oil dispersion, 28.8 mg, 0.6 mmol) 
in THF (2 mL) at room temperature under an atmosphere of anhydrous argon. After 
10 minutes hydrogen evolution had ceased and a clear solution remained. The iodide 
(3.53) (215 mg, 0.50 mmol) in THF (1 mL) was then added via a cannula and the 
mixture was heated at reflux for 48 hours. Periodic analysis by TLC (1 % MeOH in 
CH2Cli) showed no reaction during this time. To confirm formation of the J3-ketoester 
anion the reaction mixture was cooled to 20°C and the anion was 'trapped' by the 
addition of a large excess of methyl iodide (1.1 g). After 30 min, phosphate buffer 
(pH 5.0, 1.5 mL) and water (2 mL) were added and the mixture was extracted with 
CH2Cl2 (3 x 6 mL). The combined organic extracts were dried and evaporated to leave 
a pale orange oil. Radial chromatography (4 mm Si02; 0.5% MeOH in CH2Cl2) 
facilitated the recovery of the unreacted iodopropane (3.53) (206 mg, 96%) as the first 
eluted compound. The second band contained methyl 2-methyl-3-oxononanoate (3.54) 
(80 mg, 80%) as a colourless oil, which displayed identical 1 H NMR data to 3.54 
prepared by Nakajima et al. 
9 
0 0 3.54 
1H NMR (80 MHz, CDCl3) 6 0.88 (m, 3H, H9), 1.10-1.90 (m, 3H, H5,6,7,8), 1.33 (d, 
J = 1 Hz, 3H, HlO), 2.52 (t, J = 1 Hz, 2H, H4), 3.52 (q, J = 1 Hz, lH, H2), 3.72 (s, 
3H, OMe). 
EIMS mlz 200 (M+, 0.6%), 169 (M+-OMe, 1), 127 (4), 117 (5), 113 (100), 85 (29), .69 
(8), 57 (18), 55 (13), 43 (97). 
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1,3-Bis(t-butyldimethylsilyloxy )propanone (3.55) 
0 
TBDMS~OTBDMS 
3.55 
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Redistilled dihydroxyacetone dimer ( 1.00 g, 11.1 mmol) was dissolved in 
anhydrous DMF (5 mL, 20°C) and treated with a solution of TBDMS-chloride (3.37 g, 
22.4 mmol) in CH2Ch (25 mL). Triethylamine (2.43 g, 24.0 mmol) was then 
introduced, dropwise followed by DMAP (50 mg). After stirring for 17 hours at room 
temperature the resulting yellow suspension was washed sequentially with water 
(2 x 10 mL), saturated aqueous ammonium chloride solution (2 x 10 mL) and water 
(10 mL). The organic phase was dried and the solvent removed, leaving a yellow oil 
which was distilled (Kugelrohr, oven temp. 100°C / 0.25 mm Hg). After a fore-fraction 
containing DMF and a small amount of monoprotected product (4.7), the diprotected 
dihydroxyacetone (3.55) was collected as a pale yellow, viscous oil (2.90 g, 82%). 
lH NMR (300 MHz, CDC13) o 0.08 (s, 12H, SiCH3) 0.91 (s, 18H, 1Bu), 4.40 (s, 4H, 
Hl,3). 
13C NMR (50 MHz, CDCl3) 6 -5.7 (SiCH3), 18.1 (q, t-Bu), 25.6 (1Bu), 66.6 (Cl,3), 
211.1 (C=O). 
EIMS mlz 261 (M+-C4H9, 81 %), 231 (48), 145 (13), 133 (15), 129 (18), 115 (22), 89 
(100), 75 (38), 73 (93). 
CIMS mlz 336 (M+NI4+, 100%), 319 (M+H+, 92). 
Analysis: Found C 56.2, H 10.8; C15H3403Si2 requires C 56.5, H 10.8 . 
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3-(t-Butyldimethylsilyloxy )-1-hydroxypropanone ( 4. 7) 
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Redistilled dihydroxyacetone dimer (28.0 g, 0.311 mol) was dissolved in 
anhydrous DMF (50 mL) and CH2Cli (50 mL) before the addition of TBDMS-chloride 
(18.8 g, 0.125 mol) as a solid. Triethylamine (15.2 g, 0.150 mol) was then slowly 
introduced, causing some precipitation and wanning of the mixture. Finally, DMAP 
(200 mg) was added and the mixture was stirred for 18 hours at room temperature under 
an atmospheric of argon. After pouring into water (150 mL) the organic phase was 
separated and the aqueous phase extracted with CH2Cli (3 x 30 mL). Drying of the 
combined organic phases followed by removal of the solvent gave a pale yellow oil 
which was fractionally distilled under reduced pressure. A fore-fraction, mainly 
consisting of DMF was discarded before the mono-protected dihydroxyacetone (4.7) 
(17.4 g, 68% based on TBDMS-chloride) was collected; bp 72-76°C / 0.45 mm Hg. 
lH NMR (300 MHz, CDCl3) 6 0.08 (s, 6H, SiCH3), 0.91 (s, 9H, 1Bu), 4.30 (s, 2H, H3), 
4.49 (s, 2H, Hl). 
13C NMR (50 MHz, CDC!J) 6 -5.7 (SiCH3), 18.1 (q, t-Bu), 25.6 (1Bu), 66.5 (C3), 67.7 
(Cl), 211.1 (C=O). 
EIMS mlz 205 (M+H+, 0.4%), 159 (6), 147 (17), 129 (6), 117 (100), 89 (15), 75 (45), 73 
(27), 59 (12). 
CIMS mlz 205 (M+H+, 19). 
Analysis: Found C 52.9, H 9.7; yH2o03Si requires C 52.9, H 9.9. 
The residue after distillation was found by 1 H NMR to contain the diprotected 
dihydroxyacetone (3.55) (ca 1.2 g, 3% based on TBDMS-chloride) (spectral data 
above). 
The product (4. 7) readily dimerises on storage to form some 
2,5-dihydroxy-2,5-bis(t-butyldimethylsilyloxymethyl)-1,4-dioxane (4.11), a process 
which may be reversed by: i) distillation; ii) brief heating (ca 150°C, 5 min, 
under argon); or iii) chromatography on silica gel. The presence of the dimer is easily 
detected by NMR spectroscopy ( 4.11). 
1H NMR (300 MHz, CDCIJ) 6 0.05, 0.09, 0.13 (s, SiCH3), 0.88, 0.89, 0.90, 0.92, 0.93 
(s, t-Bu), 3.40-4.25 (m, CH2). 
13C NMR (50 MHz, CDCl3) 6 -5.8, 18.0, 25.6, 25.7, 63.0, 63.4, 64.2, 64.4, 72.8, 74.0, 
103.1, 103.57, 111.3, 111.3. 
Experimental 258 
3-(t-Butyldimethylsilyloxy )-2-oxopropyl 3-oxononanoate ( 4.6) 
4.6 
Mono-protected dihydroxyacetone (4.7, 2.76 g, 13.5 mmol) in a flame-dried 
flask under argon, was converted into its monomeric form by brief heating (5 min) to ca 
150°C using an oil bath. After cooling to room temperature it was dissolved in 
anhydrous CH2Cli (30 mL) before 3-oxononanoic acid (3.33c, 2.28 g, 13.2 mmol), 
DMAP (120 mg) and DMAP-hydrochloride (50 mg) were added as solids. The 
resulting solution was cooled to -10°C and stirred for 10 min before DCC (2.86 g, 
13.8 mmol) was introduced, also in solid form. After stirring the lemon-yellow 
suspension at -10°C for 30 min and then at 10°C for 1 hour, reverse phase TLC analysis 
(RPS, 10% H20 in MeOH) detected no 13-ketoacid and the mixture was then cooled to 
-20°C to encourage further crystallisation of the N,N-dicyclohexylurea. This was 
removed by filtration and the filter pad was washed well with cold ether (-15°C, 
2 x 10 mL). The filtrate was diluted with additional ether (20 mL) and washed 
sequentially with dilute aqueous hydrochloric acid (2 x 15 mL), water (2 x 10 mL), and 
pH 7.0 phosphate buffer (20 mL). The organic layer was dried, filtered and the~ 
evaporated to an oily suspension on the rotary evaporator. Dissolution in a small 
volume of ether (10 mL), cooling to -20°C for 30 min and refiltration removed more 
urea and left the crude diketoester (4.6) as a clear, light-tan oil (5.72 g) when the 
solvent was removed. The product content of this oil was estimated as ca 3.8 g (ca 
80% yield) by 1 H NMR integration, using an internal integration standard 
(diphenylmethanol). A small sample of the ester (4.6) was purified for spectroscopic 
analysis, with considerable loss, by bulb to bulb distillation in one-piece apparatus 
under very high vacuum (oven temp. 110°C / 0.004 mm Hg). 
11:J NMR (300 MHz, CDC!J) 6 0.10 (s, 6H, SiCH3), 0.80-0.95 (m, 12H, 1Bu + H9), 
1.20-1.40 (m, 6H, H6,7,8), 1.50-1.65 (m, 2H, H5), 2.59 (t, J = 7.4 Hz, 2H, H4), 
3.54 (s, 2H, H2), 4.26 (s, 2H, H3'), 5.01 (s, 2H, Hl '). 
13C NMR (50 MHz, CDCl3) 6 -5.8 (SiCH3), 13.9 (C9), 18.1 (q, 1Bu ), 22.4 (C8), 23.3 
(CS), 25.6 ('Bu), 28.6 (C6), 31.4 (C7), 42.9 (C4 ), 48. 7 (C2), 67 .4 (C3')*, 68.1 
(Cl')*, 166.5 (Cl), 202.4 (C2'}*, 203.3 (C3)*. 
EIMS mlz 301 (M+-57, 0.2%), (187 (0.4), 171 (3), 155 (3), 129 (100), 113 (20), 85 (12), 
75 (26), 73 (48), 69 (11), 59 (30), 58 (26), 57 (44). 
FIRMS: Found (M+-C4H9) 301.1470; C1~2505 requires 301.1472. 
Experimental 259 
Cyclisation of 3-(t-Butyldimethylsilyloxy )-2-oxopropyl 3-oxononanoate ( 4.6) 
OTBDMS 
. O OTBDMS 
;--11J 
0 0 
4.6 4.8 
METHOD A: USING SIUCA GEL 
Crude diketoester (4.6) (250 mg [ca 80% pure], ca 0.56 mmol) as prepared 
above was subjected to radial chromatography using a rotor coated with a 2 mm layer 
of Merck 60 PF254 silica gel. Before chromatography, the rotor was activated by drying 
for 24 hours at 70°C. Progress of the chromatography was monitored with a short 
wavelength UV lamp. Hexane (20%) in CH2Cl2 was used as eluent until the compound 
band had traversed approximately one quarter of the plate at which time the eluent was 
changed to CH2Cl2 containing a small amount of MeOH (0.1 % ). The major 
UV-absorbing band eluted was the 2-heptanoyl-3-(t-butyldimethylsilyloxymethyl)but-
2-enolide (4.8) which appeared as a pale yellow oil (152 mg, 64%) based on 
3-oxononanoic acid (3.33c ). 
1H NMR (300 MHz, CDCl3) o 0.10 (s, 6H, SiCH3), 0.80-1.00 (m, 12H, 1Bu + H9), 
1.20-1.40 (m, 6H, H6,7,8), 1.55-1.67 (m, 2H, H5), 2.97 (t, J = 1 .3 Hz, 2H, H7), 
4.95 (s, 2H, H5)*, 5.03 (s, 2H, H4)*. 
13C NMR (75.5 MHz, CDCh) o -5.7 (SiCH3), 14.0 (Cl2), 18.1 (q, 1Bu, 22.4 (Cl 1)*, 
23.1 (C8)*, 25.6 (1Bu), 28.7 (C9), 31.6 (ClO), 41.6 (C7), 61.8 (C5), 70.2 (C4), 
122.4 (C2), 170.6 (C3), 181.1 (Cl), 197.1 (C6). 
IR 'Umax (CC4) 2930 s, 2860 m, 1775 s (lactone C=O), 1688 m (ketone C=O), 1630 m 
(C=C), 1465 w, 1260 m, 1110 m, 1045 m, 1005 m cm-1. 
UV Amax (MeOH) 236 nm(£ 81C)()), 314 nm(£ 2200); (0.004 M NaOH in MeOH) 218 
nm(£ 8600), 314 nm (11600). 
EIMS mlz 340 (M+, 3%), 283 (M+-CJH9, 50), 255 (9), 253 (14), 228 (7), 213 (6), 199 
(19), 183 (7), 171 (12), 169 (12), 153 (8), 129 (7), 113 (19), 85 (14), 75 (100), 73 
(68), 43 (75). 
HR.MS: Found (M+) 340.2070; C11H15°'7 requires 340.2070. 
Experimental 260 
METHOD B: USING SODIUM HYDRIDE 
Crude diketoester (4.6) (500 mg [ca 80% pure], ca 1.1 mmol) as prepared above 
was dissolved in anhydrous THF (100 mL) and cooled to 0°C. Sodium hydride (50% 
dispersion in oil, 67 mg, 1.4 mmol) was added and the suspension stirred for 40 min 
after which time reverse phase 1LC (RPS, 10% H20 in MeOH) showed no remaining 
ester (4.6, Rt 0.38). The reaction was quenched by the addition of pH 5.0 phosphate 
buffer (15 mL) and water (20 mL) before approximately half of the THF was removed 
by rotary evaporation ( < 20°C). The mixture was extracted with CH2Cl2 (3 x 15 mL) 
and the extracts were washed with water (20 mL), dried and evaporated to leave an oil 
which was subjected to . rapid radial chromatography ( 4 mm SiQi; 0.1-1 % MeOH in 
CH2C!i). The first eluted band contained the butenolide (4.8) (304 mg, 65% based on 
3-oxononanoic acid (3.33c) (see spectroscopic data above). A minor band was eluted 
next which contained the tricyclic dimer (4.14a) (28 mg, 3% based on 3-oxononanoic 
acid) as fine colourless prisms (mp 130-131 °C from pentane ). 
4.14a R = n-hexyl 
1H NMR (300 MHz, CDCIJ> a -0.02, o.09, 0.10, 0.12 (4 x s, 12H, 4 x siCH3), 0.15-1.00 
(m, 24H, 2 x CH3 + 2 x 'Bu), 1.15-1.70 (m, 20H), 1.88 (m, lH, H7b), 2.25 (m, lH, 
H7a), 2.70 (s, lH, H2), 2.97 (m, 2H, H7'), 3.64 (d, ls~sb = 10.3 Hz, lH, H5b), 3.81 
(d, lH, lsa.5b = 10.3 Hz, H5a), 3.81 (d, J4a,4b = 9.0 Hz, lH, H4b), 3.87 (d, lH, 
l4a,4b = 9.0 Hz, H4a), 5.36 (s, lH, H5'), 5.41 (s, lH, H4'). 
EIMS mlz 680 (M+, 4%), 625 (15), 624 (38), 623 (85), 605 (21), 339 (8), 113 (12), 89 
(25), 75 (52), 73 (100), 57 (17), 55 (15). 
CIMS mlz 698 (M+NI-4+, 20%), 681 (M+H+, 58), 663 (31), 623 (M-C4H9, 100), 605 
(34), 566 (40), 549 (60), 533 (43), 341 (51), 283 (23). 
HRMS: Found (M+) 680.4139; C3~0sSi requires 680.4140. 
Experimental 261 
3-Hydroxy-2-oxopropyl 3-oxononanoate (4.15) 
4.15 
Freshly distilled dihydroxyacetone (378 mg, 4.2 mmol), 3-oxononanoic acid 
(3.33c) (200 mg, 1.16 mmol), DMAP (10 mg) and DMAP hydrochloride (10 mg) were 
dissolved, with warming, in anhydrous THF (8 mL). The solution was cooled to 0°C 
before DCC (260 mg, 1.26 mmol) was added and the temperature allowed to rise to 
20°C. After 2.5 hours pH 3.5 phosphate buffer (10 mL) was added and the mixture was 
extracted with CH2Cli (4 x 10 mL). The combined organic extracts were washed with 
water (10 mL), dried and evaporated to leave a greenish yellow semi-solid residue 
which was taken up in warm ether (20 mL). The resulting suspension was cooled to 
room temperature and filtered to remove most of the N,N-dicyclohexylurea. Solvent 
was removed from the filtrate and the residue, containing largely the ester ( 4.15), was 
purified by radial chromatography (4 mm Si02; 5% MeOH in CH2 Ch). After 
collecting a small fore-fraction containing an unidentified mixture, the f3-ketoester 
(4.15) was isolated as off-white crystals (141 mg, 50%) (mp 68-70°C, colourless plates 
from ether-hexane). A sample for analysis was sublimed under very. high vacuum 
(70°C / 0.005 mm Hg); mp 67-70°C. 
lH NMR (200 MHz, CDCl3) 6 0.89 (t, J = 1 Hz, H9), 1.15-1.45 (m, 6H, H6,7,8), 
1.55-1.75 (m, 2H, H5), 2.58 (t, J = 7.3 Hz, H4), 3.58 (s, 2H, H2), 4.40 (s, 2H, H3'), 
4.84 (s, 2H, Hl '). 
13C NMR (50 MHz, CDCIJ) 6 14.0 (C9), 22.4 (C8), 23.4 (C5), 28.6 (C6), 31.5 (C7), 
43.1 (C4), 48.5 (C2), 66.3 (C3')*, 66.6 (Cl')*, 166.5 (Cl), 202.3 (C2')*, 203.8 
(C3)*. 
EIMS mlz 213 (M+-CH20H, 0.4%), 197 (5), 174 (3), 155 (6), 113 (48), 85 (18), 84 (30), 
69 (17), 58 (16), 57 (14), 55 (16), 43 (100). 
CIMS m!z 262 (M+NI4+, 100%), 245 (M+H+, 9). 
Analysis: Found C 59.2, H 8.5; C12H2005 requires C 59.0, H 8.3. 
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3-(t-Butyldimetbylsilyloxymethyl)-2-beptanoylbutanolide ( 4.27) 
OTBDMS OTBDMS 
0 0 
4.8 4.27 
The butenolide (4.8) (40.2 mg, 0.115 mmol) in MeOH (10 mL) was 
hydrogenated over 10% palladium-on-charcoal for 40 minutes, at which time 
1 equivalent of hydrogen had been absorbed and TLC analysis (CH2Cl2; 4.8 Rt= 0.82, 
4.27 Rt= 0. 70) indicated no starting material. The catalyst was removed by filtration 
through a 5 mm bed of silica-gel (Merck 60 PF254) and the filtrate was evaporated, 
leaving the crude saturated lactone product (4.27) as a colourless oil. Radial 
chromatography (1 mm Si02; 0-5% MeOH in CH2Cl2) furnished 34.5 mg (88%) of 
purified material. 
lH NMR (300 MHz, CDC!J) 6 0.04 (s, 6H, SiCH3),0.88 (m, 12H, 'Bu+H12), 1.20-1.40 
(m, 6H, H9,10,11), 1.50-1.70 (m, 2H, H8), 2.61 (dt, l1a.1b = 17.8 Hz, 11,s = 7.3 Hz, 
lH, H7b), 2.94 (dt, lH, H7a), 3.18 (m, lH, H3), 3.62 (d, l = 4.5 Hz, 2H, H5), 3.64 
(d, 12,3 = 6.8 Hz, lH, H2), 4.12 (dd, l4a.4b = 8.9 Hz, l4b,3 = 6.5 Hz, lH, H4b), 4.39 
(dd, l4a.4b = 8.9 Hz, l4a.3 = 8.0 Hz, lH, H4a). 
13C NMR (75 MHz, CDCl3) o -5.6 (SiCH3), 14.0 (Cl2), 18.1 (q, 1Bu), 22.4 (Cl 1), 23.2 
(C8), 25.7 ('Bu), 28.6 (C9), 31.5 (ClO), 39.3 (C3), 42.5 (C7), 54.7 (C2), 61.9 (C5)~ 
69.1 (C4), 172.4 (Cl), 202.7 (C6). 
EIMS mlz 327 (M+-CH3, 2%), 285 (M+-~H9, 50), 167 (5), 201 (13), 187 (9), 173 (7), 
127 (6), 113 (C6lf13CO+, 61), 85 (30), 75 (62), 73 (38), 69 (10), 59 (11), 57 (22), 
55 (24), 43 (100). 
HRMS: Found (M+-C4H9) 285.1523; C14H2504Si requires 285.1522. 
Experimental 
3-Hydroxymethyl-2-heptanoylbutanolide (3.36) 
[i.e. 11-demethyl A-factor] 
OH 
0 0 
3.36 
METHOD A: DESILYLATION WITH GLACIAL ACETIC ACID: THF: WATER (3 : 3 : 1) 
263 
The silyl butanolide (4.27) (50 mg, 0.146 mmol) was dissolved in a mixture of 
glacial acetic acid : THF : water (2.5 mL, 3 : 3 : 1) and stirred for 48 hours at room 
temperature. The bulk of the solvent mixture was removed on the rotary evaporator and 
the remaining traces were evaporated using an oil pump. The oily residue was 
separated into two compounds using radial chromatography (1 mm Si02; 5% MeOH in 
CH2Ch). The first eluted compound was unreacted silyl butanolide (4.27) (10 mg, 
20%) followed by 11-demethyl A-factor (3.36) (19 mg, 57%) as a colourless oil, which 
was immediately analysed by NMR spectroscopy. 
lH NMR (300 MHz, acid-free CDCIJ) o 0.88 (t, J = 1 Hz, CH3), 1.15-1.45 (m, 6H, 
H9,10,ll), 1.50-1.70 (m, 2H, H8), 2.64 (dt, l1a,1b= 17.9Hz, l1b,s=7.2Hz, lH, 
H7b), 2.99 (dt, l1a,1b = 17.9 Hz, l1a,s = 7.2 Hz, lH, H7a), 3.25 (m, lH, H3), 3.67 
(d, 12,3 = 6.9 Hz, lH, H2), 3.67 (dd, lsb;3 = 5.4 Hz, lsb,5a = 10.5 Hz, lH, H5b), 3.74 
(dd, lsa,3 = 5.6 Hz, lsa,5b = 10.5 Hz, lH, H5a), 4.14 (dd, J 4b,3 = 6.6 Hz, 
l4a,4b = 9.0 Hz, lH, H4b), 4.44 (dd, 14a,3 = 8.2 Hz, 14a,4b = 9.0 Hz, lH, H4a), 11.20 
(s, enol OH) [ca 4% enol content]. Additional complex minor peaks are attributed 
to small amounts(< 20%) of the hemiacetal tautomers (5.22a and 5.22b) described 
below. 
13C NMR (75 MHz, acid-free CDC!J) o 14.0 (C12), 22.4 (Cl l), 23.5 (C8), 28.5 (C9), 
. 31.5 (ClO), 39.1 (C3), 42.5 (C7), 54.9 (C2), 61.8 (C5), 68.9 (C4), 174.7 (Cl), 
202.8 (C6). 
Fl'IR (CC4) Umax 3603 m, 3483 w, 2958 s, 2958 s, 1785 s (lactone C=O), 1720 m 
(ketone C=O), 1647 w, 1467 m, 1380 m, 1177 s, 1044 s cm-1. 
EIMS mlz 228 (M+, 0.5%), 210 (M+-H20, 0.8), 197 (M+-CH20H, 16), 171 (M+-C4H9, 
3), 158 (M+-70 McLafferty rearr., 5), 143 (M+-C6H13, 24), 127 (11), 116 (13), 113 
(68), 102 (15), 85 (100), 69 (15), 57 (39), 55 (55). 
HRMS: Found (M+) 228.1361; C12H2004 requires 228.1362. 
The above 1H NMR, IR and EIMS data are consistent with that previously 
reported for this compound. 35 
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METHOD B: DESILYLATION WITH HF aq I PYRIDINE I CH3CN 
The silyl butanolide (4.27) (192 mg, 0.56 mmol) in CH3CN (20 mL) at 0°C was 
treated sequentially with pyridine (0.27 mL) and concentrated aqueous hydrogen 
fluoride solution (50%, 1.35 mL). The mixture was stirred for 30 minutes at 0°C then 
for a further 4 hours at room temperature after which time TLC (1 % MeOH in CH2Cli, 
4.27 Rt 0.80; 3.36 Rt0.10) indicated no remaining starting material. The product 
mixture was poured into saturated NaHC0:J(aq) solution and extracted with CH2Cl2 
(3 x 10 mL). The extracts were washed sequentially with water (10 mL) and pH 7.0 
phosphate buffer (10 mL), then were dried and evaporated under high-vacuum to yield 
a yellow oil. Purification by radial chromatography (2 mm Si02; 10-40% EtOAc in 
hexane) gave 11-demethyl A-factor (3.36), (115 mg, 90%) as a colourless oil which 
partially solidified on cooling. lH and 13C NMR analyses performed immediately 
following chromatography gave identical data to that described for (3.36) above 
(Method A). However, after careful recrystallisation from cold (-15°C) CC4 / hexane, 
the bicyclic hemiacetal tautomer (5.22a) was isolated as colourless platelets 
(mp 60-65°C). The endo stereochemistry of the tertiary hydroxyl group was assigned 
by NMR comparison with the equivalent 11-methyl analogue (5.12a) whose structure 
was established by X-ray diffraction. 
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0 HOH 
~ndo-OH 
5.22a hemiketal 
Data for 5.22a: 
6-exo-OH 
5.22b hemiketal 
1H NMR (300 MHz, acid-free CDCl3) 6 0.89 (t, J = 1.0 Hz, 3H, CH3), 1.25-1.42 (m, 
6H, H9,10,l 1), 1.45-1.57 (m, 2H, H8), 1.89 ('dd', J = 6.1 Hz, J = 10.0 Hz, 2H, H7), 
2.79 (d, 12,oH = 1.1 Hz, lH, OH), 3.14 (dd, 12,3 = 10.5 Hz, 12,oH = 1.1 Hz, lH, H2), 
3.43 (m, lH, H3), 4.02 (dd, lsb,5a = 9.0 Hz, lsb,3 = 5.1 Hz, lH, H5a), 4.21 (dd, 
lsa,3 = 8.2 Hz, lsb,5a = 9.0 Hz, lH, H5a), 4.27 (dd, J4b,4a = 9.0 Hz, 14b,3 = 6.0 Hz, 
H, H4b), 4.50 (t, l4a,3 = 9.0 Hz, J4b,4a = 9.0 Hz, lH, H4a). 
13C NMR (75 MHz, acid-free CDC13) o 14.0 (Cl2), 22.5 (Cl l), 23.4 (C8), 29.2 (C9), 
31.6 (ClO), 39.1 (C3), 40.9 (C7), 53.7 (C2), 71.9 (C5)*, 72.3 (C4)*, 106.7 (C6), 
174.5 (Cl). 
Fl'IR (KBr disc) 'Umax 3397 s (OH), 2930 s, 1760 s, 1719 sh, 1466 m, 1394 m, 1190 s, 
1029 s, 948 m, 908 m, 611 m cm-1. 
EIMS mlz 228 (M+, 0.5%), 210 (M+-H20, 0.8), 197 (M+-CH20H, 16), 171 (M+-C4H9, 
3), 158 (M+-70 McLafferty rearr., 5), 143 (M+-4H13, 24), 127 (11), 116 (13), 113 
(68), 102 (15), 85 (100), 69 (15), 57 (39), 55 (55). 
HRMS: Found (M+) 228.1361; C12H2004 requires 228.1362. 
The 1 H and 13C NMR sample solutions were allowed to stand for 5 hours before 
being re-run. The new spectra indicated the presence of ca 65% of the bicyclic 
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hemiacetal product described above (5.22a), ca 10% of 2,3-trans 11-demethyl A-factor 
(3.36, see data above) and ca 25% of the alternate, exo-hydroxy diastereomer of the 
bicyclic hemiacetal (5.22b ). 
Data for 5.22b: 
1 H NMR (300 MHz, acid-free CDC13) 6 0.88 (t, J = 1 Hz, 3H, CH3), 1.25-1.42 (m, 6H, 
H9,10,ll), 1.45-1.60 (m, 2H, HS), 1.78 (ddd, l1a,1b= 13.9Hz, J= 11.5Hz, 
J = 4.8 Hz, lH, H7b), 2.06 (ddd, l1a,1b = 13.9 Hz, J = 11.6 Hz, J = 4.6 Hz, lH, 
H7a), 2.31 (s, lH, OH), 3.20 (d, J~3 = 9.3 Hz, lH, H2), 3.40 (m, lH, H3), 3.88 (dd, 
Jsa,5b = 9.3 Hz, Jsb,3 = 1.7 Hz, lH, H5b), 4.11 (dd, Isa.Sb= 9.3 Hz, lsa.3 = 4.8 Hz, 
lH, H5a), 4.27 (dd, J 4a,4b = 9.2 Hz, l4a,3 = 5.9 Hz, lH, H4b), 4.49 (dd, 
J4a,4b = 9.2 Hz, l4a,3 = 9.1 Hz, lH, H4a). 
nc NMR (75 MHz, acid-free CDCIJ) 6 14.0 (Cl2) 22.5 (Cl 1), 23.5 (C8), 29.3 (C9), 
31.6 (ClO), 36.7 (C3), 39.7 (C7), 53.6 (C2), 71.4 (C5)*, 72.5 (C4)*, 107.5 (C6), 
174.5 (Cl). 
After 1 week at room temperature the four tautomeric components reached an 
equilibrium ratio of 68 : 14 : 14 : 4, (3.36 : 5.22a : 5.22b : 3.36 enol) as determined by 
lH NMR integration. 
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Ethyl 8-methyl-3-oxononanoate (4.29) 
EtOYY 
0 0 
Br~ 
4.28 
266 
EtO 
0 0 4.29 
Ethyl acetoacetate (13.0 g, 0.10 mol) in anhydrous THF (10 mL) was converted 
to its dianion prior to alkylation by slow addition to a cold (-5°C) suspension of sodium 
hydride (50% oil dispersion, 5.3 g, 0.11 mol) in THF (250 mL), followed by the 
cautious addition of n-butyllithium solution (1.54 M in hexane, 66 mL, 0.10 mol) in a 
manner similar to that of Huckin and Weiler.118 Alkylation with 
1-bromo-4-methylpentane (18.2 g, 0.11 mol) followed by an aqueous work-up 
produced an oil which was fractionally distilled at reduced pressure. The first fraction 
contained unreacted 1-bromo-4-methylpentane (4.28) (5.1 g, bp 55°C / 27 mm Hg). 
The pressure was further reduced to collect the title ester (4.29) (13.3 g, 62%) as a 
colourless oil (bp 86-88°C / 0.1 mm Hg). 
lH NMR (200 MHz, CDC!J) 6 0.86 (d, J = 6~5 Hz, 6H, 2 x CH3), 1.10-1.40 (m, 7H, 
ethyl CH3+H6,7), 1.45-1.67 (m, 3H, H5,8), 2.2 (t, J = 1.5 Hz, enol H4), 2.54 (t, 
J = 1.5 Hz, 2H, H4), 3.43 (s, 2H, H2), 4.20 (q, J = 1.2 Hz, ethyl CH2), 4.98 (s, enol 
H2), 12.1 (s, enol OH), [ca 11 % enol]. 
13C NMR (50.3 MHz, CDC!J) 6 14.0 (ethyl CH3), 14.2 (enol ethyl CH3),. 22.5 (2xCH3), 
23.6 (C5), 26.7 (C6), 27.7 (C8), 34.9 (enol), 38.5 (C7), 43.0 (C4), 49.2 (C2), 59.8 
(enol ethyl CH2) 61.2 (ethyl CH2), 88.8 (enol C2), 167.2 (Cl), 172. (enol Cl), 
178.9 (enol C3), 202.9 (C3). 
EIMS mlz 214 (M+, 3%), 196 (M+-H20, 2), 169 (3), 143 (17), 130 (100), 127 (29.6), 
115 (16), 109 (59), 102 (12), 97 (17), 88 (46), 84 (59), 82 (48), 57 (81), 55 (52), 43 
(91). 
Analysis: Found C 67.6, H 10.5; C12H2203 requires C 67.3, H 10.4. 
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t-Butyl 8-methyl-3-oxononanoate (4.32) 
'Buo'lrr( 
0 0 
Br~ 
4.28 
267 
'Bu 
0 0 4.32 
A solution of t-butyl acetoacetate (5.7 g, 36 mmol) was converted into its 
dianion by the method of Huckin and Weiler118 and then y-alkylated with 
1-bromo-4-methylpentane (5.4 g, 32. 7 mmol). Fractional distillation of the crude 
product gave the J3-ketoester (4.32), (65%, bp 72-76°C / 0.1 mm Hg) in a 75% yield 
based on 1-bromo-methylpentane ( 4.28). 
lH NMR (300 MHz, CDC!J) 6 0.83 (d, J = 6.6 Hz, 6H, 2 x CH3), 1.08-1.20 (m, 2H, 
H7), 1.20-1.33 (m, 2H, H6), 1.45 (s, 9H, t-Bu), 1.45-1.62 (m, 3H, H5,8), 2.50 (t, 
J = 7.4 Hz, 2H, H4), 3.32 (s, 2H, H2) [ca 7% enol]. 
13C NMR (75 MHz, CDCl3) o 22.1 (2 x CH3), 23.2 (C5), 26.3 (C6), 27.3 (C8), 27.4 
(t-Bu), 28.3 (C7), 42.4 (C4), 50.2 (C2), 81.3 (t-Bu quat.), 166.5 (Cl), 203.3 (C3). 
EIMS mlz 186 (M+-C4Hs, 4%), 169 (7), 168 (3), 144 (3), 127 (19), 109 (31), 102 (41), 
97 (5), 84 (16), 82 (16), 57 (100), 43 (39). 
Analysis: Found C 69.6, H 11.0; C14li2603 requires C 69.4, H 10.8. 
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8-Metbyl-3-oxononanoic acid (4.30) 
HO 
0 o 4.30 
METHOD A: FROM THE ETHYL ESTER USING ACETIC ACID I HYDROCHLORIC ACID 
Ethyl 8-methyl-3-oxononanoate ( 4.29) (10.0 g) was hydrolysed with a mixture 
of glacial acetic acid (150 mL) and concentrated hydrochloric acid (85 mL) as 
previously described for the preparation of 3-oxononanoic acid (3.33c).120 The reaction 
mixture was evaporated under high vacuum (rotary evaporator, < 1 mm Hg, 25°C). 
Traces of water were azeotropically removed by the addition and evaporation of 
benzene (100 mL). After further drying over molecular sieves in a vacuum desiccator 
(24 hours, 4°C), the crude crystalline acid was recrystallised from cold pentane (-15°C). 
Collection by filtration of the (3-ketoacid (4.30) as fine colourless needles (3.5 g, 40%, 
mp 44-46°C dee.) and subsequent vacuum drying was carried out at 0°C (cold room) to 
avoid melting of the damp crystals. The mother liquor could not be induced to 
crystallise further but lH NMR analysis indicated the presence of ca 1.7 g (20%) of the 
(3-ketoacid (4.30). 
1H NMR (200 MHz, CDCl3) o 0.87 (d, J = 6.6 Hz, 6H, 2 x CH3), 1.10-1.40 (m, 4H, 
H6,7), 1.42-1.70 (m, 3H, H5,8), 2.24 (t, J = 6.8 Hz, enol H4), 2.57 (t, J = 6.8 Hz, 
2H, H4), 3.53 (s, 2H, H2), 5.02 (s, enol H2), 11.87 (s, enol OH), [15% enol 
tautomer]. 
13C NMR (50.3 MHz, CDCh) o 22.5 (2 x CH3), 23.6 (C5), 26.4 (enol), 26.7 (C6), 26.8 
(enol), 35.3 (enol), 38.6 (C7), 43.2 (C4), 48.2 (C2), 88.2 (enol C2), 172.3 (Cl), 
176.9 (enol Cl)*, 142.1 (enol C3)*, 203.8 (C3). 
EIMS mlz 186 (M+, 1 %), 168 (M+-H20, 1), 153 (1), 142 (2), 115 (7), 109 (15), 102 
(40), 87 (16), 84 (47), 82 (55), 71 (39), 58 (100), 57 (45), 55 (43), 43 (90). 
Analysis: Found C 64.3, H 10.0; C1oH1s03 requires C 64.5, H 9.7. 
METHOD B: FROM THE t-BUTYL ESTER USING TRIFLUOROACETIC ACID 
t-Butyl 8-methyl-3-oxononanoate (4.32) was converted to the corresponding 
(3-ketoacid (4.30) with trifluoroacetic acid as described above for the preparation of 
3-oxononanoic acid (3.33c, Method B). Recrystallisation of the crude product from 
pentane (- l 5°C) gave the acid ( 4.30) as fine colourless needles (80%) in two crops, 
mp 43-45°C. NMR data was identical to that reported above (Method A). Stored at 
4 °C, this product has been stable towards decarboxylation for over one year. 
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3-(t-Butyldimetbylsilyloxy )-2-oxopropyl 8-metbyl-3-oxononanoate ( 4.33) 
~OMS 
lT 
0 0 
4.33 
The title P-ketoester (4.33) was prepared from 8-methyl-3-oxononanoic acid 
(4.30), 1.0 g, 5.37 mmol) and l-(t-butyldimethylsilyloxy)-3-hydroxypropane (4.7), 
(1.40 g, 6.85 mmol) by the method previously described for the synthesis of P-ketoester 
(4.6). The crude ester (4.33) was isolated as a light brown oil (2.4 g) and was found by 
1H NMR analysis (using diphenylmethanol as an internal standard) to be approximately 
66% pure (ca 1.6 g, ca 80% yield). The remainder consisted largely of the 
mono-protected dihydroxyacetone (4. 7) and its dimer (4.11) as well as some 
N,N-dicyclohexylurea. A small sample of 4.33 for spectral analysis was purified by 
Kugelrohr distillation in a one-piece apparatus (oven temp 110°C / 0.004 mm Hg). 
1H NMR (300 MHz, CDCl3) 8 0.08 (s, 6H, 2 x SiCH3), 0.84 (d, J = 6.6 Hz, 6H, 
2 x CH3), 0.91 (s, 9H, t-Bu), 1.08-1.20 (m, 2H, H7), 1.20-1.35 (m, 2H, H6), 
1.40-1.62 (m, 3H, H5+H8), 2.59 (t, J = 6.8 Hz, 2H, H4), 3.54 (s, 2H, H2), 4.26 (s, 
2H, H3'), 5.01 (s, 2H, Hl '). 
13C NMR (50.3 MHz, CDCl3) 6 18.1 (quat. t-Bu ), 22.5 (2 x CH3), 23.6 (C5), 25.7 
(t-Bu), 26.7 (C6), 27.7 (CS), 38.6 (C7), 42.9 (C4), 48.8 (C2), 67.5 (C3')*, 68.1 
(Cl')*, 166.5 (Cl), 202.5 (C2'), 203.4 (C3). 
EIMS mlz 315 (M+-C~9, 1 %), 187 (1), 171 (4), 169 (4), 147 (3), 129 (100), 127 (8), 
117 (10), 109 (15), 75 (11), 73 (24), 57 (26), 56 (18), 55 (15), 43 (33). 
HRMS: Found (M+-C4H9) 315.1625; C1sH2105Si requires 315.1628. 
Experimental 
Cyclisation of 3-(t-Butyldimetbylsilyloxy )-2-oxopropyl 
8-metbyl-3-oxononanoate ( 4.33) 
O OTBDMS ~ 
O 4.33 
METHOD A: USING Si02 
270 
OTBDMS 
O 4.34 
The crude diketoester (4.33) (250 mg [ca 66% pure], ca 0.44 mmol) as prepared 
above, was subjected to radial chromatography as described previously for the 
cyclisation of the ~-ketoester (4.6). The 2-(6-methylheptanoyl)-3-
(t-butyldimethylsilyloxy)methylbut-2-enolide (4.34) appeared as a pale yellow oil 
[126 mg, ca 65% based on 8-methyl-3-oxononanoic acid (4.30)]. A sample for analysis 
was further purifed, with ca 40% loss, by radial chromatography (1 mm Si02, 15% 
EtOAc in hexane). 
1 H NMR (300 MHz, CDCIJ) 6 0.08 (s, 6H, SiCH3), 0.84 (d, J = 6.6 Hz, 6H, 2 x CH3}, 
0.89 (s, 9H, t-Bu), 1.10-1.23 (m, 2H, HlO), 1.23-1.40 (m, 2H, H9}, 1.45-1.65 (m, 
3H, H8,1 l), 2.96 (t, J = 7.3 Hz, 2H, H7), 4.98 (s, 2H, H5), 5.05 (s, 2H, H4). 
13C NMR (50.3 MHz, CDCl3} 6 -5.7 (SiCH3}, 18.1 (t-Bu quat.), 22.5 (2 x CH3}, 23.3 
(C8), 25.6 (t-Bu), 26.8 (C9), 27.8 (Cl 1), 38.7 (ClO), 41.6 (C7), 61.8 (C5), 70.2 
(C4), 122.4 (C2), 170.7 (C3), 181.2 (Cl), 197.1 (C6). 
IR t>max (CC4) 2960 s, 2940 s, 1775 s (lactone C=O), 1690 m (ketone C=O), 1625 m, 
1470 m, 1370 m, 1260 m, 1100 br, 1010 m cm-1. 
UV Amax (MeOH) 236 nm(£ 8000), 314 nm(£ 3300); (0.005 M NaOH in MeOH) 220 
nm (sh,£ ca 9000), 314 nm(£ 10000). 
EIMS mlz 354 (M+, 7%), 339 (M+-CH2, 2), 297 (M+-~H9, 16), 228 (6), 225 (3), 213 
(9), 199 (16), 183 (11), 171 (12), 169 (14), 153 (10), 109 (22), 105 (11), 83 (14), 
75 (100), 73 (73), 69 (11), 57 (36), 55 (19), 43 (43). 
Analysis: Found C 64.4, H 9.4; C19H3404Si requires C 64.4, H 9.7. 
I 
I 
Experimental 271 
METHODB: USINGNaH 
The crude diketoester (4.33) (500 mg [ca 66% pure], ca 0.88 mmol) as prepared 
above was cyclised with sodium hydride in THF as previously described for the 
cyclisation of the diketoester 4.6. 
Chromatography of the product mixture gave the butenolide (4.34) (234 mg, 
60% based on 8-methyl-3-oxononanoic acid 4.30) as the first eluted product. (See 
above for spectroscopic data). 
A second minor band contained the tricyclic dimer (4.37a) (20 mg, 5% based on 
4.30) which formed colourless prisms (mp 130-132°C) after recrystallisation from 
pentane. 
4.37a 
lH NMR (300 MHz, CDCl3) 6 -0.02, 0.08, 0.09, 0.12 (4 x s, 12H, 4 x SiCH3), 0.80-0.93 
(m, 30H, 2 x t-Bu+4 x CH3), 1.12-1.42 (m, lOH, H8,9,10,9',10'), 1.43-1.67 (m, 4H, 
Hl l,8',11 '), 1.86 (m, lH, H7b), 2.25 (m, lH, H7a), 2.67 (s, lH, H2), 2.96 (m, 2H, 
H7'), 3.62 (d, lsa.5b = 10.0 Hz, lH, H5b), 3.79 (d, Isa.Sb= 10.0 Hz, lH, H5a), 3.79 
(d, 14a,4b = 9.0 Hz, lH, H4b), 3.86 (d, 14a,4b = 9.0 Hz, lH, H4a), 5.34 (s, lH, H5')*, 
5.38 (s, 2H, H4')*. 
13C NMR (75 MHz, CDCl3) 6 -5.46, -5.46, -5.37, -4.69 (4 x SiCH3), 17.8, 18.6 
(2 x t-Bu quat.), 21.9 (C8), 22.5 (4 x CH3), 23.5 (C8'), 25.6, 25.9 (2 x t-Bu), 26.8 
(C9)*, 27.2 (C9')*, 27.8 (Cl 1, Cl l '), 34.4 (C7), 38.6 (ClO), 39.0 (ClO'), 42.1 (Ct), 
49.4 (C2), 52.1 (C3), 67.3 (C5)*, 67.4 (C5'), 68.4 (C4)*, 76.9 (C4'), 80.6 (C6), 
126.6 (C2'), 169.2 (C3'), 174.9 (Ct>*, 176.3 (Cl')*, 197.7 (C6'). 
lH and nc assignments made using lH-lH (COSY) and 1H_l3C correlated (HETCOR) 
2D spectra [see Appendices Ai) and Aii)]. 
UV Amax (MeOH) 236 nm (E 770), 317 nm (E 180); (0.005 M NaOH in MeOH) 245 nm 
(E 6000), 317 nm (7800). 
EIMS mlz 651 (M+-C4H9, 89%), 633 (19), 621 (3), 607 (8), 519 (2), 353 (s), 127 (3), 
109 (17), 89 (23), 75 (57), 73 (100), 57 (50), 55 (22), 43 (53). 
CIMS mlz 726 (M+~+, 9%), 709 (M+H+, 12). 
Analysis: Found C 64.3, H 10.0; C3sH6sOsSh requires C 64.4, H 9.7. 
Experimental 
3-(t-Butyldimethylsilyloxymethyl)-2-( 6-methylheptanoyl)butanolide ( 4.35) 
[i.e. TBDMS protected A-Factor] 
0 
OTBDMS 
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4.34 
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The butenolide (4.34) (50 mg, 0.141 mmol) in ethyl acetate (4 mL) was 
hydrogenated over 10% palladium-on-carbon (1.5 mg) for 3 hours at ambient 
temperature and pressure, after which time TLC (15% EtOAc in hexane; 4.34 Rt 0.55; 
4.35 Rt 0.43) showed no starting material. After removal of the catalyst by filtration 
through a 0.4 cm bed of silica (PTLC grade) the product was purified by radial 
chromatography (1 mm Si02; 10% EtOAc in hexane). The silyl-protected A-factor 
(4.35) was isolated as a colourless oil (45 mg, 90%). A sample for analysis was 
distilled, bulb-to-bulb (oven temp 130°C / 0.1 mm Hg). 
1H NMR (500 MHz, CDC!J) o 0.04 (d, J = 4.0 Hz, 6H, 2 x SiCH3), 0.85 (d, J = 6.8 Hz, 
6H, 2 x CH3), 0.87 (s, 9H, t-Bu), 1.14-1.20 (m, 2H, HlO), 1.25-1.33 (m, 2H, H9), 
1.47-1.55 (m, lH, Hl 1), 1.55-1.60 (m, 2H, H8), 2.61 (dt, l1a,7b = 17.6 Hz, 
lTo,8 = 7.2 Hz, lH, H7b), 2.94 (dt, l1a,1b = 17.6 Hz, l1a.s = 7.2 Hz, lH, H7a), 3.17 
(m, lH, H3), 3.62 ('d', J = 4.4 Hz, 2H, H5), 3.64 (d, 12,3 = 6.8 Hz, lH, H2), 4.12 
(dd, J 4a,4b = 8.8 Hz, J4b,3 = 5.8 Hz, lH, H46), 4.39 (dd, 14a,3 = 7.8 Hz, 
l4a,4b = 8.8 Hz, lH, H4a), 11.2 (s, enol OH), [ca 5% enol]. 
13C NMR (75 MHz, CDC!J) o -6.0 (2 x SiCH3), 17.8 (t-Bu quat.), 22.3 (2 x CH3), 23.2. 
(C8), 25.4 (t-Bu), 26.5 (C9), 27.5 (Cll), 38.4 (ClO), 39.1 (C3), 42.3 (C7), 54.5 
(C2), 61.8 (C5), 69.1 (C4), 172.8 (Cl), 203.2 (C6). A minor set of peaks were 
assigned as the enol tautomer 4.36 [content ca 5%] 13C NMR (75 MHz, CDC!J) o 
32.6 (C7), 39.3 (C3), 64.8 (C5), 70.0 (C4), 96.0 (C2), 173.2 (Cl)*, 176.8 (C6)* 
(remaining peaks obscured). lH and 13C peak assignments for the enol tautomer 
4.36 were confirmed using 2D lH-lH (COSY) and 1H_l3C (HETCOR) spectra. 
[See Appendices Bi) and ii)]. 
Fl'IR (CCl4) Umax 2957 s, 2931 s, 2859 m, 1779 s Oactone C=O), 1720 s (ketone C=O), 
1648 w, 1470 m, 1387 m, 1365 m, 1256 m, 1218 m, 1167 m, 1109 m, 1034 m, 
1004 m, 939 w cm-1. 
UV Amax (MeOH) 256 nm (E 1100); 0.005 M NaOH in MeOH) 283 nm (E 20000). 
EIMS mlz 341 (M+-CH3, 1 %), 301 (1), 300 (3.8), 299 (M+-CiH9, 19), 281 (3), 225 (2), 
201 (12), 173 (4), 161 (4), 157 (5), 149 (8), 127 (30), 109 (68), 105 (11), 89 (10), 
83 (12), 75 (60), 73 (41), 57 (53), 55 (32), 43 (100). 
Analysis: Found C 64.1, H 10.5; C19H3604Si requires C 64.0, H 10.2. 
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The TBDMS protected butanolide (4.35) (100 mg, 0.28 mmol) was desilylated 
as described above the 2-heptanoyl butanolide (3. 3 6, Method J\). J\fter 
chromatography, 15 mg (15%) of unreacted silyl butanolide (4.35) was recovered, 
followed by J\-factor (1.1) (41 mg, 61 %) as a colourless oil, a sample of which wa.s 
immediately analysed by NMR spectroscopy. 
Data for 1.la / 1.lb: 
1H NMR (500 MHz, acid-free CDC!J) 6 0.86 (d, J = 6.6 Hz, 6H, 2 x CH3), 1.13-1.24 
(m, 2H, HlO), 1.24-1.35 (m, 2H, H9), 1.46-1.55 (m, lH, Hl 1), 1.55-1.64 (m, 2H, 
H8), 2.64 (dt, l1a.,7b = 17.6 Hz, l1b,8 = 7.3 Hz, lH, H7b), 2.98 (dt. l1a.,1b = 17.6 Hz, 
l1a,8 = 7 .5 Hz, lH, H7a), 3.25 (m, lH, H3), 3.67 (d, 12,3 = 6.9 Hz, lH, H2}, 3.68 
' (dd, l5b,3 = 5.4 Hz, l5a.,5b 10.7 Hz, lH, H5b), 3.73 (dd, l5a.,3 = 5.4 Hz, 
l5a.,5b 10.7 Hz, lH, H5a), 4.14 (dd, l4a.,4b = 9.0Hz, J4b,3 = 6.7 Hz, lH, H4b}, 4.43 
(dd, l4a.,4b = 9.0 Hz, J 4a,3 = 8.2 Hz, lH, H4a), 11.27 (s, enol OH),[3% enol 
tautomer 1.lb]. J\dditional complex minor peaks are attributed to ca 10% each of 
the hemiacetal tautomers (5.12a and 5.12b), the spectroscopic data for which 
appear below. 
13C NMR (75 MHz, acid-free CDCl3} 6 22.3 (2 x CH3}, 23.3 (C8), 26.5 (C9), 27.6 
(Cl 1), 38.5 (ClO), 39.0 (C3), 42.4 (C7), 54.8 (C2), 61.7 (CS), 70.0 (C4), 172.8 
(Cl), 203.5 (C6). J\ minor set of peaks were assigned as the enol tautomer 1.lb 
[content ca 5%] 13C NMR (75 MHz, CDCh) 6 32.9 (C7), 64.4 (CS), 70.0 (C4), 
95.5 (C2), 173.7 (Cl)*, 176.6 (C6)* (remaining peaks obscured). 
Fl'IR (CCl4} Umax· 3639 m (primary OH), 3606 m (tertiary OH), 3500 w br, 2956 s, 
2870 m, 1782 s (lactone C=O), 1720 s (ketone C=O), 1647 w (chelated C=O), 
1468 m, 1385 m (gem-dimethyl), 1367 m (gem-dimethyl), 1217 m, 1177 s, 1031 s, 
962 w, 910 w, cm-1. 
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UV A.max (MeOH) 257 nm (E 1200); (0.005 M NaOH in MeOH) 283 nm (E 20100). 
EIMS mlz 242 (M+, 0.3), 227 (M+-CH3, 0.3), 224 (M+-H20, 0.5) 211 (M+-CH20H, 4), 
193 (0.5), 185 (0.4), 171 (M+-CsH11, 2), 159 (2), 158 (3), 153 (8), 143 (M+-C1H1s, 
24), 127 (23), 116 (6), 109 (61), 102 (12), 99 (10), 98 (7), 97 (6), 85 (49), 83 (22), 
82 (25), 71 (112), 69 (23), 67 (19), 57 (97), 55 (77), 43 (100), 41 (54). 
CIMS mlz 260 (M+Nat+, 100%), 243 (M+H+, 10), 242 (M+, 8), 225 (14), 109 (7). 
HRMS: Found (M+) 242.1517; C1JH2i()4 requires 242.1518; Also measured 211.133 
(C12H1903), 143.0343 (C6H104), 127.1126 (CsH1sO), 127.0392 (C6H103), 
109.1007 (CsH13). 
1 H NMR, 13C NMR, IR, EIMS, HRMS data are essentially consistent (see 
discussion Chapter 5) with those reported for this compound by Mori and Y amane.18 
The 1H NMR spectrum is identical to that of an authentic sample of A-factor supplied, 
at extortionate cost, by Funakoshi Co. Ltd.(Tokyo, Japan). The UV spectrum is 
consistent with that reported by Kleiner et a1.s1 
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METHOD B: DESILYLATION WITH HFAQ I PYRIDINE I CH3CN 
Using the method described above for the synthesis of 11-demethyl A-factor 
(3.36) (Method B), the TBDMS protected butanolide (4.35) (50 mg, 0.14 mmol) was 
desilylated to give A-factor (32 mg, 95%) as a colourless oil. lH and 13C NMR 
analyses performed immediately following chromatography gave identical data to that 
described for A-factor (1.1) above (Method A). Upon standing at 4°C for several 
weeks, the product became a waxy solid which showed, by 1 H NMR, to contain 
increased levels of the bicyclic hemiacetal tautomer (5.12a). A sample of the product 
was dissolved in CC4 (ca 20 µL/mg) then was cooled slowly to -5°C for 24 hours to 
form the pure, crystalline bicyclic hemiacetal tautomer (5.12a) as colourless plates 
(mp 69-72°C). NMR spectra of this tautomer alone, were obtained using acid-free 
CDCI3 at -20°C which retarded tautomerisation. 
lH NMR (300 MHz, acid-free CDCh -20°C) o 0.86 (d, J = 6.5 Hz, 6H, 2 x CH3), 
' 1.10-1.25 (m, 2H, HlO), 1.25-1.38 (m, 2H, H9), 1.38-1.58 (m, 3H, Hl 1,8), 
1.86-1.96 (m, 2H, H7), 2.68 (d, 12,oH = 1 Hz, lH, OH), 3.13 (dd, 12,3 = 10.8 Hz, 
12,oH = 1 Hz, lH, H2), 3.41 (m, lH, H3), 4.01 (dd, lsa,5b = 9.0 Hz, Jsb,3 = 5.2 Hz, 
lH, H5b), 4.20 (dd, lsa,5b = 9.0 Hz, lsa,3 = 8.2 Hz, lH, H5a), 4.26 (dd, 
J4a,4b = 9.0 Hz, J4b,3 = 6.2 Hz, lH, H4b), 4.49 (dd, 14a,4b = 9.0 Hz, 14a,3 = 9.0·Hz, 
lH, H4a). 
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13C NMR (75 MHz, acid-free CDC!J) 6 22.3 (2 x CH3), 23.5 (C8), 27.1 (C9), 27.6 
(Cl l), 38.6 (ClO)*, 38.8 (C7)*, 40.8 (C3), 53.7 (C2), 72.0 (C5)*, 72.6 (C4)*, 106.9 
(C6), 175.0 (Cl) (peak multiplicities determined by APT spectrum). 
Fl'IR (KBr disc) Umax. 3395 s (OH), 2955 s, 1743 s (lactone C=O), 1468 m, 1397 s, 
1366 m, 1228 s, 1211 s, 1155 s, 1116 m, 1031 s, 985 s, 741 m, 705 m cm-1. 
EIMS (identical to that reported for 1.1 above). 
HRMS: Found (M+) 242.1517; CnH2204 requires 242.1518. 
The X-ray crystal structure was determined on crystals obtained from CH2Cl2 / 
pentane (40:60, ca 50 µL/mg), mp 69-72°C, [see Fig 5.3, and Appendix Ei]. The 
structure (5.12a) confirmed the C6-tertiary hydroxyl group was in the endo position. 
Crystallographic data including a table of selected interatomic distances and angles 
appear in Appendix Eii. 
Another sample of the product was crystallised from pentane-CH2Cl2 (1 : 1) by 
slow evaporation at -5°C to give an amorphous colourless powder (mp 40-60°C) which 
was shown by lH NMR to contain a 55: 45 mixture of the endo-hydroxy hemiacetal 
(5.12a) (described above) and its diastereomer, the exo hydroxy hemiacetal (5.12b). 
Data for 5.12b: 
lH NMR (300 MHz, acid-free CDC}J) o 0.86 (t, J = 6.5 Hz, 6H, 2 x CH3), 1.10-1.25 
(m, 2H, HlO), 1.25-1.40 (m, 2H, H9), 1.40-1.60 (m, 3H, H8,ll), 1.77 (m, lH, 
H7b), 2.05 (m, lH, H7a), 2.16 (s, lH, OH), 3.19 (d, 12,3 = 9.0 Hz, lH, H2), 3.41 
(m, lH, H3), 3.87 (dd, Jsa,5b = 9.2 Hz, Jsb,3 = 1.7 Hz, lH, H5b), 4.10 (dd, 
lsa,5b = 9.2 Hz, lsa,3 = 4.8 Hz, lH, H5a), 4.16 (dd, 14a,4b = 9.2 Hz, J4b,3 = 6.2 Hz, 
lH, H4b), 4.48 (dd, l4a,4b = 9.2 Hz, J4a,3 = 9.0 Hz, lH, H4a). 
13C NMR (75 MHz, acid-free CDCl3) 6 22.3 (2 x CH3), 23.6 (C8), 27.2 (C9), 27.6 
(Cll), 36.5 (C7), 38.6 (ClO), 39.5 (C3), 53.6 (C2), 71.4 (C5)*, 72.4 (C4)*, 107.6 
(C6), 175.1 (Cl). 
After 1 week at room temperature the NMR sample had reached an equilibrium 
between the four tautomeric forms· of A-factor, which was 62.: 17 : 17 : 4 [2,3-trans 
keto (I.la) : endo-hydroxy hemiacetal (5.12a) : exo-hydroxy hemiacetal (5.12b) : enol 
form (I.lb)]. 
Experimental 
11-Demethyl A-Factor (3.36) from Meldrum's acid (4.51) 
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The required ~-ketoester ( 4.6) was prepared following the general method of 
Oikawa et al.162 Thus, a stirred solution of Meldrum's acid (4.51) (0.648 g, 4.5 mmol) 
in CH2Ch (5 mL) was cooled to 0°C and treated sequentially with pyridine (0.712 g) 
and a solution of heptanoyl chloride (0.72 g, 4.8 mmol) in CH2Cl2 (5 mL). The 
resulting mixture became orange and was stirred for 1 hour at 0°C then at room 
temperature for a further 1 hour. Dilute aqueous hydrochloric acid (1 M, 10 mL) was 
added and the phases were separated. The aqueous phase was extracted with CH2Cl2 
(5 mL) and the combined organic phase was washed well with water (4 x 5 mL). 
Drying and removal of the solvent left the crude heptanoyl derivative (4.52) as an 
orange oil (1.13 g). 
1H NMR (300 MHz, CDC!J) 6 0.86 (t, J = 6.6 Hz, 3H, H9), 1.20-1.47 (m, 6H, H6,7,8), 
1.55-1.78 (m, 2H, H5), 1.70 (s, 6H, C(CH3)2), 3.04 (t, J = 7.6 Hz, 2H, H4), 15.2 (s, 
lH, enolic OH), [100% enol]. 
The crude acyl Meldrum's acid (1.13 g) in benzene (7 mL) was combined with 
TBDMS protected dihydroxyacetone (4. 7) (2.4 g, 11.8 mmol) which had been 
converted to its monomer by brief heating to ca 150°C (5 min). The mixture was 
heated at reflux for 2 hours and then the solvent was removed by rotary evaporation. 
Unreacted silyl dihydroxyacetone ( 4. 7) and heptanoic acid were removed by Kugelrohr 
distillation (oven temp 100°C / 0.1 mm Hg) to leave the crude ~-ketoester (4.6) (1.30 g) 
as a yellow-orange oil. 1 H NMR analysis using an internal integration standard 
(diphenylmethanol) indicates a purity of ca 85% and thus a yield of ca 69% from 
Meldrum's acid. lH and 13C NMR data are identical to that reported above for the 
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P-ketoester (4.6). The product is stable on storage at 4°C and is suitable for cyclisation 
without further purification. 
The crude P-ketoester (4.6) (200 mg, ca 0.47 mmol) prepared above in 
anhydrous THF ( 40 mL at 0°C was treated with sodium hydride ( 60% oil dispersion, 
19 mg, ca 0.48 mmol). After 15 minutes reverse phase TLC testing (RPS, 10% H20 in 
MeOH) indicates no starting material and the reaction is quenched by the addition of 
pH 5.0 phosphate buffer (20 mL) and water (10 mL). Approximately half of the THF 
was removed by rotary evaporation (20°C) before the mixture was extracted with 
CH2Ch (3 x 10 mL). The combined extracts were washed with saturated brine (5 mL) 
and water (10 mL), dried and evaporated to leave the butenolide (4.8) as an orange oil 
(spectroscopic data as reported above). The residue was dissolved in EtOAc (15 mL) 
and hydrogenated over 10% palladium-on-carbon (5 mg) for 12 hours after which time 
no butenolide ( 4.8) was detected by TLC. Filtration of the catalyst and solvent removal 
left a yellow oily residue which was purified by radial chromatography (2 mm Si02; 
10-20% EtOAc in hexane). The TBDMS protected 11-demethyl A-factor (4.27) was 
isolated as a colourless oil (115 mg) which corresponds to an overall yield of 48% from 
Meldrum's acid. The product was spectroscopically identical to that described above. 
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Dimerisation of A-factor (1.1) 
0 5.8a 0 5.8b 
A slow stream of HCl gas was briefly (ca 3 sec) bubbled through a solution of 
A-factor (1.1) (25 mg) in acid-free CDCIJ (0.3 mL). After 1 hour, TLC analysis 
(1 % MeOH in CH2Ch) showed the appearance of 4 new less polar compounds [Rt 
values 0.53, 0.50, 0.44, 0.38; A-factor (1.1) Rt 0.15]. Removal of the solvent followed 
by careful radial chromatography (1 mm SiQi) using a mildly basic eluent system 
(0-1 % MeOH and 0.1 % pyridine in CH2Cl2), separated the new compounds into 
3 fractions, followed by a band containing an unchanged A-factor (1.1) (7 mg). 
The first eluted band contained 2 diastereomers of 5.8b (7 mg) in which the 
2,3-trans A-factor portion is attached exo- to the fused bicyclic ring system: 
1H NMR (300 MHz, acid-free CDCl3) (2 diastereomers) 6 0.85 (d, l = 6.6 Hz, 24H, 
8 x CH3), 1.1-2.0 (m, 2 x 16H, 2 x H8',9',10',11'+2 x H7,8,9,10,ll), 2.53-2.67 (m, 
2 x lH, 2 x H7b), 2.87-3.03 (m, 2 x lH, 2 x H7a), 3.12 (d, 12,3 = 9.0 Hz, lH, H2'), 
3.16 (d, 12,3 = 9.1 Hz, lH, H2'), 3.2-3.6 (m, lOH, 2 x H2,3,5,3'), 3.8-4.5 (m, 12H., 
2 x H4,4',5'). 
The second and third bands ( 4 mg each) each contained one diastereomer of the 
alternate type (5.8a) in which the 2,3-trans portions join endo- to the fused bicyclic 
systems. 
5.8a (1 diastereomer, higher Rt): 
1H NMR 6 0.87 (d, l = 6.6 Hz, 12H, 4 x CH3), 1.10-1.65 (m, 14H), 1.71 (m, lH, H7b'), 
1.96 (m, lH, H7a'), 2.64 (dt, l1a,7b = 18.3 Hz, l1b,8 = 7.2 Hz, lH, H7b), 2.97 (dt, 
l1a,1b = 18.3 Hz, l1a,8 = 7.2 Hz, lH, H7a), 3.18 (d, 12•,3• = 11.0 Hz, lH, H2'), 
3.22-3.40 (m, lH, H3), 3.38 (dd, lsa,5b = 8.9 Hz, 15b,3 = 7 .8 Hz, lH, H5b ), 
3.35-3.50 (m, lH, H3'), 3.56 (d, 12,3 = 6.7 Hz, lH, H2), 3.63 (dd, 15a,5b = 8.9 Hz, 
15a,3 = 5.3 Hz, lH, H5a), 3.78 (dd, l5a',5b' = 9.1 Hz, lsb',3' = 5.3 Hz, lH, H5b'), 3.99 
(dd, l 4a,4b = 8.9 Hz, 14b,3 = 8.6 Hz, lH, H4b), 4.00 (dd, l 4a',4b' = 9.2 Hz, 
14b',3' = 6.2 Hz, lH, H4b'), 4.22 (dd, l 5a',5b' = 9.1 Hz, lsa',3' = 8.6 Hz, lH, H5a'), 
4.40 (dd, 14a,4b = 8.9 Hz, 14a,3 = 7.7 Hz, lH, H4a), 4.43 (dd, 14a',4b' = 9.2 Hz, 
14a',3' = 9.2 Hz, lH, H4a'). 
5.8a (1 diastereomer, lower Rt): 
1 H NMR 6 0.86 (d, l = 6.6 Hz, 12H, 4 x CH3), l.1(}.1.60 (m, 14H), 1.69 (m, lH, H7b'), 
1.96 (m, lH, H7a'), 2.61 (dt, l1a,7b = 18.1 Hz, 17b,8 = 7.2 Hz, lH, H7b), 2.99 (dt, 
l1a, 7b = 18.1 Hz, l1a,8 = 7 .5 Hz, lH, H7a), 3.21 (d, 12·,3· = 11.1 Hz, lH, H2'), 3.22 
(m, lH, H3), 3.43 (m, lH, H3'), 3.44 (dd, 15a,5b = 9.5 Hz, 15b,3 = 5.8 Hz, lH, H5b), 
II 
lo 
~ 
II 
' I 
Ii 
IJi 
l.1 
, 
n 
/( 
I 
I 
Experimental 279 
3.56 (dd, Isa.Sb= 9.5 Hz, lsa.3 = 4.2 Hz, lH, H5a), 3.59 (d, 12,3 = 7.6 Hz, lH, H2), 
3.79 (dd, lsa',Sb' = 9.1 Hz, lsb',3' = 5.4 Hz, lH, H5b'), 4.04 (dd, 14a,4b = 8.9 Hz, 
J4b,3 = 7.1 Hz, lH, H4b), 4.08 (dd, 14a',4b' = 9.2 Hz, J4b',3' = 6.2 Hz, lH, H4b'), 4.25 
(dd, lsa',5b' = 9.1 Hz, lsa',3' = 8.4 Hz, lH, H5a'), 4.41 (dd, 14a,4b = 8.9 Hz, 
14a,3 = 8.2 Hz, lH, H4a), 4.43 (dd, ]4a•,4b' = 9.2 Hz, ]48 •,3• = 9.0 Hz, lH, H4a'). 
Assignments confirmed by 2D lH-lH COSY spectrum. 
13C NMR (75 MHz, acid-free CDC}J) 5.8a (lower R., diastereomer) 6 22.5 (C12, C12'), 
23.4, 23.9 (C8, C8'), 26.7, 27.4 (C9, C9'), 27.8, 27.9 (Cll, Cll'), 33.7 (C7'), 37.2 
(C3), 38.6, 38.7 (ClO, ClO'), 41.0 (C3'), 42.5 (C7), 54.1, 54.4 (C2, C2'), 59.3 (C5), 
69.3 (C4), 72.0 (C5')*, 72.8 (C4')*, 109.7 (C6'), 171.8, 173.1 (Cl, Cl'),202.7 (C6). 
Multiplicities determined by APT spectrum, see Appendix C. 
EIMS (all 4 diastereomers show identical fragmentations): mlz 367 (M+-99, 0.5%), 243 
(0.5), 225 (100), 153 (26), 141 (11), 140 (16), 127 (30), 109 (53), 95 (11), 85 (17), 
83 (22), 81 (23), 69 (19), 67 (17), 57 (41), 55 (52), 53 (12), 43 (87), 41 (37). 
CIMS (all 4 diastereomers show identical fragmentation): mlz 484 (M+Nl4+, 42%), 
467 (M+H+, 1), 260 (5), 243 (4), 242 (5), 225 (100), 109 (7). 
Experimental 280 
(3aa,6aa)-6-Methoxy-6-(5-methylhexyl)-1H,3H-furo[3,4-c] tetrahydrofuran-1-one 
(5.9) 
lj 
~I 
0 rr1:f.~i',/'J--...._ 
O H OMe 
5.9a 5.9b 
To A-factor (1.1) (10 mg, 0.041 mmol) in acid-free CDC13 (0.8 mL) in an NMR 
tube [initial tautomer ratio I.la (2,3-trans) : 5.12a (endo-OH) : 5.12b (exo-OH), 28 : 44 
: 28] was added methanolic HCl (ca 0.25 M, 8.5 µL). The reaction was followed by lH 
NMR. After 1 hour at 20°C the reaction was quenched by the addition of triethylamine 
(2 µL) and the solvent was evaporated. Radial chromatography of the residual oil 
(1 mm Si02; 40-50% EtOAc / hexane) yielded the bicyclic methylacetal (5.9) (5.1 mg, 
50%) as an inseparable 85: 15 mixture of diastereomers (tentatively assigned exo-OMe 
5.9b : endo-OMe 5.9a respectively by comparison of their l 2,3 values with those of the 
hemiacetal forms of A-factor). A final band contained unreacted A-factor (1.1) (3 mg, 
30%), (spectroscopic data above). 
lH NMR (300 MHz, CDCl3) 5.9b (major): o 0.87 (d, l = 6.6 Hz, 6H, 2 x CH3), 
1.15-1.60 (m, 7H), 1.65 (m, lH, H7b), 1.98 (m, lH, H7a), 3.16 (d, 12,3 = 9.1 Hz, 
lH, H2), 3.16 (s, 3H, OMe), 3.33 (m, lH, H3), 3.84 (dd, lsa,5b = 9.1 Hz, 
lsb,3 = 2.2 Hz, lH, H5b), 4.04 (dd, lsa,5b = 9.1 Hz, lsa,3 = 6.7 Hz, lH, H5a), 4.13 
(dd, 14a,4b = 9.4 Hz, l 4b,3 = 3.9 Hz, lH, H4b), 4.45 (dd, l 4a,4b = 9.4 Hz, 
14a,3 = 8.0 Hz, lH, H4a). 
5.9a (minor): o 0.87 (d, l = 6.6 Hz, 6H, 2 x CH3), 1.15-1.62 (m, 7H), 1.73 (m, lH, 
H7b), 1.99 (m, lH, H7a), 3.16 (d, 12,3 = 10.9 Hz, lH, H2), 3.22 (s, 3H, OMe), 3.43 
(m, lH, H3), 3.80 (dd, lsa,5b = 8.9 Hz, lsb,3 = 5.2 Hz, lH, H5b), 4.14 (dd, 
14a,4b = 9.0 Hz, 14b,3 = 6.6 Hz, lH, H4b), 4.20 (dd, lsa,5b = 8.9 Hz, lsa,3 = 6.7 Hz, 
lH, H5a), 4.45 (dd, 14a,4b = 9.0 Hz, l4a,3 = 8.0 Hz, lH, H4a). 
13C NMR (75 MHz, CDCl3) 5.9b: o 22.7 (2 x CH3), 24.2 (C8), 27.5 (C9), 27.9 (Cl l), 
30.1 (C7), 38.7 (ClO), 39.4 (C3), 47.7 (OMe), 53.1 (C2), 71.8 (C5)*, 72.6 (C4)*, 
110.8 (C6), 174.4 (Cl). 
5.9a: o 22.6 (2 x CH3), 23.8 (C8), 27.4 (C9), 27.9 (Cl l), 32.9 (C7), 38.8 (ClO), 
41.5 (C3), 48.0 (OMe), 54.6 (C2), 72.0 (C5)*, 72.5 (C4)*, 109.6 (C6), 174.4 (Cl). 
Peak multiplicities determined by APT spectrum, see Appendix D. 
EIMS mlz 225 (M+-OCH3, 16%), 157 (M+-C1H15, 100), 153 (13), 140 (10), 127 (7), 
109 (9), 99 (24), 83 (11), 82 (14), 81 (21), 71 (10), 69 (19), 57 (17), 55 (33), 53 
(12), 43 (62), 41 (45). 
CIMS mlz 251 (M+H+, 100%). 
HRMS: Found (M+-OCH3) 225.1492; C13H2103 requires 225.1491. 
Experimental 281 
4-Hydroxymethyl-2-(S-methylhexyl)-4,S-dihydrofuran-3-carboxylic acid methyl 
ester (5.11) 
s 
5.11 6' 
A-factor (1.1) (4 mg) in anhydrous MeOH (0.5 mL) was treated with methanolic 
HCl (0.6 M, 0.1 mL) and stirred for 48 hours at room temperature. Triethylamine 
(10 µL) was added to quench the reaction, and after removal of the solvent, the residue 
was separated by preparative 1LC (1 % MeOH in CH2Cl2) into two components. The 
higher Rt product (Rf 0.43) was identified as a 55 : 45 diastereomeric mixture of the 
bicyclic methylketals (S.9a : S.9b, 1.5 mg, 35%; spectroscopic data as above). 
The lower Rt product (Rt 0.11) was the carbomethoxy-3,4-dihydrofuran (5.11) 
(1.5 mg, 35% ): 
1H NMR (300 MHz, CDCh) 6 0.86 (d, J = 6.6 Hz, 6H, 2 x CH3), 1.12-1.37 (m, 4H, 
H8,9), 1.45-1.60 (m, 3H, H7, 10), 2.59-2.67 (m, 2H, H6), 3.39 (m, lH, H3), 3.62 
(dd, 15a.5b = 10.6 Hz, J5b;3 = 5.0 Hz, lH, H5b), 3.72 (dd, Isa.Sb= 10.6 Hz, 
lsa,3 = 6.1 Hz, lH, H5a), 3.74 (s, 3H, C(hMe), 4.23 (dd, 14a.4b = 9.5 Hz, 
J4b,3 = 5.8 Hz, lH, H4b), 4.47 (dd, 14a.4b = 9.5 Hz, 14a.3 = 10.2 Hz, lH, H4a). 
13C NMR (75 MHz, CDCh) o 22.6 (2xCH3), 27.1, 27.8, 28.3, 38.5, 45.1, 51.2 (Cl'), 
65.4 (CH20H), 73.5 (C5), 104.0 (C3), 156.0 (C2), 175.3 (ester C=O) EIMS mlz 
256 (M+, 3%), 225 (M+-OCH3, 92), 209 (2), 189 (2), 185 (2), 181 (2), 169 (2), 153 
(6), 157 (0.7), 147 (3), 141 (3), 127 (14), 109 (12), 97 (10), 95 (13), 83 (15), 81 
(29), 71 (11), 69 (47), 67 (12), 59 (51), 57 (51), 55 (57), 43 (100). 
EIMS mlz 256 (M+, 3%), 226 (15), 225 (92), 153, (6), 127 (14), 109 (12), 97 (10), 95 
(13), 83 (15), 81 (29), 71 (11), 69 (47), 67 (12), 59 (52), 57 (51), 55 (57), 53 (15), 
43 (100). 
CIMS mlz 257 (M+H+, 100%), 239 (3), 225 (M+-CH20H, 55), 153 (4), 123 (4), 109 (9), 
99 (7). 
HR.MS: Found (M+) 256.1676; C1~2404 requires 256.1675. 
Experimental 282 
Preparation of [J.2H]-A-factor (5.15) and [3a-2H]-(3aa,6f3,6aa)-6-hydroxy-6-(S-
methylhexyl)-1H ,3H-furo[3,4-c ]tetrahydrofuran-1-one 
0 
4.34 
(5.16a) 
0 
D 
5.14 R = TBDMS 
5.15 R=H 
1 crystallise 
om~.~ 
O HOH 
5.16a 6-endo-OH 
The butenolide (4.34) (100 mg, 0.282 mmol) in MeOH was stirred with 10% 
palladium-on-carbon (6 mg) in an atmosphere of deuterium for 45 minutes at ambient 
temperature and pressureat which time a TLC test showed no starting material. . 
Filtration through P1LC-grade silica gel and removal of solvent gave an oil which was 
purified by radial chromatography to give [3-2H]-TBDMS-protected A-factor (5.14) 
(78 mg, 77%) as a colourless oil. 
1H NMR (300 MHz, CDCb). The product contained ca 28% undeuterated silyl 
protected A-factor (4.35) whose data is reported above. Data for the [3-2H] 
compound (S.14):- o 0.05 (d, J = 4 Hz, 2 x SiCH3), 0.85 (d, J = 6.8 Hz, 6H, 
2 x CH3), 0.88 (s, 9H, t-Bu), 1.10-1.40 (m, 4H, H9,10), 1.45-1.70 (m, 3H, H8,ll), 
2.63 (dt, l1a, 7b = 18.0 Hz, J7b,8 = 7 .2 Hz, lH, H7b ), 2.96 (dt, J 7a, 7b = 18.0 Hz, 
l1a,8 =7.2Hz, lH, H7a), 3.54-3.73 (m, 3H, H5,2), 4.13 (d, 14a,4b= 8.9Hz, lH, 
H4b), 4.40 (d, 14a,4b = 8.9 Hz, lH, H4a). 
EIMS mlz 342 (M+-CH3, 1 %), 302 (1.1) 301 (3.5), 300 (M+-C4H9, 14.5), 299 (4.6), 282 
(2), 226 (2), 202 (5), 201 (7), 174 (3), 172 (3), 158 (2), 150 (4), 149 (2), 129 (3), 
128 (6), 127 (19), 109 (78), 105 (12), 89 (15), 83 (19), 77 (10), 76 (12), 75 (100), 
73 (73), 69 (30), 67 (16), 59 (25), 58 (16), 57 (99), 56 (15), 55 (65). Peaks 299, 
300, 301, 302 indicate 24% non-deuterated product; 72% mono-deuterated and ca 
3% di-deuterated, after correction for M + 1 and M + 2 (mlz 300, 301) peaks 
previously observed for the non-deuterated compound ( 4.35, see above). 
The deuterated silyl A-factor (5.14) (78 mg) was desilylated with 
HF I pyridine/ CH3CN as described for the preparation of 11-demethyl A-factor (3.36, 
Method B), to give [3-2H]-A-factor (5.15) (42 mg, 80%). Recrystallisation from CC4 
;V 
: I 
I 
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(0.6 mL) at 0°C gave the [3-2H]-endo-hydroxy hemiacetal tautomer (5.16a) as 
colourless plates (32 mg, mp 65-71 °C): 
lH NMR (300 MHz, CDC!J) Contains ca 30% non-deutero A-factor hemiketal (5.12a) 
(data above). Compound 5.16a: o 3.13 (s, lH, H2), 4.01 (d, J 5a.5b 9.0 Hz, lH, 
H5b), 4.20 (d, lsa.5b 9.0 Hz, lH, H5a), 4.26 (d, 14a.4b 9.0 Hz, lH, H4b), 4.49 (d, 
J4a.4b 9.0 Hz, lH, H4a) (other peaks identical to 5.12a, as reported above). 
EIMS mlz 243 (M+, 0.3%), 228 (M+-CH3, 3), 225 (M+-H20, 0.4), 212 (6), 211 (2), 172 
(5), 171 (2), 160 (3), 159 (8), 158 (2), 154 (4), 144 (9), 143 (3), 128 (14), 127 (25), 
117 (12), 116 (5), 111 (6), 110 (10), 109 (80), 102 (21), 86 (61), 85 (28), 84 (11), 
83 (30), 82 (38), 81 (6), 71 (10), 70 (9), 69 (23), 68 (7), 67 (22), 58 (14), 57 (100), 
56 (22), 55 (84 ). 
Experimental 
2,3-trans-2-(1-Hydroxy-6-methylheptyl)-3-(t-butyldimethylsilyloxymethyl) 
butanolides (6.11) and (6.12b) 
284 
OTBDMS OTBDMS OTBDMS 
R + 0 
·····, 
R 
0 0 0 OH 
4.35 6.11 
R=~ 
6.12b 
To a well-stirred solution of TBDMS protected A-factor (4.35) (100 mg, 
0.28 mmol) in anhydrous methanol (10 mL) -10°C was added sodium borohydride 
(9 mg, 0.24 mmol). After 5 minutes the mixture was allowed to warm to room 
temperature for another 40 minutes at which time no starting material was detected by 
TLC (Si02; 15% EtOAc in hexane). 
The reaction was quenched by the addition of phosphate buffer solution (pH 5.0, 
3 mL) and the bulk of the methanol was removed from the resulting mixture on a rotary 
evaporator (20°C). After extraction with EtOAc (3 x 5 mL) the combined extracts were 
washed successively with water (5 mL) and saturated brine, then dried and evaporated 
to give an oily residue. Radial chromatography (1 mm Si02; 1-3% MeOH in CH2Cl2) 
allowed separation of the two 2,3-trans diastereomers. 
The first eluted (6.11, Rt= 0.73; 4% MeOH in CH2Cli) was isolated as a 
colourless oil in 65% yield. 
lH NMR (300 MHz, CDC13) 6 0.70 (s, 6H, SiCH3), 0.85 (d, l = 6.6 Hz, 6H, H12,13), 
0.89 (s, 9H, 'Bu), 1.12-1.23 (m, 2H, HlO), 1.23-1.43 (m, 3H, H8a,9), 1.43-1.66 (m, 
4H, H7, 8a,1 l), 2.60 (dd, 12,3 = 8.6 Hz, 12,6 = 5.2 Hz, lH, H2), 2.64 (m, lH, H3), 
ca 3.0 (d, loH,6 = 6 Hz, lH, OH), 3.66 (dd, lsb,3 = 4.8 Hz, lsb,5a = 11.5 Hz, lH, 
H56), 3.69 (dd, lsa.,3 = 4.9 Hz, lsa.,5b = 11.5 Hz, lH, H5a), 3.84 (m, lH, H6), 4.03 
(dd, 14b,3 = 7.8 Hz, l 4b,4a = 8.9 Hz, lH, H4b), 4.37 (dd, 14a,3 = 8.0 Hz, 14a,4b = 
8.9 Hz, lH, H4a). 
13C NMR (50 MHz, CDCh) 6 -5.9 (SiCH3), 17.9 (q, 'Bu), 22.4 (C12, 13), 25.5 ('Bu), 
25.6 (C8), 27.0 (C9), 27.7 (Cl 1), 34.4 (C7), 38.7 (ClO), 40.3 (C3), 47.2 (C2), 62.5 
(CS), 68.7 (C4), 71.0 (C6), 178.2 (Cl). 
EIMS m/z 301 (M+-C4H9, 0.4%), 283 (2.5), 173 (22), 155 (11), 145 (4), 143 (6) , 115 
(5), 95 (8), 89 (6), 85 (14), 82 (10), 75 (100), 73 (16), 69 (17), 59 (11), 57 (29), 56 
(17), 55 (62). 
CIMS mlz 376 (M+~+, 3%), 359 (M+H+, 85), 341 (70). 
HRMS Found 301.1843; C1sH2~4Si (M+-C4H9) requires 301.1835. 
The second eluted diastereomer (6.12b, Rt= 0.52; 4% MeOH in CH2Ch) isolated 
as a colourless oil in 25% yield. 
1H NMR (300 MHz, CDCl3) 6 0.60 (s, 6H, SiCH3), 0.86 (d, J = 6.6 Hz, 6H, H12,13), 
0.89 (s. 9H, 'Bu), 1.12-1.23 (m, 2H, Hl 0), 1.25-1.38 (m, 3H, H8b,9), 1.43-1.64 (m, 
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4H, H7,8a,ll), ca 2.1 (m, lH, OH), 2.60 (dd, 12,3 = 7 Hz, 12,6 = 3.1 Hz, lH, H2), 
2.82 (m, lH, H3), 3.65 ('d', l = 5.1 Hz, 2H, H5), 4.08 (dd, 14a,4b = 8.9 Hz, 14b,3 = 
6.5 Hz, lH, H4b), 4.15 (m, lH, H6), 4.36 (dd, 14a,4b = 8.9 Hz, 14a,3 = 8.7 Hz, lH, 
H4a). 
13C NMR (50 MHz, CDCl3) o -5.9 (SiCH3), 17.9 (q, 1Bu), 22.4 (C12, 13), 25.5 (tBu), 
25.9 (C8), 27.0 (C9), 27.7 (Cll), 34.7 (C7), 37.5 (C3), 38.7 (ClO), 47.4 (C2), 63.1 
(C5), 69.5 (C4), 70.6 (C6), 179.0 (Cl). 
EIMS mlz 283 (M+-C4H9,-H20, 1%), 173 (12), 145 (3), 143 (4), 115 (4), 95 (8), 85 
(14), 82 (12), 75 (100), 73 (16), 69 (20), 59 (12), 57 (36), 56 (24), 55 (68). 
CIMS mlz 376 (M+NR4+, 19%), 359 (M+H+, 84), 341 (100). 
HRMS Found 301.1843; C1sH2904Si (M+-C4H9) requires 301.1835. 
Experimental 286 
2-(1-Hydroxy-6-methylheptyl)-3-(hydroxymethyl)butanolide (1.2) [Le. Factor I] 
OH 
0 H OH 
1.2 factor-I 
To an iced cooled (0°C) solution of the lower polarity TBDMS-protected 
butanolide diastereomer (isolated above) (6.11, 26 mg, 0.072 mmol) in THF (5 mL) 
was added and 1.0 M solution of tetra n-butylammonium fluoride in THF (0.27 mL, 
0.27 mmol). After stirring for 35 min the mixture was allowed to warm to room 
temperature before being quenched with the addition of phosphate buffer solution 
(pH 7 .0, 2 mL). After dichloromethane extraction (3 x 5 mL), the combined extracts 
were dried and evaporated to leave an oily residue which was purified by radial 
chromatography (1 mm Si02, 1-3% MeOH in CH2Cl2). The title compound (1.2) was 
isolated as a colourless oil, (1.5 mg, 79%) and had NMR and mass spectral data in full 
agreement with factor-I 1.2.26 
lH NMR (300 MHz, CDCh) 6 0.85 (d, l = 6.6 Hz, 6H, Hl 1,12), 1.10-1.23 (m, 2H, 
HlO), 1.23-1.40 (m, 3H, H8b,9), 1.43-1.67 (m, 4H, H7 ,8a,l 1), 2.65 (dd, 12,6 = 4.7 
Hz, 12,3 = 9.5 Hz, lH, H2), 2.77 (m, lH, H3), 3.67 (dd, 15a,5b = 10.7 flz, 15a,3 = 5.2 
Hz, lH, H5a), 3.97 (dd, 14b,4a = 8.9 Hz, 14b,3 = 8.8 Hz, lH, H46), 4.01 (m, lH, H6), 
4.41 (dd, 14a,4b = 9.0 Hz, 14a,3 = 8.2 Hz, lH, H4a). 
13C NMR (50 MHz, CDCl3) 6 22.4 (C12, 13), 25.9 (C8), 27.0 (C9), 27.7 (Cl 1), 33.8 
(C7), 38.7 (ClO), 39.9 (C3), 49.1 (C2), 62.9 (C5), 68.3 (C4), 70.8 (C6), 177. 7 (Cl). 
EIMS mlz 226 (M+-H20, 0.7%), 195 (7), 171 (2), 153 (2), 145 (19), 139 (4), 129 (4), 
127 (4), 116 (15), 111 (7), 95 (13), 85 (37), 69 (30), 67 (15), 56 (56), 55 (24), 54 
(36), 42t (100). 
t This value may have deeper significance as "The Answer to the Great Question of Life, the Universe, 
and Everything" (see "The Hitch Hiker's Guide to the Galaxy", Douglas Adams, Pan Books: London 
1979, p 135). 
Experimental 287 
2-(1-Hydroxy-6-methylheptyl)-3-(hydroxmethyl)butanolide ( 1.5) [i.e. Grafe' s 
factor from S. bildniensis and S. cyaneofuscatus] 
OH 
O H OH 
1.5 Grafe's factor 
The higher polarity TBDMS-protected butanolide diastereomer (6.12b, 11.0 mg, 
0.031 mmol), was deprotected using the same procedure as that described above for the 
less polar diastereomer 6.11. After chromatography, the title compound was isolated as 
a colourless oil (7 mg, 93%) and displayed NMR and mass spectra in full agreement 
with the naturally derived compound. 28 
lH NMR (300 MHz, CDC!J) 6 0.86 (d, J = 6.6 Hz, 6H, H12,13), 1.12-1.23 (m, 2H, 
HlO), 1.23-1.38 (m, 3H, H8b,9), 1.43-1.68 (m, 4H, H7,8a,l l), 2.56 (dd, 12,6 = 3.7 
Hz, 12,3 = 7.4 Hz, lH, H2), 2.86 (m, lH, H3), 3.69 (dd, lsb;J = 6.2 Hz, lsb,5a = 10.6 
Hz, lH, H5b), 3.75 (dd, lsa,5b = 10.6 Hz, lsa.3 = 5.6 Hz, lH, H5a), 4.10 (dd, 14b,4a 
= 9.0 Hz, 14b,3 = 6.8 Hz, lH, H4b), 4.12 (m, lH, H6), 4.42 (dd, 14a,3 = 8.6 Hz, lH, 
H4a). 
13C NMR (50 MHz, CDCl3) 6 22.4 (C12, 13), 25.9 (C8), 27.0 (C9), 27.7 (Cl l), 34.7 
(C7), 37.9 (C3), 38.7 (ClO), 48.0 (C2), 63.3 (C5), 69.4 (C4), 70.8 (C6), 180.3 (Cl). 
EIMS mlz 226 (M+-H20, 0.5%), 195 (6), 171 (3), 153 (2), 145 (22), 139 (3), 129 (4), 
127 (5), 116 (19), 111 (9), 95 (16), 85 (39), 69 (38), 67 (20), 56 (65), 55 (34), 54 
(43), 42 (100). 
Experimental 
1,2-Reduction of the Butenolide 4.34 
OTBDMS 
0 4.34 
0 
OTBDMS 
+ 
OTBDMS 
4.35 
288 
A solution of TBDMS-protected butenolide (4.34, 64 mg, 0.18 mmol) in 
anhydrous methanol ( 4 mL) was cooled to 0°C under an atmosphere of argon before the 
addition of a solution of anhydrous cerium trichloride (45 mg, 0.18 mmol) in methanol 
(2 mL). Sodium borohydride was then added (6.8 mg, 0.18 mmol as a solid) and the 
mixture was stirred for 5 mins. The reaction was quenched with the addition of 
phosphate buffer solution (pH 5.0, 1 mL) and water (2 mL). Extraction with CH2Cl2 
(4 x 4 mL), successive washing of the combined extracts with water (5 mL) and brine 
(5 mL) followed by drying and evaporation afforded an oily residue which was 
subjected to radial chromatography (2 mm Si02, 0-2% MeOH in CH2Cl2). 
After a fore-fraction which was found to contain 8.4 mg (13%) of a 4:1 mixture of 
TBDMS-A factor (4.35) and unreacted butenolide (4.34), the 1,2-reduction product 
(6.15) was isolated as a colourless oil (45 mg, 70%). 
1H NMR (300 MHz, CDC!J) 6 0.10 (s, 6H, SiCH3), 0.85 (d, J = 6.6 Hz, 6H, H12,13), 
0.91 (s, 9H, 1Bu), 1.10-1.21 (m, 2H, HlO), 1.24-1.37 (m, 3H, H8b,9), 1.37-1.46 (m, 
lH, H8a), 1.46-1.58 (m, lH, Hll), 1.58-1.83 (m, 2H, H7), 2.70 (br s, lH, OH), 
4.51 ('t', J = 5 Hz, lH, H6), 4.66 (d, lsa,5b = 16.8 Hz, lH, H5b), 4.73 (d, lsa.5b = 
16.8 Hz, lH, H5a), 4.78 (s, 2H, H4). 
13C NMR (50 MHz, CDC13) o -5.6 (SiCH3), 18.2 (q, 1Bu), 22.6 (Cl2,13), 25.7 ('Bu), 
25.8 (C8), 27.1 (C9), 27.9 (Cll), 36.7 (C7), 38.9 (ClO), 58.8 (C5), 67.3 (C6), 70.5 
(C4), 127.7 (C2}, 1(,().3 (C3), 173.7 (Cl). 
EIMS mlz 299 (M+-CtH9, 2%), 257 (M+-C1H15, 8), 207 (2), 161 (2), 151 (4), 137 (5), 
125 (4), 123 (4), 119 (4), 111 (6), 109 (8), 107 (6), 105 (9), 97 (8), 95 (6), 93 (7), 
91 (6), 89 (6), 86 (15), 84 (25), 77 (12), 75 (100), 73 (51), 69 (17), 59 (11), 57 (35), 
55 (27). 
HRMS Found 299.1679; C1sH2.,04Si (M+-C4H9) requires 299.1679. 
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Reduction of the Butenolide 4.34 with Sodium Borohydride in Methanol 
OTBDMS OTBDMS OTBDMS 
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6.11, 6.12b 
To a cooled solution (-10°C) of the butenolide 4.34 (21.7 mg, 0.061 mmol) in 
anhydrous methanol (2 mL) was added sodium borohydride (2.0 mg, 0.053 mmol). 
The mixture was stirred at this temperature for 5 minutes and then was allowed to warm 
room temperature a over 40 minute period. After quenching with the addition of 
phosphate buffer (pH 5, 1 mL) and water (5mL), the mixture was extracted with 
CH2Cl2 (3 x 2mL), dried and evaporated to afford a pale yellow oil. 1 H NMR 
spectroscopy of the product revealed the presence of a mixture of the 2,3-trans 
6-hydroxybutanolides 6.11 and 6.12b, and a small amount of the 1,2-reduction product 
6.15 (ratio ca 16:4:1). After radial chromatography (1 mm Si02 / 1-4% MeOH in 
CH2Cl2) the first eluted compound was the butenolide 6.15 (0.9 mg, 4% ), followed by 
the 6-hydroxybutanolides 6.11 (12.5 mg, 58%) and the other C6 epimeric compound 
6.12b (3.2 mg, 15%). 1H NMR data and TLC characteristics for all three products were 
identical to those reported above. 
Experimental 290 
Catalytic Hydrogenation of the 6-Hydroxybutenolide (6.15) 
OfBDMS 
R 
6.15 R=~ 
J 
OfBDMS OfBDMS OfBDMS OfBDMS 
+ + + R 
0 0 0 0 0 
6.16a and 6.16b 6.17 6.18 4.35 
MEI'HOD A: USING P AUADIUM-ON-CARBON CATALYSIS 
The 6-hydroxybutenolide (6.15, 47 mg, 0.132 mmol), in methanol solution 
(20 mL) was hydrogenated at room pressure and temperature in the presence of 10%. 
palladium-on-carbon (3 mg). After 3 hours, one equivalent of hydrogen had been 
absorbed and the catalyst was removed by filtration through a bed of TLC grade silica 
gel (0.5 cm). The oily residue remaining after removal of the solvent was subjected to 
careful radial chromatography (1 mm Si02; 10-20% EtOAc in hexane) which enabled 
the isolation of four products, followed by a small amount of unreacted starting 
material. 
The first eluted compound (Rt 0.73, 30% EtOAc in hexane) was 2-(6'-
methylheptyl)-3-(t-butyldimethylsilyloxymethyl)butanolide (6.18, 7 .8 mg, 17%) as a 
70: 30 mixture of diastereomers. 
1 H NMR (300 MHz, CDCl3) 6.18a (major diastereomer) o 0.06 (s, 6H, SiCH3), 0.87 (d, 
J = 6.6 Hz, 6H, H12,13), 0.89 (s, 9H, 1Bu), 1.05-1.90 (m, 1 lH, H6-l 1), 2.50-2.62 
(m, 2H, H2,3), 3.60 _(dd, Isa.Sb= 10.3 Hz, lsb,3 = 5.7 Hz, lH, H5b), 3.68 (dd, Isa.Sb 
= 10.3 Hz, lsa,3 = 3.3 Hz, lH, H5a), 4.23 (dd, J4b,4a = 9,0 Hz, J4b,3 = 5.5 Hz, lH, 
H46), 4.30 (dd, 14a,4b = 9.0 Hz, 14a,3 = 1.2 Hz, lH, H4a). 
1 H NMR (300 MHz, CDCh) 6.18b (minor diastereomer) o 0.06 (s, 6H, SiCH3), 0.87 (d, 
J = 6.6 Hz, 6H, H12,13), 0.89 (s, 9H, 1Bu), 1.05-1.90 (m, 1 lH, H6-1 l), 2.38-2.49 
(m, 2H, H2,3), 3.57-3.72 (m, 2H, H5a,5b), 4.07 (dd, J4b,4a = 9.1 Hz, 14b,3 = 7.1 Hz, 
lH, H4b), 4.33 (dd, l4a,4b = 9.1 Hz, l4a,3 = 7.6 Hz, lH, H4a). 
13C NMR (50 MHz, CDC13) 6.18a (major diastereomer) o -5.6 (SiCH3), 18.2 (q, 1Bu), 
22.6 (C12,13), 24.8 (C8), 25.6 ('Bu), 27.1 (C9), 27.9 (Cl 1), 28.1 (C7)*, 29.8 (C6)*, 
38.9 (ClO), 39.8 (C3)**, 41.4 (C2)**, 58.5 (C5), 70.3 (C4), 174.8 (Cl). Signal to 
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noise ratio did not allow unambiguous identification of the 13C peaks of the minor 
diastereomer. 
EIMS mlz 327 (M+-CH3, 1%), 285 (M+-CtH9, 11), 257 (6), 197 (5), 173 (6),145 (5), 
117 (6), 109 (26), 105 (14), 95 (27), 89 (18), 85 (14), 83 (27), 81 (20), 75 (100), 73 
(40), 69 (38), 67 (18), 59 (13), 57 (15), 55 (23). 
CIMS mlz 360 (M+Nli4+, 38%), 343 (M+H+, 43%), 285 (M-C4H9, 18). 
HRMS Found 327.2356; C1gH3503Si (M+-CH3) requires 327.2355. 
The second eluted and major product (Rf 0.71, 30% EtOAc in hexane) was the 
butenolide (6.17, 21 mg, 47%). 
1H NMR (300 MHz, CDCl3) 6 0.10 (s, 6H, SiCH3), 0.86 (d, J = 6.6 Hz, 6H, H12,13), 
0.90 (s. 9H, 1Bu), 1.10-1.60 (m, 9H, H7-ll), 2.24 (t, J = 7.7 Hz, 2H, H6), 4.58 (s, 
2H, HS), 4.77 (s, 2H, H4). 
13C NMR (50 MHz, CDCl3) 6 -5.6 (SiCH3), 18.2 (q, 1Bu), 22.6 (C12, 13), 23.8 (C8)*, 
25.7 (1Bu), 27.1 (C9), 27.9 (Cll), 28.0 (C7)*, 29.7 (C6)*, 38.9 (ClO), 58.5 (CS), 
70.3 (C4), 126.3 (C2), 159.2 (C3), 174.8 (Cl). 
EIMS mlz 325 (M+-CH3, 0.6% ), 283 (M+-C4H9), 25), 129 (3), 123 (3), 117 (3), 111 (5), 
109 (11), 107 (4), 105 (6), 97 (6), 95 (11), 89 (8), 85 (6), 83 (13), 81 (11), 79 (6), 
77 (9), 75 (100), 73 (42) 69 (27), 67 (11), 59 (15), 57 (19), 55 (22). 
CIMS mlz 358 (M+Nli4+, 38%), 341 (M+H+, 33), 283 (M+-C4H9, 17). 
HRMS Found 325.5199; C1gH3303Si (M+-CH3) requires 325.5199. 
Third eluted (Rf 0.53, 30% EtOAc in hexane) was 2,3-cis-2-(1 '-hydroxy-6'-
methylheptyl)-3-(t-butyldimethylsilyloxymethyl)butanolide (6.16a, 1.9 mg, 4% ). 
1H NMR (300 MHz, acid-free CDC!J) 6 0.07 (s, 6H, SiCH3), 0.87 (d, J = 6.5 Hz, 6H, 
H12,13), 0.89 (s, 9H, tBu), 1.12-1.26 (m, 2H, HlO), 1.26-1.47 (m, 4H, H8,9), 1.47-
1.65 (m, 3H, H7,ll), 2.58 ('t', J = 8 Hz, lH, H2), 2.61 (m, lH, H3), 3.68 (dd, lsb,5a 
= 10.3 Hz, Jsb,3 = 3.8 Hz, lH, H5b), 3.71 (dd, lsB.y5b = 10.3 Hz, lsa,3 = 3.5 Hz, lH, 
H5a), 3.99 (m, lH, H6), 4.16 (d, 16,0H = 2.0 Hz, lH, OH), 4.28 (dd, J4b,4a = 9.1 Hz, 
J4b,3 = 5.2 Hz, lH, H46), 4.32 (dd, l4a,4b = 9.0 Hz, l4a,3 = 2.1 Hz, lH, H4a). 
13C NMR (50 MHz, acid-free CDCh) 6 -5.7 (SiCH3), 18.1 (q, 1Bu), 22.6 (Cl2,13), 25.5 
(C8), 25.6 (1Bu), 27.3 (C9), 27.9 (Cl l), 35.5 (C7), 38.9 (ClO), 39.7 (C3), 46.2 
(C2), 61.1 (C5), 67.8 (C4), 70.0 (C6), 179.0 (Cl). 
EIMS mlz 325 (M+-CH3, 0.3%), 301 (M+-C4H9, 1), 283 (3), 173 (11), 155 (6), 145 (3), 
143 (3), 127 (6), 115 (5), 109 (6), 107 (4), 105 (8), 95 (12), 89 (12), 85 (15), 81 
(11), 75 (100), 73 (35), 69 (25), 67 (10), 59 (15), 57 (30), 56 (13), 55 (65). 
CIMS mlz 359 (M+H+, 100%), 341 (30), 301 (22). 
HRMS Found 301.1834; C1sJI29Si04 (M+-C4H9) requires 301.1835. 
The fourth product eluted (Rf 0.44, 30% EtOAc in hexane) was the alternative C6 
epimer of 2,3-c is-2-(1 '-hydroxy-6'-methylheptyl)-3-(t-butyldimethylsilyloxymethyl)-
butanolide ( 6.16b, 2.0 mg, 4% ). 
1H NMR (300 MHz, acid-free CDCl3) 6 0.10 (s, 6H, SiCH3), 0.87 (d. J = 6.6 Hz, 6H, 
Hl2,13), 0.91 (s, 9H, 'Bu), 1.12-1.25 (m, 2H, HlO), 1.25-1.44 (m, 3H, H8b,9), 
1.47-1.66 (m, 3H, H7b,8a,11), 1.97 (m, lH, H7a), 2.74 (t, J = 7.2 Hz, lH, H2), 
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2.83 (m, lH, H3), 3.ITT (d. 16,0H = 4.3 Hz, lH, OH), 3.76 (dd, Jsb.Sa = 10.6 Hz, lsb;J 
= 5.6 Hz, lH, H5b), 3.87 (dd, Isa.Sb= 10.6 Hz, lsa;3 = 7 Hz, lH, H5a), 4.03 (m, lH, 
H6), 4.19 (dd, J4b,4a = 9.3 Hz, J4b,3 = 2.0 Hz, lH, H4b), 4.23 (dd, 14a,4b = 9.3 Hz, 
Jw = 4.8 Hz, lH, H4a). 
13C NMR (50 MHz, acid-free CDC13) 6 -5.6 (SiCH3), 18.1 (q, 'Bu), 22.6 (C12,13), 25.7 
('Bu), 26.0 (C8), 27.2 (C9), 27.9 (Cl l), 34.7 (C7), 39.0(ClO), 40.7 (C3), 48.9 (C2), 
62.3 (C5), 68.2 (C4), 69.1 (C6), 176.0 (Cl). 
EIMS mlz 325 (M+-CH3, 0.3%), 301 (M+-C4H9, 1), 283 (3), 173 (11), 155 (6), 145 (3), 
143 (3), 127 (6), 115 (5), 109 (6), 107 (4), 105 (8), 95 (12), 89 (12), 85 (15), 81 
(11), 75 (100), 73 (35), 69 (25), 67 (10), 59 (15), 57 (30), 56 (13), 55 (65). 
CIMS mlz 359 (M+H+, 100%), 341 (30), 301 (22). 
HRMS Found 301.1834; C1sH29Si04 (M+-CtH9) requires 301.1835. 
METHOD B: USING PLATINUM CATALYSIS 
The 6-hydroxy butenolide (6.15, 20.2 mg, 0.057 mmol) in benzene (5 mL) was 
hydrogenated over platinum black (3 mg) for 20 hours at room temperature and 
pressure. After workup and chromatography described above the following products 
were collected; (in order of elution) TBDMS-protected A-factor (4.35, 3.0 mg, 15%); 
butanolide (6.18, 1.8 mg, 10%); butenolide (6.17, 0.7 mg, 4%); 2,3-cis-6-hydroxy 
butanolides (6.16a, 4.0 mg, 20%) and (6.16b, 4.0 mg, 20%) followed by unreacted 
(6.15, 0.8 mg, 4% ). (Spectroscopic data as described_ above). 
METHOD C: USING RHODIUM-ON-ALUMINA 
Hydrogenation of (6.15, 35.6 mg, 0.10 mmol) in methanol (20 mL) over 5% 
rhodium-on-alumina (5 mg) until hydrogen absorption ceased (4 hours) gave a mixture 
of products which was purified as described above. In order of elution, the products 
collected were; TBDMS-protected A-factor (4.35, 11.5 mg, 32%); butanolide (6.18, 
4.8 mg, 14%); 2,3-cis-6-hydroxy butanolide (6.16a, 5.7 mg, 16%); 2,3-trans-6-
hydroxy butanolide (6.11, 0.7 mg, 2%); 2,3-trans-6-hydroxy butanolide (6.12, ca 
0.5 mg, ca 2%) and 2,3-cis-6-hydroxy butanolide (6.16b, 5.3 mg, 15%). (Spectroscopic 
data for all compounds described above). 
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t-Butyl (E,E)-3-oxoocta-4,6-dienoate (7.8) 
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A solution of lithium diisopropylamide (LDA) was prepared by the dropwise 
addition of n-butyllithium solution (1.55 M in hexane, 64 mL, 0.1 mol) to a cooled 
(-50°C) solution of diisopropylamine (10.1 g, 0.1 mol) in anhydrous THF (100 mL) 
under an atmosphere of argon. After stirring for 10 minutes at -50°C, t-butylacetate 
(5.8 g, 0.05 mol) was slowly (2 mm) introduced. The mixture was stirred for a further 
10 minutes then cooled to -78°C before sorbyl chloride231 (6.5 g, 0.05 mol) was added 
over 10 minutes. During the addition the solution became yellow and the temperature 
rose to -50°C. After 10 minutes at this temperature, the reaction was quenched with the 
addition of dilute hydrochloric acid (20% w/v, 30 mL). 
Following extraction with ether (3 x 50 mL) the combined organic extracts were 
washed sequentially with saturated aqueous sodium bicarbonate solution (2 x 30 mL) 
and saturated brine (30 mL). Drying and evaporation of the solvent gave a yellow oil 
which was purified by fractional distillation under reduced pressure. The· required 
t-butyl ester (7.8, 5.6 g, 53%) was isolated as a yellow oil, boiling at 90-92°C / 0.3 mm 
Hg. Upon cooling the oil solidified and a sample was recrystallised from hexane to 
give pale yellow needles (mp 47-51 °C). 
lH NMR (300 MHz, CDC!J) 6 1.44 (s, 9H, 1Bu), 1.48 (s, enol 1Bu), 1.82 (d, J = 6.5 Hz, 
enol H8), 1.87 (d, J = 5.1 Hz, 3H, H8), 3.47 (s, 2H H2), 4.93 (s, enol H2), 5.75 (d, 
14,5 = 15.3 Hz, enol H4), 6.02 (m, enol H7), 6.11 (d, 14,5 = 15.4 Hz, lH, H4), 5.94-
6.32 (m, 2H, H6,7+enol H6), 6.98 (dd, ]5,4 = 15.2 Hz, 15,6 = 10.6 Hz, enol H5), 
7.14 (dd, ]5,4 = 15.7 Hz, 15,6 = 8.9 Hz, lH, H5), [enol content 23%]. 
13C NMR (50 MHz, CDCl3) o 18.5 (enol C8), 18.7 (C8), 27.8 (1Bu), 28.2 (!Bu), 48.5 
(C2), 80.6 (enol 9, 1Bu), 81.5 (q, 1Bu), 92.4 (enol C2), 123.0 (enol C4), 126.7 (C4), 
130.0 (C6), 130.5 (C6 enol), 136.0 (enol C7)*, 136.6 (enol C5)*, 141.3 (C7), 144.6 
(C5), 166.6 (Cl), 169.0 (enol Cl)*, 172.5 (enol C3)*, 192.7 (C3). 
EIMS mlz 210 (M+, 5%), 195 (M+-15, 0.4), 154 (M+-C4Hs, 16), 139 (29), 137 (10), 136 
(15), 121 (11), 109 (17), 108 (11), 95 (52), 80 (21), 69 (8), 67 (30), 65 (10), 59 
(18), 57 (100). 
Analysis: Found C 68.2, H 8.6; C12H1s03 requires C 68.5, H 8.6. 
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A solution of the t-butyl ester (7.8, 1.6 g, 7.6 mmol) in CH2C!i (12 mL) was 
treated with trifluoroacetic acid (TFA, 8 mL) at room temperature. After 1 hour, the 
resulting dark yellow solution was evaporated to dryness on a rotary evaporator, to 
afford a yellow solid residue. Traces of 1F A were removed under high vacuum before 
the solid was recrystallised from ether to give the P-keto acid (7.9) was fine, pale 
yellow needles (0.59 g, 50% ), melting at 97-99°C. The product could be sublimed at ca 
90°C I 0.03 mm Hg but the resulting product contained ca 10% of the decarboxylation 
product, hepta-3,5-diene-2-one (7.10)232 by lH NMR. 
lH NMR (300 MHz, CDC13) 6 1.86 (d, J = 6.0 Hz, enol H8), 1.92 (d, J = 6.3 Hz, 3H, 
H8), 3.66 (s, 2H, H2), 5.07 (s, enol H2), 5.82 (d, J = 15.3 Hz, enol H4), 6.14 (d, J = 
15.7 Hz, lH, H4), 6.02-6.43 (m, 2H, H6,7), 7.08 (dd, J = 10.5 Hz, J = 15.5 Hz, 
enol H5), 7.26 (dd, /4,5 = 15.7 Hz, Js,6 = 10.5 Hz, lH, H5), 11.61 (s. enol OH), 
[enol content 38%]. 
13C NMR (50 MHz, CD3COCDJ) 6 18.0 (C8)*, 18.2 (enol C8}*, 46.2 (C2), 90.2 (enol 
C2), 123.3 (enol C4), 127.5 (C4), 130.5 (enol C6)*, 130.8 (C6)*, 136.8 (enol C7)*, 
137.6 (enol C5)*, 141.3 (C7), 144.7 (C5), 168.4 (Cl), 171.2 (enol Cl}*, 174.5 (enol. 
C3)*, 193.0 (C3). 
EIMS mlz 154 (M+, 2%), 139 (M+-CH3, 5), 136 (M+-H20, 2), 121 (2), 110 (38), 109 
(9), 96 (7), 95 (100), 91 (7), 81 (6), 79 (5), 77 (16), 69 (4), 68 (5), 67 (71), 66 (9), 
65 (18), 63 (6), 55 (12), 53 (12), 51 (11). 
HRMS Found 154.0630; CsH1o03 requires 154.0650. 
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3-(t-Butyldimethylsilyloxymethyl)-2-(hexa-2,4-dienoyl)but-2-enolide (7.12) 
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3-0xoocta-4,6-dienoic acid (7.9, 154 mg, 1.0 mmol) was esterified with 
1-hydroxy-3-t-butyldimethylsilyloxypropan-2-one (4. 7, 234 mg, 1.15 mmol) using 
dicyclohexylcarbodiim.ide (DCC, 216 mg, 1.05 mmol) catalysed by DMAP (15 mg) and 
DMAP hydrochloride (5 mg) in CH2Cl2 (5 mL), following the procedure described 
above for the preparation of 3'-(t-Butyldimethylsilyloxy)-2'-oxopropyl 3-oxononanoate 
(4.6). 
After aqueous work-up the crude product mixture (425 mg) was shown by lH 
NMR analysis, using an internal standard (triphenylmethane), to contain ca 180 mg 
(ca 53%) of the required J3-ketoester intermediate (7.11): 
1H NMR (300 MHz, CDC13) 6 0.10 (s, 6H, SiCH3), 0.91 (s, 9H, 1Bu),l.84 (d, J = 6.5 
Hz, enol H8), 1.88 (d, J = 5.6 Hz, 3H, H8), 3.71 (s, 2H, H2), 4.27 (s, enol H3')*, 
4.29 (s, 2H, H3')*, 5.01 (s, enol Hl ')**, 5.02 (s, 2H, Hl ')**, 5.17( s, enol H2), 5.81 
(d, J = 15.4 Hz, enol H4), 6.04 (d, 14,5 = 15.0 Hz, lH, H4), 5.98-6.37 (m, 2H, 
H6,7), 7.04 (dd, J = 10.4 Hz, J = 15.1 Hz, enol H4), 7.21 (dd, ]5,4 = 15.5 Hz, ls,6 = 
9.6 Hz, lH, H5), [enol content 50%]. 
During subsequent radial chromatography (2 batches; 2 mm Si02; 10-30% 
EtOAc in hexane), the intermediate ester cyclised to afford the title butenolide (7.12, 
135 mg) as the first eluted compound. Later bands contained the unreacted 
silyloxypropanone (4.7, 125 mg) and hepta-3,5-dien-2-one (7.10)232 (50 mg). 
The butenolide product (7.12) appeared as an orange oil (ca 80% pure by 1H 
NMR; 34% yield over 2 steps) and was used in the subsequent reduction without 
further purification. A sample was recrystallised from pentane to give orange needles, 
mp 82-88°C. 
1 H NMR (300 MHz, CDCI3) o 0.11 (s, 6H, SiCH3), 0.91 (s, 9H, 1Bu), 1.90 (d, J = 5.5 
Hz, 3H, Hl l), 5.00 (s, 2H, H4)*, 5.12 (s, 2H, H5)*, 6.18-6.47 (m, 2H, H9,10), 7.26 
(d, 11,s = 15.3 Hz, lH, H7), 7.38 (dd, ls,1 = 15.1 Hz,ls,9 = 9.2 Hz, lH, H8). 
13C NMR (50 MHz, CDCh) o -5.6 (SiCH3), 18.1 (q, 1Bu), 25.7 ('Bu), 62.0 (C5), 70.3 
(C4), 122.7 (C2), 124.0 (C7), 130.8 (C9), 142.8 (ClO), 145.8 (C8), 170.8 (C3)*, 
181.7 (Cl)*, 184.9 (C6). 
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EIMS mlz 322 (M+, 3%), 266 (5), 265 (M+-~H9, 21), 235 (5), 219 (3), 211 (2), 209 (2), 
207 (2), 196 (3), 191 (3), 190 (3), 169 (3), 147 (3), 146 (3), 145 (4), 129 (4), 117 
(5), 115 (5), 105 (5), 103 (3), 95 (45), 91 (7), 77 (12), 75 (100), 73 (52), 67 (27), 65 
(9), 59 (15), 57 (18). 
HRMS Found 322.1602; C11H2604Si (M+) requires 322.1600. 
Experimental 
3-(t-Butyldimethylsilyloxymethyl)-2-(hexa-2,4-dienoyl)butanolide (7.14) 
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To a cooled (-5°C) solution of the crude butenolide (7.12, 88 mg, ca 80% pure, 
0.22 mmol) in anhydrous THF (5 mL) was added sodium borohydride (25 mg, 
0.66 mmol) as a solid. The mixture was allowed to warm to room temperature for 
30 min. before quenching with aqueous hydrochloric acid (0.2 M, 10 mL). After 
dichloromethane extraction (3 x 7 mL), the combined extracts were washed 
sequentially with water (2 x 5 mL) and phosphate buffer (pH 7.0, 10 mL), then dried 
and evaporated to give a dark oily residue. Radial chromatography (1 mm, Si02; 15-
30% EtOAc in hexane) afforded the saturated lactone (7.14; Rt= 0.41, 25% EtOAc in 
hexane) as an orange oil (44 mg, 65%). 
1H NMR (300 MHz, CDCl3) o 0.04 (s, 6H, SiCH3), 0.88 (s, 9H, 'Bu), 1.87 (d, J = 6.2 
Hz, enol Hl 1), 1.89 (d, J = 5.6, lH, Hl 1), 3.15-3.31 (m, lH, H3+enol H3), 3.53 
(dd, lsb,5a = 10.0 Hz, lsb,3 = 8.1 Hz, enol H5b), 3.64 (dd, Isa.Sb= 9.8 Hz, lsa.3 = 5.3 
Hz, enol H5a), 3.66 ('d', J = 4.6 Hz, 2H, H5a,5b), 3.85 (d, 12,3 = 6.3 Hz, lH, H2), 
4.17 (dd, J4b,4a = 8.8 Hz, J4b,3 = 6.0 Hz, lH, H4b), 4.31-4.39 (m, enol H4a,4b), 
4.43 (dd, J4a,4b = 8.8 Hz, 14a,3 = 7.8 Hz, lH, H4a), 5.94 (d, J = 15.2 Hz, enol H7), 
6.04-6.25 (~, enol H9,10), 6.26-6.33 (m, 2H, H9,10), 6.40 (d, J = 15.4 Hz, lH, 
H7), 7.11 (dd, ls.1 = 15.2 Hz, ls,9 = 10.3 Hz, enol H8), 7.25-7.35 (m, lH, H8), 
10.95 (s, enol OH) [content of enol 7.14b; 55%]. 
13C NMR (50MHz, CDCl3) 6-5.5 (SiCH3), 18.2 (q, 'Bu), 18.8 (enol Cll)*, 19.0 
(ell)*, 25.7 ('Bu)**, 25.8 (enol 1Bu)**, 39.5 (enol C3)*, 39.9 (C3)*, 52.9 (C2), 62.1 
(C5), 65.4 (enol C5), 69.3 (C4), 70.0 (enol C4), 97.2 (enol C2), 119.6 (enol C7), 
125.6 (C7), 130.2 (C9), 130.6 (enol C9), 138.0 (enol ClO)*, 139.1 (enol C8)*, 
142.7 (ClO), 146.0 (C8), 163.6 (Cl), 172.9 (enol Cl)*, 176.8 (enol C3)*, 191.8 
(C3). 
EIMS mlz 324 (M+, 0.3%), 309 (M+-CH3, 1), 267 (M+-CiH9, 30), 179 (9), 173 (4), 119 
(3), 117 (4), 115 (5), 111 (3), 105 (6), 96 (7), 95 (100), 91 (7), 89 (14), 85 (3), 83 
(4), 77 (7), 75 (54), 73 (39), 67 (28), 59 (12), 57 (12). 
HRMS Found 324.1758; C11H2s04Si (M+) requires 324.1757. 
Experimental 298 
(E,E)-3-(t-Butyldimethylsilyloxymethyl)-2-(hexa-2,4-dienoyl)-2-hydroxybutanolide 
(7.21a and 7.21b) 
H'CITBDMS 
Y·· ~ 
0 0 7.14a 
OTBDMS 
0 7.21a + 7.21b 
To a solution at room temperature of the butanolide (7.14, 30 mg, 0.092 mmol) in 
anhydrous THF (3 mL) was added sodium hydride (60% oil dispersion, 4.1 mg, 
0.10 mmol). Ultrasonication of the reaction mixture for 3 min. gave a clear, yellow 
solution to which was added m-chloroperbenzoic acid (m-CPBA, ca 80% pure, 44 mg, 
0.20 mmol). After further ultrasonication (3 min.) the solution was almost completely 
decolourised and subsequent TLC analysis revealed no starting material. After 
15 mins. the oxidation was quenched by the addition of 2-propanol (0.3 mL) and water 
(2 mL). Extraction with dichloromethane (3 x 5 mL), followed by sequential washing 
of the combined extracts [saturated NaHC03(aq) (10 mL); H20 (10 mL) and phosphate 
buffer (pH 7.0, 5 mL)], drying and evaporation, gave a pale yellow oil which was 
subjected to radial chromatography (1 mm, SiQi; 10-30% EtOAc in hexane) which 
allowed isolation of two compounds. 
First eluted (RJ · 0.38, 25% EtOAc in hexane) was the ~-hydroxy diastereomer of 
the title hydroxydiene (7.21a) as a colourless oil (9.3 mg, 29%). Relative ge~metry of 
the products was determined by NOE studies as described in Chapter 7. 
1H NMR (300 MHz, CDCl3) 6 0.05 (s, 6H, SiCH3), 0.86 (s, 9H, 'Bu), 1.90 (d, J = 5.9 
Hz, 3H, Hll), 2.96 (m, lH, H3), 3.79 (dd, lsb,3 = 5.2 Hz, lsb,5a = 10.5 Hz, lH, 
H5b), 3.84 (dd, lsa,3 = 4.9 Hz, lsa,5b = 10.4 Hz, lH, H5a), 4.21 (s, lH, OH), 4.27 
(dd, J4b;3 = 4.9 Hz, J4b,4a = 8.9 Hz, lH, H4b), 4.56 (dd, 14a,3 = 7.4 Hz, J4a,4b = 9.0 
Hz, lH, H4a), 6.20-6.43 (m, 2H, H9,10), 6.54 (d, 11,s = 15.1 Hz, lH, H7), 7.43 (dd, 
ls,9 = 10.1 Hz, ls,1 = 15.0 Hz, lH, H8). 
13C NMR (50 MHz, CDC13) o -5.7 (SiCH3), 18.0 (q, 1Bu), 19.0 (Cl 1), 25.6 ('Bu), 44.6 
(C3), 60.5 (C5), 69.3 (C4), 81.1 (C2), 119.6 (C7), 130.3 (C9), 143.9 (ClO), 147.3 
(C8), 173.9 (Cl), 194.2 (C6). 
EIMS mlz 283 (M+-CtH9, 3%), 253 (4), 237 (2), 225 (10), 157 (5), 96 (7), 95 (100), 89 
(3), 75 (20), 73 (13), 67 (23), 65 (3), 59 (4), 57 (3), 55 (5). 
HRMS Found 283.1003; C13H1~5Si (M+-C4H9) requires 283.1002. 
The second eluted compound (Rt = 0.27, 25% EtOAc in hexane) was the 
a-hydroxy diastereomer of the title compound (7.21b) as a colourless oil (16.5 mg, 
52%). 
1H NMR (300 MHz, CDCI3) o 0.00 (s, 6H, SiCH3), 0.84 (s, 9H, 1Bu), 1.91 (d, J = 6.1 
Hz, 3H, Hl l), 2.98 (m, lH, H3), 3.67 (dd, lsb~5a = . 10.4 Hz, J 5b,3 = 6.8 Hz, lH, 
H5b), 3.78 (dd, Isa.Sb= 10.5 Hz, lsa,3 = 5.9 Hz, lH, H5a), 4.12 (s, lH, OH), 4.31 
(dd, J4b.4a = 10.5 Hz, J4b,3 = 5.9 Hz, lH, H4b), 4.54 (dd, 14a,4b = 9.0 Hz, 14a,3 = 8.7 
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Experimental 299 
Hz, lH, H4a), 6.17-6.45 (m, 2H, H9,10), 6.41 (d, 11,s = 15.2 Hz, lH, H7), 7.39 (dd, 
ls,1 = 15.2 Hz, ls,9 = 10.7 Hz, lH, H8). 
13C NMR (50 MHz, CDC}J) 6 -5.7 (SiCH3), 18.2 (q, 'Bu), 19.1 (Cl 1), 25.7 ('Bu), 50.3 
(C3), 59.2 (C5), 67.9 (C4), 82.0 (C2), 120.5 (C7), 130.2 (C9), 144.6 (ClO), 147.0 
(C8), 174.5 (Cl), 194.4 (C6) . 
EIMS mlz 283 (M+-C4H9, 7%), 253 (1), 225 (9), 157 (3), 115 (3), 105 (3), 96 (7), 95 
(100), 89 (3), 77 (3), 75 (28), 73 (17), 69 (3), 67 (24), 65 (3), 59 (5), 57 (4), 55 (7). 
HRMS Found 283.1003; C1Jli1g()5Si (M+-C4H9) requires 283.1002. 
Experimental 
(2R* ,JS *)-3-(t-Butyldimethylsilyloxymethyl)-2-[ (E)-3-(3-methyloxiranyl)-
1-oxoprop-2-enyl]-2-hydroxy-butanolide (7 .25) 
OTBDMS OTBDMS 
7.21b 7.25 
300 
To a CDC!J (1.5 mL) solution of the diene 7.21b (9.3 mg, 0.027 mmol) in an 
NMR tube containing a single activated molecular sieve ( 4A), was added m-CPBA (ca 
80% pure, 6.3 mg, ca 0.03 mmol) and the mixture was allowed to stand at room 
temperature with periodic lH NMR analysis. After 16 hours, about 30% of the diene 
7.21b had reacted as judged by comparative integration of the emerging new methyl 
doublets between 6 1.2 and 1.8 and the diminishing methyl doublet of the starting 
dienone at 6 1.9. A further quantity of m-CPBA (ca 80% pure, 12.0 mg, ca 0.054 
mmol) was then added and the reaction was monitored for 29 hours more, by which 
time only about 10% of the starting material remained and the reaction mixture had 
become more complex. Isopropanol (0.3 mL) and water (1.5 mL) were added, followed 
by extraction with _CH2Cl2, then sequential washing of the extracts with saturated 
sodium bicarbonate solution (3 x 1 mL) and phosphate buffer solution (pH 7, 1 mL),. 
Drying and evaporation afforded an oil which was purified by radial chromatography ( 1 
mm Si02 / 10-30% EtOAc in hexane). First eluted was some unreacted 7.21b (0.7 mg, 
8%) followed by the mono-epoxides 7.25 (2.4 mg, 25%) and then a complex mixture of 
more polar compounds. 
7.25 (1:1 diastereomeric mixture), <Rt= 0.13, 25% EtOAc in hexane) 
1H NMR (300 MHz, CDCl3) 6 0.02 (s, 6H, SiCH3), 0.86 (s, 9H, 1Bu), 1.40 (d, J = 
5.2 Hz, 3H, Hl 1), 2.90-3.06 (m, 2H, H3,10), 3.22 (m, lH, H9), 3.73 ('d', J = 
5.7 Hz, 2H, H5a,5b), 3.94 (s, lH, OH), 4.33 (2 x dd, J4b.4a = 10.7, 10.7 Hz, 14b,3 = 
9.1, 9.1 Hz, lH, H4b), 4.52 (2 x 't', J = 8.8, 8.8 Hz, lH, H4a), 6.80-6.86 (m, 2H, 
H7, H8). 
13C NMR (50 MHz, CDCl3) 6 -5.7 (SiCH3), 17.5 (2 x Cl 1), 18.2 (q, 'Bu), 25.7 ('Bu), 
50.6 (2 x C3), 57.3, 57.4 (2 x c:9), 57.9, 58.1 (2 x ClO), 58.7, 58.8 (2 x C5), 67.4 (2 
x C4), 82.2 (2 x C2), 124.8, 125.0 (2 x C7), 146.6, 146.7 (2 x C8), 174.2 (2 x Cl), 
194.1 (2xC6). 
EIMS mlz 299 (M+-C4H9, 0.3%), 281 (1), 241 (1), 225 (2), 223 (2), 211 (2), 157 (8), 
143 (3), 131 (3), 129 (3), 115 (6), 111 (16), 105 (8), 101 (6), 99 (4), 97 (3), 95 (12), 
91 (3), 89 (10), 85 (5), 84 (7), 83 (74), 77 (9), 76 (7), 75 (100), 74 (5), 73 (52), 59 
(15), 57 (19), 55 (51). 
CIMS mlz 374 (M+NI4+, 50%), 357 (M+H+, 31), 341 (100), 339 (59). 
HRMS Found 299.0950; C1:µi1~6Si (M+-C4H9) requires 299.0951. 
Experimental 301 
Baeyer-Villager Oxidation of 7.14 
OIBDMS OIBDMS 
7.14 
-- ~;-,) + 7.21b + 7.25 ~o~ 
0 OHO 
7.26a + 7.26b 
In the same manner as described above for the a-hydroxylation of butanolide 
7.14, the diene (7.14, 10 mg, 0.031 mmol) in anhydrous TIIF (1 mL) was oxidised by 
the sequential addition of sodium hydride (60% oil dispersion, 1.4 mg, 0.034 mmol) 
and m-chloroperbenzoic acid (m-CPBA, 21 mg, 0.10 mmol, 3.2 equiv.). After 16 hours 
of room temperature, a further quantity of m-CPBA was added (6.5 mg, 0.031 mmol, 
1.0 equiv.) and stirring was continued for a further 13 hours. After workup (described 
above) the three major components of the crude reaction mixture were isolated by radial 
chromatography (1 mm Si(h, 10-30% EtOAc in hexane). 
After a small initial fraction containing an impurity derived from m-CPBA, two 
diastereomers of the butyrolactone ester (7 .26a and 7 .26b) were isolated as colourless 
oils (1.0 mg, 9% and 1.4 mg, 13% respectively). 
7.26a (Rt= 0.36, 25% EtOAc in hexane): 
lH NMR (300 MHz, CDCh) o 0.05 (s, 6H, SiCH3), 0.86 (s, 9H, 1Bu), 1.78 (d, 1 = 6.8 
Hz, 3H, H5'), 3.10 (m, lH, H3), 3.77 (dd, lsb,5a = 10.0 Hz, lsb,3 = 5.5 Hz, lH, 
H5b), 3.78 (s, lH, OH), 3.85 (dd, l5a,5b = 10.3 Hz, lsa.3 = 6.5 Hz, lH, H5a), 4.29 
(dd, 14b.4a = 8.7 Hz, 14b,3 = 6.3 Hz, lH, H4b), 4.56 (dd, 14a,4b = 8.7 Hz, 14a,3 = 7.3 
Hz), 5.68-5.83 (m, lH, H4'), 5.96 (m, lH, H3'), 6.13 (dd, 12·,3• = 11.3 Hz, 12·.1· = 
12.3 Hz, lH, H2'), 7.26 (d, 11',2' = 12.1 Hz, lH, Hl '). 
EIMS mlz 356 (M+, 0.3%), 299 (M+-C,487, 1), 255 (1), 241 (5), 217 (5), 199 (6), 187 
(15), 159 (5), 158 (12), 157 (88), 131 (4), 129 (7), 115 (11), 113 (5), 105 (3), 101 
(3), 99 (6), 89 (25), 85 (12), 84 (94), 83 (11), 76 (7), 75 (100), 74 (8), 73 (74), 67 
(46), 59 (30), 58 (17), 57 (27), 56 (21), 55 (79), 53 (15). 
HRMS Found 356.1664; C11H2s06Si (M+) requires 356.1665. 
7.26b (RJ = 0.26, 25% EtOAc in hexane): 
1H NMR (300 MHz, CDCh) o 0.03 (d, 1 = 1.2 Hz, 6H, SiCH3), 0.86 (s, 9H, 1Bu), 1.78 
(d, 1 = 6.6 Hz, 3H, H5'), 3.00 (m, lH, H3), 3.72 (s, lH, OH), 3.79 (m, 2H, H5a,5b), 
4.36 (dd, 14b.4a = 8.9 Hz, 14b,3 = 10.9 Hz, lH, H4b), 4.51 (dd, 14a,4b = 8.8 Hz, 14a,3 
= 8.6 Hz, lH, H4a), 5.67-5.84 (m, lH, H4'), 5.95 (m, lH, H3'), 6.11 (dd, 12•,3• = 
10.7 Hz, 12·.1· = 12.1 Hz, lH, H2'), 7.25 (d, 11·.2· = 12.1 Hz, lH, Hl '). 
EIMS m/z 299 (M+-~H9, 4%), 274 (1), 273 (8), 257 (5), 243 (2), 242 (2), 241 (6), 215 
(4), 199 (3), 198 (4), 187 (3), 159 (3), 158 (4), 157 (27), 141 (4), 113 (4), 101 (3), 
99 (5), 95 (6), 89 (14), 85 (7), 84 (28), 83 (7), 77 (6), 76 (5), 75 (73), 74 (9), 73 
(100), 69 (6), 67 (44), 59 (20), 57 (16), 55 (43). 
HRMS Found 299.0950; C1~1906Si (M+-C4H9) requires 299.0951. 
The third and final compound isolated was the previously isolated diene (7.21b, 
2.8 mg, 27%) (spectroscopic data above). 
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lff.lH COSY NMR Spectrum of Dimer (4.37a) 
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Appendix Aii 
lff.13C HETCOR NMR Spectrum of Dimer (4.37a) 
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lH-lH COSY NMR Spectrum of TBDMS-Protected A-Factor (4.35) 
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lff.13C HETCOR NMR Spectrum of TBDMS-Protected A-Factor 
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13C NMR Spectrum (APT, 50 MHz, CDCI3) 
of One Diastereomer of A-factor Dimer 5.8a 
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13C NMR Spectrum (APT, 50 MHz, CDCl3) 
of A-factor Methyl Ketal Diastereomers 5.9a and 5.9b 
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Appendix Ei 
X-Ray Crystal Structure of A-Factor Hemiketal S.12a 
(50% ellipsoids; superposition of three conformers) 
Individual atom sites for CS, 
C9b, Cl Ob, Cll and C12a 
were not resolved 
" 
5.12a 6-endo-hydroxyl 
C13c 
Alkyl Chain Conformers Present 
C8 
C13c 
25% 
C13b C12a 
25% 50% 
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Appendix Eii 
Supplimentary Crystallographic Data for S.12a 
X-ray crystal structure determination performed by Dr Jonathan White, RSC, 
ANU. 
Crystal Data: C1JH2i()4, MW = 242.32, monoclinic, spacegroup 12/a (Alt. 
C2/c), a= 10.734(2), b = 6.330(1), c = 39.588(4) A, f3 = 97.63(2)0 , Ve= 2666.0 A3, Z = 
8, Deale = 1.21 Mg m-3, A (CuKa1) = 1.5405 A, µ = 6.39 cm-I, F(OOO) = 1052, 
T = 130 K. Specimen crystal dimensions 0.5 x 0.64 x 0.03 mm. 
A Philips PWl 100/20 diffractometer with a Leybold-Heraeus nitrogen 
cooling device was used. At convergence R = 0.061, wR = 0.093 and S = 3.57 for 2012 
reflections measured (I > 3a) and 199 variable parameters. 
0 
Bond Lengths (A) for 5.12a 
Atoms Bond Length Atoms Bond Length 
0(1)-C(l) 1.412(3) C(7)-C(8) 1.508(4)* 
0(1)-H(lOl) 0.95 C(8)-C(9a) 1.555(6)* 
0(2)-C(l) 1.337(3) C(8)-C(9b) 1.610(6)* 
0(2)-C(4) 1.447(3) C(9a)-C(10a) 1.519(7) 
0(3)-C(l) 1.205(3) C(9b )-C( 1 Ob) 1.487(7)* 
0(4)-C(5) 1.432(3) C(lOa)-C(l 1) 1.655(6)* 
0(4)-C(6) 1.428(3) C(lOb)-C(l 1) 1.562(7)* 
C(l)-C(2) 1.506(3) C(l 1)-C( 12a) 1.573(8)* 
C(4)-C(3) 1.523(3) C(l 1)-C( 13a) 1.507(8)* 
C(5)-C(3) 1.532(3) C(l l)-C(l3b) 1 .73(1)* 
C(6)-C(2) 1.554(3) C(l l)-C(l2b) 1.67(1)* 
C(6)-C(7) 1.506(3) C(l 1)-C( 13c) 1.56(1)* 
C(2)-C(3) 1.525(3) 
* Involves centroid of unresolved atom sites, C(8), C(9b), C(lOb), 
C(l 1) and C(12a) 
11 
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u Appendix Eii (continued) I 
I 
I k 
Interbond Angles ( 0 ) for 5.12a 
11 Ato~ Angle Ato~ Angle ~ 
i~ C(6)-0(1)-H(101) 107 C(5)-C(3)-C(2) 104.5(2) 
I: C(l)-0(2)-C(4) 111.5(2) C(6)-C(7)-C(8) 115.0(2)* 
t 
C(5)-0( 4 )-C( 6) 108.0(2) C(7)-C(8)-C(9a) 128.7(3)* 
0(2)-C(l)-0(3) 121.1(2) C(7)-C(8)-C(9b) 98.5(3)* 
C(2)-C(l)-0(3) 128.1(2) C(8)-C(9a)-C( 1 Oa) 106.4(4)* 
0(2)-C(4)-C(3) 107.3(2) C(8)-C(9b)-C(10b) 106.3(4)* 
0(4)-C(5)-C(3) 106.3(2) C(9a)-C(10a)-C(l 1) 104.2(4)* 
0( 1 )-C( 6)-0( 4) 110.4(2) C(9b )-C( 1 Ob )-C( 11) 110.9(5)* 
; 
I 0( 1 )-C( 6)-C(2) 106.3(2) C(10a)-C(l 1)-C(12a) 93.0(3)* ; 
' 
0( 1 )-C( 6)-C(7) 112.8(2) C(10a)-C(l 1)-C(13a) 104.7(4)* 
0( 4)-C(6)-C(2) 102.8(2) C(12a)-C(l 1)-C(l3a) 101 .9(4)* 
I 0( 4 )-C( 6)-C(7) 107.1(2) C(10b)-C(l 1)-C(12a) 121.5(4)* 
II C(2)-C( 6)-C(7) 116.9(2) C(10b)-C(l 1)-C(13b) 96.8(5)* 
C(l )-C(2)-C( 6) 113.5(2) C(12a)-C(l 1)-C(13b) 109.4(5)* 
C( 1 )-C(2)-C(3) 104.8(2) C(10b)-C(l 1)-C(12b) 96.8(6)* 
C(6)-C(2)-C(3) 104.2(2) C(10b)-C(l 1)-C(13c) 114.5(6)* 
• C(4)-C(3)-C(5) 114.4(2) C(l2b)-C(l 1)-C(13c) 97.4(7)* 
C(4)-C(3)-C(2) 104.2(2) 
~ 
* Involves centroid of unresolved atom sites, C(8), C(9b), C(lOb), C(l l) and C(l2a) ~ 
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Appendix F 
Revision of the C6 Absolute Stereochemical Assignment of 
6-Hydroxybutanolides 1.5 and 1.2 made by Mori and Chiba 
312 
The following analyses are based on the IH NMR data (500 MHz, CDCI3) for 
the MTPA ester derivatives 6.8a, 6.8b and 6.9a, 6.9b of the 6-hydroxybutanolide 
autoregulators 1.5 and 1.2 as reported by Mori and Chiba30 The method of data analysis 
described below is based on the description of the high-field Ff NMR application of 
Mosher's method reported by Ohtani et al. 118 and is consistent with the original 
description of Dale and Mosher.176 
i) Butanolide 1.5 (Grife's factor from S. bikiniensis and 
S. cyaneofuscatus) 
OR1 
0 
12 
6.8a R 1 = -SiMei(CMeiPh) 
R2= (R)-M1PA 
6.8b R 1 = -SiMe2(CMeiPh) 
R2 = (S)-M1P A 
CF3 
MfPA = a-methoxy-0.-(trifluoromethyl)- = }-f--Ph 
phenylacetyl o OMe 
Table Fi lff NMR Data for 6.8a and 6.8b from Mori and Chiba 
with ~6 Calculations as Described by Ohtani et al. 
MTPA 6 ppm 
Config. H2 H3 H4a H4b H5a H5b H6 H7-12 
6.8a R 2.71 2.57 3.98 3.86 3.37 3.32 5.57 11 
6.8b s 2.73 2.55 4.03 3.88 11 3.39 5.51 11 
~6 = 6(S)-6(R) +o.02 -0.02i +o.05 +o.02 -- +0.07 -0.06 --
i) anomalous result 
ii) no data 
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Appendix F (Continued) 
The anomalous sign of the Ao value for H3 [ calculated above, Ao = o(S )-o(R), 
as defined by Ohtani 178] is a serious defect in the data since Ohtani and coworkers 
recommend abandonment of an attempted analysis if Ao values of mixed signs are 
obtained for protons on the same side of the 'MTP A plane' .178 Confusingly, however, in 
a diagram accompanying these data Mori and Chiba show the Ao value for H3 with the 
same sign as those displayed by nearby resonances.30 
Fitting the lH NMR information (ignoring the Ao value for H3) to the model of 
Ohtani et al., 178 such that the molecule is drawn with the protons having positive Ao 
values on the right hand side and those with a negative Ao on the left, gives: 
OMTPA 
H 
'6S'\ 
~,, ..... 
-0.02• 
H 
H,, ... 
H OMTPA 
~6 values -0.06 ( 
+-0.07 
• = anomalous result 6.8a and 6.8b 
Thus, other than for H3, all Ao data measured indicate the assignment of '6S' 
configuration to butanolide derivatives 6.8a and 6.8b, and hence to the parent , 
butanolide 1.5. Mori and Chiba, however, using the same data have erroneously 
assigned '6R' configuration. 30 
Appendices 
ii) Bu tanolide 1.2 
OR1 
s 
Appendix F (Continued) 
(factor-I) 
12 
1.2 Ri,R2 =H 
6.9a R 1 = -SiMe2(CMeiPh) 
R2 = (R )-MTP A 
6.9b R 1 = -SiMe2(CMeiPh) 
R2 = (S)-MTP A 
MTP A = a-methoxy-a-(trifluoromethyl)-
phenylacetyl 
CF3 
= H-Ph 
0 OMe 
Table Fii lff NMR Data for 6.9a and 6.9b from Mori and Chiba 
with L\6 Calculations as Described by Ohtani et al. 
MTPA 0 ppm 
Config. H2 H3 H4a H4b H5a H5b H6 
6.9a R 2.69 2.38 4.13 3.90 3.45 3.41 5.31 
6.9b s 2.64 2.18 3.81 3.76 3.35iii 3.35iii 5.23 
L\o = o(S)-o(R) 
-0.05 -0.20 -0.32 -0.14 -0.10 -0.06 -0.08 
ii) no data 
iii) assigned as 1I5' only 
314 
H7-12 
11 
11 
-
Fitting data to the model of Ohtani et al.,118 such that the molecule is drawn with 
the protons having positive L\6 values [calculated above, L\6 = o(S )-o(R)] on the right 
hand side and those with a negative L\6 on the left, gives: 
' I 
Appendices 
Appendix F (Continued) 
-0.10 
J-0.06 
OMTPA 
.. ,,H -
--0.20 ..... ~ -
0 H ~6R' 
6.9a and 6.9b 
0 
315 
OSiMeiC(MeiPh) 
I '6R' 
Thus all L\o values support the assignment of 'fR' configuration to the butanolide 
derivatives 6.9a and 6.9b, and hence to the parent butanolide autoregulator 1.2. Again 
however, Mori and Chiba derive the erroneous assignment '6S', by analysis of the same 
data. 
Conclusions 
The 1 H NMR data for the MTP A ester derivatives 6.8a, 6.8b and 6.9a, 6.9b as 
reported by Mori and Chiba30 do not support their stereochemical assignments of _the 
parent butanolide autoregulators 1.5 and 1.2. Careful re-analysis of their data indicates 
the opposite C6 stereochemical conclusions for both 1.5 and 1.2. The reported 
erroneous assignments may reflect the confusing definition of L\o employed in their 
analysis of the data.30 Note also however, that the lack of complementary L\o values for 
the protons of the alkyl chains (H7-Hl2) makes any assignment based on these data 
unreliable.178 Also of concern is that the absolute L\o values do not show the expected 
reduction in magnitude with increasing distance from the MTPA moiety, 178 although 
this may reflect conformational effects. 
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